EHRA EUROPACE 2013 - European Society of Cardiology

FINAL ProgrAmme

OB1 - d5799 

BUILDING 

FLOOR PLAN

Dear Colleagues 

On the occasion of the 10th anniversary of the creation of the European 

Heart Rhythm Association (EHRA) it is with great honour that I greet you 

for this the sixth edition of our biennial Congress. 

Welcome to EHRA EUROPACE 2013! 

“To improve the quality of life of the European population by reducing the 

impact of cardiac arrhythmias and reduce sudden cardiac death” – from this 

simple mission statement 10 years ago EHRA has grown into an influential and globally recognised 

reference in our community. Education is available in person or online, certification is widely 

accessible, new opportunities abound with the Training Fellowships programme, knowledge is 

freely available through the website and The EHRA White Book, original work and reviews are 

published in the EP Europace journal and targeted projects are launched; the tireless work of EHRA 

volunteers and our industry partners means that all of this, and more, is available now before the 

association has become a teenager. 

Nowhere is the desire and drive of our community better shown than at our EHRA EUROPACE 

Congresses and for us to be able to bring our young association’s Congress to Athens; one of the 

oldest cities in the world and widely referred to as the cradle of Western civilisation, must surely 

act to further motivate and refocus us in our common goal. 

For this year’s Congress I am delighted that we have been joined by the ESC Working Group on 

Cardiac Cellular Electrophysiology and the ESC Working Group on e-Cardiology, highlighting the 

multidisciplinary and translational approach in modern electrophysiology and also consolidating our 

work in providing united sessions with contributors from different continents, societies and now 

sub-specialties. Prof Andreas Götte, Prof John Morgan and the Scientific Programme Committee 

have put together an outstanding line-up for us, with summits on Lead Management and Genetics, 

the latest guidelines and research, insights direct from the Cath lab and hard learned wisdom from 

world renowned faculty. 

Thank you for being with us in Athens and I fully hope that this Congress offers you the chance to 

DISCOVER something or someone new, better TRANSLATE the information available, take away 

the best PRACTICE and ultimately TRANSFORM the future of our patients. 

I wish you all an excellent and rewarding Congress. 

1 

WElCOME ADDREss 

Professor Angelo Auricchio MD, PhD 

EHRA President, 2011-2013

All participants are personally invited 

by the President of EHRA to the 

Inaugural Session 

Sunday 23 June 2013, 

16:45 - 18:00 

in Room Crete 

Welcome address by EHRA President 

2 

Performance 

Highlights of EHRA 2013 

Performance 

Honorary Awards 

Training Fellowship Winners 

Academic Research Grant 

Opening Address 

The European Heart Rhythm Association is pleased 

to invite you to the networking reception 

in the Exhibition Area 

Full details available in the Scientific Programme. 

(see pages 46 & 47)

Global Organising Committee 

Prof. Angelo Auricchio 

EHRA President 

Prof. Andreas Götte 

EHRA Scientific 

Programme Committee 

Chairperson 

Prof. John Morgan 

EHRA Scientific 

Programme Committee 

Vice-Chairperson 

Prof. Georg Schmidt 

ESC Working Group on 

e-Cardiology 

Dr. Paul Volders 

ESC Working Group on 

Cardiac Cellular 

Electrophysiology 

3 

COMMiTTEEs 

local Host Committee 

Dr. Michalis Efremidis 

HCS Working Group of 

Electrophysiology and Pacing 

Chairman 

Assistant Prof. Emmanuel Simantirakis 

HCS Working Group of 

Electrophysiology and Pacing 

Vice-Chairman 

Scientific Programme 

Committee 

Prof. P. Amman 

Dr. D. Arnar 

Prof. M. Borggrefe 

Prof. J. Brachmann 

Prof. F. Braunschweig 

Prof. J. Brugada Terradellas 

Prof. J.C. Daubert 

Prof. C. Deaton 

Prof. M. Duytschaever 

Dr. F. Halimi 

Prof. E. Hoffmann 

Dr. I. Fernandez Lozano 

Prof. P. Geelen 

Prof. J. Hastrup Svendsen 

Dr. D. Husser 

Prof. W. Jung 

Dr. S. Knecht 

Prof. J.Y. Le Heuzey 

Prof. G.Y.H. Lip 

Prof. M. Markijarvi 

Prof. E. Pokushalov 

Prof. L. Saghy 

Dr. R. Schilling 

Dr. U. Schotten 

Assist. Prof. E. Simantirakis 

Prof. I. Van Gelder 

Prof. A. Zaza 

Prof. I. Zupan

COnGREss REsOURCEs 

CME Accreditation 

The EHRA EUROPACE 2013 Congress is accredited by the European Board for Accreditation 

in Cardiology (EBAC) for 21 hours of External CME credits. 

Each participant should claim only those hours of credit that have actually been spent in the 

educational activity. EBAC works in cooperation with the European Accreditation Council for 

Continuing Medical Education (EACCME) which is an institution of the European Union of 

Medical Specialists (UEMS). EBAC credits are recognised by the American Medical Association towards 

the Physician’s Recognition Award (PRA). Detailed instructions for converting these credits to AMA PRA 

Category 1 Credits are available on the AMA website. 

EBAC Certificates will be available at the Registration desk on Tuesday 25 June and Wednesday 26 June. 

e-library 

All slide presentations, abstracts and posters are available for electronic consultation on-site in the 

e-library located in the Poster Area. 

Erratum 

The Erratum includes the latest changes, updates and corrections to the Programme that occurred after 

the printing of the Final Programme and Industry Programme. A copy of the Erratum is included in the 

delegate bag. 

NEW! industry Programme 

Consult this new document to find: 

• List of Industry Partners, exhibition floor plan and Satellite Symposia Programmes 

• Venue floor plan and general information 

• A Notepad! 

EHRA EUROPACE 2013 at your fingertips! 

Download EHRA EUROPACE 2013 Congress Mobile app! 

Have the most up-dated programme 

• View the entire scientific programme including all accepted abstracts 

• Search for sessions, presentations, abstracts 

• Find exhibitors and sponsors 

• Navigate the floor plans 

• Create your personal programme 

• Make your own “to do” list and take notes 

• Share sessions and notes with colleagues 

• Receive the latest news 

Search for “EHRA2013” in App Store/Google Play 

The Mobile app is supported by Medtronic in the form of an unrestricted 

educational grant 

Scientific Programme & Planner 

The online version of the scientific programme available on www.escardio.org allows you to plan 

SPP your personal Congress schedule and review abstracts online. Make your own selection according 

to your needs and interests. Search sessions by topic, session title, topic, day, time or by presenter. 

4 

I N D U S T R Y P R O G R A M M E 

Including: 

• Venue Floor Plan 

• Useful Information 

• Exhibition Floor Plan 

• Notepad

5 

COnGREss TiMETAblE 

07:30 

08:00 

08:30 

09:00 

09:30 

10:00 

10:30 

11:00 

11:30 

12:00 

12:30 

13:00 

13:30 

14:00 

14:30 

15:00 

15:30 

16:00 

16:30 

17:00 

17:30 

18:00 

18:30 

19:00 

19:30 

07:30 

08:00 

08:30 

09:00 

09:30 

10:00 

10:30 

11:00 

11:30 

12:00 

12:30 

13:00 

13:30 

14:00 

14:30 

15:00 

15:30 

16:00 

16:30 

17:00 

17:30 

18:00 

18:30 

19:00 

19:30 

20:00 20:00 

SATURDAY SUNDAY WEDNESDAY 

MONDAY TUESDAY 

E 

X 

H 

I 

B 

I 

T 

I 

O 

N 

R 

E 

G 

I 

S 

T 

R 

A 

T 

I 

O 

N 

R 

E 

G 

I 

S 

T 

R 

A 

T 

I 

O 

N 

SESSIONS 

WORKING GROUPS SESSIONS 



SATELLITE 

SYMPOSIA 

SESSIONS 

SESSIONS 

SESSIONS 

INAUGURAL 

SESSION 

NETWORKING 

RECEPTION 

SESSIONS 

MODERATED 

POSTERS 

MODERATED 

POSTERS 

MODERATED 

POSTERS 

SESSIONS 

SATELLITE 

SYMPOSIA 

SATELLITE 

SYMPOSIA 

SESSIONS 

SESSIONS 

P 

O 

S 

T 

E 

R 

S 

P 

O 

S 

T 

E 

R 

S 

R 

E 

G 

I 

S 

T 

R 

A 

T 

I 

O 

N 

E 

X 

H 

I 

B 

I 

T 

I 

O 

N 

SESSIONS 

MODERATED 

POSTERS 

MODERATED 

POSTERS 

SESSIONS 

SATELLITE 

SYMPOSIA 

EHRA 

GENERAL 

ASSEMBLY 

SESSIONS 

SESSIONS 

P 

O 

S 

T 

E 

R 

S 

P 

O 

S 

T 

E 

R 

S 

P 

O 

S 

T 

E 

R 

S 

R 

E 

G 

I 

S 

T 

R 

A 

T 

I 

O 

N 

E 

X 

H 

I 

B 

I 

T 

I 

O 

N 

SESSIONS 

MODERATED 

POSTERS 

CLOSING & 

AWARDS 

P 

O 

S 

T 

E 

R 

S 

R 

E 

G 

I 

S 

T 

R 

A 

T 

I 

O 

N 

E 

X 

H 

I 

B 

I 

T 

I 

O 

N 

SESSIONS

sCiEnTiFiC PROGRAMME 

EHRA EUROPACE 2013 will be a truly exceptional opportunity 

for interaction, learning and scientific endeavour amongst the 

global community. 

We will meet colleagues from the four corners of the earth when 

the Connecting Continents sessions take us around the EP world 

and will encounter like-minded specialists at the Summits. We will 

be granted exclusive access, via live and recorded transmissions, 

to some of the leading cath labs in Europe and we will observe the 

huge variety of interest through an extensive abstract programme. 

Specialist subjects will be presented and discussed with the 

inclusion this year of the ESC Working Groups on Cardiac Cellular 

Electrophysiology and e-Cardiology in the programme as well as 

exciting sessions from the growing collaboration with Cardiostim. 

Our theme of Translate, Discover, Practise, Transform is in 

evidence throughout the more than 100 sessions that make up 

the congress and is set to help us all focus our expertise. 

Welcome to Athens. Welcome to this opportunity. 

Professor Andreas Götte 

Chairperson Scientific Programme Committee 

Session Categories 

TRANSLATE 

Translating basic science, imaging modalities and computer modeling 

to new technologies and pharmacological therapies which will offer 

better outcomes. 

DISCOVER 

Discover new horizons in basic science, improving our understanding 

of pathophysiology and arrhythmogenesis. The journey will be from 

gene to disease throughout the life-course. 

PRACTISE 

Practising new skillsets, development of optimal care pathways and 

best practice. 

TRANSFORM 

Transforming experiences so that attendees will have enhanced 

clinical effectiveness, can marshal arguments for cost effectiveness, 

and deliver better care and better outcomes to their patients. 

6

Techno live and in the Cath lab sessions 

Building on the success of the Congress in 2011 the “Techno Live” 

case transmissions will be broadcast to Athens allowing the audience 

to closely follow the procedures and benefit from the experience of 

the experts. 

Additionally pre-recorded cases have been added this year as “In the 

Cath Lab” sessions and will be presented within an interactive format 

where real life challenging cases will be: 

• Demonstrated by the experts 

• Discussed with the audience 

• Concluded with recommendations and take-home messages 

On sunday, Monday and Tuesday in Room Rhodes 

summits 

HiGHliGHT On 

lead Management summit 

The specialised nature of this field, along with a surge in needs, is now well recognised by our community. 

Participants will have the opportunity to meet leading authorities in this field, to discuss emerging issues 

and the implementation of new solutions to improve patient treatment and safety. Education, innovation 

and data collection issues will be at the centre of the debates. 

On sunday, Monday in Room lefkada and Tuesday in Room Kythira 

Genetics summit 

The Summit is designed to offer attendees a comprehensive learning opportunity that will encompass all 

aspects of Cardio-genetics of Arrhythmias, spanning from basic science to genetic screening to patient 

management. Beside conventional lectures, the programme will include a session dedicated to the 

discussion of clinical cases with involvement of the audience. On Tuesday in Room lefkada 

NEW 

late breaking Trials 

Due to the exceptionally high quality level of abstracts submitted for the 

Late Breaking Trials session we felt obliged to add a second session to 

give more time to present the latest information on trials, registries and 

other relevant information in the field of Arrhythmias. These sessions 

will include discussants to add an objective view to each abstract. 

On Tuesday in Room Crete and Wednesday in Room lefkada 

EsC Guidelines session 

The new 2013 version of the ESC Guidelines on Cardiac Pacing and Cardiac 

Resynchronisation Therapy will be made public for the first time. These guidelines 

provide an up to date specialists’ view of the field and play a pivotal role in contributing 

to the European system of cardiology. On Tuesday in Room Rhodes 

Honorary lectures 

Come and listen to world renowned experts in our community talk on their chosen subject: 

Intercontinental lecture - Doctor Stanley Nattel, on Monday in Room Naxos 

Einthoven Lecture - Professor John Camm on Monday in Room Naxos 

Pioneer in clinical Electrophysiology Lecture - Professor Lukas Kappenberger on Wednesday in Room Crete 

7 

Version 

2013

PROGRAMME AT A GlAnCE 

SUnDAy 23 JUnE 2013 

Poster session sunday 08:30 to Monday 18:00 

On behalf of the EsC Working Group on Cardiac Cellular Electrophysiology in the Poster Area 

14:00 - 18:00 

Moderated Posters: new challenges in cardiac pacing in the Moderated Poster Area 

Poster session 1 in the Poster Area 

08:30 - 10:00 

Mechanical stress and cell function ..................................................................................Ithaca 

Καρδιακες αρρυθμιες σε ασθενεις που ........................................................Santorini 

νοσηλευονται στη στεφανιαια μοναδα 

Cardiac arrhythmias in the coronary care unit * 

10:15 - 11:45 

Cardiac lead engineering: designing for the .................................................Lefkada 

future to improve reliability, performance, 

and extractability 

Molecular mechanisms in cardiomyopathies ...................................................Ithaca 

Νεωτερα δεδομενα σε καθιερωμενες θεραπειες ............................Santorini 

new developments in established therapies * 

12:00 - 13:30 

in the Cath lab session .................................................................................................................Rhodes 

special consideration of ventricular tachycardia ....................................Naxos 

ablation in patients with arrhythmogenic right 

ventricular dysplasia 

Quality of care and data .................................................................................................................Lefkada 

Remote monitoring of patients with iCD ........................................................Kythira 

Scientific Projects of new e-Cardiology nucleus......................................Ithaca 

members 

Autonomic function ..........................................................................................................................Mykonos 

new types antiarrhythmic drugs for atrial fibrillation .........Santorini 

Preventing and managing device and procedure ......................................Hydra 

complications 

* These sessions are presented in Greek. No translation available. 

08:30 - 10:00 

state of the art lecture: cardiac resynchronization therapy ...........Crete 

Flash abstract presentations: atrial fibrillation ablation .....................Rhodes 

Mapping and ablation of focal atrial tachycardias ...........................................Naxos 

European-wide surveys on the practice and real world...............Lefkada 

status in clinical electrophysiology 

Ablation techniques in atrial fibrillation and in VT/VF ..........................Kythira 

(Part I). Atrial fibrillation: case-based presentations 

Microcompartments in cell function ....................................................................................Ithaca 

Clues to successful catheter ablation of ventricular .......................Mykonos 

tachycardia: overcoming frequent hurdles 

new technologies in the treatment of complex .....................................Santorini 

arrhythmias 

How to measure?................................................................................................................................................Hydra 

MOnDAy 24 JUnE 2013 

8 

13:45 - 15:15 

in the Cath lab session ...................................................................................................................Rhodes 

How to ablate ventricular tachycardia: new tools ..............................Naxos 

and approaches 

What can the implanter do to avoid lead extraction ................Lefkada 

or to make it easier? 

Implantable cardioverter defibrillator given for rare ...................Kythira 

indications 

Channelopathies ..............................................................................................................................................Ithaca 

What the electrophysiologists need to know about .............Mykonos 

renal denervation 

Devices and antiarrhythmic drugs .........................................................................Santorini 

Atrial fibrillation: do we know what to advise patients? ...........Hydra 

15:30 - 16:30 

iCD therapy: patient selection, device technology ...........................Naxos 

and clinical results - Sponsored by Medtronic 

innovations in the diagnosis and treatment of cardiac ..............Kythira 

arrhythmias - Sponsored by Philips Healthcare and AtriCure 

Women competence session - state of the art in .......................Santorini 

interventional electrophysiology 

Sponsored by Biosense Webster 

15:30 - 16:45 

improving outcomes in AF patients in Europe:.....................................Lefkada 

10 years (German) Atrial Fibrillation network (AFnET) 

Carmeliet-Coraboeuf-Weidmann lecture...........................................................Ithaca 

16:45 - 18:00 

inaugural session ...............................................................................................................................................Crete 



08:30 - 12:30 

Moderated Posters: iCD therapy: current issues and future strategies in the Moderated Poster Area 


Abstract Session 

11:00 - 12:30 

state of the art lecture: iCD therapy and telemedicine.......................Crete 

Techno live session ....................................................................................................................................Rhodes 

EHRA document .................................................................................................................................................Naxos 

Difficult tracings with interactive discussions ..............................................Lefkada 

Managing cardiac resynchronisation therapy patients ..........................Kythira 

(Part i) - When the situation is tricky 

Experimental models of proarrhythmia ........................................................................Ithaca 

Clinical challenges of patients with iCD and CRT-D ......................Mykonos 

Atrial fibrillation management in 2013: what do the ........................Santorini 

Guidelines tell us and how do they compare? 

Assessment of left-ventricular dyssynchrony........................................................Hydra 

Basic Science Clinical Practice Transforming Translational Satellite Symposium Special Session


MOnDAy 24 JUnE 2013 



14:00 - 18:00 

Moderated Posters: J-wave syndromes and arrhythmia complication after TAVI in the Moderated Poster Area 


12:45 - 13:45 

novel oral anticoagulants for stroke prevention .............................................Crete 

in atrial fibrillation: understanding our way forward 

Sponsored by Bristol Myers Squibb/Pfizer 

improved patient and economic outcomes with .......................................Rhodes 

advanced HF solutions - Sponsored by St. Jude Medical 

Reducing stroke risk: early AF detection and new ......................................Naxos 

anticoagulants - Sponsored by Medtronic 

left atrial appendage closure for risk reduction of ...............................Lefkada 

AF related stroke: what every electrophysiologist should know 

Sponsored by Boston Scientific 

Home Monitoring of cardiac devices: clinic efficiencies ....................Kythira 

and improved patient outcomes - Sponsored by BIOTRONIK 

Manage every lead - From implantation to extraction .........................Ithaca 

Sponsored by Spectranetics 

AF: a riddle wrapped in a mystery inside an enigma? .............Mykonos 

Sponsored by Bard Electrophysiology 

Fresh perspectives on hemodynamic ambulatory .......................Santorini 

optimization in CRT - Sponsored by Sorin Group 

Will percutaneous mitral valve repair impact ...............................................Hydra 

your management of patients with mitral regurgitation? 

Sponsored by Abbott Vascular 

14:00 - 15:30 

state of the art lecture: novel anticoagulants in atrial .....................Crete 

fibrillation 

Techno live session .................................................................................................................................Rhodes 

Honorary lectures .......................................................................................................................................Naxos 

Device and lead infections ..........................................................................................................Lefkada 

Managing cardiac resynchronisation therapy patients .................Kythira 

(Part ii) – The future is now! 

14:00 - 15:30 (continued) 

Gap junctions in myocardial disease ................................................................................Ithaca 

Translational session on brugada’s syndrome ....................................Mykonos 

Reduce iCD shocks: improve quality of life ..............................................Santorini 

Oral Abstract session: outcomes in CRT ............................................................Hydra 

15:30 - 16:30 

Working Group on Cardiac Cellular Electrophysiology ...........Ithaca 

General Assembly 

16:30 - 18:00 

State of the art lecture: atrial fibrillation ablation ..................................Crete 

in the Cath lab session .....................................................................................................................Rhodes 

Multimodality imaging of cardiac arrhythmias ...........................................Naxos 

Case session: lead extraction in challenging cases .....................Lefkada 

Pacing/ICDs/CRT:ECG/EGMs discussion (Part I).................................Kythira 

Calcium-store stability and arrhythmias ..................................................................Ithaca 

Gap junctions under cardiac ischaemia ..........................................................Mykonos 

Ablation of ventricular complex substrates..............................................Santorini 

Flash abstract presentations: cardiac resynchronisation...........Hydra 

therapy/Implantable cardioverter-defibrilator/Pacing 

18:15 - 19:15 

EPiC Advances: updated guidelines and clinical trials .....................Ithaca 

shaping the future of device and EP therapy 

Sponsored by EPIC Alliance 

18:15 - 19:45 

CRT Care Pathway: from patient selection to clinical ..................Naxos 

outcome - Sponsored by Medtronic 

status quo: antithrombotic management in atrial ........................................Kythira 

fibrillation - Sponsored by Bayer HealthCare 

TUESDAy 25 JUnE 2013 

08:30 - 12:30 

Moderated Posters: Hot topics in genetics and anticoagulation in the Moderated Poster Area 


08:30 - 10:00 

nightmares in electrophysiology: my worst case ever ..................Crete 

The new 2013 EsC Guidelines on pacing and cardiac .................Rhodes 

resynchronisation therapy 

Epicardial ventricular tachycardia ablation ......................................................Naxos 

The “unknowns“ in arrhythmogenic diseases .........................................Lefkada 

lead extraction, extension of the lead management .....................Kythira 

summit (Part i) indications for lead extraction 

Oral Abstract session: ablation: technical aspects................................Ithaca 

Worldwide debatable topics ..............................................................................................Mykonos 

Catheter ablation of outflow tract ventricular ...................................Santorini 

tachycardia 

Oral Abstract session: translational view on atrial .............................Hydra 

fibrillation 

11:00 - 12:30 

late breaking Trial session i .......................................................................................................Crete 

Techno live session ....................................................................................................................................Rhodes 

Ablation of idiopathic ventricular tachycardias and ...........................Naxos 

premature ventricular complexes 

Debated issues in channelopathies.............................................................................Lefkada 

lead extraction, extension of the lead management .....................Kythira 

summit (Part ii) state of the art in lead extraction techniques 

Oral Abstract Session: atrial fibrillation: Clinical Aspects .......Ithaca 

How to solve clinical problems in pacemakers patients .....Mykonos 

Catheter ablation of longstanding persistent atrial .....................Santorini 

fibrillation 

Oral Abstract session: translational view on ventricular.........Hydra 

electrophysiology 

9


TUESDAy 25 JUnE 2013 

14:00 - 18:00 

Moderated Posters: Catheter ablation in the Moderated Poster Area 


12:45 - 13:45 

Changing paradigms in electrophysiological arrhythmia ........Rhodes 

treatment - Sponsored by St. Jude Medical 

AF ablation: transforming complexity into safe, effective .......Naxos 

and efficient - Sponsored by Medtronic 

novel oral anticoagulants during clinical procedures ................Lefkada 

in patients with AF: translating promising data into 

real-life practice - Sponsored by Boehringer Ingelheim 

A new paradigm in iCD therapy: clinical perspectives ................Kythira 

on a novel single-chamber iCD system with complete 

atrial diagnostics - Sponsored by BIOTRONIK 

Ground breaking new therapies for electrophysiologists .......Ithaca 


Advances in ablation catheter technology and role .................Mykonos 

of contact force - Sponsored by Biosense Webster 

Benefits of sleep apnea screening in the management ........Santorini 

of atrial fibrillation patients 

Sponsored by Sorin Group and ResMed 

new opportunities and new challenges of anticoagulation ...Hydra 

in atrial fibrillation - Sponsored by Daiichi Sankyo Europe 

14:00 - 15:30 

new tools for atrial fibrillation ...............................................................................................Crete 

Techno live session .................................................................................................................................Rhodes 

Ablation of accessory pathways ............................................................................................Naxos 


10 

14:00 - 15:30 (continued) 

The grey areas in genetic syndromes ...................................................................Lefkada 

Pacing/ICDs/CRT:ECG/EGMs discussion (Part II) ..............................Kythira 

Oral Abstract session: optimizing right ventricular ............................Ithaca 

and left ventricular pacing 

iCD: controversial indications in primary prevention .........Mykonos 

Understanding complex ECG’s: a case based approach .......Santorini 

Oral Abstract session: syncope .............................................................................................Hydra 

16:30 - 18:00 

Tailored catheter ablation of atrial fibrillation:.............................................Crete 

toward less arrhythmia recurrence 

in the Cath lab session ...................................................................................................................Rhodes 

Systemic effects of atrial fibrillation ...............................................................................Naxos 

Let’s discuss my most difficult clinical case ................................................Lefkada 

Ablation techniques in atrial fibrillation and in VT/VF .................Kythira 

(Part II) Ventricular Arrhythmias: case-based presentations 

Oral Abstract session: advances in iCD therapy and ......................Ithaca 

sCD prevention 

Management of patients with iCD ..........................................................................Mykonos 

Catheter ablation of atrial fibrillation and concomitant .....Santorini 

renal ablation: a new strategy? 

Oral Abstract session: novel non-invasive risk marker ..............Hydra 

18:15 - 19:45 

WEDnESDAy 26 JUnE 2013 

08:30 - 12:30 

Moderated Posters: Atrial fibrillation in the Moderated Poster Area 


08:30 - 10:00 

How can cardiac imaging help in ablating atrial ....................................Lefkada 

fibrillation? 

Thoracoscopic ablation of longstanding persistent...........................Kythira 

AF – bail out in failed catheter ablation or as primary 

procedure? 

Risk stratification of primary electrical diseases in the ................Ithaca 

iCD era: changing horizons 

Flash abstract presentations: atrial fibrillation ablation .....Mykonos 

From deciphering molecular pathogenesis to .......................................Santorini 

developing targeted new therapies 

Pathophysiological insights provided by EUTRAF: ...............................Hydra 

Progressive electrical uncoupling as determinant 

of AF chronification 

EHRA General Assembly .................................................................................................................Kythira 

11:00 - 12:30 

late breaking Trials session ii .............................................................................................Lefkada 

Ablation of complex fractionated atrial electrogrammes .....Kythira 

Arrhythmias and valvular heart disease ....................................................................Ithaca 

How to optimise CRT-D programming ...........................................................Santorini 

Oral Abstract session: prolonged rhythm monitoring .................Hydra 

for detection of atrial fibrillation 

12:45 - 13:45 

Awards and Closing Ceremony .............................................................................................Crete 

Basic Science Clinical Practice Transforming Translational Satellite Symposium Special Session

ORGANISER 

EUROPEAn sOCiETY OF CARDiOlOGY 

EHRA EUROPACE Secretariat 

Email: europace@escardio.org 

Web Site: www.escardio.org/europace 

MEETING OF 

THE EUROPEAn HEART RHYTHM AssOCiATiOn (EHRA) 

A Registered Branch of the ESC 

Email: ehra@escardio.org 

Web Site: www.escardio.org/EHRA 

JOINT WITH 

EsC Working Group on Cardiac Cellular Electrophysiology 

Email: workinggroups@escardio.org 

Web Site: www.escardio.org/ewgcce 

EsC Working Group on e-Cardiology 

Email: workinggroups@escardio.org 

Web Site: www.escardio.org/e-cardiology 

VENUE 

METROPOliTAn EXPO 

Athens International Airport 

“Eleftherios Venizelos” 

19019 Spata, Greece 

P.O. Box 80072 

Email: info@metropolitanexpo.gr 

Web Site: www.metropolitanexpo.gr 

speaker service Centre 

11 

COnTACT DETAils 

All speakers are requested to upload and validate their presentations in the Speaker Service Centre 

(SSC) located in Hall 4, a minimum of 3 hours before the session starts or the day before if the session 

is at 08:30. 

Opening Hours * : 

Saturday 22 June: 14:00 - 18:30 

Sunday 23 June: 07:30 - 18:30 

Monday 24 June: 07:30 - 18:30 

* Hours may be subject to change 

Tuesday 25 June: 07:30 - 18:30 

Wednesday 26 June: 07:30 - 13:00

NEW 

Save lives: 

learn the latest CPR Guidelines 

Free of charge for 

EHRA Europace delegates 

90 minutes CPR Workshops organised 

at EHRA Europace for the first time! 

• Refresher CPR skills 

• Advanced CPR skills 

• learn about the latest Guidelines 

and meet qualified ERC instructors 

Make sure you have a place 

Pre book your workshop at 

CPR Workshops Area in the Exhibition 

12


2003 - 2013 

EUROPEAN HEART 

RHYTHM ASSOCIATION 

From Sunday to Monday - Posters 

Sunday 23 June - Sessions 

Don’t miss! Lead management summit and Inaugural session 

Sunday 23 June - Posters 

Monday 24 June - Sessions 

Don’t miss! Techno Live sessions and Honorary lectures 

Monday 24 June - Posters 

Tuesday 25 June - Sessions 

Don’t miss! New 2013 ESC Guidelines and Genetic summit 

Tuesday 25 June - Posters 

Wednesday 26 June - Sessions 

Don’t miss! Late breaking trials and Closing ceremony 

Wednesday 26 June - Posters 

Index 

EHRA

EUROPEAN HEART RHYTHM ASSOCIATION (EHRA) 

2003-2013: 

EHRA celebrates 10 years of spectacular achievements 


2003 - 2013 

2003 

2009 

European Heart Rhythm Association (EHRA) Mission: 

“To improve the quality of life of the European 

population by reducing the impact of cardiac 

arrhythmias and reduce sudden cardiac death“ 

EHRA was the first sub-specialty Association created within the 

European Society of Cardiology (ESC). During this Congress, 

EHRA will celebrate its ten year anniversary: we are happy 

that you have joined us to celebrate this important milestone! 

EHRA is leading the development of the electrophysiology 

community within the 55 ESC Member countries and beyond. 

It is fostering cross-collaboration with other ESC Constituent 

Bodies and is an evolution driver within the ESC with 

innovative ideas. 

2005 

2011 

15 

2007 

2013 



EHRA AT EUROPACE 2013 

Inaugural Session 

Sunday 23 June from 16:45 to 18:00 in Room Crete 

• Welcome address by EHRA President 

• EHRA EUROPACE 2013 Highlights 

• Honorary Awards 

• Training Fellowship Winners 

• Academic Research Grant 

• Opening Address 

EHRA General Assembly 

Tuesday 25 June from 18:15 to 19:45 in Room Kythira 

• Discover the newly elected Board members (President-Elect, Secretary and Treasurer) 

for the 2013-2015 term 

• Get a report on EHRA past year’s achievements activities 

All EHRA members 2013 are welcome and encouraged to attend. 

EHRA Members Lounge 

The EHRA Members Lounge is an exclusive area 

in Hall 3 providing all 2013 EHRA members with 

a pleasant and cosy environment to meet with 

colleagues, read email or simply enjoy a cup of coffee. 

ESC-EHRA stand H3-B250 

Visit us on the ESC-EHRA stand H3-B250 and 

find out more about EHRA activities including 

membership, certification, educational courses & 

webinars, training fellowship grants, EP Europace 

journal and the next Cardiostim Congress to be 

held in Nice, France in 2014 from 18 to 21 June. 

You will also be able to get more information 

on all ESC activities, products and services such 

as Journals and the ESC Congress 2013 that 

will be held in Amsterdam, Netherlands from 

31 August to 4 September. 

EP Europace Journal & Key Messages 

Come and get your free copy at the ESC-EHRA stand H3-B250!! 

16 

EHRA Certification Exams 

(at the Divani Caravel Hotel in 

Athens – please note that you must 

be pre-registered to participate: 

no on-site registration available) 

• Sunday 23 June: 09:00 - 12:00, 13:00 - 16:00 

Certification in Invasive Cardiac 


• Sunday 23 June: 09:00 - 12:00, 13:00 - 16:00 

Certification for Allied Professionals 

• Monday 24 June: 09:00 - 12:00, 13:00 - 16:00 

Certification in Cardiac Pacing and 

Implantable Cardioverter Defibrillators (ICDs) 

To find out more about future exam registration 

conditions and enrolment (during Cardiostim 2014 

in Nice), come and see us on ESC-EHRA stand 

H3-B250 or visit the certification section of the 

EHRA website: www.escardio.org/EHRA 

d5522_Couv5_DP_EHRA_Lead_Extraction.indd 1 30/07/12 16:27:57 

2012 Activities Report (available in your Congress bag) 

Discover EHRA 2012 key achievements in the EHRA activities report 2012 including the 

programme of our next educational courses on Electrophysiology, Cardiac Pacing, Device 

Practice and online courses (monthly webinars). 

D5367_Couv_DP_AFNET_EHRA.indd 1 17/02/12 9:14:09

14 

12 

December 2012 

Europace Pages 1677–1810 

EUROPEAN 

SOCIETY OF 

CARDIOLOGY ® 

Volume 14 Number 12 December 2012 

ISSN 1099-5129 (Print) ISSN 1532-2092 (Online) 

EP 

www.europace.oxfordjournals.org 

Europace Europace 

of the European Heart Rhythm Association, 

a Registered Branch of the ESC, and the ESC Working 

Groups on Cardiac Cellular Electrophysiology 

EPJournal 

and e-Cardiology 

Ablation for ventricular fibrillation: evidence, 

techniques, and future directions 

European survey on duty-cycled 

RF ablation for AF 

Predictors of permanent pacemaker 

implant after TAVI 

Managing fatigue in the syncope unit: 

a review 

Should all dysfunctional high-voltage 

leads be extracted? A long-term registry 

EP Wire – EHRA survey: performing MRI in 

patients with CIEDs in Europe 

Editor-in-Chief: John Camm 

Deputy Editors: Luc Jordaens and 

Antonio Zaza 

MEMBER OF THE ESC JOURNAL FAMILY 

Pulmonary vein isolation in a patient with dextrocardia. See figure legend on page 1725. 

17 

EHRA AT A GLANCE 

EP Europace Journal 

EP Europace is the official journal of the European Heart Rhythm Association, the 

ESC Working Group on Cardiac Cellular Electrophysiology and the ESC Working 

Group on e-Cardiology. 

Its impact factor went from 808 in 2001 to 1.980 end of 2011 

Scientific papers / documents 

Over the years, EHRA has published over 20 scientific documents. Some of these have been produced 

in collaboration with main players in the field of arrhythmias and systematically published in EP Europace 

Journal. Today EHRA continues to tackle new areas of interest in the field and produce scientific 

statement, recommendations and position papers. 

Since 2008, EHRA has also produced Scientific Documents in collaboration with different organisations 

(HRS, ACC, AHA, ESC, HRS...), and is active in continuously launching new Task Forces that tackle new 

and challenging scientific topics. 

Upcoming: 

• Position paper on new device technologies in heart failure 

• Radiation dose reduction during EP procedures 

• Health Technology Assessment in arrhythmia management: a consensus statement 

the European Heart Rhythm Association 

• Practical questions with new oral anticoagulant agents 

• EHRA / AEPC pediatric cardiac arrhythmias consensus document 

• ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy 

Key Messages 

The Scientific Documents committee has begun to produce “EHRA Key Messages” containing the main 

messages from scientific documents in a concise format making all the knowledge easily accessible. 

White book 

The White Book of the European Heart Rhythm Association (EHRA) has 

become a reference for those seeking information about electrophysiological 

procedures and implantation of cardiac implantable electronic devices (CIEDs) 

in Europe. No other publication provides such a comprehensive collection 

of data from 46 of the 55 member countries of the European Society of 

Cardiology (ESC). Moreover, the EHRA White Book contains valuable 

updated information about country demographics, key national healthcare 

and educational information, and reports about possible obstacles to ESC 

Guidelines implementation in each country. 

Albania . Algeria . Armenia . Austria . Azerbaijan . Belarus . Belgium . Bosnia & Herzegovina . Bulgaria . Croatia . Cyprus 

Czech Republic . Denmark . Egypt . Estonia . Finland . The Former Yugoslav Republic of Macedonia . France 

Georgia . Germany . Greece . Hungary . Iceland . Ireland . Israel . Italy . Kazakhstan . Kosovo . Latvia . Lebanon 

Libya . Lithuania . Luxembourg . Malta . Moldova . Montenegro . Morocco . Netherlands . Norway . Poland 

Portugal . Romania . Russian Federation . San Marino . Serbia . Slovakia . Slovenia . Spain . Sweden . Switzerland 

Syria . Tunisia . Turkey . Ukraine . United Kingdom 

The EHRA White Book 2013 

The Current Status of Cardiac Electrophysiology 

in ESC Member Countries 

A. Auricchio, K.-H. Kuck, R. Hatala, F. Arribas 

www.escardio.org/EHRA 



EHRA OFFERS 

Educational courses and meetings 

Today: 

• The Basic EP course is addressed to EP fellows at the beginning of their training and covers the 

mechanisms, diagnosis and treatment of arrhythmias. 

• The Advanced EP course provides participants with knowledge of advanced electrophysiology 

techniques, ablation and imaging, and is a preparation for the EHRA certification exam. 

• The Cardiac Pacing, ICD and Resynchronisation course combines clinical lectures and advanced 

technical troubleshooting of devices from all major companies to prepare for the EHRA certification 

exam. 

• The Advanced Case-based Arrhythmia and Device Course addresses established electrophysiologists 

(performing ablations and/or device implants) and provides the opportunity to work interactively 

on new and old diagnostic and therapeutic questions, including troubleshooting of complex 

situations. This course is not intended for fellows-in training. 

Over the years: 

In addition to its regular courses, EHRA held an EP advanced course in Egypt in June in Alexandria and one day course 

on daily arrhythima and device pratice on 15 May, St Petersbourg Russia. 

Educational Products 

Webinars (online courses) 

Since 2009, EHRA has been expanding the frontiers of knowledge by providing interactive online courses, 

helping physicians to continue their medical education in a new efficient and practical way. Attending 

EHRA Webinars can also aide in the preparation of Certification exams. You can also access recordings 

from previous sessions. 

18

Certification 

Today: 

19 


EHRA provides the first European certification of professional excellence in three areas: Invasive Cardiac 

Electrophysiology and Cardiac Pacing, ICD and Allied Professionals (available in 6 languages). 

The system is designed to certify both practical experience and knowledge in these three fields. 


160 

140 

120 

100 

80 

60 

40 

20 

0 

Europace 

2005 


Cardiac Pacing 

Allied Professionals 

WCC 

2003 

Europace 

2007 

Cardiostim 

2008 

Europace 

2009 

Cardiostim 

2010 


Europace 

2011 

Cardiostim 

2012 




Training Fellowships 

Today: 

Each year, the Training Fellowship Committee offers physicians working in 

the field of Cardiac Pacing and Electrophysiology the opportunity to continue 

their medical training outside their countries of residence. 

Two specialties are available: 

• Clinical Electrophysiology with emphasis on catheter ablation - One or two-year programme 

• Arrhythmias and Cardiac Pacing with emphasis on ICD/CRT - One-year programme 

Available to centres and individuals. 

EHRA also offers an academic grant to promote a potential career within academic electrophysiology. 

Number of applicants in 2013: 

Clinical programme: 150! 

Academic programme: 7! 


25 

20 

15 

10 

5 

0 

2010 2011 2012 

20 

Sorin 2 

APHRS 3 

Argentina 1 

St Jude Medical 2 

Siemens 1 

GE 1 

Medronic 2 

Biotronik 5 

Biosense 8 

NEW ! The ESC eLearning platform on heart rhythm (ESCeL) 

The ESC eLearning platform is a web based tool which facilitates the harmonisation of cardiovascular 

training across sub-specialties of cardiology, as well as at the national level. 

This tool is designed for cardiologists in training as well as to experienced cardiologists: 

• Knowledge and skills assessment 

• Professional development 

• Laboratory accreditation 

The platform is now available for EHRA members only. 

Become an EHRA member and get the right to use the ESC eLearning 

platform on heart rhythm. 

ESCeL 

ESC eLEARNING PLATFORM

NEW! 

North America 

Latin America 

ESC member countries 

Asia Pacific 

21 


Website for Patients 

Afibmatters.org is an educational website designed by health professionals 

and patients for people suffering from Atrial Fibrillation, as well as their 

families and carers. Developed by the European Heart Rhythm Association 

(EHRA) of the European Society of Cardiology, this informative and easy 

to use website is designed to raise awareness of Atrial Fibrillation and the 

importance of its proper detection and management and to provide a 

reliable resource for patients and doctors to use as part of a treatment programme. 

Afibmatters.org has been developed to help people better understand and manage Atrial 

Fibrillation in straightforward, easy to understand terms, which is both user-friendly and compatible 

with mobile devices. 

International Affairs 

The International Affairs Committee promotes EHRA beyond the traditional regions of Europe and the 

Mediterranean basin. This Committee is specifically responsible for increasing the number of international 

Fellows and members, reinforcing links with other specialty groups, and increasing general awareness 

of EHRA’s activities. Close relationships are maintained with sister societies, often working closely with 

the President of those groups. The major external meetings and congresses are identified, and the 

Committee coordinates the appropriate EHRA representation, as well as encouraging bi-directional 

participation at EHRA EUROPACE. 



Why become 

an EHRA 

member? 

EHRA membership is open 

to specialist cardiologists with 

expertise in arrhythmias and 

electrophysiology, as well as to 

basic scientists, members of allied 

professions, and general cardiologists. 

The benefits of EHRA membership: 

• Special registration fee for EHRA Educational Courses 

• Special registration rates for EHRA courses 

• Free registration for EHRA webinars 

• 10% off all cardiology publications from Oxford University Press 

• Reduced fee for EP Europace Journal 

• Exclusive access to Training Fellowship and online educational content 

• Automatic membership of ESC and benefits 

• EHRA newsletter 

• Voting rights 

New benefits since 2013! 

• Registration discount for EHRA EUROPACE 2013 Congress 

• Unlimited access to EHRA Lounge during EHRA EUROPACE 2013 

• Free access to the ESC eLearning Platform (ESCeL) 

Sign up now at www.escardio.org/EHRA 

in the membership section

Download 

EHRA EUROPACE 2013 

Congress Mobile app! 

Have 

the most 

up-dated 

programme 

The Mobile app is supported by Medtronic, 

in the form of an unrestricted educational grant 

• View the entire scientific programme 

including all accepted abstracts 

• Search for sessions, presentations, abstracts 

• Find exhibitors and sponsors 

• Navigate the floor plans 

• Create your personal programme 

• Make your own “to do” list and take notes 

• Share sessions and notes with colleagues 

• Receive the latest news 

Search for “EHRA2013” in App Store/Google Play 

23 

WG CCE 

postErs

POstERs On bEHAlf Of tHE EsC WG On CARdiAC CEllUlAR ElECtROPHysiOlOGy 

Posters on behalf of the ESC Working Group on Cardiac Cellular 


25 

Poster 

All day Poster session: sunday 08:30 to Monday 18:00. 

Poster session organised on behalf of the Working Group on Cardiac Cellular Electrophysiology. 

This session will take place over 2 days (All day Sunday & Monday) 

Sunday: Posters must be set up between 08:00 and 8:30 

Sunday & Monday 10:00-11:00 and 15:30-16:30 the Presenter should be present throughout the break 

in order to discuss the research with the audience 

Monday: the Poster should be removed between 18:00 and 18:30 

nucleoside diphosphate Kinase b is a Critical Regulator of G-protein signaling in 

Atrial fibrillation. P1 

I. Abu-Taha (Essen, DE) 

blockade of l-type ca++ channels abrogates ibutilide but not atx ii induced plateau 

prolongation of ventricular action potential in rabbits. P2 

I. Aidonidis (Larissa, GR) 

Panoramic imaging of isolated rabbit hearts enables correlation of ventricular 

activation and repolarisation patterns to ECG recordings. P3 

A. Allan (Glasgow, GB) 

Dual effect of ethanol on cardiac inward rectifier potassium current IK1: possible 

role in ethanol-induced atrial fibrillation? P4 

M. Bebarova (Brno, CZ) 

Cardiac arrhythmias associated with HCn4 mutations. P5 

A. Bucchi (Milan, IT) 

Effect of Acetylcholine on different Regions of the Canine Heart. P6 

To be announced 

the effect of exercise training on Ca2+ wave probability after myocardial infarction 

depends on cardiac function at onset of training. P7 

T.K. Danielsen (Oslo, NO) 

Measurements of ventricular activation and repolarisation during deep hypothermia 

and rewarming using panoramic optical mapping of isolated langendorff perfused 

rabbit hearts. P8 

E.S. Dietrichs (Glasgow, GB) 

A non-iKr blocker potentially torsadogenic: in vitro electrophysiological effects of 

fK506 (tacrolimus). P9 

B.M.P. Dumotier (Basel, CH) 

iPsC-derived Cardiomyocytes: Effects of drugs on spontaneous rhythm. P10 

E. Ertel (Allschwil, CH) 

NOD-1 agonist induces cardiac dysfunction, inflammation a calcium handling modulation. P11 

M. Fernandez-Velasco (Madrid, ES) 

Cardiac remodeling in dOCA-salt induced mouse model of cardiorenal disease. P12 

M.S.C. Fontes (Utrecht, NL) 

Variable t-tubule density and calcium homeostasis across the atria. P13 

M. Frisk (Oslo, NO) 

WG CCE 

postErs

WG CCE 

POstERs 


simultaneous measurement of cytoplasmic and sR calcium during modulation of 

ryanodine receptor open probability in canine ventricular myocytes. P14 

D. Greensmith (Manchester, GB) 

Calcium-activated chloride current in different regions of canine ventricular 

myocardium. P15 

B. Hegyi (Debrecen, HU) 

Heart rate variability as a sensitive indicator of sepsis development in clinically 

relevant pig model. P16 

D. Jarkovska (Plzen, CZ) 

Effects of pioglitazone on action potential beat-to-beat variability and cardiac ionic 

currents of canine ventricular myocytes. P17 

K. Kistamas (Szerencs, HU) 

the controversial ina,late in human atrial myocytes: a computational analysis of 

Ranolazine's effects. P18 

J. Koivumaki (Lysaker, NO) 

Cardioprotective effect of partial nCX inhibition by ORM10103 in simulated 

ischaemia-reperfusion injury in canine ventricular cardiomyocytes. P19 

A. Kormos (Szeged, HU) 

Electrophysiological characterisation of human pluripotent stem cell-derived 

cardiomyocytes. P20 

G.R. Kosmidis (Leiden, NL) 

PdE5 inhibition reduces iCa-l and systolic calcium transient in the failing sheep 

ventricle. P21 

M. Lawless (Manchester, GB) 

loss-of-function mutations in the potassium channel tAsK-1 are associated with 

atrial fibrillation. P22 

B. Liang (Copenhagen, DK) 

ns5806 partially restores APd but fails to ameliorate Ca2+-transient dysfunction in 

a computational model of canine heart failure. P23 

M.M.C. Maleckar (Oslo, NO) 

Can exercise training prevent arrhythmogenic Ca2+ release in RyR2-R2474S mice? P24 

R. Manotheepan (Oslo, NO) 

Hypothermic solutions cause reduced contractility in ventricular cardiomyocytes 

following rewarming. P25 

K. McGlynn (Glasgow, GB) 

tdP Arrhythmias in Methoxamine-sensitized Hypercholesterolemic Rabbit. P26 

L. Nalos (Plzen, CZ) 

Effects of endotoxin on beating rate of embryonic chick ventricular myocytes. P27 

B. Pelzmann (Graz, AT) 

Characterisation of a KCnJ2 mutation found in a patient with short Qt syndrome. P28 

I. Rivolta (Monza, IT) 

Ventricular activation and repolarisation prior to ischaemia determine 

predisposition to Vf in rabbit model of acute ischaemia. P29 

R. Roslan (Glasgow, GB) 

Calcium wave probability in cardiomyocytes from rats with failing and non-failing 

cardiac function after myocardial infarction. P30 

M. Sadredini (Oslo, NO) 

26


Effects of species-dependent differences in action potential shape in setting Î²adrenergic-stimulation 

induced current. P31 

L. Sala (Milan, IT) 

increasing sr calcium leak results in a biphasic decay of the systolic ca transient. P32 

R. Sankaranarayanan (Manchester, GB) 

Properties of smooth muscle-like cells differentiated from human amniotic fluid stem cells. P33 

L. Sartiani (Florence, IT) 

Reducing sarcolemmal sodium Current decreases spontaneous sarcoplasmic 

Reticulum Ca2+ Release. P34 

M.B. Sikkel (London, GB) 

GiRK channel activation via adenosine or muscarinic receptors has similar effects on 

rat atrial electrophysiology. P35 

L. Skibsbye (Copenhagen, DK) 

Regulation of intracellular na+ in local domains affects Ca2+ handling in 

cardiomyocytes through interaction between nKA and nCX. P36 

J. Skogestad (Oslo, NO) 

Transthyretin amyloid fibrils affect viability and functional properties of cardiomyocytes. P37 

V. Spinelli (Florence, IT) 

Effects of clinically relevant acute hypercapnic and metabolic acidosis on the porcine 

diovascular system. P38 

M. Stengl (Plzen, CZ) 

the effect of nCX and nHE inhibition on the development and duration of postischaemic 

arrhythmias. P39 

J. Szepesi (Szeged, HU) 

Influence of phosphorylation, pH and redox modulation on TTX-sensitivity of 

l-type calcium channel in canine ventricular myocytes. P40 

K. Vaczi (Hajduszoboszlo, HU) 

Membrane currents in human embryonic stem cells with atrial- and ventricular-like 

action potentials. P41 

A. Verkerk (Amsterdam, NL) 

impaired sodium-dependent Regulation of Acetylcholine-activated iK,ACh 

Modulates Action Potential Rate dependence in Patients with Chronic Atrial fibrillation. P42 

N. Voigt (Essen, DE) 

Neuronal nitric oxide synthase modulation of myofilament Ca2+ sensitivity resets 

intracellular Ca2+ handlings and maintains inotropy in left ventricular myocytes 

from hypertensive rat heart. P43 

Y. Wang (Seoul, KR) 

Calcium transient and sodium-Calcium Exchange Current in Human Versus Rabbit 

sinoatrial node Pacemaker Cells. P44 

R. Wilders (Amsterdam, NL) 

Electrophysiological effects of late sodium current inhibition in scn5a-1798insd/+ mice. P45 

R. Wolswinkel (Amsterdam, NL) 

Atrium specific kir3.x determines inducibility and dynamics of fibrillation by 

regulating voltage-dependent alternans in atrial cardiomyocyte monolayers P46 

B.O. Bingen, A.A. Ramkisoensing, Z. Neshati, S.F.A. Askar, I.V. Kazbanov, D.L. Ypey, 

A.V. Panfilov, M.J. Schalij, A.A.F. De Vries, D.A. Pijnappels (Leiden, NL; Ghent, BE) 

27 

WG CCE 

postErs

WG CCE 

POstERs 


subthreshold high frequency electrical stimulation of ventricular cardiomyocytes 

induces VEGF expression in vitro: a technique for therapeutic angiogenesis? P47 

G. Rackauskas, E. Saygili, O.R. Rana, C.H. Gemein, A. Laucevicius, A. Aidietis, 

G. Marinskis, P. Serpytis, P. Schauerte (Vilnius, LT; Dusseldorf and Aachen, DE) 

forced cellular fusion of human ventricular scar cells with neonatal rat 

cardiomyocytes ameliorates their arrhythmicity P48 

S.F. Askar, B.O. Bingen, M.J. Schalij, Z.N. Neshati, R.J.M. Klautz, A.A.F. De Vries, 

D.A. Pijnappels (Leiden, NL) 

Cellular electrophysiological and antiarrhythmic efficacy of new sodium/calcium 

exchanger inhibitors in the canine heart P49 

Z.S. Kohajda, A. Horvath, J. Levijoki, P. Pollesello, T. Koskelainen, L. Otsomaa, 

A.P. Koivisto, J.G.Y. Papp, A. Varro, L. Virag (Szeged, HU; Espoo, FI) 

frequency-dependent effects of the selective iKur blocker XEn-d0103 in human 

atrial tissue P50 

J. Mueller, E. Wettwer, J. Ford, S. Loose, J. Milnes, U. Ravens (Dresden, DE; Cambridge, GB) 

Chronic myocardial infarction promotes atrial action potential alternans, 

afterdepolarisations and fibrillation P51 

S. Kettlewell, F.L. Burton, G.L. Smith, A.J. Workman (Glasgow, GB) 

The comparative study of rapid and slow delayed rectifier currents in undiseased 

human, dog, rabbit and guinea pig ventricular myocytes P52 

N.L. Jost, Z.S. Kohajda, C. Corici, A. Horvath, M. Bitay, G. Bogats, J.G.Y. Papp, A. Varro, 

L. Virag (Szeged, HU) 

Heart failure in sheep shortens ventricular action potential without affecting 

regional wall heterogeneity or Qt interval P53 

G. Kirkwood, A.W. Trafford (Manchester, GB) 

Changes in conduction velocity and action potential characteristics with increases of 

intracellular cyclic adenosine monophosphate in the intact rat heart P54 

A.M. Campbell, R. Te Vootris, F.L. Burton, G.L. Smith (Glasgow, GB; Amsterdam, NL) 

Early onset lone atrial fibrillation is associated with susceptibility mutations in 

sodium channel beta subunits sCn1-2b in Caucasians P55 

L.E.I. Yuan, L. Lorentzen, T. Jespersen, M. Olesen (Copenhagen, DK) 

Up-regulation of atrial A2A receptors: a new step in the remodeling mechanisms 

underlying atrial fibrillation? P56 

M.M. Oliveira, M. Carvalho, S. Laranjo, I. Rocha (Lisbon, PT) 

Sodium currents in cardiac fibroblasts isolated from patients with atrial fibrillation P57 

C. Poulet, E. Buettner, U. Ravens (Dresden, DE) 

the effect and mechanism of pioglitazone on atrial remodeling in diabetic rabbits hearts P58 

C. Liu, G.P. Li, H.Y. Fu, J. Li, L.J. Cheng, X.H. Wang, W.S. Yang, T. Liu (Tianjin, CN) 

Human ventricular action potential prolongation in response to extracellular 

calcium: a computational study P59 

E. Passini, S. Severi (Bologna, IT) 

Anabolic androgenic steroid treatment induces disturbances in ventricular 

repolarisation in wistar rats P60 

M. Marocolo, O. Barbosa Neto, D. Schimitz De Freitas, G. Ribeiro Da Mota 

(Uberaba and Juiz de Fora, BR) 

the effect of intracellular Mg2+ on calcium spikes in rat cardiac myocytes P61 

R. Janicek, I. Zahradnik, A. Zahradnikova (Bratislava, SK) 

28


nonsense mutations in the sodium channel and risk for severe cardiac events in 

brugada syndrome P62 

M. Blich, D. Spears, R. Bloise, N. Monteforte, M. Memmi, M. Boulos, C. Napolitano, 

S.G. Priori (Haifa, IL; Toronto, CA; Pavia, IT) 

Development of new and efficient IK1 blocker based on pentamidine P63 

H. Takanari, L. Nalos, A. Stary-Weinzinger, R. Varkevisser, M. Houtman, M. Pescher, 

T. De Boer, R. Tidwell, M. Vos, M. Van Der Heyden (Utrecht and Den Bosch, NL; 

Vienna, AT; North Carolina, US) 

Cellular and molecular determinants of arrhythmias in the myocardium of patients 

with hypertrophic cardiomyopathy P64 

R. Coppini, C. Ferrantini, P. Fan, L. Yao, I. Olivotto, L. Belardinelli, C. Poggesi, E. Cerbai, 

A. Mugelli (Florence, IT; Palo Alto, California, US) 

Chronic effect of bepridil on expression and trafficking of cardiac potassium channels. P65 

H. Takanari, M. Houtman, R. Varkevisser, R. Tieland, M. Vos, M. Van Der Heyden 

(Utrecht, NL) 

A possible blood test for Brugada Syndrome without defined genetic defects P66 

L. Gu, G. Gao, C. Rutledge, A. Xie, S. Priori, C. Napolitano, R. Bloise, M. Denegri, 

S.C. Dudley (Chicago, US; Pavia, IT) 

Electrical activity in the t-tubules and its relationship with local calcium release. P67 

C. Ferrantini, L. Sacconi, C. Crocini, R. Coppini, P. Yan, L. Loew, C. Tesi, C. Poggesi, 

E. Cerbai, F.S. Pavone (Florence, IT; Connecticut, US) 

Arrhythmogenic remodeling in calcineurin-induced cardiac hypertrophy P68 

M.S.C. Fontes, G.J.M. Kok, T. Van Doorn, A.J.A. Raaijmakers, S. Nieuwenhuis, 

R. Van Der Nagel, M.A. Vos, T.P. De Boer, H.V.M. Van Rijen, M.F.A. Bierhuizen 

(Utrecht, NL) 

Electrophysiological and hemodynamic effects of vernakalant and flecainide during 

epicardial and endocardial biventricular pacing in canine hearts P69 

L.B. Van Middendorp, M. Strik, P. Houthuizen, M. Kuiper, J.G. Maessen, A. Auricchio, 

F.W. Prinzen (Maastricht, NL; Lugano, CH) 

Amiodarone and dronedarone increase KiR2.1 ion channel expression by backward 

trafficking inhibition P70 

M.A.G. Van Der Heyden, M.J.C. Houtman, R. Heukers, H. Takanari, R.G. Tieland, 

L. Nalos, P.M.P. Van Bergen En Henegouwen, M.A. Vos (Utrecht, NL; Pilsen, CZ) 

Effects of irbesartan on gene expression revealed by transcriptome analysis of left 

atrial tissue in a porcine model of acute rapid pacing in vivo P71 

U. Lendeckel, R.K. Chilukoti, J. Mostertz, A. Bukowska, S.B. Felix, M. Busch, U. Voelker, 

A. Goette, C. Wolke, G. Homuth (Greifswald and Magdeburg, DE) 

Effect of renal sympathetic denervation on the initiation of a substrate for atrial 

fibrillation in obstructive sleep apnea P72 

D. Linz, M. Hohl, A. Nickel, F. Mahfoud, K. Wirth, C. Maack, U. Schotten, M. Böhm 

(Homburg and Frankfurt/Main, DE; Maastricht, NL) 

Influence of heterogneities in atrial substrate on capture of atrial fibrillation: study in 

a biophysical model P73 

N. Virag, A. Rusu, J.-M. Vesin, L. Kappenberger (Tolochenaz and Lausanne, CH) 

29 

WG CCE 

postErs

WG CCE 

POstERs 


Conduction disturbances accompanying tdP arrhythmias in the methoxaminesensitised 

rabbit model; relevance and influence of anesthesia P74 

R. Varkevisser, H.D.M. Beekman, R.G. Tieland, M.A.G. Van Der Heyden, M.A. Vos 

(Utrecht, NL) 

Genotype-Phenotype correlation in patients with brugada syndrome P75 

B. Rudic, R. Schimpf, C. Veltmann, C. Doesch, E. Tulumen, S.O. Schoenberg, 

M. Borggrefe, T. Papavassiliu (Mannheim, DE) 

the electromechanical window: not superior to Qt as surrogate parameter for 

risk of dofetilide-induced torsade de pointes in the anesthetized canine complete 

atrioventricular block model P76 

T.R.G. Stams, V.J.A. Bourgonje, H.D.M. Beekman, M. Schoenmakers, R. Van Der Nagel, 

P. Oosterhoff, J.M. Van Opstal, M.A. Vos (Utrecht, NL) 

Exon-3 deletion of RyR2 encoding cardiac ryanodine receptor related to left 

ventricular non-compaction (lVnC) with ventricular arrhythmia and bradycardia. P77 

S. Ohno, M. Omura, M. Kawamura, H. Kimua, H. Itoh, T. Makiyama, H. Ushinohama, 

N. Makita, M. Horie (Otsu, Shimonoseki, Kyoto, Fukuoka and Nagasaki, JP) 

Expression of transient receptor potential channels (tRPCs) in a porcine model of 

acute rapid pacing in vivo P78 

J. Linke, U. Lendeckel, A. Giese, A. Bukowska, A. Goette, C. Wolke (Greifswald and 

Magdeburg, DE) 

30

SUNDAY SESSIONS 

Lead Management Summit 

The specialised nature of this field, along with a surge in needs, 

is now well recognised by our community. Participants will have 

the opportunity to meet leading authorities in this field, to discuss 

emerging issues and the implementation of new solutions to 

improve patient treatment and safety. Education, innovation and 

data collection issues will be at the centre of the debates. 

On Sunday, Monday in Room Lefkada 

and Tuesday in Room Kythira 

31 

sunday 

sessions

sUndAy 23 JUnE 2013 - MORNING 

08:30 - 10:00 Main session ithaca 

Mechanical stress and cell function 

session organised on behalf of the EsC Working Group on Cardiac Cellular Electrophysiology 

Chairpersons: G.l. smith (Glasgow, Gb); A. Gomez (Chatenay-Malabry, fR) 

basic science 

08:30 stretch-induced signalling and sR function. 79 

W.J. Lederer (Baltimore, US) 

09:00 Contribution of active and passive stiffness to diastolic dysfunction in rats following 

aortic banding. 80 

W. Louch (Oslo, NO) 

09:15 Electro-mechanical dysfunction of cardiomyocytes from transgenic mouse models of 

hypertrophic cardiomyopathy. 81 

R. Coppini (Florence, IT) 

09:30 shift in the reversal potential of the na/Ca-exchange (nCX) current modulates the 

inotropic effect of ORM10103, a new selective nCX-inhibitor, in dog cardiac myocytes. 82 

K. Acsai (Szeged, HU) 

09:45 Arrhythmogenic right ventricular cardiomyopathy-like phenotype induced by 

endurance training in heterozygous desmoglein-2 mutant mice 83 

E. Vloumidi, L. Fortmueller, S. Sakhtivel, F. Syeda, P. Kirchhof, R. Leube, C. Krusche, 

L. Fabritz (Birmingham, GB; Munster and Aachen, DE) 

08:30 - 10:00 special session santorini 

Καρδιακες αρρυθμιες σε ασθενεις που νοσηλευονται στη στεφανιαια μοναδα 

Cardiac arrhythmias in the coronary care unit 

Chairpersons: d. Pistolas (Athens, GR); E. Kletsiou (Athens, GR) 

Clinical Practice 

08:30 Καρδιακες αρρυθμιες σε ασθενεις με οξν στεφανιαιο σννδρομο. Επιπτωση-αντιμετωπιση. 

Cardiac arrhythmias in patients with acute coronary syndromes. 

incidence-treatment 84 

A. Alevizaki (Gazi, GR) 

08:52 Κολπικη μαρμαρυγη μετα απο αορτοστεφανιαια παρακαμψη. Νεωτερα δεδομενα. 

Atrial fibrillation after coronary artery bypass surgery. Contemporary management 85 

N. Giakis (Athens, GR) 

09:15 Βραδυκαρδια μετα απο διαδερμικη αντικατασταση αορτικης βαλβιδας. 

Επιπτωση- ντιμετωπιση. 

bradycardic complications after tAVi 86 

E. Stamatopoulou (Athens, GR) 

09:37 Η αντιμετωπιση του ασθενονς με καρδιακη ανακοπη εκτος νσοκομειου. 

Management of the patient with out of Hospital cardiac arrest 87 

P. Rammou (Gerakas, GR) 

33 

sunday 

sessions

SUNday 

SeSSioNS 

SUNday 23 JUNe 2013 - MORNING 

10:15 - 11:45 Main session lefkada 

Cardiac lead engineering: designing for the future to improve reliability, 

performance, and extractability 

summit on lead Management 

Chairpersons: J. Helland (tallahassee, Us); C.E.H. Kennergren (Goteborg, sE) 


10:15 What unique applied forces, flexing, and interaction with other leads, devices, and 

tissue do leads need to withstand? . 

W. Baxter (Santa Ana, US) 

88 

10:30 What are engineers, physicians, & regulators doing to improve reliability & 

pre-clinical testing? 

D. Cooke (St. Paul, US) 

89 

10:45 the science of lead design i: what do engineers need to consider in the selection of 

materials used in cardiac leads to improve reliability, performance, and extractability? 

J.P. Miller (Mounts View, US) 

90 

11:00 the science of lead design ii: what do engineers need to consider in the physical 

design & mechanics of cardiac leads to improve reliability, performance, and extractability? 91 

A. Roy (Sylmar, US) 

11:15 What key lead design aspects do lead extraction physicians need to be aware of? 

M. Marshall (Mounds View, US) 

92 

11:30 Panel discussion: lead engineer speakers address audience questions. 

W. Baxter (Santa Ana, US); D. Cooke (St. Paul, US); J.P. Miller (Mounts View, US); 

A. Roy (Sylmar, US); M. Marshall (Mounds View, US) 

93 


Molecular mechanisms in cardiomyopathies 


Chairpersons: s. Kaab (Munich, dE); to be announced 

basic science 

10:15 deciphering the sR Ca-cycling regulatome in cardiac physiology and pathology. 94 

D. Sanoudou (Athens, GR) 

10:45 High resolution multidimensional proteomics detects candidate arrhythmia biomarkers 95 

J.A. Rosengarten, P.A. Scott, S.E. Larkin, S. Garbis, N.P. Curzen, P.A. Townsend, 

J.M. Morgan (Southampton, GB) 

11:00 Regulation of the small conductance calcium-activated potassium channel 3 by 

microRNA-499 - potential role in atrial fibrillation 96 

H. Lee, T.-Y. Ling, X.-L. Wang, Q. Chai, T.-W. Lau, C.M. Koestler, S.J. Park, R.C. Daly, 

K.L. Greason, Y.-M. Cha (Rochester MN, US) 

11:15 functional, molecular and structural mechanisms underlying atrio-ventricular 

conduction disturbances in pressure overloaded scn5a-1798ind/+ mice. 97 

M. Rivaud (Amsterdam, NL) 

11:30 Kir2.x and two-pore ion channels are responsible for changed iK1 current in dilated 

cardiomyopathy. 98 

V. Szuts (Szeged, HU) 

34



Νεωτερα δεδομενα σε καθιερωμενες θεραπειες 

new developments in established therapies 

Chairpersons: i. Hatzina (Athens, GR); E. stamatopoulou (Athens, GR) 


10:15 Επιπλοκες σε ασθενεις με συσκευες ρνθμισης του καρδιακον ρυθμον. 

Complications in patients with CRM devices 99 

E. Athanasakis (Heraklion, GR) 

10:37 Παρακολονθηση ασθενων με συσκευες ρνθμισης του καρδιακον ρυθμον. 

follow up of patients with CRM devices 100 

V. Antonakos (Athens, GR) 

11:00 Αντιθρομβωτικη αγωγη στην κολπικη μαρμαρυγη. Νεωτερα δεδομενα. 

Antithrombotic therapy in patients with atrial fibrillation 101 

E. Simantirakis (Heraklion, GR) 

11:22 Καταλυση πνευμονικων φλεβων. Ενδειξεις-παρακολονθηση. 

Atrial fibrillation ablation. Indications-follow up 102 

K. Batsikas (Nea Ionia, GR) 

12:00 - 13:30 special session Rhodes 

In the Cath Lab Session 

At the time of going to print, the full details were not available. Please see the erratum for finalised 

programme. 


35 

sunday 

sessions

SUNday 

SeSSioNS 


12:00 - 13:30 symposium naxos 

Special consideration of ventricular tachycardia ablation in patients with 

arrhythmogenic right ventricular dysplasia 

Chairpersons: d. Corrado (Padova, it); s. Willems (Hamburg, dE) 


Objective of the session is to demonstrate special considerations of ventricular tachycardia ablation in 

patients with ARVC 

12:00 Arrhythmogenic right ventricular dysplasia: from cellular disorders to ventricular 

arrhythmogenic substrate. 106 

C. Calkins (Baltimore, US) 

12:22 layered activation of epicardial scar in arrhythmogenic right ventricular dysplasia. 107 

H.M. Haqqani (Brisbane, AU) 

12:45 Progression of endocardial scar in patients with arrhythmogenic right ventricular 

dysplasia and ventricular tachycardia. 108 

M.P. Riley (Philadelphia, US) 

13:07 Endocardial and epicardial ablation in arrhythmogenic right ventricular dysplasia. 

the scar dechanneling technique. 109 

A. Berruezo Sanchez (Barcelona, ES) 


Quality of care and data 


Chairpersons: C. blomstrom-lundqvist (Uppsala, sE); J.M. Morgan (stockbridge, Gb) 


12:00 EHRA recommendations on training and accreditation. 110 

A. Rozkovec (Bournemouth, GB) 

12:18 the role of simulators in training programmes. 111 

R.G. Carrillo (Miami, US) 

12:36 Risks of lead extraction. 112 

E.S. Platou (Oslo, NO) 

12:54 In the operating room or in the electrophysiology lab? 113 


13:12 What is our practice? Insight into registries. 114 

G. Marinskis (Vilnius, LT) 

36


12:00 - 13:30 symposium Kythira 

Remote monitoring of patients with ICD 

Chairpersons: J.H. svendsen (Copenhagen, dK); H. Heidbuchel (leuven, bE) 

transforming 

12:00 the advantages in clinical outcome. 115 

J.C. Daubert (Rennes, FR) 

12:22 Remote monitoring of ICD patients: what is the patient's opinion? 116 

W. Jung (Villingen-Schwenningen, DE) 

12:45 How to organise the workflow? 117 

N. Varma (Cleveland, US) 

13:07 Monitoring the haemodynamic profile of heart failure patients: useful and cost effective? 118 

F. Braunschweig (Stockholm, SE) 

12:00 - 13:30 Meet the Experts ithaca 

Scientific Projects of new e-Cardiology nucleus members 

session organised by the EsC Working Group on e-Cardiology 

Chairpersons: E.t. van der Velde (leiden, nl); G. Krstacic (Zagreb, HR) 

translational 

12:00 interaction between aorta and left ventricle. 119 

N. Kachenoura (Paris, FR) 

12:18 t-Wave variability. 120 

A. Bauer (Tuebingen, DE) 

12:36 spatial repolarisation heterogeneity. 121 

F. Lombardi (Milan, IT) 

12:54 deceleration runs. 122 

P. Guzik (Poznan, PL) 

13:12 Remote monitoring of implantable Electronic devices supported by Adaptive Care Plans. 123 

C.E. Chronaki (Heraklion, GR) 

37 

sunday 

sessions

SUNday 

SeSSioNS 


12:00 - 13:30 Meet the Experts Mykonos 

Autonomic function 

Chairpersons: M. Efremidis (Nea Smirni, GR); S.M. Rafla (Alexandria, EG) 

transforming 

12:00 Autonomic regulation of the heart. 124 

J.A. Cabrera (Madrid (Pozuelo), ES) 

12:22 How to diagnose autonomic dysfunction. 125 

M. Malik (Purley, GB) 

12:45 Reflex syncope. 126 

J.G. van Dijk (Leiden, NL) 

13:07 Risk stratification after myocardial infarction by means of autonomic measures. 127 

G. Schmidt (Munich, DE) 

12:00 - 13:30 symposium santorini 

New types antiarrhythmic drugs for atrial fibrillation 

Chairpersons: A. Capucci (bologna, it); A. Oto (Ankara, tR) 

translational 

12:00 Mechanisms of atrial fibrillation – potential targets for prevention of atrial fibrillation. 128 

A.J. Camm (London, GB) 

12:22 Atrial selective antiarrhythmic drugs. 129 

H.J.G.M. Crijns (Maastricht, NL) 

12:45 Effects of hypertension, diabetes mellitus and heart failure medication. 130 

J.-Y. Le Heuzey (Paris, FR) 

13:07 drugs involved in calcium handling. 131 

I.C. Van Gelder (Groningen, NL) 

38


12:00 - 13:30 Meet the Experts Hydra 

Preventing and managing device and procedure complications 

Chairpersons: l. Hinterbuchner (salzburg, At); E. lambrinou (nicosia, Cy) 


This session is intended to update nurses and AHPs on specific complications including, 1) lead 

extraction; 2) controlling bleeding for patients on anti-coagulation regiments; 3) promoten patient 

safety and well-being in the Cath Lab 

12:00 the delicate touch of lead extraction. 132 

M.G. Bongiorni (Pisa, IT) 

12:22 Managing complications of CRt. 133 

C. Leclercq (Rennes, FR) 

12:45 the patient on anticoagulation: controlling bleeding. 134 

R. Schilling (London, GB) 

13:07 Patient safety and well-being in the cath lab. 135 

A. Benoit (Lausanne, CH) 

39 

sunday 

sessions

SUNday 

SeSSioNS 

SUNday 23 JUNe 2013 - afternoon 




programme. 


13:45 - 15:15 Main session naxos 

How to ablate ventricular tachycardia: new tools and approaches 

Chairpersons: P. della bella (Milan, it); A. Arenal Maiz (Madrid, Es) 

transforming 

New substrate ablation allow wider application of ventricular tachycardia ablation 

13:45 Computer modelling of ventricular tachycardia: from bench to EP lab. 139 

N. Trayanova (Baltimore, US) 

14:07 Endpoints for ventricular tachycardia ablation: is non-inducibility required? 140 

C. Piorkowski (Dresden, DE) 

14:30 Role of unipolar endocardial voltage mapping to detect epicardial ventricular tachycardias. 141 

B. Schmidt (Frankfurt, DE) 

14:52 Elimination of local abnormal ventricular activities (lAVAs): a new approach for 

ventricular tachycardia ablation? 142 

S. Willems (Hamburg, DE) 


What can the implanter do to avoid lead extraction or to make it easier? 


Chairpersons: b. Wilkoff (Cleveland, Us); M.G. bongiorni (Pisa, it) 


13:45 Choice of the lead(s). 143 

L. Van Erven (Leiden, NL) 

14:03 Choice of the implanting technique. 144 

P. Mitkowski (Poznan, PL) 

14:21 implantation in the youth. 145 

C. Berul (Boston, US) 

14:39 Prevention of infections. 146 

F. Regoli (Lugano, CH) 

14:57 implantation of patients with comorbidities. 147 

P. Bordachar (Pessac, FR) 

40

sUndAy 23 JUnE 2013 - AFTERNOON 


Implantable cardioverter defibrillator given for rare indications 

Chairpersons: J.M. Morgan (stockbridge, Gb); s. tzeis (Maroussi, GR) 


To understand the indications if ICD in specific situations: grown up congenital heart diseases, Brugada 

syndrome, long QT syndrome, early repolarisation syndrome 

13:45 Grown up congenital heart diseases. 148 

G. Boriani (Bologna, IT) 

14:07 brugada syndrome. 149 

J. Brugada Terradellas (Barcelona, ES) 

14:30 long Qt syndrome. 150 

W. Haverkamp (Berlin, DE) 

14:52 Early repolarisation syndrome. 151 

H. Burri (Geneva, CH) 

13:45 - 15:15 Meet the Experts ithaca 

Channelopathies 


Chairpersons: s.E. lehnart (Gottingen, dE); C. napolitano (Pavia, it) 

basic science 

13:45 Genetics and genomics of cardiac arrhythmias. 152 

S. Kaab (Munich, DE) 

14:07 Complexities of genotype-phenotype relations. 153 

S.G. Priori (Pavia, IT) 

14:30 Electrophysiologic testing in induced pluripotent stem cells. 154 

K.-L. Laugwitz (Munich, DE) 

14:52 sodium channel abnormalities and cardiac conduction diseases. 155 

F. Charpentier (Nantes, FR) 

41 

sunday 

sessions

SUNday 

SeSSioNS 


13:45 - 15:15 Main session Mykonos 

What the electrophysiologists need to know about renal denervation 

Chairpersons: E. Pokushalov (novosibirsk, RU); R. Hatala (bratislava, sK) 

transforming 

13:45 the autonomic nervous system. 156 

S. Stavrakis (Oklahoma City, US) 

14:07 Renal denervation: novel tools and trial results. 157 

C. Stefanadis (Paleo Psychico, GR) 

14:30 Renal denervation: novel tools and PVI: a must in hypertensive atrial fibrillation patients? 158 

H.-R. Neuberger (Homburg, DE) 

14:52 Renal denervation and ventricular arrhythmia. 159 

A. Oto (Ankara, TR) 


Devices and antiarrhythmic drugs 

Chairpersons: f. Gaita (turin, it); i. Zupan (ljubljana, si) 


To understand the relationship between devices used in arrhythmology and drugs in various situations: 

assessment of thresholds, CRT, frequent ICD shocks and arrhythmic storm 

13:45 Pathophysiology and pharmacotherapy of electrical storm. 160 

D. Dobrev (Essen, DE) 

14:07 Effect of antiarrhythmic drugs on stimulation and defibrillation thresholds. 161 

J.R. Ehrlich (Frankfurt, DE) 

14:30 Optimised pharmacotherapy in CRt-d patients. 162 

B. Gorenek (Eskisehir, TR) 

14:52 Pharmacotherapy of idiopathic Vt and PVCs 163 

C. Wolpert (Ludwigsburg, DE) 

42



Atrial fibrillation: do we know what to advise patients? 

Chairpersons: E. Kletsiou (Athens, GR); t. lewalter (Munich, dE) 


This session is intended to provide information updates for nurses and AHPs, specifically 1) discuss 

nursing knowledge and practice regarding anti-coagulation; 2) update participants on choosing anticoagulation 

regimens; 3) discuss the benefits of exercise for those with AF; 4) consider how to assess 

symptom burden in patients with arrhythmias 

13:45 What is current nursing knowledge and practice regarding anti-coagulation? 164 

E. Tsiftsidou (Athens, GR) 

14:07 Choosing the best anti-coagulation regimen for individual patients. 165 

G.Y.H. Lip (Birmingham, GB) 

14:30 Do patients with atrial fibrillation benefit from exercise training? 166 

L.E.M. Vanhees (Leuven, BE) 

14:52 Measuring symptom burden in arrhythmias. 167 

U. Walfridsson (Linkoping, SE) 

43 

sunday 

sessions

SUNday 

SeSSioNS 


15:30 - 16:30 satellite symposium naxos 

ICD therapy: patient selection, device technology and clinical results 

sponsored by Medtronic 

Chairpersons: f.d. Murgatroyd (london, Gb); f. Arribas (Madrid, Es) 

Discuss and present the design and testing of ICD leads to better understand the reliability and clinical performance. 

Explain the learnings from clinical trials to optimally program ICDs in order to avoid inappropriate and unnecessary 

shocks. 

Present the latest device technologies and algorithms to reduce ICD shocks including the latest clinical results. 

15:30 introduction. 168 

F. Arribas (Madrid, ES) 

15:35 Reliability of iCd leads: design, testing and clinical performance. 169 

M. Biffi (Bologna, IT) 

15:50 Shock reduction using optimal programming: what have we learned? 170 

J.O. Schwab (Bonn, DE) 

16:05 Latest device technologies to reduce shocks and first clinical results. 171 

M. Meine (Utrecht, NL) 

16:20 Conclusions. 172 

F.D. Murgatroyd (London, GB) 

15:30 - 16:30 satellite symposium Kythira 

Innovations in the diagnosis and treatment of cardiac arrhythmias 

sponsored by Philips Healthcare and AtriCure 

Chairpersons: K.-H. Kuck (Hamburg, dE); J. Kautzner (Prague, CZ) 

15:30 MRi imaging to improve diagnosis and treatment of arrhythmias. 

H. Kottkamp (Zurich, CH) 

15:45 Pre-recorded life case: Catheter ablation in MRi interventional suites. 

C. Piorkowski (Dresden, DE); G. Hindricks (Leipzig, DE) 

16:00 Surgical treatment of atrial fibrillation with minimal invasive techniques – State of the art. 

N. Doll (Leipzig, DE) 

16:15 Pre-recorded life case: combined surgical and catheter ablation of atrial fibrillation. 

M. La Meir (Maastricht, NL) 

44



Women competence session - State of the art in interventional electrophysiology 

sponsored by biosense Webster 

Chairpersons: C. blomstrom-lundquvist (Uppsala, sE); s.G. Priori, (Pavia, it) 

15:30 Genetic testing to predict sudden cardiac death. 180 

D. Husser (Leipzig, DE) 

15:45 Catheter ablation of atrial fibrillation. 181 

S. Ernst (London, UK) 

16:00 Catheter ablation of ventricular tachycardia. 182 

K. Zeppenfeld (Leiden, NL) 

16:15 Lead extraction – safe and successful. 183 

M. Bongiorni (Pisa, IT) 

15:30 - 16:45 symposium lefkada 

Improving outcomes in AF patients in Europe: 10 years (German) Atrial 

Fibrillation Network (AFNET) 

Chairpersons: M. naebauer (Munich, dE); to be announced 


This is a joint session conducted for education on issues related to the treatment of complex ventricular 

arrhythmias, including highly prevalent pathologies in participating countries. 

15:30 Organisation and structure of the AfnEt. 173 

G. Breithardt (Munster, DE) 

15:42 Results of the AfnEt registry. 174 

G. Steinbeck (Starnberg, DE) 

15:55 AntiPAf trial. 175 

A. Goette (Paderborn, DE) 

16:07 flec-sl trial. 176 

R. Bosch (Ludwigsburg, DE) 

16:20 EAst trial. 177 

P. Kirchhof (Birmingham, GB) 

16:32 Results of the AfnEt/EHRA consensus conferences. 178 



Carmeliet-Coraboeuf-Weidmann lecture 


Chairperson: U. Ravens (dresden, dE) 

basic science 

15:30 Calcium cycling in the heart: from basics to cardiac arrhythmias. 179 

D.A. Eisner (Manchester, GB) 

45 

sunday 

sessions

sunday 

sessions 

46 

inaugural session * 

sunday 23 June 2013, 16:45 - 18:00 

in Room Crete 

Welcome address by EHRA President 

Professor Angelo Auricchio 

EHRA President 

Professor Panos Vardas 

ESC President & EHRA Past President 

Professor lukas Kappenberger 

First EHRA President 

***** 

EHRA 2013 Highlights 

Professor Andreas Götte 

Chairperson Scientific Programme Committee 

Professor John Morgan 

Vice-Chairperson Scientific Programme Committee 

Professor Georg schmidt 

ESC Working Group on e-Cardiology 

doctor Paul Volders 

ESC Working Group on Cardiac Cellular Electrophysiology 

doctor Philippe Ritter 

Chairperson Cardiostim 

***** 


Pioneer in clinical Electrophysiology Award 

Professor lukas Kappenberger 

presented by Professor Panos Vardas 

Einthoven Lecture 

Professor John Camm 

presented by Professor Karl-Heinz Kuck 

Intercontinental Lecture 

doctor stanley nattel 

presented by Professor Gerhard Hindricks

inaugural session * 

Continued 

sunday 23 June 2013, 16:45 - 18:00 

in Room Crete 


Best Basic Science Abstract and Best Clinical Abstract 

Miss Eva Wagner 

& doctor soren Hjortshoj 

presented by Doctor Michalis Efremidis 

& Assistant Professor Emmanuel Simantirakis 

Special award for activities fighting sudden cardiac death 

Ms. Antigoni Papadopoulou 

(member of the European Parliament) 

presented by Professor Angelo Auricchio 

***** 

Training Fellowship Winners 

doctor Jose l. Merino 

***** 

Academic Research Grant 

Professor Carina blomström lundqvist 

***** 

Opening Address 

Professor Angelo Auricchio 

The European Heart Rhythm Association is pleased 

to invite you to the networking reception 

in the Exhibition Area 

* All participants are personally invited 

by the President of EHRA to the Inaugural session 

47 

sunday 

sessions

49 

sunday 

posters

sUndAy 23 JUnE 2013 - POSTERS AFTERNOON 

14:00 - 18:00 Moderated Posters Moderated Poster 

New challenges in cardiac pacing 

Chairpersons: P. bordachar (Pessac, fR); l. Mont (barcelona, Es) 

Moderated Posters must be set up between 13:30 and 14:00, removed between 18:00 and 18:30 and 

be on display between 14:00 and 18:00. The Presenter should be present throughout the break 

(15:30 - 16:30) in order to discuss the poster. 

The following abstracts were chosen for their outstanding quality and will be discussed during the 

Moderated Poster session animated by two Chairpersons between 15:30 - 16:30. Each presenter will 

have 5 minutes to present and discuss their research in front of the audience and the chairpersons. 

Long-term safety and benefits of vagal stimulation in heart failure P184 

G. Milasinovic, H.J.G.M. Crijns, J. Smid, H. Klein, A. Gavazzi, S. Raspopovic, 

M. Borggrefe, M. Zabel, G.M. De Ferrari, P.J. Schwartz (Belgrade, RS; Maastricht, NL; 

Magdeburg, Mannheim and Göttingen, DE; Bergamo and Pavia, IT) 

the ventricular intrinsic preference feature reduces heart failure hospitalisations 

and associated medical costs in pacemaker patients P185 

B. Faulknier, M. Richards, X. Min, J. Snell, R.K. Thakur (Charleston, Toledo, Sylmar and 

Lansing, US) 

Cardiac resynchronisation iCd or pacemaker in people with heart failure P186 

K.L. Looi, P. Gajendragadkar, F.Z. Khan, M. Elsik, D.A. Begley, A.A. Grace, P.M. Heck, 

S.P. Fynn, M. Virdee, S. Agarwal (Cambridge, GB) 

Ventricular arrhythmias in super-responders to cardiac resynchronisation therapy P187 

I. Garcia Lunar, V. Castro Urda, M. Sanchez Garcia, C. Mitroi, E. Gonzalez Lopez, 

F. Dominguez Rodriguez, H. Delgado, E. Perez Pereira, J. Toquero Ramos, 

I. Fernandez Lozano (Madrid, ES) 

left ventricular pacing from a site of late electrical activation improves acute 

hemodynamics in CRt patients implanted with a quadripolar left ventricular lead P188 

C. Pappone, Z. Calovic, A. Cuko, L.C. Mcspadden, K. Ryu, M. Saviano, A. Petretta, 

M. Moscatiello, R. Vitale, G. Vicedomini (Cotignola, IT; Sylmar, California, US) 

feature-tracking cardiovascular magnetic resonance as a novel technique for the 

assessment of mechanical dyssynchrony P189 

R.J. Taylor, F. Umar, C. Meyyappan, W.E. Moody, B. Stegemann, R.P. Steeds, 

J.N. Townend, F. Leyva (Birmingham, GB; Maastricht, NL) 

Risk and predictors of complications after cardiac implantable electronic device 

implantations; an analysis of a complete, nationwide cohort in denmark. P190 

R. Kirkfeldt, J.B. Johansen, E.A. Nohr, O.D. Jorgensen, J.C. Nielsen (Aarhus and Odense, DK) 

Coronary sinus lead extraction - single centre experience of 145 procedures and 

153 cs located ingrown leads P191 

A. Kutarski, B. Malecka, A. Zabek, K. Boczar, M. Czajkowski (Lublin and Krakow, PL) 

ICD lead extraction - is it more dangerous than PM lead extraction? P192 

A. Kutarski, B. Malecka, A. Zabek, K. Boczar, M. Czajkowski (Lublin and Krakow, PL) 

High prevalence of fluoroscopically detected insulation failure in st jude quiksite and 

quikflex leads. P193 

U. Lakshmanadoss, D. Lahoda, K. Anderson, P. Deshmukh (Sayre, PA, US) 

51 

sunday 

posters

sunday 

posters 


14:00 - 18:00 Poster session Poster 

Poster session 1 

Posters must be set up between 13:30 - 14:00, removed between 18:00 - 18:30, to be on display 

between 14:00 - 18:00. 

The presenter should be available by the poster during the break (15:30 to 16:30) in order to discuss 

the research with the audience. 

Atrial fibrillation 

Effects of pioglitazone on atrial ionic channel remodeling in diabetic rabbits hearts P194 

C. Liu, G. Li, H. Fu, J. Li, L. Cheng, W. Yang, T. Liu (Tianjin, CN) 

Adjunctive dose of oral flecainide or propafenone in acute management of atrial fibrillation 

patients on top 1 C antiarrhythmic drug therapy P195 

M.G. Bolognesi, L.R. Rossi, G.R. Rusticali, F.G. Groppi, D.B. Bertoncelli, M.S.P. Pisati, G.Q. Villani 

(Piacenza, IT) 

Comparing the efficacy, hospitalisation time and safety of vernakalant to propafenone in 

recent-onset atrial fibrillation in the emergency department P196 

M. Aragon, D. Conde, J.P. Costabel, M.F. Lambardi, M. Trivi, A. Giniger 

(Ciudad Autónoma de Buenos Aires, AR) 

Clinical and procedural features associated with high risk of multiple procedures to achieve 

PAf ablation P197 

S. Amraoui, N. Derval, F. Sacher, M. Hocini, M. Haissaguerre, P. Jais (Bordeaux-Pessac, FR) 

Progression of atrial fibrillation and clinical correlates in patients hospitalised for systolic 

heart failure P198 

G. Marchetti, A. Barbieri, R. Roncuzzi, M.A. Ribani, S. Urbinati (Bologna and Modena, IT) 

Lipid peroxidation disorders in patients with recent-onset atrial fibrillation P199 

A.P. Penev, M.N. Negreva, A.A. Aleksandrova (Varna and Sofia, BG) 

Clinical implications of and factors influencing spontaneous activities in dissociated 

pulmonary veins P200 

S. Chen, G. Chen, S. Liu (shanghai, CN) 

Quantitative assessment of a new generation cryoballoon ablation catheter with new cooling 

technology P201 

S. Knecht, M. Kuehne, S. Osswald, C. Sticherling (Basel, CH) 

Perimitral atrial flutter ablation by transaortic radiofrequency application P202 

A. Estrada, J. Figueroa, D. Doiny, S. Castrejon, D. Filgueiras, M. Ortega, R. Delgado, I. Plaza, 

J.L. Lopez-Sendon, J.L. Merino (Madrid, ES) 

Low voltage areas in atrial fibrillation do not correlate to LGE-MRI defined scar in patients 

with persistent atrial fibrillation. P203 

N.A. Qureshi, W. Bai, B. Ariff, S. Kim, S. Hayat, S. Jamil-Copley, W. Davies, P. Kanagaratnam, 

N. Peters, P.B. Lim (London, GB; St Paul, MN, US) 

Biomarkers of myocardial injury with different energy sources for atrial fibrillation catheter 

ablation P204 

E. Russo, M. Casella, A. Dello Russo, G. Izzo, M. Zucchetti, G. Fassini, L. Di Biase, A. Natale, 

C. Carbucicchio, C. Tondo (Milan, IT; Austin, US) 

Retinal microvascular changes and atrial fibrillation incidence: the ARIC Study P205 

S.K. Agarwal, T. Shah, F. Lopez, E.Z. Soliman, T. Wong, R. Klein, G. Heiss, J. Coresh, A. Alonso, 

R. Sharrett (Baltimore, Minneapolis, Winston-Salem, Milwaukee and Chapel Hill, US) 

52


Chronic atrial fibrillation is a risk factor for cognitive impairment? P206 

N. Diaconu, A. Grosu, C. Gratii, V. Racila, G. Pavlic (Chisinau, MD) 

Atrial fibrillation occurrence and clinical impact in heart failure patients treated with cardiac 

resynchronisation therapy defibrillators P207 

M. Santini, R. Ricci, M. Lunati, M. Landolina, A. Proclemer, G. Botto, M. Gasparini, L. Padeletti, 

A. Grammatico, G. Boriani (Rome, Milan, Pavia, Udine, Como, Rozzano, Florence and Bologna, IT) 

The effects of eosinophil on the left atrial thrombus in patients with atrial fibrillation P208 

S. Keceoglu, M. Demir, U. Uyan, M. Melek (Bursa, TR) 

The association of biomarkers of inflammation and neurohumoral activation with the 

progression of atrial fibrillation to permanent arrhythmia P209 

M. Polovina, T. Potpara, M. Licina, M.C. Ostojic (Belgrade, RS) 

Continuous rhythm-monitoring following catheter ablation of paroxysmal or persistent atrial 

fibrillation, long term data of patients with implanted pacemaker or ICD P210 

H. Servatius, C. Schad, B.A. Hoffmann, J. Lueker, A. Sultan, B. Schaeffer, M.A. Aydin, 

D. Schreiber, S. Willems, D. Steven (Hamburg, DE) 

Outcome of thoracoscopic epicardial left atrial posterior box lesion with bipolar 

radiofrequency energy in treatment of longstanding persistent atrial fibrillation P211 

M.G. Compier, J. Braun, P. Klein, K. Zeppenfeld, R.J.M. Klautz, M.J. Schalij, S.A. Trines (Leiden, NL) 

Mesh ablator vs. Cryoballoon vs. PVAC for pulmonary vein ablation of symptomatic 

paroxysmal atrial fibrillation: acute and long term results P212 

A. Pappalardo, A. Avella, P.G. De Girolamo, F. Laurenzi (Rome, IT) 

Pulmonary vein isolation for atrial fibrillation has no short-term effect on cognitive function: 

a comparison of different ablation techniques P213 

A. Kiss, E. Nagy-Balo, I. Edes, Z. Csanadi (Debrecen, HU) 

intra-tissue ablation & visualisation system to monitor lesion formation to minimise 

extracardiac ablation P214 

M.J. Wright, D. Haines, E. Harks, F. Zuo, F. Budzelaar, D. Rankin, W.C. Stoffregen, J. Nguyen, 

V. Reddy, P. Jais (London, GB; Royal Oak, San Jose and New York, US; Best and Eindhoven, NL; 

Bordeaux, FR) 

A segmental approach is superior to a circumferential approach for pulmonary vein isolation 

using the endoscopic laserballoon P215 

A. Metzner, P. Rausch, R.R. Tilz, A. Rillig, S. Mathew, S. Deiss, F. Ouyang, K.H. Kuck, E. Wissner 

(Hamburg, DE) 

Optimisation of electrogram filtering enables activation mapping of wavelets during human 

atrial fibrillation. insights from multi-electrode mapping in AF P216 

A. Jadidi, S. Kim, H. Lehrmann, C.I. Park, R. Weber, J. Schiebeling-Roemer, J. Allgeier, P. Jais, 

M. Haissaguerre, T. Arentz (Bad Krozingen, DE; Saint Paul, US; Bordeaux, FR) 

A three-year improvement in quality of life, hospitalisations and working incapacity after 

ablation for paroxysmal versus long-standing persistent atrial fibrillation P217 

V. Bulkova, M. Fiala, S. Havranek, L. Souckova, J. Simek, J. Pindor, J. Januska, M. Novak, 

D. Wichterle (Brno, Trinec and Prague, CZ) 

Homogenous lesion formation as mechanism for higher procedural efficiency of the novel 

entire-tip irrigated rf ablation technology (thermocool sf) in patients undergoing pulmonary 

vein isolation P218 

P. Schurr, C.I. Park, H. Lehrmann, R. Weber, J. Schiebeling-Roemer, J. Allgeier, 

C. Herrera Siklody, D. Shah, T. Arentz, A. Jadidi (Bad Krozingen, DE; Geneva, CH) 

53 

sunday 

posters

sunday 

posters 


Catheter ablation/except atrial 

Biventricular distribution of human ventricular fibrillation rotors P219 

D.E. Krummen, D.J. Morris, J. Ho, M.R. Smetak, W.-J. Rappel, S.M. Narayan (San Diego, US) 

Association between endocardial and epicardial unipolar mapping and late enhancement 

imaging scar characteristics in patients with prior myocarditis-related ventricular tachycardia P220 

J. Silberbauer, G. Maccabelli, A. Esposito, D. Tsiachris, C. Colantoni, F. Baratto, C. Bisceglia, 

F. De Cobelli, A. Del Maschio, P. Della Bella (Milan, IT) 

Electroanatomical substrate-guided catheter ablation of ventricular tachycardia: is additional 

activation mapping required to improve results? P221 

G. Izzo, E. Russo, V. Marino, A. Dello Russo, M. Casella, M. Zucchetti, L. Di Biase, A. Natale, 

C. Tondo, C. Carbucicchio (Milan, IT; Texas, US) 

lower catheter tip temperatures are associated with inhomogeneous lesion formation 

during radiofrequency catheter ablation in a canine thigh muscle model P222 

F. Akca, E. Zima, E. Vegh, G. Szeplaki, J. Skopal, M. Hubay, Z. Lendvai, B. Merkely, T. Szili-Torok 

(Rotterdam, NL; Budapest, HU) 

local ventriculo-atrial intervals during tachycardia and entrainment: diagnostic value for 

supraventricular tachycardia mechanism. P223 

D. Calvo Cuervo, P. Avila, J. Garcia-Fermandez, E. Gonzalez-Torrecilla, J.M. Rubin, F. Atienza, 

G. Eidelman, A. Arenal (Oviedo, Madrid and Burgos, ES) 

Single center experience of fluoroless AVNRT ablation guided by electroanatomic 

reconstruction in children and adolescents P224 

E. Ebrille, M. Scaglione, D. Caponi, A. Blandino, P. Di Donna, A. Siboldi, G. Bertero, F. Gabbarini, 

M. Marasini, F. Gaita (Turin, Asti and Genoa, IT) 

A new criterion based on virtual unipolar electrogram morphology to distinguish left from 

right outflow tract tachycardia origin P225 

A. Radinovic, N. Trevisi, P. Vergara, G. Maccabelli, P. Della Bella (Milan, IT) 

Utility of a contact force catheter on atrial based right sided radiofrequency ablation P226 

J. Chaumont, M. Badra, J.F. Roux, S. Rivera, D. Arseneau, F. Ayala Paredes (Montreal and 

Sherbrooke, CA) 

Catheter ablation of arrhythmias with exclusive electroanatomic mapping: a case series P227 

L.M. Pires, T.L.L. Leiria, M.L. Kruse, R. Ronsoni, C.S. Gensas, G.G. De Lima (Porto Alegre, BR) 

impact on catheter design and orientation on contact force in magnetically guided catheters P228 

G. Noelker, B.G. Muntean, D. Horstkotte, K.J. Gutleben (Bad Oeynhausen, DE) 

Relationship between pressure and depth in an experimental model of cavoriscuspid isthmus 

ablation with force monitoring contact systems. P229 

R. Matia, A.H. Madrid, L. Carrizo, A. Delgado, H. Del Castiilo-Carnevali, S. Fernandez-Santos, 

C. Lazaro, C. Pindado, C. Moro, J. Zamorano (Madrid, ES) 

Underlying scar tissue significantly influences impedancebBased catheter tip-to-tissue 

contact assessment P230 

M. Izquierdo De Francisco, J.M. Sanchez-Gomez, J. Nunez, A. Ferrero, A. Martinez, V. Gonzalez, 

S. Morell, J. Chorro, R. Ruiz-Granell (Valencia, ES) 

Objectivisation of pace mapping by automated matching technique in patients ablated due to 

outflow tract ventricular arrhythmias. P231 

R. Kuteszko, M. Pytkowski, M.M. Farkowski, A. Maciag, A. Jankowska, D. Zajac, H. Szwed 

(Warsaw, PL) 

54


Electrophysiological and anatimical differences of the reentrant circuit between the fast-slow 

form and slow-slow form of atrioventricular nodal reentrant tachycardia 232 (W) 

Y. Nakatani, K. Kumagai, K. Mizumaki, K. Nishida, T. Sakamoto, Y. Yamaguchi, N. Kataoka, 

S. Naito, H. Inoue (Maebashi and Toyama, JP) 

incremental His-to-coronary sinus ostium distance maneuver for complete cavo-tricuspid 

isthmus conduction block Assessment P233 

E. Valles Gras, V. Bazan, B. Benito, M.E. Jauregui, J. Bruguera, J. Marti (Barcelona, ES) 

Cryotherapy ablation for septal accessory pathways in children P234 

M. Swissa, T. Dagan, E. Bruckheimer, E. Birk, R. Fogelman (Rehovot and Petach Tikva, IL) 

Electro physiological study and ablation in children with asymptomatic Wolff-Parkinson- 

White syndrome P235 

M. Swissa, G. Yager-Yarom, T. Dagan, E. Bruckheimer, E. Birk, R. Fogelman (Rehovot and 

Petach Tikva, IL) 

Sudden cardiac death and implantable defibrillators 

clinical impact of late revealing ECG abnormalites in patients with idiopathic ventricular 

fibrillation and unknown cause ventricular tachycardia undergoing impantable cardioverter 

defibrillator P236 

K.H. Lee, H.Y. Park, J.G. Cho, N.S. Yoon, K.H. Park, D.S. Sim, Y.J. Hong, Y.K. Ahn, M.H. Jeong, 

J.C. Park (Gwangju, KR) 

flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with 

CAsQ2 associated catecholaminergic polymorphic ventricular tachycardia P237 

I. Marai, M. Boulos, M. Suleiman, M. Blich, A. Khoury (Haifa, IL) 

Assessment of heart rate turbulence in ischaemic cardiomyopathy patients with implantable 

cardioverter defibrillator (ICD) shock therapy P238 

E. Cekirdekci, N. Cakmak, I. Tekkesin, C. Turkkan, B. Erer, T. Alper, K. Gurkan (Istanbul, TR) 

syncope in primary prevention P239 

G. Goldenberg, T. Bental, R. Zarabroski, J. Kusniek, U. Kadmon, G. Golovchiner, M. Haim, 

B. Strasberg (Petah Tikva, IL) 

Mortality in iCd recipients and the relationship with renal function. P240 

M.S. Buiten, A.C. Van Der Heijden, J.I. Rotmans, J.W. Jukema, M.J. Schalij, L. Van Erven (Leiden, NL) 

Predictive value of deceleration and acceleration capacity for risk stratification of sudden 

cardiac death in patients after myocardial infarction P241 

E. Okisheva, D. Tsaregorodtsev, V. Sulimov (Moscow, RU) 

Implantable cardioverter defibrillator therapies and mortality in elderly patients. Long term 

follow up. P242 

N. Galizio, N. Martinenghi, M. Mysuta, X. Vallejos, F. Robles, A. Palazzo, G. Carnero, 

A. Gargano, J. Gonzalez (Capital Federal, AR) 

Additional criteria of long Qt diagnostics and primary prevention of sudden cardiac death in 

athletes P243 

L.A. Balykova, L.M. Makarov, V.N. Komolyatova, I.A. Gorbunova, N.V. Zhekina (Saransk and 

Moscow, RU) 

i123-MibG prognostic value in patients with idiopathic cardiomyopathy candidate to iCd: 

a pilot study. P244 

F. Rabajoli, G. Scrima, G. Bertuccio, G. Canavese, C. Tolardo, C. Checchinato, M. Imazio, 

E. Brscic, M.T. Spinnler (Moncalieri and Torino, IT) 

55 

sunday 

posters

sunday 

posters 


Efficacy of primary preventive ICD therapy in an unselected population of patients with 

reduced left ventricular ejection fraction. P245 

R. Borgquist, I. Litterfeldt, J. Brandt, C.-J. Hoijer, F. Holmqvist, P.G. Platonov (Lund, SE) 

Remote monitoring for implantable defibrillators: the nation-wide Italia-RPM survey P246 

M. Luzi, A. De Simone, C. Amellone, S. Favale, E. Pisano, M.G. Bongiorni, R. Luise, F. Folino, 

F. Accardi, G. Buja (Ancona, Maddaloni, Ciriè (Turin), Bari, Lecce, Pisa, L'Aquila, Padua and Milan, IT) 

location and degree of conductor externalization in recalled st. Jude Medical Riata 

defibrillator leads. Results of a nation-wide fluoroscopic screening. P247 

J.M. Larsen, S. Riahi, J.C. Nielsen, R. Videbaek, J. Haarbo, K.M. Due, D.A.M.J. Theuns, 

J.B. Johansen (Aalborg, Aarhus, Copenhagen, Gentofte and Odense, DK; Rotterdam, NL) 

Is post-mortem evaluation of cardiac rhythm management devices useful? P248 

P. Nolan, S. Hynes, S. Tuohy, B.D. Macneill, P.J. Nash, J. Crowley, K. Daly (Galway, IE) 

Prevalence of Riata lead failure according to lead-specific relative risk among 680 ICD carriers P249 

K. Kouraki, M. Strauss, A. Skarlos, R. Zahn, T. Kleemann (Ludwigshafen am Rhein, DE) 

Single centre experience on multi-brand implantable cardioverter-defibrillator (ICD) 

replacements, what is their real longevity? P250 

R. Salgado Aranda, E. Mejia Martinez, A. Fontenla Cerezuela, M. Lopez Gil, R. Salguero Bodes, 

S. Mayordomo Gomez, J. Molina Martin De Nicolas, B. Diaz Anton, B. Rubio Alonso, 

F. Arribas Ynsaurriaga (Madrid, ES) 

Implantable cardioverter defibrillator oversensing in the operating room P251 

P.M. Dejong, A.M. Baranchuk, K.A. Michael, D.P. Redfearn, H. Abdollah, C.S. Simpson (Kingston, CA) 

Pacing 

impact of body mass index on the development of pocket hematoma P252 

J.P. Guo, W.Y.T. Wang (Beijing, CN) 

transvenous lead Extraction in Octagenarians. P253 

E.V. Dovellini, A. Michelucci, L. Giurlani, G. Cerisano, R. Valenti, M. Trapani, D. Antoniucci 

(Florence, IT) 

frequency of thrombotic vessel obstruction after pacemaker- or iCd -implantation P254 

H. Bogossian, I. Ninios, F. Hasan, D. Mijic, Z. Karosiene, B. Lemke, M. Zarse, A. Kloppe 

(Luedenscheid, Witten and Bochum, DE) 

Safety and efficacy of dabigatran therapy in patients undergoing cardiac rhythm devices 

interventions P255 

J. Kosiuk, S. Nedios, A. Darma, E. Koutalas, M. Doering, S. Richter, G. Hindricks, A. Bollmann 

(Leipzig, DE) 

Use of transesophageal Echocardiogram in patients undergoing laser lead extraction P256 

Y. Okamoto, C. Balabanoff, R. Carrillo (Okayama, JP; Miami, US) 

Pocket infections treated by negative pressure wound therapy P257 

T. Mcgarry, R. Joshi, H. Kawata, J. Patel, G. Feld, U. Birgersdotter-Green, V. Pretorius 

(San Diego, US) 

Influence of remote monitoring systems on prognosis in an unselected population of ICD 

recipients P258 

J. Fernandez-Pastor, J.L. Pena- Hernandez, F.J. Alzueta- Rodriguez, C. Medina-Palomo, 

A. Linde- Estrella, A. Barrera-Cordero, E. De Teresa-Galvan (Malaga, ES) 

Mid-long term follow-up of patients submitted to Percutaneous lead Extraction (PlE): a 

single centre experience P259 

G. Mascioli, B. Nikoloz, E. Lucca, C. Belvito, F. Canevese, F. Michelotti (Bergamo, IT) 

56


impact of the Advisa MRi surescan pacing system on the diagnostic quality of cardiac 

magnetic resonance images and contraction patterns of cardiac muscle tissue during scans P260 

J. Schwitter, M. Kanal, M. Schmitt, F. Anselme, T.A. Albert, D.L. Hayes, D.B. Bello, A. Toth, 

Y. Chang, T. Sommer (Lausanne, CH; Pittsburgh, Salinas, Rochester MN, Orlando and Mounds 

View, US; Manchester, GB; Rouen, FR; Budapest, HU; Neuwied, DE) 

Transvenous removal of ICD leads: riata vs sprint fidelis P261 

L. Segreti, G. Zucchelli, E. Soldati, A. Di Cori, R. De Lucia, S. Viani, L. Paperini, A. Boem, 

D. Levorato, M.G. Bongiorni (Pisa, IT) 

A comparison between lead extraction results using 80 Hz and 40 Hz laser-powered sheaths P262 

L. Bontempi, M. Elmaghawry, M. Cerini, A. Lipari, C. Pagnoni, F. Vassanelli, A. Raweh, 

E. Locantore, F. Salghetti, A. Curnis (Brescia and Milan, IT; Aswan, EG) 

Evaluation of same-day home discharge after cardiac pacing devices implantation P263 

J. Fernandez-Pastor, J. Rodriguez-Capitan, J.L. Pena- Hernandez, I. Fernandez-Perez, 

C. Medina-Palomo, A. Linde- Estrella, A. Barrera-Cordero, F.J. Alzueta- Rodriguez, 

E. De Teresa-Galvan (Malaga, ES) 

Extrathoracic subclavian vein puntcure without contrast venography for pacemaker and 

defibrillator leads implantation. P264 

D. Antonelli, A. Feldman, A.N. Freedberg, Y. Turgeman (Afula, IL) 

follow up of phrenic nerve stimulation measurements in quadripolar left ventricular lead 

implanted patients P265 

J. Alzueta Rodriguez, F. Cabrera Bueno, J. Olague Ros, I. Fernandez-Lozano, J.J. Garcia Guerrero, 

J. Fernandez De La Concha, A. Hernandez Madrid, J.M. Tolosana Viu (Malaga, Valencia, Madrid, 

Badajoz and Barcelona, ES) 

deterioration of left ventricular (lV) systolic function in patients (Pts) treated with 

antibradycardic pacemakers (PM) and rightventricular (RV) stimulation: is it a clinically 

relevant problem? P266 

M. Ebert, T. Blum, C. Maring, C. Restle, J. Stockinger, T. Arentz, D. Kalusche 

(Freiburg - Bad Krozingen, DE) 

Resynchronisation therapy 

discrepancy between echocardiographic and patient-reported CRt response: results of the 

PsyHEARt-CRt study P267 

H. Versteeg, J. Van 'T Sant, S.S. Pedersen, P.A. Doevendans, J. Denollet, M.J. Cramer, M. Meine 

(Utrecht and Tilburg, NL) 

Impact of atrial fibrillation-related inappropriate shocks on clinical outcome in heart failure 

patients treated with cardiac resynchronisation therapy defibrillators P268 

M. Landolina, M. Santini, M. Gasparini, M. Lunati, G. Boriani, R. Ricci, L. Padeletti, 

A. Grammatico, S. Bisetti, A. Proclemer (Pavia, Rome, Rozzano, Milan, Bologna, Florence and Udine, IT) 

Comparison of the change of intrinsic AV intervals with increased heart rate associated 

with atrial pacing between chronotropic competent and incompetent patients: results of the 

RAVE study P269 

M.R. Gold, Y. Yu, J.L. Sturdivant, J. Everidge, P. Kaveney, C. Athill (Charleston, St. Paul and San Diego, US) 

follow up of capture threshold measurements in quartet lead implanted patients P270 

F. Cabrera Bueno, J. Alzueta Rodriguez, J. Olague Ros, I. Fernandez-Lozano, J.J. Garcia Guerrero, 

J. Fernandez De La Concha, A. Hernandez Madrid, J.M. Tolosana Viu (Malaga, Valencia, Madrid, 

Badajoz and Barcelona, ES) 

57 

sunday 

posters

sunday 

posters 


CRt therapy in iAbP dependent heart failure patients P271 

Z. Kis, Z. Som, P. Abraham, A. Csillik, K. Zupan, S. Szoke, Z. Piroth, P. Andreka, C. Foldesi, 

A. Kardos (Budapest, HU) 

is there any alternative for patients in nyHA iii heart failure and low ejection fraction not 

qualified for CRT? P272 

T. Chwyczko, E. Smolis-Bak, M. Sterlinski, A. Maciag, R. Dabrowski, I. Kowalik, A. Borowiec, 

M. Pytkowski, H. Szwed (Warsaw, PL) 

short electrode spacing on left ventricular quadripolar leads enables a targeted lV site pacing 

for CRt despite phrenic nerve stimulation P273 

M. Biffi, E. Schotzko, L. Foerster, J. Schell, J. Sommer, C. Bounds, P. Yang (Bologna, IT; Minneapolis, US) 

Offline clinical performance of a hybrid left ventricular autothreshold technology in a clinic 

follow-up setting P274 

D. Mahajan, G. Kalahasty, C. Schulze, M. Giudici, M. Vloka, A. Brisben, S. Shome, S. Eddy, 

V. Huebert, K.A. Ellenbogen (St Paul, Richmond, Yardley, Iowa City and Wauwatosa, US) 

loss of continuous biventricular pacing in cardiac resynchronisation therapy patients: 

incidence, causes and outcomes P275 

M. Pachon, M.A. Arias Palomares, T. Colchero, A. Puchol, J. Jimenez-Lopez, F. Lopez-Sanchez, 

L. Rodriguez-Padial (Toledo, ES) 

Using surface ECG for cardiac resynchronisation therapy optimisation P276 

V. Lebedeva, T. Lubimceva, D. Lebedev (Saint Petersburg, RU) 

Does left atrial early negative strain predict outcome after cardiac resynchronisation therapy? P277 

N. Moreira, F. Soares, R. Teixeira, N. Antonio, L. Elvas, R. Martins, A.J. Barbosa, M.J. Ferreira, 

M. Pego (Coimbra, PT) 

should reduction in left ventricular end-systolic volume be used to assess response to 

biventricular pacing? P278 

F. Soares, N. Moreira, N. Antonio, R. Teixeira, R. Martins, J. Cristovao, M. Ventura, L. Elvas, 

L. Goncalves, M. Pego (Coimbra, PT) 

Relation of QRs duration to left ventricular dyssynchrony in patients with dilated 

cardiomyopathy: tissue velocity and strain imaging study P279 

H. Mohamed Fereig Hamed, A. Hamdy, M. Nabih, A. Abd El Aziz, A. Ahmed Ali (Cairo, EG) 

three-dimensional trajectory of coronary sinus lead tip in CRt recipients: relations with left 

ventricular resynchronisation P280 

S. Severi, D. Turco, M. Margheri, S. Argnani, A. Dal Monte, I. Rubino, C. Corsi, C. Tomasi 

(Bologna, Ravenna and Lugo (RA), IT) 

is routine adjustment of pacing intervals after implantation worthwhile for response 

following cardiac resynchronisation therapy (CRT)? P281 

D.H. Brahmbhatt, V. Nayar, F.Z. Khan, L. Ayers, D.P. Dutka, P.J. Pugh (Cambridge, GB) 

Effectively delivered CRt using wireless endocardial pacing in previous CRt non-responder P282 

F. Regoli, M. Acena, E. Pasotti, T. Moccetti, A. Auricchio (Lugano, CH) 

triventricular pacing in patients non responders to cardiac resynchronisation P283 

P. Mondoly, C. Cardin, A. Rollin, E. Thomson, R. Noblemaire, M. Rezai, P. Maury, M. Delay, 

D. Carrie, A. Duparc (Toulouse, FR) 

58


Cardiac arrhythmias, non invasive 

t peak-t end interval as a risk factor for iCd therapies in patients with arrhythmogenic right 

ventricular cardiomyopathy P284 

K. Yalin, E. Golcuk, E.B. Karaayvaz, A. Elitok, A.K. Bilge, K. Adalet (Istanbul, TR) 

st segment depression during supraventricular tachycardia determined by VA intervals P285 

S. Rivera, M. Ricapito, M. Badra, J.F. Roux, F. Ayala-Paredes (Sherbrooke, CA) 

Early repolization variant frequently detected in young adults in Algeria P286 

W. Amara, N. Hammoudi, S. Bouallouche, A. Elhraiech, R. Bougherbal (Montfermeil, FR; Alger, DZ) 

the Jt interval is inversely correlated with ventricular depolarisation time P287 

E. Kramarz, K. Makowski (Warsaw, PL) 

Prevalence and clinical predictors of elevated electromagnetic QRs-fragmentation index in 

patients with acute myocardial infarction undergoing cardiac magnet field imaging P288 

T. Kleemann, K. Kouraki, M. Strauss, H. Zarif, R. Zahn, U. Zeymer (Ludwigshafen, DE) 

Relation of the depression with proarrhythmogenic electrocardiographic parameters. P289 

S. Bulur, S. Selek, S. Bulur, O. Alper Alkoc, E. Onder, S. Albayrak, Y. Aslantas, I. Ekinozu 

(Istanbul, TR) 

detection of Atrial Electromechanical dysfunction in non-dipper Pre-Hypertensive Patients P290 

S. Ozturk, A. Erdem, F. Ozlu, S. Ayhan, M. Yazici (Bolu, TR) 

Microvolt t-wave alternation as predictor of ventricular tachyarrhythmic events in patients 

with non-ischaemic dilated cardiomyopathy and iCd P291 

T. Vaikhanskaya, I. Sidorenko, T. Kaptsiukh, T. Kurushko, V. Hlianishcha (Minsk, BY) 

What is the necessary intermittent rhythm monitoring frequency required for reliable atrial 

fibrillation recurrence detection? Insights from continuously monitored patients using a 

robust probabilisti P292 

E. Charitos, U. Stierle, P.D. Ziegler, H.H. Sievers, T. Hanke (Luebeck, DE; Minneapolis, US) 

Association of anabolic steroids and autonomic cardiovascular risk in athletes P293 

O. Barbosa Neto, M. Marocolo Junior, G. Ribeiro Mota, E. Januario Nogueira, R. Silva Cortes, 

V.J. Dias Da Silva (Uberaba, BR) 

interruption of anabolic steroid treatment does not reverse the dysfunction caused on 

ventricular repolarisation and autonomic cardiac system in rats P294 

M. Marocolo, G. Ribeiro Da Mota, D. Schimitz De Freitas, W. Wey Moreira, O. Barbosa Neto 

(Uberaba and Juiz de Fora, BR) 

Pregnancy in patients with brugada syndrome P295 

M. Rodriguez Manero, R. Casado-Arroyo, A. Sarkozy, E. Leyse, J. Sieira, M. Namdar, 

G.B. Chierchia, G. Conte, M. Levinstein, P. Brugada (Brussels, BE) 

Heart rate: an important confounder in the assessment of left atrial volume P296 

P. Haemers, R. Willems, P. Claus (Leuven, BE) 

Circadian and seasonal variations of cardiac arrest and ventricular arrhythmias in patients 

with arrhythmogenic right ventricular cardiomyopathy P297 

E. Chong, Y.J. Lin, S.A. Chen (Singapore, SG; Taipei, TW) 

59 

sunday 

posters

MONDAY SESSIONS 

Techno Live and In the Cath Lab sessions 

Building on the success of the Congress in 2011 the “Techno Live” case 

transmissions will be broadcast to Athens allowing the audience to closely 

follow the procedures and benefit from the experience of the experts. 

Additionally pre-recorded cases have been added this year as “In the Cath 

Lab” sessions and will be presented within an interactive format where 

real life challenging cases will be: 

• Demonstrated by the experts 

• Discussed with the audience 

• Concluded with recommendations and take-home messages 

On Sunday, Monday and Tuesday 

in Room Rhodes 

61 

monday 

sessions

MOndAy 24 JUnE 2013 - MORNING 

08:30 - 10:00 Meet the Experts Crete 

State of the art lecture: cardiac resynchronisation therapy 

Chairpersons: E. simantirakis (Heraklion, GR); M. santini (Rome, it) 

translational 

08:30 Molecular basis on left ventricular dyssynchrony. 298 


08:52 non-invasive strategies to predict CRt response. 299 

D. Francis (London, GB) 

09:15 Optimal implantation procedure 300 

A. Auricchio (Lugano, CH) 

09:37 Multiscale computer simulations. 301 

F.W. Prinzen (Maastricht, NL) 

08:30 - 10:00 Oral Abstract session Rhodes 

Flash abstract presentations: atrial fibrillation ablation 

Chairpersons: R. Cappato (san donato, it); to be announced 

Each speaker will present and discuss their research. This same research will also be available in a poster 

format for discussion and presentation in a dedicated zone of the Poster area. 

08:30 direct or coincidental elimination of stable rotors and focal sources explains 

successful ablation of atrial fibrillation 302 

S. Narayan, D. Krummen, P. Clopton, K. Shivkumar, J. Miller (San Diego, Los Angeles 

and Indianapolis, US) 

08:38 similar results between sites new to focal impulse and rotor modulation (fiRM) for 

atrial fibrillation and original sites 303 

S. Narayan, J. Day, K. Ellenbogen, J. Hummel, R.C. Kowal, J. Miller, V. Reddy, 

K. Shivkumar, J. Steinberg, K. Wheelan (San Diego, Murray, Richmond, Columbus, 

Dallas, Indianapolis, New York, Los Angeles and Ridgewood, US) 

08:46 Ablation effect indicated by impedance fall is correlated with contact force level 

during ablation for atrial fibrillation 304 

A. De Bortoli, L.Z. Sun, E. Solheim, P.I. Hoff, P.M. Schuster, O.-J. Ohm, J. Chen 

(Bergen, NO) 

08:54 Enhanced efficiency of a novel porous irrigated RF ablation catheter for pulmonary 

vein isolation 305 

C.I. Park, H. Lehrmann, R. Weber, C. Keyl, J. Allgeier, J. Schiebeling, P. Schur, D. Shah, 

T. Arentz, A. Jadidi (Bad Krozingen, DE; Geneva, CH) 

09:02 two major determinants for durable lesion formation in PVi: lesion to target 

distance and catheter-tissue contact force 306 

C.I. Park, H. Lehrmann, R. Weber, C. Keyl, J. Schiebeling, J. Allgeier, A. Arentz, A. Jadidi 


63 

monday 

sessions

MOndAy 

sEssiOns 

moNday 24 JuNe 2013 - morning 

08:30 - 10:00 Oral Abstract session Rhodes 

Flash abstract presentations: atrial fibrillation ablation (continued) 

Chairperson: R. Cappato (san donato, it) 



09:10 Accurate determination of catheter-tissue interaction with intra-tissue visualisation 

& ablation system 307 

M.J. Wright, D. Haines, S. Deladi, E. Harks, N. Mihajlovic, D. Rankin, W.C. Stoffregen, 

J. Nguyen, V. Reddy, P. Jais (London, GB; Royal Oak, San Jose and New York, US; 

Best and Eindhoven, NL; Bordeaux, FR) 

09:19 Differences in the inflammatory response generated by radiofrequency and 

cryoballon catheter ablation in patients with atrial fibrillation 308 

T. Tahin, O.M. Kovacs, L. Geller, S.Z. Szilagyi, I. Osztheimer, Z.S. Jenei, Z. Prohaszka, 

B. Merkely, G. Szeplaki (Budapest, HU) 

09:27 increased incidence of esophageal thermal lesions using the second-generation 

28mm cryoballoon 309 

A. Metzner, A. Burchard, P. Wohlmuth, P. Rausch, A. Bardyszewski, R.R. Tilz, A. Rillig, 

F. Ouyang, K.H. Kuck, E. Wissner (Hamburg, DE) 

09:35 Cryoballoon versus radiofrequency for pulmonary vein re-isolation after a failed 

initial ablation procedure in patients with paroxysmal atrial fibrillation 310 

A. Romanov, E. Pokushalov, S. Artyomenko, V. Baranova, D. Losik, S. Bairamova, 

A. Karaskov, J.S. Steinberg, S. Mittal (Novosibirsk, RU; New York, US) 

09:43 Ganglionated plexi ablation vs linear ablation in patients undergoing pulmonary vein 

isolation for persistent/longstanding persistent atrial fibrillation: a randomized 

comparison 311 

E. Pokushalov, A. Romanov, D. Katritsis, S. Artyomenko, N. Shirokova, A. Karaskov, 

S. Mittal, J.S. Steinberg (Novosibirsk, RU; Athens, GR; New York, US) 

09:51 Mri-guided approach to localize and ablate gaps in repeated atrial fibrillation ablation 

procedure: a pilot study. 312 

F. Bisbal, E. Guiu, A. Berruezo, P. Cabanas, S. Prat, B. Vidal, J. Fernandez-Armenta, 

T.M. De Caralt, J. Brugada, L. Mont (Barcelona, ES) 

64



Mapping and ablation of focal atrial tachycardias 

Chairpersons: J. Kautzner (Prague, CZ); M. lunati (Milan, it) 


Mechanisms, challenging localisation and diagnosis of atrial tachycardias. 

08:30 Electrophysiological characteristics and ablation approach to focal atrial tachycardias 

originating from the aorta. 313 

R. Pap (Szeged, HU) 

08:52 focal atrial tachycardias demonstrating early septal activation: can we tell left from 

right before the transseptal? 314 

V.B. Traykov (Sofia, BG) 

09:15 focal atrial tachycardias originating from the atrial appendages: electrophysiological 

characteristics and ablation. 315 

J. Kalman (Victoria, AU) 

09:37 P wave morphology during focal atrial tachycardia: can we trust the algorhythms? 316 

S.P. Fynn (Cambridge, GB) 

08:30 - 10:00 special session lefkada 

European-wide surveys on the practice and real world status in clinical 

electrophysiology 

Chairpersons: C. blomstrom-lundqvist (Uppsala, sE); J.H. svendsen (Copenhagen, dK) 


08:30 lead extraction in clinical practice. 317 


08:45 MRi in devices. 318 

G. Marinskis (Vilnius, LT) 

09:00 Surgical and hybrid atrial fibrillation. Ablation procedures. 319 

L. Pison (Maastricht, NL) 

09:15 Periprocedural anticoagulation therapy. 320 


09:30 Atrial fibrillation ablation techniques and strategies. 321 

T. Lewalter (Munich, DE) 

09:45 Management of survival of out of hospital arrest. 322 

A. Proclemer (Udine, IT) 

65 

monday 

sessions

MOndAy 

sEssiOns 


08:30 - 10:00 Main session Kythira 

Ablation techniques in atrial fibrillation and in VT/VF (Part I). Atrial 

fibrillation: case-based presentations 

session organised by Cardiostim 

Chairpersons: M. O’neill (london, Gb); E. Pruvot (lausanne, CH) 


The aim of these two sessions is to discuss in depth the methods to ablate complex arrhythmias and 

the tools used to achieve procedure success. The first session will focus on atrial arrhythmias, and the 

second, on ventricular arrhythmias. 

08:30 Management of asymptomatic Paroxysmal atrial fibrillation. 323 

M.O’neill (London, GB) 

09:00 Step by step analysis and treatment of atrial tachycardias after atrial fibrillation ablation. 324 

S. Knecht (Bruxelles, BE) 

09:30 Role of non-invasive cartography for persistent atrial fibrillation. 325 

M. Hocini (Pessac, FR) 


Microcompartments in cell function 


Chairpersons: J.-P. benitah (Chatenay-Malabry, fR); E. Cerbai (florence, it) 

basic science 

08:30 t-tubules and cardiac electrical activity. 326 

C. Orchard (Bristol, GB) 

09:00 selective modulation of coupled ryanodine receptors during microdomain activation 

of CaMKii in the dyadic cleft. 327 

E. Dries (Leuven, BE) 

09:15 A vital role for Amphiphysinii in controlling t-tubule formation in cardiac muscle. 328 

J. Caldwell (Manchester, GB) 

09:30 Superresolution analysis identifies proliferative changes of excitable membranes 

(t-tubules) during cardiac remodeling leading to orphaning of Ca2+ release sites and 

prolonged action potentials 329 

E. Wagner, T. Kohl, H.T.M. Tuan, V. Westphal, U. Parlitz, S. Luther, S.W. Hell, M.S. Jafri, 

W.J. Lederer, S.E. Lehnart (Gottingen and Gottingen, DE; Manassas and Baltimore, US) 

09:45 PDZ-domain-binding motif regulates cardiomyocyte compartment-specific Nav1.5 

channel expression and function. 330 

H. Abriel (Bern, CH) 

66


08:30 - 10:00 symposium Mykonos 

Clues to successful catheter ablation of ventricular tachycardia: 

overcoming frequent hurdles 

Chairpersons: C. de Chillou (Vandoeuvre-les-nancy, fR); J.M. Almendral Garrote (Madrid, Es) 


The objective of this session is to analyse and to deal with regular difficult issues around ventricular 

tachycardia ablations and to prove new strategies to face them. 

08:30 the right window of opportunity. What is the optimal timing for a ventricular 

tachycardia ablation? 331 

T. Arentz (Bad Krozingen, DE) 

08:52 Adopting a different point of view. When to perform transseptal and epicardial mapping? 332 

F. Sacher (Bordeaux Pessac, FR) 

09:15 Cardiac imaging to optimise substrate mapping. image acquisition and registration in 

difficult cases. 333 

L. Mont (Barcelona, ES) 

09:37 the dilemma of non-documented ventricular tachycardia. should we really target all 

inducible ventricular tachycardia? 334 

D. Steven (Hamburg, DE) 

08:30 - 10:00 Main session santorini 

New technologies in the treatment of complex arrhythmias 

Connecting Continents - CHRs - EHRA 

Chairpersons: G. Guerra (Montreal, CA); H. Kottkamp (Zurich, CH) 

transforming 

08:30 Will balloon technologies change approaches to Af. 335 

M. Dubuc (Montreal, CA) 

08:52 Advanced radiofrequency ablation: contact sensing and lesion visualisation technologies. 336 

E. Wissner (Hamburg, DE) 

09:15 tackling Vt with new ablation tools. 337 

J.L. Sapp (Halifax, CA) 

09:37 Robotic catheter navigation: any advantages for complex arrhythmias? 338 

J.L. Merino (Madrid, ES) 

67 

monday 

sessions

MOndAy 

sEssiOns 


08:30 - 10:00 How-to session Hydra 

How to measure? 


Chairpersons: E.t. van der Velde (leiden, nl); G. schmidt (Munich, dE) 

transforming 

08:30 Scientific performance. 339 

N. Bruining (Rotterdam, NL) 

08:52 Complexity in biosignals. 340 

J.W. Kantelhardt (Halle, DE) 

09:15 Cardiac arrhythmic risk. 341 

A. Bollmann (Leipzig, DE) 

09:37 Clinical usefulness of new risk predictors. 342 

T. Schuster (Montreal, CA) 


State of the art lecture: ICD therapy and telemedicine 

Chairpersons: G. breithardt (Munster, dE); l. Kappenberger (lausanne, CH) 

transforming 

11:00 Optimal ICD implantation: do we need DFT testing? 343 


11:22 treatment strategies in iCd patients with electrical storm. 344 

M. Borggrefe (Mannheim, DE) 

11:45 Remote monitoring in iCd patients and novel sensors. 345 

C. Linde (Stockholm, SE) 

12:07 legal and economic considerations of remote monitoring. 346 

M. Landolina (Pavia, IT) 

68



Techno Live Session 


programme. 


11:00 - 12:30 special session naxos 

EHRA document 

Chairpersons: P. Kirchhof (birmingham, Gb); A. Raviele (Mestre, it) 

transforming 

11:00 left atrial appendage occluders: indications and evidence. 350 

M. Glikson (Ramat Gan, IL) 

11:18 New oral anticoagulants - practical advice for difficult situations. 351 

H. Heidbuchel (Leuven, BE) 

11:36 imaging the heart in patients undergoing ablation procedures. 352 

C. Blomstrom-Lundqvist (Uppsala, SE) 

11:54 Electrophysiological procedures in children. 353 


12:12 Health technology assessment for electrophysiological procedures. 354 



Difficult tracings with interactive discussions 

Educational session organised by the REtAC group 

Chairpersons: t. Arentz (bad Krozingen, dE); f. Halimi (le Chesnay, fR) 


11:00 surface ECGs (narrow QRs complex). 355 

M. Zimmermann (Meyrin, CH) 

11:30 intracardiac electrocardiogrammes (narrow QRs complex). 356 

T. Lewalter (Munich, DE) 

12:00 Electrocardiogrammes from pacemakers. 357 

S. Boveda (Toulouse, FR) 

69 

monday 

sessions

MOndAy 

sEssiOns 



Managing cardiac resynchronisation therapy patients (Part I) - When the 

situation is tricky 


Chairpersons: b. Wilkoff (Cleveland, Us); P. Ritter (Pessac, fR) 


The aim of these two sessions is to discuss the main steps of the therapy: patient selection, implantation 

and optimisation. These sessions are case-based and should trigger large discussions between 

presenters and attendees. 

Part I is about indications and programming. Discussions should cover the patients with RV failure, renal 

failure, chronic atrial fibrillation, very elderly patients, … 

Part II is about implantation techniques, focusing on new techniques to approach the left ventricle 

and optimize lead placement, through the veins, with robotic technology, transeptal LV endocardial, 

epicardial, … 

11:00 Atrial fibrillation in patients selected for cardiac resynchronisation therapy. 358 


11:30 Can we really do nothing for patients without LBBB? 359 


12:00 Patients are coming too late to transplantation or lVAd! 360 



Experimental models of proarrhythmia 


Chairpersons: M.A. Vos (Utrecht, nl); to be announced 

basic science 

11:00 Human iPs cells as experimental model: potential and limits. 361 

A. Hansen (Hamburg, DE) 

11:30 functional comparison of hiPs-derived cardiomyocytes of patients with familial atrial 

fibrillation and healthy individuals. 362 

A. Barbuti (Milan, IT) 

11:45 Chronic exposure to low doses of arsenic trioxide prolongs action potential 

duration in human induced pluripotent stem cells cardiomyocytes (iPsC-CMs). 363 

M. Hortigon-Vinagre (Glasgow, GB) 

12:00 tdP Arrhythmias in Methoxamine-sensitized Hypercholesterolemic Rabbit. 364 


12:15 torsadogenic proclivity in a canine model of drug-induced long-Qt1 syndrome: left- 

versus right-stellate ganglion stimulation. 365 

R. Bekke (Maastricht, NL) 

70



Clinical challenges of patients with ICD and CRT-D 

Chairpersons: l. Padeletti (florence, it); A. Quesada dorador (Valencia, Es) 

transforming 

This session will review some clinical issues and difficult decisions in ICD patients 

11:00 Which ICD and CRT-D patients does not need a device replacement? 366 

G.H. Van Welsenes (Amsterdam, NL) 

11:22 Results of ICD/CRT-D therapy in the elderly: how old is old? 367 

M.R. Gold (Charleston, US) 

11:45 When to consider iCd deactivation. 368 


12:07 How to manage sport in ICD patients? 369 



Atrial fibrillation management in 2013: what do the Guidelines tell us and 

how do they compare? 

Connecting Continents - HRs - EHRA 

Chairpersons: A. Auricchio (lugano, CH); G. Hindricks (leipzig, dE) 


11:00 Recommendations for rate control. 370 

A. Gillis (Calgary, CA) 

11:22 Recommendations for antiarrhythmic drug therapy. 371 


11:45 Recommendations for catheter ablation. 372 


12:07 Recommendations for antithrombotic therapy. 373 


71 

monday 

sessions

MOndAy 

sEssiOns 



Assessment of left-ventricular dyssynchrony 


Chairpersons: G. schmidt (Munich, dE); A. Grace (Cambridge, Gb) 

transforming 

11:00 ECG imaging. 374 

C. Kolb (Munchen, DE) 

11:22 Echocardiography. 375 

D. Francis (London, GB) 

11:45 Magnetic resonance imaging. 376 

J. Petryka (Warsaw, PL) 

12:07 Multiscale computer simulation on top. 377 

T. Delhaas (Maastricht, NL) 

72

MOndAy 24 JUnE 2013 - AFTERNOON 

12:45 - 13:45 satellite symposium Crete 

Novel oral anticoagulants for stroke prevention in atrial fibrillation: 

understanding our way forward 

Sponsored by Bristol Myers Squibb/Pfizer 

Chairpersons: A. Goette (Paderborn, dE); P.E. Vardas (Heraklion, GR) 

The session will aim at addressing the value of the novel oral anticoagulants compared with standard 

of care anticoagulation (vitamin K antagonists) in patients with non-valvular atrial fibrillation. The focus 

will be on identifying those patients that should be initiated on these new treatments in light of available 

evidence. Practical guidance for the use of this class of treatments, including Apixaban, will be provided 

and clinical situations from routine practice will be addressed. 



12:50 Anticoagulation in non-valvular atrial fibrillation (NVAF): a paradigm shift. 379 

S.H. Hohnloser (Frankfurt, DE) 

13:15 Guidance for use of novel oral anticoagulants (nOACs) in nVAf patients: the 

apixaban case. 380 


13:40 Wrap-up and conclusions. 381 

P.E. Vardas (Heraklion, GR) 

12:45 - 13:45 satellite symposium Rhodes 

Improved patient and economic outcomes with advanced HF solutions 

sponsored by st. Jude Medical 

Chairperson: C. leclercq (Rennes, fR) 

12:45 Reducing fluroscopic exposure during CRT implant. 382 

P. Sommer (Leipzig, DE) 

13:00 Addressing CRt nonresponders with multipoint pacing. 383 

Z. Calovic (Belgrade, RS) 

13:15 improving Hf patient outcomes with new technology. 384 

J. Osca Asensi (Valencia, ES) 

13:30 further improving cost effectiveness of Hf therapy options. 385 

G.L. Botto (S.Fermo Db - Como, IT) 

73 

monday 

sessions

MOndAy 

sEssiOns 

moNday 24 JuNe 2013 - afternoon 


Reducing stroke risk: early AF detection and new anticoagulants 


Chairpersons: A.J. Camm (london, Gb); P. Kirchhof (birmingham, Gb) 

Present and discuss the role of new oral anticoagulants in stroke prevention of atrial fibrillation. 

Provide an overview of the relationship between device detected atrial fibrillation and stroke and 

present the latest findings. 

Explain the role of AF monitoring in cryptogenic stroke patients. 



12:50 novel oral anticoagulants for stroke prevention in patients with Af: protecting 

patients during clinical procedures. 387 


13:05 stroke prevention strategies with Af data from implantable devices (sOs Af). 388 


13:25 Cryptogenic stroke: role of continuous Af monitoring. 389 

J. Brachmann (Coburg, DE) 

13:40 Closing remarks. 390 


74


12:45 - 13:45 satellite symposium lefkada 

Left atrial appendage closure for risk reduction of AF related stroke: 

what every electrophysiologist should know 


Chairperson: C. tondo (Milan, it) 

•To understand the new evidence for left atrial appendage closure including the PREVAIL trial results 

•To define patient selection and access for left atrial appendage closure while understanding implant 

mechanics and tissue reaction among current devices 

•To discuss the role of left atrial appendage closure versus anticoagulation for stroke prevention in atrial 

fibrillation 

•To discuss and understand the current practice 


C. Tondo (Milan, IT) 

12:50 latest insights on the clinical evidences and their meaning in daily practice: from 

PROtECt Af to PREVAil. 392 

V.Y. Reddy (New York, US) 

13:05 differences among devices: the pathophysiologist's point of view. 393 

R. Virmani (Gaithersburg, US) 

13:15 Concomitant LAAC implant and AF ablation: what have we been learning? 394 

L.V.A. Boersma (Nieuwegein, NL) 

13:25 Patient profile and referring pathway: the importance of the team approach. 395 

T.R. Betts (Oxford, GB) 

13:35 discussion and conclusion. 396 

C. Tondo (Milan, IT) 


Home Monitoring of cardiac devices: clinic efficiencies and improved 

patient outcomes 

sponsored by biOtROniK 

Chairperson: G. Hindricks (leipzig, dE) 

Discuss clinical evidence supporting use of BIOTRONIK Home Monitoring to reduce in-office followups, 

to detect anomalies earlier, and to improve clinical outcomes. Review practical issues involved 

in integrating BIOTRONIK Home Monitoring into daily clinical practice. Evaluate an appropriate 

BIOTRONIK Home Monitoring workflow model for your individual institution. 


G. Hindricks (Leipzig, DE) 

12:55 How far have we come? What’s the evidence? What’s next? 398 


13:15 integrating Home Monitoring into daily clinical practice. 399 

R.P. Ricci (Rome, IT) 

13:35 summary and conclusions. 400 

G. Hindricks (Leipzig, DE) 

75 

monday 

sessions

MOndAy 

sEssiOns 


12:45 - 13:45 satellite symposium ithaca 

Manage every lead - From implantation to extraction 

sponsored by spectranetics 

Chairperson: C.E.H. Kennergren (Goteborg, sE) 

Identify major lead components and extraction consideration and make implanters aware that some 

leads need to be revised and that some present higher risk of complication during the extraction 

procedure. Highlight the importance of a multidisciplinary team approach for successful lead extraction. 

Techniques, tools and basic principles in transvenous lead extraction. 

12:45 implant leads that can be extracted. 401 

R.G. Carrillo (Miami, US) 

13:05 Who should perform transvenous lead extraction? 402 

P. Defaye (Grenoble, FR) 

13:25 How to extract leads safely - techniques, tools and principles. 403 

B. Osswald (Dusseldorf, DE) 

12:45 - 13:45 satellite symposium Mykonos 

AF: a riddle wrapped in a mystery inside an enigma? 

sponsored by bard Electrophysiology 

Chairperson: J.M. Almendral Garrote (Madrid, Es) 

After this session, participants will gain an understanding of current thinking in relation to advanced 

mapping and pulmonary vein isolation for ablation of atrial fibrillation and patient management with 

regard to enhanced safety of pumononary vein isolation procedures. 

Debate: high tech tools are the only choice for successful pulmonary 

vein isolation. 

12:45 Pro: 404 

A. Meissner (Hattingen, DE) 

13:00 Contra: 405 

G. Stix (Vienna, AT) 

Optimizing the safety of pulmonary vein isolation. 

13:15 safety outcomes with advanced combined mapping and ablation catheters for 

pulmonary vein isolation. 406 

D.T.J. Keane (Dublin, IE) 

13:30 Minimizing silent cerebral ischaemic events during catheter ablation of atrial fibrillation. 407 

F. Gaita (Turin, IT) 

76


12:45 - 13:45 satellite symposium santorini 

Fresh perspectives on hemodynamic ambulatory optimisation in CRT 

sponsored by sorin Group 

Chairpersons: C.W. israel (bielefeld, dE); H. burri (Geneva, CH) 

Recurrent optimisation of AV- and VV timing in CRT devices has shown to improve the rate of patients 

responding favorably to this therapy. In this symposium we will discuss state-of-the-art, recurrent 

hemodynamic device-based optimisation and its impact on daily clinical practice, as well as the costeffectiveness 

of such practice 

12:45 Rationale for hemodynamic systematic CRt optimisation. 408 

F.D. Murgatroyd (London, GB) 

13:05 What does hemodynamic device-based optimisation bring to my daily practice? 409 

M.M. Oliveira (Lisbon, PT) 

13:25 Health economic benefits of optimisation. 410 

A. Proclemer (Udine, IT) 

12:45 - 13:45 satellite symposium Hydra 

Will percutaneous mitral valve repair impact your management of 

patients with mitral regurgitation? 

sponsored by Abbott Vascular 

Chairpersons: A. Auricchio (lugano, CH); K.-H. Kuck (Hamburg, dE) 


A. Auricchio (Lugano, CH) 

12:55 How to perform a percutaneous mitral valve repair. 412 

C. Butter (Bernau/Berlin, DE) 

13:05 Reaching 10.000 patients treated, what are the data telling us? 413 

S. Baldus (Hamburg, DE) 

13:25 Which patients are candidates to PMVR? 414 


13:40 take home messages. 415 

K.-H. Kuck (Hamburg, DE) 

77 

monday 

sessions

MOndAy 

sEssiOns 



State of the art lecture: novel anticoagulants in atrial fibrillation 

Chairpersons: l.H. Rasmussen (Aalborg, dK); J.-y. le Heuzey (Paris, fR) 

transforming 

Understanding the use of new oral anticoagulant for stroke prevention in AF - practical issues in daily life 

14:00 An overview of the new oral anticoagulants for stroke prevention in atrial fibrillation. 416 


14:22 What do the Guidelines currently say... and what should updates modify. 417 


14:45 Management peri-procedure (surgery, devices) and ablation. 418 

I. Savelieva (London, GB) 

15:07 special situations: ischaemic stroke and thrombolysis, acute coronary syndrome, 

PCi/stent, bridging, cardioversion etc. 419 

F. Marin (Murcia, ES) 




programme. 


14:00 - 15:30 special session naxos 

Honorary Lectures 

Chairpersons: J.M. Morgan (stockbridge, Gb); A. Auricchio (lugano, CH) 

14:00 intercontinental lecture. 

Clinically relevant advances in the molecular pathophysiology of atrial fibrillation 423 

S. Nattel (Montreal, CA) 

14:45 Einthoven lecture. 424 


78



Device and lead infections 


Chairpersons: J.-C. deharo (Marseille, fR); C.A. Rinaldi (london, Gb) 


14:00 new diagnostic methods for device infection. 425 

C. Tascini (Pisa, IT) 

14:18 lead vegetations: how big is too big. 426 

B. Valente (Lisbon, PT) 

14:36 therapeutic approaches of the infected patient. 427 

A. Pichlmaier (Hannover, DE) 

14:54 When and how to reimplant an infected patients? 428 

M.R. Sohail (Rochester, US) 

15:12 How to avoid device infection? 429 

J.H. Svendsen (Copenhagen, DK) 


Managing cardiac resynchronisation therapy patients (Part II) – The 

future is now! 


Chairpersons: b. Wilkoff (Cleveland, Us); P. Ritter (Pessac, fR) 


The aim of these two sessions is to discuss the main steps of the therapy: patient selection, implantation 

and optimisation. These sessions are case-based and should trigger large discussions between 

presenters and attendees. 

Part I is about indications and programming. Discussions should cover the patients with RV failure, renal 

failure, chronic atrial fibrillation, very elderly patients, … 

Part II is about implantation techniques, focusing on new techniques to approach the left ventricle 

and optimize lead placement, through the veins, with robotic technology, transeptal LV endocardial, 

epicardial, … 

14:00 Robots help humans! Mini-invasive surgical implantation of devices. 430 

J.L. Jansens (Brussels, BE) 

14:30 Is there a role for bifocal LV pacing in cardiac resynchronisation therapy? 431 


15:00 finally choose its position! Endocardial lV pacing. 432 


79 

monday 

sessions

MOndAy 

sEssiOns 



Gap junctions in myocardial disease 


Chairpersons: A. Zaza (Milan, it); R. Wilders (Amsterdam, nl) 

basic science 

14:00 The interplay between connexins, ion channels and fibrosis. 433 

H.V.M. Van Rijen (Utrecht, NL) 

14:30 Gap19, a peptide selectively targeting Cx43 hemichannels, confers cardioprotection 

against ischaemia/reperfusion injury. 434 

N. Wang (Gent, BE) 

14:45 the role of macrophage migration inhibitory factor in the regulation of connexin 43 

in atrial myocytes 435 

F. Rao, C.Y. Deng, Y.M. Xue, Q.H. Zhang, H. Deng, S.L. Wu (Guangzhou, CN) 

15:00 Up-regulation of myocardial connexin-43 by melatonin: novel mechanism involved in 

its antiarrhythmic effects in spontaneously hypertensive rats. 436 

N. Tribulova, T. Benova, C. Viczenczova, J. Radosinska, B. Bacova, V. Knezl, M. Zeman, 

R. Hatala (Bratislava, SK) 

15:15 Arrythmogenic remodelling in pulmonary arterial hypertension: Significant 

alterations in the atrium and atrioventricular node. 437 

I.P. Temple (Manchester, GB) 


Translational session on Brugada's syndrome 

Chairpersons: J. brugada terradellas (barcelona, Es); C. napolitano (Pavia, it) 

translational 

14:00 Should we systematically perform genetic testing in Brugada syndrome? 438 

V. Probst (Nantes, FR) 

14:22 Electrophysiological mechanisms of brugada syndrome: depolarisation vs. 

repolarisation hypothesis. 439 

P.G. Postema (Amsterdam, NL) 

14:45 Value of electrophysiological study for risk-stratification in patients with Brugada 

syndrome. 440 


15:07 Preventing ventricular fibrillation episodes in Brugada syndrome by radiofrequency 

ablation. 441 

K. Nademanee (Los Angeles, US) 

80



Reduce ICD shocks: improve quality of life 

Connecting Continents - south America - EHRA 

Chairpersons: C. Wolpert (ludwigsburg, dE); R. Oyarzun (santiago, Cl) 

transforming 

14:00 inappropriate shocks: reasons and prevention. 442 

W. Uribe (Medellin, CO) 

14:22 Reduction of appropriate shocks: role of optimal device programming. 443 


14:45 Reduction of appropriate shocks: role of drug therapy. 444 

O. Bazzino (Montevideo, UY) 

15:07 Reduction of appropriate shocks: role of catheter ablation. 445 

C. Carbucicchio (Milan, IT) 

14:00 - 15:30 Oral Abstract session Hydra 

Oral Abstract Session: outcomes in CRT 

Chairpersons: J.C. daubert (Rennes, fR); l. Kappenberger (lausanne, CH) 

14:00 Cardiac resynchronisation therapy in patients with atrial fibrillation: the CERTIFY study 446 

M. Gasparini, C. Leclercq, M. Lunati, M. Landolina, A. Auricchio, M. Santini, G. Boriani, 

A. Proclemer, A. Curnis, F. Leyva (Rozzano, Pavia, Rome, Bologna, Udine and 

Brescia, IT; Rennes, FR; Lugano, CH; Birmingham, GB) 

14:15 differences in occurrence of device therapy in echocardiographic responders and 

super responders to cardiac resynchronisation therapy 447 

A.C. Van Derh Heijden, U. Hoke, C.J.W. Borleffs, J. Thijssen, J.B. Van Rees, 

E.T. Van Der Velde, M.J. Schalij, L. Van Erven (Leiden, NL) 

14:30 Is CRT-P beneficial in heart failure patients with LBBB and LVEF 36-50%? The design 

of the MiRAClE Ef study. 448 

C. Linde, A. Curtis, G. Fonarow, K. Lee, W. Little, A. Tang, F. Levya, S. Momomura, 

T. Bergmann, M. Cowie (Stockholm, SE; Buffalo, Los Angeles, Durham, NC, 

Winston-salem and Minneapolis, US; Victoria, CA; Birmingham and London, GB; Saitama, JP) 

14:45 Right ventricular to left ventricular interlead sensed electrical delay predicts 

all-cause mortality in CRt patients 449 

V. Kutyifa, L. Geller, E. Zima, S.Z. Szilagyi, G. Szucs, V.K. Nagy, A. Kosztin, L. Molnar, 

G. Szeplaki, B. Merkely (Budapest, HU) 

15:00 Effect of intrinsic conduction delays on clinical outcomes with CRt: analysis of the 

adaptive CRt trial 450 

B. Lemke, A. Kloppe, D. Birnie, K. Aonuma, H. Krum, K.L.L. Lee, M. Gasparini, 

R. Starling, A. Sambelashvili, D.O. Martin (Luedenscheid and Bochum, DE; Ottawa, 

CA; Tsukuba, JP; Melbourne, AU; Hong Kong, HK; Rozzano, IT; Cleveland and Mounds View, US) 

15:15 decreased rate of left ventricular lead deactivation and replacement associated with 

use of a quadripolar lV lead 451 

M.P. Turakhia, M.R. Gold, A. Fischer, L.S. Sloman, C. Kumar, N. Dalal, K. Ryu, J.D. Snell, 

M. Cao (Palo Alto, Charleston, Sylmar, California and Los Angeles, US) 

81 

monday 

sessions

MOndAy 

sEssiOns 


15:30 - 16:30 special session ithaca 

The ESC Working Group on Cardiac Cellular Electrophysiology General Assembly 


State of the art lecture: atrial fibrillation ablation 

Chairpersons: s.-A. Chen (taipei, tW); K.-H. Kuck (Hamburg, dE) 

transforming 

16:30 Pathophysiology aspects of atrial fibrillation ablation. 452 

U. Schotten (Maastricht, NL) 

16:52 Ablation of paroxysmal atrial fibrillation. 453 


17:15 Ablation of persistent atrial fibrillation. 454 


17:37 Ablation of longstanding persistent atrial fibrillation. 455 

A. Natale (Austin, US) 




programme. 


16:30 - 18:00 Meet the Experts naxos 

Multimodality imaging of cardiac arrhythmias 

Chairpersons: M. Malik (Purley, Gb); n. bruining (Rotterdam, nl) 

translational 

16:30 Visualising the electrocardiogramme on a multislice computed tomography model . 459 

P. Van Dam (Nijmegen, NL) 

16:52 late enhancement as risk predictor of sudden death. 460 

H.V. Huikuri (Oulu, FI) 

17:15 Fibrosis as AF substrate identification and its impact on ablation strategies . 461 

N. Marrouche (Salt Lake City, US) 

17:37 integration o 3-dimensional mapping and MRi for epicardial Vt ablation. 462 


82



Case session: Lead extraction in challenging cases 


Chairpersons: C. butter (bernau/berlin, dE); P. defaye (Grenoble, fR) 


16:30 Extraction of Riata® leads. 463 

E. Soldati (Pisa, IT) 

16:45 Extraction of lead(s) inaccessible from the pocket. 464 

S. Boveda (Toulouse, FR) 

17:00 Extraction of coronary sinus lead(s). 465 

A. Kutarski (Jastkow Marysin, PL) 

17:15 Extraction of lead(s) damaged by a previous attempt. 466 

A. Curnis (Brescia, IT) 

17:30 Extraction of lead(s) from an occluded vessel. 467 

F.A.L.E. Bracke (Eindhoven, NL) 

17:45 Extraction in patients with anomalous placement of leads. 468 

D. Klug (Lille, FR) 


Pacing/ICDs/CRT:ECG/EGMs discussion (Part I). 



Two sessions are dedicated to ECGs and EGMs on pacing and defibrillation. The majority of ECG/EGM 

trouble shooting that can be found during pacemaker and ICD visits are covered and discussed. EGMs 

provided by the devices of 5 companies are presented, including remote monitoring data. 

16:30 Hundreds of cases in databank! Presenters:. 469 

P. Bordachar (Pessac, FR); S. Garrigue (Bordeaux, FR); S. Reuter (Bordeaux, FR); 

P. Ritter (Pessac, FR) 

17:15 Hundreds of cases in databank! Challengers:. 470 

C.W. Israel (Bielefeld, DE); P. Ammann (St.Gallen, CH) 

83 

monday 

sessions

MOndAy 

sEssiOns 



Calcium-store stability and arrhythmias 


Chairpersons: d. dobrev (Essen, dE); to be announced 

basic science 

16:30 lessons from the sERCA knock-out mouse. 471 

O.M. Sejersted (Oslo, NO) 

17:00 Calcium signalling in RyR2-R420Q mouse CPVt model. 472 

A. Zahradnikova (Chatenay-Malabry, FR) 

17:15 the effects of adrenergic agonists on irregular sarcoplasmic reticulum Ca2+-release 

in atrial myocytes from normal vs. failing canine hearts. 473 

S. Grubb (Copenhagen, DK) 

17:30 Post-operative atrial fibrillation is associated with an increase in sarcoplasmic 

reticulum calcium load in human atrial myocytes. 474 

C. E Molina (Barcelona, ES) 

17:45 discussion. 

16:30 - 18:00 Meet the Experts Mykonos 

Gap junctions under cardiac ischaemia 

Chairpersons: R. Hansen (Glostrup, dK); K. steinbach (Vienna, At) 

basic science 

16:30 The intricate interplay between sodium channels, fibrosis and connexins. 475 

H.V.M. Van Rijen (Utrecht, NL) 

16:52 the molecular interaction partners of Cx43. 476 

M. Delmar (New York, US) 

17:15 Phosphorylation of Cx43 following ischaemia. 477 

M.S. Nielsen (Copenhagen, DK) 

17:37 Mitochondrial connexins – impact on cellular respiration. 478 

K. Boengler (Essen, DE) 

84



Ablation of ventricular complex substrates 

Connecting Continents - Argentina - EHRA 

Chairpersons: s.J. dubner (buenos Aires, AR); C. blomstrom-lundqvist (Uppsala, sE) 


16:30 Usefulness of new imaging techniques to identify complex arrhythmogenic 

substrates in the ventricle. 479 


16:52 The challenge of ablation of substrates in the outflow tract of the right ventricle and 

left ventricle. 480 

L.E. Aguinaga Arrascue (Tucuman, AR) 

17:15 the challenge of ablation of ventricular arrhythmias in Chagasic patients. 481 

D.L. Pozzer (Corrientes, AR) 

17:37 Ventricular fibrillation ablation: current status. 482 

M. Haissaguerre (Pessac, FR) 


Flash abstract presentations: cardiac resynchronisation therapy/ 

Implantable cardioverter-defibrilator/Pacing 

Chairpersons: l.R. scott (Phoenix, Us); C. stellbrink (bielefeld, dE) 



16:30 Myocardial scar characterisation predicts device therapy in cardiac 

resynchronisation therapy patients. a three years follow-up 483 

D. Penela, A. Berruezo, R. Evertz, J. Fernandez-Armenta, D. Andreu, J.M. Tolosana, 

J.T. Ortiz, M. Sitges, L. Mont, J. Brugada (Barcelona, ES) 

16:38 Heterogeneity in electromechanical delay in heart failure patients referred for CRt 484 

W. Kroon, M. Potse, F. Prinzen, H. Fischer, F. Regoli, M. Acena, R. Krause, A. Auricchio 

(Lugano, CH; Maastricht, NL; Irwindale, US) 

16:46 strain evaluation with echocardiography speckle tracking needs to be combined 

with cardiac MRi in order to accurately predict left ventricular segments suitable for 

lead placement in CRt treatment. 485 

Z. Bakos, E. Ostenfeld, H. Markstad, A. Roijer, M. Carlsson, H. Arheden, R. Borgquist 

(Lund, SE) 

16:54 Multisite left ventricular pacing in a single coronary sinus branch improves systolic 

and diastolic acute hemodynamic response assessed with pressure-volume loops 486 

C. Pappone, Z. Calovic, A. Cuko, L.C. Mcspadden, K. Ryu, M. Saviano, L. Giannelli, 

C. Ciaccio, G. Vicedomini, V. Santinelli (Cotignola, IT; Sylmar, California, US) 

17:02 Crt patients with better preserved intrinsic conduction benefit more from 

left-ventricular pre-excitation 487 

V. Levin, A. Sambelashvili (Allentown and Mounds View, US) 

85 

monday 

sessions

MOndAy 

sEssiOns 



Flash abstract presentations: cardiac resynchronisation therapy/ 

Implantable cardioverter-defibrilator/Pacing 

Chairpersons: l.R. scott (Phoenix, Us); C. stellbrink (bielefeld, dE) 



17:10 Implantable cardioverter defibrillator therapy or cardiac resynchronisation therapy 

with defibrillation in patients with left ventricular dysfunction: a cost-impact study 488 

F. Umar, R. Taylor, A. Vakharia, H. Marshall, F. Leyva (Birmingham, GB) 

17:19 Plasma tissue inhibitor of matrix metalloproteinase-1 (tiMP-1) is a powerful predictor 

of long term mortality in patients treated whith cardiac resynchronisation therapy. 489 

M.E. Trucco, J.M. Tolosana, A. Castel, M. Batlle, M. Sitges, E. Guasch, E. Arbelo, 

A. Berruezo, J. Brugada, L. Mont (Barcelona, ES) 

17:27 Alterations in the expression of genes related to contractile function and 

hypertrophy of the left ventricle in chronically paced patients from the right 

ventricular apex (Preliminary Results) 490 

E.N. Simantirakis, I. Kontaraki, E. Arkolaki, S.I. Chrysostomakis, A.P. Patrianakos, 


17:35 Defibrillation threshold testing at the time of implantable cardioverter defibrillator 

implantation does not predict clinical outcomes during long-term follow up: a meta-analysis 491 

S. Stavrakis, N. Patel, D.W. Reynolds (Oklahoma City, US) 

17:43 transvenous removal of pacing and iCd leads: 15 years experience from an italian 

referral center 492 

M.G. Bongiorni, E. Soldati, L. Segreti, G. Zucchelli, A. Di Cori, R. De Lucia, L. Paperini, 

S. Viani, A. Boem, D. Levorato (Pisa, IT) 

17:51 The Canadian experience with DURATA and RIATA-ST-Optim defibrillator leads 493 

J.S. Healey, A. Ha, S. Tung, D.V. Exner, E. Crystal, S. Connors, B. Coutu, F. Philippon, 

A.D. Krahn, R. Parkash (Hamilton, Toronto, Vancouver, Calgary, St. John's, Montreal, 

Quebec and Halifax, CA) 

86

MOndAy 24 JUnE 2013 - EVENING 


CRT Care Pathway: from patient selection to clinical outcome. 


Chairpersons: l. Padeletti (florence, it); J.M. Morgan (stockbridge, Gb) 

Provide an update on which patients benefit from cardiac resynchronisation therapy, which latest 

technologies and algorithms will improve the response rate and how to use the diagnostics device 

information during remote monitoring. 


L. Padeletti (Florence, IT) 

18:20 Which patients benefit from cardiac resynchronisation therapy? 495 

J.C. Daubert (Rennes, FR) 

18:40 new technologies for pacing the left ventricle. 496 

D. Gras (Nantes, FR) 

19:00 An innovative algorithm to optimize cardiac resynchronisation pacing to individual 

patient needs. 497 

B. Lemke (Luedenscheid, DE) 

19:20 Remote monitoring of cardiac resynchonization therapy patients. 498 

H. Burri (Geneva, CH) 


J.M. Morgan (Stockbridge, GB) 


Status quo: antithrombotic management in atrial fibrillation. 

sponsored by bayer HealthCare 

Chairpersons: P.E. Vardas (Heraklion, GR); K.-H. Kuck (Hamburg, dE) 

Following this symposium, the attendees will have an understanding of key facts from the existing 

clinical data. Further, current guideline recommendations and real-world experience surrounding 

novel oral anticoagulant use in patients with atrial fibrillation will be reflected. Guidance on practical 

management of the novel anticoagulants in special cases will also be a topic for discussion. 

18:15 Welcome and introduction. 500 


18:20 Rivaroxaban – More than an anticoagulant? 501 


18:40 Practical Management of novel anticoagulants in special cases. 502 

M. Antz (Oldenburg, DE) 

19:00 Guideline versus reality. 503 

H. Darius (Berlin, DE) 

19:20 Clinical impact of devices for identification of atrial fibrillation. 504 


19:35 discussion and conclusion. 505 


87 

monday 

sessions

MOndAy 

sEssiOns 

MOndAy 24 JUnE 2013 - EVENING 

18:15 - 19:15 special session ithaca 

EPIC Advances: updated guidelines and clinical trials shaping the future of 

device and EP therapy 

sponsored by EPiC Alliance (Electrophysiologist international Community Alliance) 

Chairpersons: s. Ernst (london, Gb); M.G. bongiorni (Pisa, it) 

Review latest clinical trial data and guideline implications for device and EP therapy. 

18:15 Welcome and introduction to the EPiC Alliance. 506 

S. Ernst (London, GB) 

18:25 Updates on indications for CRt: QRs width, QRs morphology, and patient selection. 507 

L. Vitali Serdoz (Trieste, IT); J. Poole (Seattle, US) 

18:40 AF ablations: is there enough evidence for first-line therapy? 508 

I. Deisenhofer (Munich, DE); E. Hoffmann (Munich, DE) 

18:55 Device implant complications: the patient or the procedure? The REPLACE Study 

dARE score. 509 

M. Chung (Cleveland, US); A. Russo (Moorestown, US) 



88

EURJHF_13_1_Cover.qxd 12/7/10 9:22 PM Page 1 

13 1 

January 2011 European Journal of Heart Failure 

Pages 1–114 

2 

EP Europace Journal 

at the heart of the EsC Journal family 

All EHRA EUROPACE 2013 Congress delegates (standard fees) 

receive a fREE 2014 combined journal subscription 

(Print & Online) 

Visit the EsC booth nOW! 

Position Statement on cardiovascular 

side effects of cancer therapy 

Epidemiology of HFPEF 

Study design papers: 

ATMOSPHERE and ASTRONAUT 

Urinary 8-OHdG: a biomarker in chronic HF 

Cardiorenal anaemia syndrome 

Human neuregulin-1 therapy 

Editor-in-Chief: 

Dirk J. van Veldhuisen 

Deputy Editors: 

Adriaan A. Voors 

Wiek H. van Gilst 

Volume 13 Number 1 January 2011 



Eheart_32_1_cover.qxd 12/3/10 6:20 PM Page 1 

ISSN 0195-668X (Print) 

ISSN 1522-9645 (Online) 

EUROPEAN 

SOCIETY OF 

CARDIOLOGY ® 

Peri-procedural myocardial injury during PCI 

Optimal timing of coronary intervention 

in non-STEMI 

Primary angioplasty in very old patients 

Rosuvastatin for primary prevention 

CD14CD16 monocytes and 

cardiovascular outcome 

Editor-in-Chief: Thomas F. Lüscher 

Deputy Editors: Josep Brugada 

Bernard J. Gersh 

Ulf Landmesser 

Eupace_14_12_Cover.qxd Frank Ruschitzka 11/15/12 1:30 PM Page 1 

William Wijns 

Senior Consulting Editors: John A. Camm 

Diederick E. Grobbee 

Tiny Jaarsma 

Gerald Maurer 

Michael Piper 

Patrick W. Serruys 

Dirk van Veldhuisen 

www.eurheartj.org 

European Journal of 

HeartFailure 

1 www.eurjhf.oxfordjournals.org 

Journal of the Heart Failure Association of the ESC 


Volume 32 Number 1 January 2011 

European 

Heart Journal 

Journal of the European Society of Cardiology 

Mediterranean jellyfish sting-induced Tako–Tsubo cardiomyopathy. 

See figure legend on page 18. 

www.eurointervention.org Volume 8 - Number 2 - June 2012 - ISSN: 1774-024X 

EuroIntervention 

Offi cial Journal of EuroPCR and the European Association 

of Percutaneous Cardiovascular Interventions (EAPCI) 

Longitudinal stent deformation: 

QCA analysis 

Longitudinal stent deformation: 

MAUDE insights 

OCT guidance for bifurcations 

IVUS and VH assessment of stent edges 

SYNERGY/PROMUS stent vascular compatibility 

Polylactic acid-based resorbable stent study 

Risk stratification and aortic stenosis 

ESC for Nurses 

ESC for General Practice 

Physicians 

Learning objective: To know when and how to use antithrombotic/ 

antiarrhythmic drugs and ablationfor atrial fibrillation 

Learning objective: To know when and how to use natriuretichormones in case of dyspnea 

Learning objective: To know therapeutic targets after acute coronary 

syndrome and the management of antiplatelet drugs 

www.escardio.org/journals 

Contact us using publications@escardio.org for any questions about the EsC Journals 

14 

12 

PAGE EDITOR-IN-CHIEF 

Patrick W. Serruys 

205 

27-31 August 2011 

CO-EDITORS 

Pim de Feyter 

Carlo Di Mario 

Jean Marco 

Marie-Claude Morice 

Manel Sabaté 

Horst Sievert 

William Wijns 

DEPUTY EDITORS 

Nico Bruining 

Pieter Kappetein 

Let’s meet in Paris on Saturday 27 

Pascal Vranckx 

August to combine our efforts! 

SUPPLEMENTS EDITORS 

Jean Fajadet 

Alec Vahanian 

Learning objectives: To inform the patient with PM or ICD -Understand 

and educate the patient with a defibrillator life vest 

Learning objective: Discover fun ways to educate the patient with heart failure 

Nurses, attend this one-day programme for €50*! 

Register now online at www.escardio.org 

December 2012 

Europace Pages 1677–1810 

EUROPEAN 

SOCIETY OF 

CARDIOLOGY ® 

3 

10 

3 

September 2011 European Journal of Cardiovascular Nursing 

Pages 137–194 

ELSEVIER 

Volume 14 Number 12 December 2012 


EP 


www.europace.oxfordjournals.org 

89 

Cvrese_89_1_cover.qxd 12/9/10 8:28 PM Page 1 

Volume 10 Number 3 September 2011 ISSN 1474-5151 

European Journal of 

Cardiovascular 

Nursing 

Journal of the Council on Cardiovascular 

Nursing and Allied Professions 

Frailty 

Heart failure 

Motivational interviewing 

Self-efficacy 

Patient education 

Patients and Partners 

Exercise 

Editor- in- Chief: Tiny Jaarsma 

Co-Editors: Anna Strömberg 

David R. Thompson 

www.elsevier.com/locate/ejcnurse 

Europace 

of the European Heart Rhythm Association, 

a Registered Branch of the ESC, and the ESC Working 

Groups on Cardiac Cellular Electrophysiology 

EPJournal 

and e-Cardiology 

Ablation for ventricular fibrillation: evidence, 

techniques, and future directions 

European survey on duty-cycled 

RF ablation for AF 

Predictors of permanent pacemaker 

implant after TAVI 

Managing fatigue in the syncope unit: 

a review 

Should all dysfunctional high-voltage 

leads be extracted? A long-term registry 

EP Wire – EHRA survey: performing MRI in 

patients with CIEDs in Europe 

Editor-in-Chief: John Camm Pulmonary vein isolation in a patient with dextrocardia. See figure legend on page 1725. 

Deputy Editors: Luc Jordaens and 

Antonio Zaza 

Impact Factor 2011 

1.980 

89 1 

1 January 2011 

Cardiovascular Research Pages 1–253 

ISSN 0008-6363 (Print) 

ISSN 1755-3245 (Online) 

Mast cells in myocardial remodelling 

Protecting mitochondria with angiotensin II 

G-CSF in cardiac stem cell therapy 

Prevention of reentrant arrhythmias 

Cardiac sodium pump as signal transducer 

Editor-in-Chief: H. Michael Piper 

Co-Editor: David Garcia-Dorado 

2 

Ejecho_New_cover_1_Sample.qxd 14/7/11 5:01 PM Page 1 

Volume 89 Number 1 1 January 2011 


Research 

www.cardiovascres.org 


Journal of the European Society of Cardiology 

00 

0 

Month 2011 

European Heart Journal Cardiovascular Imaging Pages XXX–XXX 

2 

2012 


European Heart Journal 


Imaging 

Cardiovascular imaging including 

echocardiography 

Magnetic resonance 

Computed tomography 

Nuclear and invasive imaging 

Editor-in-Chief: Gerald Maurer 

Deputy Editors: Thomas Binder 

Heinz Sochor 

Senior Associate Editors: Juhani Knuuti 

Luc Piérard 

Sven Plein 


Formerly European Journal of Echocardiography 

See pp. XXX. 

www.ehjcimaging.oxfordjournals.org 

monday 

posters

MOndAy 24 JUnE 2013 - POSTERS MORNING 


ICD therapy: current issues and future strategies 

Chairpersons: s. Viskin (tel Aviv, il); C. sticherling (basel, CH) 


be on display from 08:30 until 12:30. The presenter should be present throughout the coffee break 





New defibrillator algorithms are associated with low levels of inappropriate shocks 

despite real-world programming P511 

D. Barker, M.J. Ng Kam Chuen, S. Hughes, D.J. Wright, A. Rao (Liverpool, GB) 

Prediction of ATP effectiveness for fast VT based on the analysis of far-field 

electrograms: a multicenter study. P512 

J. Jimenez-Candil, I. Anguera, C. Ledesma, J. Morinigo, J. Fernandez-Portales, 

P. Dallaglio, C. Martin-Luengo (Salamanca, L'Hospitalet de Llobregat, Barcelona 

and Caceres, ES) 

Right ventricular fractional area change predicts long-term adverse outcome in 

arrhythmogenic right ventricular cardiomyopathy/dysplasia P513 

A.M. Saguner, A. Vecchiati, S.H. Baldinger, A. Medeiros-Domingo, A. Mueller-Burri, 

L.M. Haegeli, T.F. Luescher, C.B. Brunckhorst, F.C. Tanner, F. Duru (Zurich and Bern, CH) 

Prediction of ventricular arrythmias by QRs-fragmentation detected with magnetic 

field imaging (MFI) among patients with primary preventive ICD-indication P514 

T. Tonnis, A. Ujeyl, M. Krueger, K.H. Kuck (Hamburg, DE) 

Safety and clinical efficacy of mid-septal versus apical ICD electrode positioning P515 

C. Kolb, U. Solzbach, J. Biermann, A. Kloppe, N. Klein, I. Szenday, G. Andrikopooulos, 

C. Lennerz, S. Tzeis, S. Asbach (Munich, Aalen, Freiburg, Luedenscheid, Leipzig and 

Mönchengladbach, DE; Athens, GR) 

iCd related complications in a large single center cohort. does kidney dysfunction 

cause more complications? P516 

M.S. Buiten, M.K. De Bie, A.C. Van Der Heijden, J. Rotmans, M. Groeneveld, 

J.W. Jukema, M.J. Schalij, L. Van Erven (Leiden and The Hague, NL) 

do failed remote evaluations result from transmission failure or (mis-)handling by 

receiving facilities? Home Monitoring in the TRUST trial P517 

N. Varma, J. Michalski, T.R.U.S.T. Invesigators (Cleveland and Lake Oswego, US) 

Effects of medical therapy on ventricular arrhythmias in patients with cardiac sarcoidosis P518 

K. Kusano, S.K. Kamakura, S.M. Morimoto (Okayama, Suita, Osaka and Toyoake, JP) 

survival in patients with non-ischaemic cardiomyopathy receiving cardiac 

resynchronisation therapy without a defibrillator P519 

D. Mustafa, A. Li, S. Jones, D. Ward, M. Saba (London, GB) 

Implantable cardioverter-defibrillators in ventricular assist device-supported heart 

failure patients. P520 

A. Gkouziouta, G. Karavolias, A. Kostopoulou, A. Katsianis, J. Rassias, A. Poulos, 

E. Maounis, E. Livanis, G. Theodorakis, S. Adamopoulos (Athens, GR) 

91 

monday 

posters

monday 

posters 





between 08:30 - 12:30. 

The presenter should be available by the poster during the coffee break (10:00 to 11:00) in order to 

discuss the research with the audience. 


Autonomic denervation during cryoballoon isolation of the pulmonary veins in patients with 

paroxysmal atrial fibrillation P521 

R.M. Kiedrowicz, J. Kazmierczak, M. Wielusinski, J. Zielonka (Szczecin, PL) 

Influence of age and gender on complications of cathetere ablation for atrial fibrillation P522 

G. Stabile, E. Bertaglia, C. Pappone, F.C. Zoppo, C. Pandozi, G. Augello, L. Calo, V. Calzolari, 

A. Zorzi, L. Padeletti (Naples, Padua, Cotignola, Mirano, Rome, Milan, Treviso and Florence, IT) 

segmental variability in lesion size is controlled using contact force during pulmonary venous 

isolation P523 

J. Kautzner, A. Natale, G.F. Michaud, A.D.avila, E. Wissner, P. Della Bella, L. Jordaens, A. Yulzari, 

D. Shah (Prague, CZ; Austin, Boston and New York, US; Hamburg, DE; Milan, IT; 

Rotterdam, NL; Geneva, CH) 

Comparison of left atrial diameters in Ct and echocardiography as predictors of long-term 

success after catheter ablation of atrial fibrillation. P524 

S. Nedios, E. Koutalas, S. Pastromas, J. Kosiuk, P. Sommer, A. Arya, S. Rolf, D. Husser, 

G. Hindricks, A. Bollmann (Leipzig, DE) 

Mobilization of oct-4+ very small embryonic like stem cells, hematopoietic stem cells and 

endothelial progenitor cells in patients with atrial fibrillation undergoing percutaneous 

Rf ablation. P525 

A.M. Wnuk-Wojnar, E. Kamycka, W. Wojakowski, A. Hoffmann, S. Nowak, M. Faryan, J. Kolasa, 

K. Mizia-Stec, Z. Madeja, E. Zuba-Surma (Katowice and Krakow, PL) 

Real time contact force measurement during pulmonary vein antrum isolation P526 

H. Makimoto, A. Rillig, A. Metzner, E. Wissner, S. Mathew, S. Deiss, P. Rausch, K.-H. Kuck, 

F. Ouyang, R. Tilz (Hamburg, DE) 

Revealing dormant conduction with adenosine after cryoballoon ablation reduces atrial 

fibrillation recurrence at mid-term follow-up P527 

M.G. Compier, K. Zeppenfeld, M. De Riva Silva, K.M. Dyrda, M.J. Schalij, S.A. Trines (Leiden, NL) 

Af ablation: evaluation of procedural parameters and acute results comparing ablation 

catheters with traditional and new irrigation design P528 

C. Raimondo, E. Ebrille, A. Blandino, D. Caponi, P. Di Donna, M. Appendino, A. Battaglia, 

A. Negro, F. Gaita, M. Scaglione (Turin and Asti, IT) 

Evaluation of left atrial contractile function after successful ablation of long standing 

persistent atrial fibrillation utilizing combined epicardial and endocardial approach. P529 

D.E. Pajitnev, T. Neumann, S.W. Zaltsberg, H. Greiss, E. Akkaya, Z. Szalay, M. Schoenburg, 

T. Walther, C.W. Hamm, M. Kuniss (Bad Nauheim, DE) 

Recurrence of paroxysmal atrial fibrillation despite isolated pulmonary veins: - what to do? 

ablation strategies and long-term results of a 2 year follow-up P530 

A. Sultan, J. Luker, B. Hoffmann, H. Servatius, B. Schaffer, J. Nuhrich, D. Schreiber, M. Knoll, 

D. Steven, S. Willems (Hamburg and Stuttgart, DE) 

92


Medication management and atrial fibrillation recurrence in catheter ablation patients with 

an insertable loop recorder for continuous cardiac rhythm monitoring P531 

H. Purerfellner, E. Pokushalov, A. Mrochak, M. Block, J. Bucx, T. West, G. Rieger, M. De Melis, 

A. Ungar, T. Lewalter (Linz, AT; Novosibirsk, RU; Minsk, BY; Munich, DE; Utrecht and 

Maastricht, NL; Florence, IT) 

interest of real-time contact force sensing for pulmonary vein isolation. mid-term outcome 

after paroxysmal atrial fibrillation catheter ablation P532 

J.P.A. Albenque, S.F. Fazaa, E.M. Marijon, B.G.M. Guy-Moyat, A.B. Bouzeman, F.T. Treguer, 

N.C. Combes, S.C. Combes, S.B. Boveda (Toulouse, FR) 

Ablation of atrial tachycardias following persistent atrial fibrillation ablation: What is the 

challenge? P533 

S. Ammar, A. Bruhm, T. Reents, A. Buiatti, R. Dillier, V. Semmler, S. Kathan, C. Kolb, G. Hessling, 

I. Deisenhofer (Munich, DE) 

Clinical outcomes of catheter ablation in patients with paroxysmal atrial fibrillation in a 

developing country: results of a long term follow-up P534 

W. Uribe, J. Aristizabal, J. Velasquez, E. Medina, J. Marin, J. Bareno, A. Baranchuk, M. Duque 

(Medellin, CO; Kingston, CA) 

PR interval as predictor of atrial fibrillation ablation rhythm outcome P535 

D. Stuebner, D. Husser, L. Ueberham, J. Carlson, A. Arya, P. Sommer, A. Bollmann, P. Platonov 

(Leipzig, DE; Lund, SE) 

Electrical Remodeling Progress albeit no progression in the structural remodeling in patients 

with recurrence after atrial fibrillation ablation P536 

Y. Nagamoto, T. Tsuchiya, T. Yamaguchi, D. Mine, N. Shirahama, Y. Koga, T. Shiomi, K. Yoshida, 

K. Sadamatsu, K. Hayashida (Saga and Kumamoto, JP) 

Atrial fibrillation ablation: recurrence and symptomatic improvement P537 

F. Moscoso Costa, D. Cavaco, H. Dores, P. Santos, P. Carmo, G. Cardoso, S. Carvalho, 

A. Soares, F. Morgado, P. Adragao (Lisbon, PT) 

Cryoballoon, the next generation: faster, cooler and therefore better pumonary vein isolation? P538 

S.A. Wijchers, Y. De Greef, D. Stockman, F. Van Den Branden, B. Schwagten (Antwerpen, BE) 

Assessing the left atrial appendage size for deployment of an occlusion device post-Af ablation. P539 

A. Malhotra, K. Wong, T. Betts, Y. Bashir, J. Newton, K. Rajappan (Oxford, GB) 

Influence of intraprocedural administration of antiarrhythmic drugs on termination of atrial 

fibrillation during defragmentation ablation P540 

J. Luker, A. Sultan, B.A. Hoffmann, M. Knoll, J. Nuhrich, B. Schaffer, D. Schreiber, H. Servatius, 

S. Willems, D. Steven (Hamburg, DE) 

Predictive value of pulmonary venous flow assessed by intracardiac echocardiography on 

recurrence of atrial fibrillation P541 

Y. Sasaki, A. Kobori, Y. Furukawa (Kobe, JP) 

Quality of life after catheter ablation versus surgical ablation treatment for atrial fibrillation P542 

V.F. Van Dijk, J.C. Kelder, M.C.E.F. Wijffels, J.C. Balt, A. Berruezo, M. Castella, J. Brugada, 

L. Mont, L.V.A. Boersma (Nieuwegein, NL; Barcelona, ES) 

Pulmonary vein isolation using contact force sensing technology: reduction of procedure and 

fluoroscopy duration P543 

A. Schade, J. Krug, K. Nentwich, J. Majewski, G.A. Szoelloesi, M. Hautmann, T. Deneke 

(Bad Neustadt/ Saale, DE) 

93 

monday 

posters

monday 

posters 



impact of adenosine triphosphate on complex fractionated atrial electrograms in human 

atrial fibrillation P544 

I. Watanabe, R. Kogawa, Y. Okumura, K. Nagashima, M. Kofune, H. Mano, K. Sonoda, N. Sasaki, 

T. Nakai, A. Hirayama (Tokyo, JP) 

Critical isthmus and slow conduction sites of ventricular tachycardia circuits identified by 

preprocedural cardiac scar imaging on MRi and Ct. insight from high density Vt mapping P545 

A. Jadidi, H. Lehrmann, R. Weber, G. Pache, H. Cochet, S. Kim, J. Schiebeling-Roemer, 

M. Haissaguerre, P. Jais, T. Arentz (Bad Krozingen, DE; Bordeaux, FR; Saint Paul, US) 

typical contrast-enhanced MRi-derived scar patterns and associated ventricular tachycardias 

in non-ischaemic cardiomyopathy: implications for the ablation strategy P546 

S.R.D. Piers, Q. Tao, C.F.B. Van Huls Van Taxis, M.J. Schalij, R.J. Van Der Geest, K. Zeppenfeld 

(Leiden, NL) 

contact force monitoring for cardiac mapping in patients with ventricular tachycardia P547 

P. Vergara, H. Mizuno, G. Maccabelli, N. Trevisi, C. Brombin, S. Colombo, P. Della Bella (Milan, IT) 

Reduction of fluoroscopy time for conventional and complex catheter ablation procedures 

with novel navigation system P548 

P. Peichl, D. Wichterle, R. Cihak, J. Kautzner (Prague, CZ) 

Comparison of radiation exposure in supraventricular arrhythmia ablation using the Ensite 

NavXTM mapping system or conventional fluoroscopic approach P549 

E. Russo, M. Casella, A. Dello Russo, M. Zucchetti, G. Pelargonio, M.G. Bongiorni, M. Piacenti, 

M. Del Greco, A. Natale, C. Tondo (Milan, Rome, Pisa and Trento, IT; Austin, US) 

Catheter ablation in children and young adults: is there an additional benefit from remote 

magnetic navigation? P550 

R. Roudijk, P. Marchese, M. Gujic, I. Horduna, S. Ernst (London, GB) 

long-term outcomes of robotic magnetic navigation for ablation of supraventricular 

tachycardias: the impact of learning period and site of accessory pathway P551 

S.H. Kim, Y.S. Oh, T.S. Kim, W.S. Shin, J.H. Kim, S.W. Jang, M.Y. Lee, T.H. Rho (Seoul, KR) 

subclavian approach to intracardiac echo for visualising structures in the left ventricle P552 

A. Gopi, M.L. Jesuraj, K. Lalukota, C. Sridevi, K. Sharadha, C. Narsimhan (Hyderabad, IN) 

safety and feasibility of arrythmia ablation using the amigo remote robotic navigation system 

as compared with manual ablation P553 

T. Datino, M. Pelliza, A. Arenal, J. Hernadez-Hernadez, E. Gonzalez-Torrecilla, F. Atienza, 

P. Avila, L. Bravo, F. Fernandez-Aviles (Madrid, ES) 

Pouch depth is the sole important factor that affects radiofrequency duration and energy in 

catheter ablation of right atrial cavotricuspid isthmus P554 

K. Yoshitani, K. Kujira, R. Fukuhara, R. Taniguchi, M. Toma, T. Miyamoto, Y. Sato, Y. Takatsu 

(Amagasaki, JP) 

fascicular Vt ablation- the origin of the Vt P555 

S. Rosenheck, J. Banker, Z. Sharon (Jerusalem, IL) 

High risk accessory pathway ablation inside a large coronary sinus diverticulum in a patient 

with coexistent drug induced type 1 brugada ECG pattern P556 

G. Zucchelli, G. Coluccia, L. Segreti, A. Di Cori, E. Soldati, S. Viani, L. Paperini, D. Levorato, 

R. De Lucia, M.G. Bongiorni (Pisa, IT) 

feasibility of four chamber 4d rotational angiography P557 

S. De Buck, D. Dauwe, J.-Y. Wielandts, P. Claus, S. Janssens, H. Heidbuchel, D. Nuyens (Leuven, BE) 

94


Catheter ablation of focal atrial tachycardia from the non-coronary aortic cusp P558 

A. Lebreiro, M. Vega, J. Gonzalez-Ferrer, J.M. Aguirre, L. Borrego, M. Pulido, J. Moreno, 

N. Perez-Castellano, M.J. Maciel, J. Perez-Villacastin (Porto, PT; Madrid, ES) 

double ventricular response during sinus rhythm as a potential form of proarrhythmia 

following catheter ablation of atrioventricular nodal reentrant tachycardia P559 

N. Kalleinen, A. Estrada, D. Doiny, J.A. Figueroa, S. Castrejon, D. Filgueiras, M. Ortega, I. Plaza, 

E. Prieto, J.L. Merino (Turku, FI; Madrid, ES) 

Catheter ablation in patients with Ebstein's anomaly P560 

M. Orczykowski, F. Walczak, P. Derejko, R. Bodalski, P. Urbanek, A. Przybylski, 

M. Miszczak-Knecht, K. Bieganowska, M. Bilinska, L. Szumowski (Warsaw, PL) 

Acute rate of transmural lesions induced by the Epicor system during peri-operative left 

atrial ablation for atrial fibrillation P561 

P. Maury, A. Bennadji, B. Marcheix, C. Cron, A. Duparc, P. Mondoly, A. Rollin, C. Cardin, 

M. Sadron, Y. Glock (Toulouse, FR) 


Comparison of therapy with amiodarone or implantable cardioverter defibrillators for 

secondary prevention of mortality in Chagas' heart disease P562 

A. Sarabanda, W.L. Gali, J.M. Baggio Jr, L.G. Ferreira, G.G. Gomes, J.A. Marin-Neto, 

L.F. Junqueira Jr (Brasilia and Ribeirao Preto, BR) 

Effectiveness of implantable defibrillators in patients with channelopathies evaluated at the 

moment of replacement P563 

A. Fontenla, R. Salgado, J.L. Pena, J. Martinez-Ferrer, X. Vinolas, A. Garcia-Alberola, R. Pavon, 

J. Villacastin, J. Brugada, F. Arribas (Madrid, Malaga, Alava, Barcelona, Murcia and Seville, ES) 

Outcome comparison of primary preventative cardioverter-defibrillator implantations in 

patients after myocardial infarction in Western and Central Europe P564 

M. Svetlosak, A. Vachulova, M. Sasov, C. Leclercq, J.C. Daubert, P. Mabo, R. Hatala 

(Bratislava, SK; Rennes, FR) 

Impact of atrial fibrillation in an implantable cardioverter defibrillator cohort P565 

K. Kraaier, B. Van Rennes, B. Oude Velthuis, H.G.R. Dorman, Y.J. Stevenhagen, J. Van Opstal, 

M.F. Scholten (Enschede, NL) 

Heart rate turbulence predicts iCd resistant mortality in ischaemic cardiomyopathy P566 

T. Marynissen, V. Flore, H. Heidbuchel, D. Nuyens, J. Ector, R. Willems (Leuven, BE) 

Effectiveness of implantable defibrillators in patients with structural heart disease evaluated 

at the moment of replacement P567 

A. Fontenla, E. Mejia, J. Martinez-Ferrer, A. Barrera, J. Toquero, X. Vinolas, D. Pereferrer, 

R. Romero, A. Garcia-Alberola, F. Arribas (Madrid, Alava, Malaga, Barcelona, 

Santa Cruz de Tenerife and Murcia, ES) 

Implantable cardioverter-defibrilator in heart transplant recipients P568 

M. Blaha, V. Capkova, I. Malek, J. Kautzner (Prague, CZ) 

survival, incidence and time-dependence of appropriate therapy in patients receiving iCds 

for primary prevention: long-term follow-up in a tertiary single center P569 

I. Saloustros, E.K. Kanoupakis, H.M. Mayrakis, E.K. Kallergis, E.K. Koutalas, M.V. Vernardos, 

S.M. Maragkoudakis, S.P. Petousis, P.V. Vardas (Heraklion, GR) 

Gender differences in characteristics and outcome of unselected implantable cardiac 

defibrillator receivers: an observational cohort analysis P570 

M. Zavatta (Modena, IT) 

95 

monday 

posters

monday 

posters 


Atrial fibrillation does not increase risk of inappropriate shocks in primary prevention single 

chamber implantable cardioverter defibrillator population: cheaper is not worse P571 

B. Kircanski, N. Radovanovic, S. Pavlovic, V. Jovanovic, S. Raspopovic, G. Nikcevic, M. Zivkovic, 

G. Milasinovic (Belgrade, RS) 

Lead position contribute to the incidence of medtronic fidelis sprint lead fracture; 

comparison of interventricular septum and right ventricular apex P572 

K. Kondo, J. Miake, K. Ogura, M. Kato, K. Iitsuka, K. Yamamoto, K. Shirota, Y. Inoue (Yonago and 

Matsue, JP) 

Management of fidelis leads at box change: a decision analysis model P573 

H. Burri, C. Combescure (Geneva, CH) 

subcutaneous iCd - 3 year experience P574 

P. Galvao Santos, D. Cavaco, P. Adragao, P. Carmo, C. Soares, F. Costa, F. Morgado, J. Neves, 

M. Abecasis, M. Mendes (Lisbon, PT) 

ICD recipients, mortality and shock burden: is the debate still open? P575 

V. Exposito Garcia, S. Gonzalez Enriquez, F. Rodriguez Entem, C. Castrillo, A. Canteli, 

A. Solloso, I. Madrazo, J.J. Olalla Antolin (Santander, ES) 

Long term follow up and safety of ICD with RV lead in outflow tract comparising with apex P576 

G. Rodriguez-Diez, M. Cortes, M. Ortiz, J.D. Morales-Portano, R. Robledo-Nolasco 

(Mexico City, MX) 

Pacing 

Predictors of advanced lead extraction based on a systematic stepwise approach. Results 

from a high volume center. P577 

P. Mazzone, D. Tsiachris, A. Marzi, G. Paglino, N. Sora, S. Sala, G. Ciconte, F. Guarracini, 

S. Gulletta, P. Della Bella (Milan, IT) 

The severity of left ventricular failure in patients with implanted defibrillating devices is 

reflected in high voltage impedance. P578 

M. Bryl, T. Krauze, D. Przymuszala, J. Piskorski, J. Kaczmarek, M. Dziarmaga, K. Barecka, 

K. Klimas, D. Karbowy, P. Guzik (Poznan, PL) 

dry late heart wall perforation with intracardiac lead - not all patients needs cardiac surgery P579 

A. Kutarski, A. Tomaszewski, W. Brzozowski, M. Czajkowski, A. Zabek (Lublin and Krakow, PL) 

Performance evaluation of a right ventricular and a right atrial automatic capture verification 

algorithms: the EssEntiAl registry P580 

M. Biffi, M. Bertini, F. Quartieri, G. Belotti, C. Tomasi, P. Diotallevi, A. Pucci, G. Mazzocca, 

D. Giorgi, D. Saporito (Bologna, Ferrara, Reggio Emilia, Treviglio, Ravenna, Alessandria, Carrara, 

Cecina, Lucca and Rimini, IT) 

Non-invasive pacing study (NIPS) via pacemakers and implantable cardioverter defibrillators 

to differentiate atypical from typical atrial flutter P581 

N.Y.J. Al Jefairi, M. Zimmermann, H. Sunthorn, C. Stettler, F. Trentaz, D. Shah, H. Burri 

(Geneva and Meyrin, CH) 

Pocket irrigation with tranexamic acid reduces the risk of hematoma formation in patients 

on anticoagulant therapy submitted to pacemaker/defibrillator surgery P582 

Q. Parisi, L. Messano, M. Santamaria, F. Alessandrini (Campobasso, IT) 

Outcomes of a conservative approach to device reimplant after laser lead extraction P583 

J. Patel, H. Kawata, V. Gadiyaram, T. Mcgarry, R. Joshi, G. Feld, G. Pretorius, 

U. Birgersdotter-Green (La Jolla, US) 

96


Defibrillator with and without resynchronisation therapy leads implantation through axillary 

vein: 363 lectrodes long-term ollow-up P584 

I. Roca Luque, N. Rivas, J. Perez-Rodon, J. Francisco, O. Cenusa, A. Porta, G. Acosta, 

D. Garcia-Dorado, A. Moya (Barcelona, ES) 

Does changing the pace anode affect phrenic nerve stimulation thresholds? P585 

S. Saha, H. Rockweiler, M. Biffi, D. Babuty, M. Glikson (St. Paul, US; Bologna, IT; Tours, FR; 

Tel Hashomer, IL) 

long-term outcome and complications of transvenous pacemaker implantation in small infants P586 

L.M. Vos, A.C. Blank, J.A. Kammeraad, M.W. Freund, J.M.P.J. Breur (Utrecht, NL) 


late elevation of left ventricular pacing threshold in patients with cardiac resynchronisation 

therapy P587 

M. Fatemi, S. Ropars, G. Le Gal, Y. Etienne, J. Mansourati (Brest, FR) 

Does left and right ventricle lead positioning really influence outcome in patients who 

underwent cardiac resynchronisation therapy? P588 

E. Zubarev, V. Lebedeva, M. Trukshina, T. Lyubimtseva, D. Lebedev (Saint-Petersburg, RU) 

impact of left and right ventricular lead position on mortality and morbidity in patients with 

chronic atrial fibrillation and cardiac resynchronisation therapy P589 

M. Jastrzebski, J. Wilinski, K. Fijorek, D. Czarnecka (Cracow, PL) 

interaction between gender and left ventricular reverse remodelling predicts survival at very 

long (9 years) follow-up in heart failure patients candidates to cardiac resynchronisation therapy P590 

A. Paoletti Perini, A. Lilli, S. Bartolini, P. Pieragnoli, G. Ricciardi, L. Perrotta, L. Padeletti 

(Florence and Viareggio, IT) 

Atrial fibrillation in cardiac resynchronisation therapy with a defibrillator: a risk factor for 

mortality, appropriate and inappropriate shocks P591 

N. Van Boven, D.A. Theuns, K. Bogaard, J.H. Ruiter, G.P. Kimman, L.M. Berman, 

T. Van Der Ploeg, I. Kardys, V.A. Umans (Alkmaar and Rotterdam, NL) 

left atrial volume as independent predictor of response to cardiac resynchronisation therapy P592 

G. Morani, M. Morosato, G. Mugnai, C. Stevanello, L. Tomasi, R. Tomei, C. Vassanelli (Verona, IT) 

Automated motion artifacts compensation in multi-view cardiac magnetic resonance images 

for patient-specific modeling. P593 

C. Carminati, F. Regoli, F. Maffessanti, A. Auricchio, E.G. Caiani (Milan, IT; Lugano, CH) 

Difficult implantations of cardiac resynchronisation therapy devices P594 

S. Popov, S. Krivolapov, D. Lebedev, G. Savenkova (Tomsk, RU) 

sonR signal vs lPEi during the acute optimisation of lead position in CRt patients P595 

I. Kosmidou, D. Dan, A. Wickliffe, T. Deering, P. Milpied, D. Guerrero, S. Cazeau (Piedmont and 

Arvada, US; Clamart and Paris, FR) 

Cardiac computed tomography is superior to fluoroscopy in assessing right ventricular lead 

position in cardiac resynchronisation therapy P596 

A. Sommer, C. Gerdes, P.T. Mortensen, M.B. Kronborg, B.L. Noergaard, J.C. Nielsen (Aarhus, DK) 

the presence of mechanical dyssynchrony determined by pulsed wave doppler predicts left 

ventricular remodeling after cardiac resynchronisation therapy. sub-analysis of the PObREE trial P597 

D. Silva, N. Cortez-Dias, J. Silva Marques, P. Carrilho-Ferreira, A. Magalhaes, S. Goncalves, 

S. Ribeiro, L. Santos, L. Sargento, J. Sousa (Lisbon, PT) 

97 

monday 

posters

monday 

posters 



noninvasive electrocardiographic imaging and results of ablation of tachyarrhythmias. P598 

A. Revishvili, O. Sopov, E. Labartkava, T. Dzhordzhikiya, V. Kalinin, V. Kuptsov (Moscow, RU) 

desmosomal gene mutations and left ventricular involvement of arrhythmogenic right 

ventricular dysplasia P599 

J. Jimenez Jaimez, E. Lopez Moreno, T. Gil Jimenez, R. Macias, T. Berrio, M. Alvarez, L. Tercedor 

(Granada and Marbella. Málaga, ES) 

Morphological properties and prevalence of anatomical isthmuses related to monomorphic 

ventricular tachycardia in repaired tetralogy of fallot. P600 

G.F.L. Kapel, S. Laranjo, K. Zeppenfeld, N.A. Blom, M.J. Schalij, M.M. Bartelings, M.R. Jongbloed 

(Leiden, NL; Lisbon, PT) 

long term outcomes of ivabradine in inappropriate sinus tachycardia patients: appropriate 

efficacy or inappropriate patients? P601 

J. Benezet Mazuecos, J.M. Rubio, J. Farre, M.A. Quinones, P. Sanchez-Borque, E. Macia (Madrid, ES) 

severity of sleep apnea syndrome correlates with burden of ventricular tachyarrhythmias in 

unselected iCd patients P602 

F. Anselme, T. Manounis, G. Mantovani, F. Kruemel, A. Kowsar, A. Kaplan, S. Singh, D. Contardi, 

E. Aime (Rouen and Limoges, FR; Athens, GR; Desio, Milan and San Donato Milanese, IT; 

Lueneburg, DE; Mesa and Waukesha, US) 

Electrocardiographic abnormalities are common in patients with idiopathic ventricular 

fibrillation, but do not offer predictive value in regard to future serious arrhythmic events 603 (W) 

R. Borgquist, P.G. Platonov (Lund, SE) 

Propranolol for catecholaminergic polymorphic ventricular tachycardia P604 

P.M. Ruiz Hernandez, F. Wanguemert, P. Berne, O. Campuzano, R. Brugada, J. Brugada 

(Las Palmas de Gran Canaria, Barcelona and Girona, ES) 

Inducibility of ventricular fibrillation in a swine model of rapidly induced mild therapeutic 

hypothermia P605 

J. Kudlicka, M. Mlcek, P. Hala, S. Lacko, D. Janak, M. Hrachovina, S. Havranek, P. Neuzil, J. Malik, 

O. Kittnar (Prague, CZ) 

frequent atrial ectopic activity and risk of recurrent cryptogenic ischaemic stroke and 

transient ischaemic attack P606 

C. Galvao Braga, J. Pinho, S. Rocha, A.F. Santos, A. Cabreiro, A. Gomes, S. Magalhaes, 

C. Ferreira, A. Correia (Braga and Porto, PT) 

Atrial fibrillation density: a novel measure of atrial fibrillation temporal aggregation for the 

characterisation of atrial fibrillation recurrence pattern P607 

E. Charitos, U. Stierle, H.H. Sievers, P.D. Ziegler, T. Hanke (Luebeck, DE; Minneapolis, US) 

Prediction of epicardial scar in patients with arrhythmogenic cardiomyopathy using 

vectorcardiography and principle component analysis of surface ECG in sinus rhythm P608 

Y.-J. Lin, M.-T. Lo, L.-W. Lo, S.-L. Chang, F.-P. Chung, E. Chong, C. Lin, Y.-C. Chang, N. Huang, 

S.-A. Chen (Taipei and Chung Li, TW) 

Measurement of autonomic training effects; the importance of standardisation 609 (W) 

C.C. Grant, D.C. Janse Vanrensburg (Pretoria, ZA) 

Age and heart rate variability at rest predict vasovagal syncope P610 

M. Spaziano, A. Vinet, G. Becker, T. Kus, M. Sturmer (Montreal, CA) 

transesophageal echocardiography for thrombus screening prior to catheter ablation of 

non-valvular atrial fibrillation P611 

J. Huang, T. Liu, Y.M. Xue, H.W. Fei, X.Z. Zhan, X.H. Fang, S.L. Wu (Guangzhou, CN) 

98


Usefulness of late ventricular potentials in diagnosing patients suspected of brugada syndrome P612 

A. Wozniak, B. Sredniawa, S. Cebula, J. Kowalczyk, A. Musialik-Lydka, Z. Kalarus (Zabrze, PL) 

the safety of levothyroxin treatment in patients with congestive heart failure and subclinical 

hypothyreosis. P613 

Z.N. Blankova, F.T. Ageev, E.M. Seredenina, O.N. Svirida, E.S. Zhubrina, I.V. Barinova, 

O.Y. Ryabceva (Moscow, RU) 

99 

monday 

posters

monday 

posters 

MOndAy 24 JUnE 2013 - POSTERS AFTERNOON 


J-wave syndromes and arrhythmia complication after TAVI 

Chairpersons: d. Husser (leipzig, dE); to be announced 


be on display between 14:00 and 18:00. The Presenter should be present throughout the coffee break 





Prevalence and location of j-wave in patients with implantable cardioverter defibrillator P614 

H. Kohjitani, A. Kobori, Y. Sasaki, K. Kim, T. Kitai, N. Ehara, M. Kinoshita, S. Kaji, T. Tani, 

Y. Furukawa (Kobe, JP) 

Relationship between J-wave and vagal activity in the patients who do not have 

structural heart disease P615 

S.H. Kim, K.D.H. Kim, Y.D.H. Yang, J.J.H. Jang, S.S.H. Shin, W.S.I. Woo, K.J. Kwan, 

P.K.S. Park (Incheon, KR) 

the incidence and clinical impact of j wave in hypothermic patients P616 

S. Higuchi, T. Hasegawa, Y. Kabeya, H. Mitamura, S. Nakagawa (Tokyo, JP) 

Early repolarisation pattern associated electrocardiographic phenotype for the 

prediction of sudden cardiac death in patients with chronic heart failure P617 

Y. Furukawa, T. Yamada, T. Morita, Y. Iwasaki, M. Kawasaki, A. Kikuchi, T. Naito, 

T. Fujimoto, M. Fukunami (Osaka, JP) 

The J-wave related with primary ventricular fibrillation during acute myocardial 

infarction P618 

S.H. Kim, K.D.H. Kim, Y.D.H. Yang, J.J.H. Jang, S.S.H. Shin, W.S.I. Woo, K.J. Kwan, 

P.K.S. Park (Incheon, KR) 

Outcome of patients with left bundle branch block after tAVi (tran aortic Valve 

implantment) P619 

G.G. Goldenberg, R.K. Kornowski, A.A. Assali, H.V.A. Vaknin-Assa, A.S. Sagie, 

P.C. Codner, T.B. Bental, G.G. Golovchiner, B.S. Strasberg, M.H. Haim (Petah Tikva, IL) 

left bundle branch block occurring after transcatheter aortic valve implantation: 

what is the prognostic significance? P620 

S. Conti, G.P. Pruiti, D. Tempio, S.A. Romano, E. Tavano, C. Liotta, A. Di Grazia, 

C. Tamburino, V. Calvi (Catania, IT) 

Ventricular arrhythmias before and after transcatheter aortic valve implantation P621 

S. Conti, G.P. Pruiti, D. Tempio, S.A. Romano, E. Tavano, C. Liotta, A. Di Grazia, 

D. Capodanno, C. Tamburino, V. Calvi (Catania, IT) 

severe conduction disorders after tAVi: can a perprocedure electrophysiological 

study predict the risk of post-procedure pacemaker implantation? P622 

S. Thomann, T.T.C. Cung, F.M. Massin, O.A. Alfalasi, F.C. Cransac, C.P. Piot, 

F.L. Leclercq, J.M.D. Davy, B.A. Albat, J.L.P. Pasquie (Montpellier, FR) 

no increase of ventricular arrhythmias after alcohol septal ablation in patients with 

hypertrophic obstructive cardiomyopathy and previously implanted iCd P623 

A.G. Rigopoulos, S. Daci, B. Pfeiffer, A. Neugebauer, H. Seggewiss (Schweinfurt, DE) 

100





between 14:00 - 18:00. 




Ranolazine accelerates amiodarone-mediated conversion of paroxysmal atrial fibrillation in man P624 

K.C. Kokinas, N. Fragakis, E. Pagourelias, K. Rossios, D. Tanos, P. Kyriakou, V. Skeberis, 

D. Katritsis, V. Vassilikos (Thessaloniki and Athens, GR) 

Long term follow up in patients with atrial fibrillation treated with digoxine versus 

conventional regimen; results from the AfbAR study P625 

M. Rodriguez Manero, F. Otero-Ravina, J. Garcia-Seara, A. Garcia-Castelo, M. Lado, J.M. Vidal, 

R. Vidal Perez, J.R. Gonzalez Juanatey (Santiago de Compostela, A Coruña and Coruña, ES) 

comparison of intravenous vernakalant and oral loading dose of propafenone for conversion 

of acute atrial fibrillation to sinus rhythm P626 

D. Conde, J.P. Costabel, M. Aragon, M.F. Lambardi, A. Barboza, A. Giniger, M. Trivi (Buenos Aires, AR) 

The impact of heart rate variability on the frequency of paroxysmal atrial fibrillation P627 

S.V. Grigoryan, Y.S. Makaryan (Yerevan, AM) 

Antiarrhythmic effect of ethyl esters of omega-3 polyunsaturated fatty acids in patients with 


A. Kuchmin, D. Cherkashin (St. Petersburg, RU) 

Atrial fibrillation ablation with a novel remote navigation system P629 

J.A. Figueroa, A. Estrada, D. Doiny, S. Castrejon-Castrejon, D. Filgueiras, L. De Pablos, 

M. Battle, M. Ortega, R. Delgado, J.L. Merino (Madrid, ES) 

High density mapping in patients with paroxysmal atrial fibrillation: impact on long term outcome P630 

P. Vergara, T. Oloriz Sanjuan, M. Cireddu, G. Fassini, P. Rancoita, G. Maccabelli, P. Della Bella (Milan, IT) 

Remote catheter navigation by electromagnets for left atrial flutter mapping and ablation P631 

A. Estrada, S. Castrejon, J.A. Figueroa, D. Doiny, D. Filgueiras, M. Ortega, J. De Juan, J. Shachar, 

E. Gang, J.L. Merino (Madrid, ES; Inglewood and Los Angeles, US) 

PITX2c gain-of-function mutations associated with atrial fibrillation P632 

A. Mechakra, Y.-Q.Y.S. Yang, T.F. Footz, M.W. Walter, A.A.-J. Aranega-Jimenez, 

F. Hernandez-Torres, E.M. Morel, G.M. Mllat, P.C. Chevalier, G.C. Christe 

(Lyon, FR; Shanghai, CN; Edmonton, CA; Jaen, ES) 

Atrial fibrillation sources identified by focal impulse and rotor mapping (FIRM) are stable for 

thousands of cycles P633 

V. Swarup, D. Krummen, J. Miller, K. Shivkumar, S. Narayan (Phoenix, San Diego, Indianapolis 

and Los Angeles, US) 

Inflammation of epicardial adipose tissue around ganglionated plexus is associated with 


T. Kusayama, H. Furusho, N. Kanamori, A. Chikata, S. Kaneko, M. Yamagishi, M. Takamura 

(Kanazawa, JP) 

Risk factors of ischaemic stroke in patients with atrial fibrillation P635 

A. Rubanenko, Y. Shchukin, A. Germanov, O. Tereshina (Samara, RU) 

101 

monday 

posters

monday 

posters 


Moderate consumption of marine n-3 fatty acids is associated with a lower risk of atrial 

fibrillation - a cohort study P636 

T.A. Rix, A.M. Joensen, S. Lundbye-Christensen, S. Riahi, E.B. Schmidt, K. Overvad (Aalborg 

and Aarhus, DK) 

Predictors for the recurrence of atrial fibrillation: what should we really use? P637 

L.V. Paiva, R. Providencia, S. Barra, A.C. Faustino, P. Dinis, J. Nascimento, A.M. Botelho, 

A. Leitao-Marques (Coimbra, PT) 

Pre-existent advanced interatrial block may predict atrial fibrillation recurrence after 

successful pulmonary vein isolation for paroxysmal atrial fibrillation. P638 

J.C. Caldwell, S. Koppikar, W. Barake, D. Redfearn, K. Michael, C. Simpson, W. Hopman, 

A. Baranchuk (Kingston, CA) 

Atrial fibrillation recurrence after the first episode in context of acute coronary syndrome P639 

V. Ramos, C. Braga, J. Martins, C. Arantes, C. Vieira, J. Marques, A. Gaspar, P. Azevedo, 

M. Alvares Pereira, A. Correia (Braga, PT) 

dynamics of functional status and collagen matrix markers of arterial wall in patients with 

chronic heart failure and permanent atrial fibrillation during therapy including omega-3 

unsaturated fatty P640 

N. Koziolova, Y. Shilova, J. Nikonova, E. Polyanskaya (Perm, RU) 

Efficacy of ablation of atrial fibrillation in Brugada syndrome P641 

E. Arbelo, P.M. Berne, E. Guiu, P. Ramos, P. Cabanas, D. Andreu, F. Bisbal, J. Brugada, L.L. Mont 

(Barcelona, ES) 

Evaluation of reduction of asymptomatic cerebral embolism (ERACE) in phased rf-ablation P642 

S.G. Spitzer, A. Verma, P. Debruyne, S. Nardi, T. Deneke, Y. De Greef, J. Balzer, L. Boersma 

(Dresden, Bad Neustadt an der Saale and Mainz, DE; Newmarket, CA; Bonheiden and 

Antwerpen, BE; Castel Volturno, IT; Nieuwegein, NL) 

Enhanced lesion formation as mechanism for higher procedural efficiency of the novel 

entire-tiP irrigated Rf ablation technology tthermocool sf) in patients undergoing 

pulmonary vein isolation 643 (W) 

P. Schurr, C.I. Park, H. Lehrmann, R. Weber, J. Schiebeling-Roemer, J. Allgeier, 

C. Herrera Siklody, D. Shah, T. Arentz, A. Jadidi (Bad Krozingen, DE; Geneva, CH) 

Use of real-time 3d transoesophageal echocardiography during pulmonary vein isolation in 

patients with atrial fibrillation P644 

M. Acena, F. Regoli, F. Faletra, E. Faragasso, C. Klersy, A. Auricchio (Lugano, CH) 

Efficiency of Heparin infusion may take more than 20 minutes during ablation of atrial fibrillation P645 

V. Gabus, A. Rollin, Y. Roux, D. Graf, J. Schlaepfer, M. Fromer, P. Maury, P. Pascale, A. Forclaz, 

E. Pruvot (lausanne, CH; Toulouse, FR) 

Clinical predictors for late recurrences of atrial fibrillation after catheter ablation P646 

J. Kornej, J. Kosiuk, A. Arya, C. Piorkowski, P. Sommer, S. Rolf, D. Husser, G. Hindricks, G. Lip, 

A. Bollmann (Birmingham, GB; Leipzig, DE) 

low dose rotational angiography P647 

S. De Buck, B.S.N. Alzand, J.-Y. Wielandts, C. Garweg, T. Phlips, J. Ector, D. Nuyens, 


Concentric hypertrophy of left ventricle independently predicts atrial aibrillation recurrence 

in patients treated with rhythm control strategy: a post-hoc analysis from AffiRM trial P648 

N. Shah, P. Grover, N. Patel, A. Chothani, K. Mehta, A. Deshmukh, A. Badheka, H. Paydak, 

R.D. Mitrani, J. Viles-Gonzalez (Staten Island, Miami, Washington, Philadelphia and Little Rock, US) 

102


impact of additional low-dose dipyridamole injection on adenosine test aftrer pulmonary 

vein isolation 649 (W) 

S. Miyazaki, H. Taniguchi, T. Uchiyama, S. Kusa, H. Nakamura, H. Hachiya, Y. Iesaka (Tsuchiura, JP) 


Contrast-enhanced MRi-derived scar characteristics at re-entry circuit sites of scar-related 

ventricular tachycardia P650 

S.R.D. Piers, Q. Tao, M.J. Schalij, R.J. Van Der Geest, K. Zeppenfeld (Leiden, NL) 

the value of endocardial bipolar vs. unipolar voltage mapping to detect subepicardial scar in 

non-ischaemic cardiomyopathy: Validation by contrast-enhanced MRi P651 

S.R.D. Piers, Q. Tao, C.F.B. Van Huls Van Taxis, M.J. Schalij, R.J. Van Der Geest, K. Zeppenfeld 

(Leiden, NL) 

Evidence of perimitral reentry as a potential mechanism of ventricular tachycardia 

demonstrated by tridimensional electroanatomic entrainment map. P652 

S. Castrejon Castrejon, A. Estrada Mucci, M. Ortega Molina, J. Figueroa, D. Doiny, 

D. Filgueiras Rama, J.L. Lopez Sendon, J.L. Merino Llorens (Madrid, ES) 

Anatomic Characterisation of Cavotricuspid isthmus (Cti) by three-dimensional 

Transoesophageal Echocardiography (3D-TEE) in Patients with Difficult CTI Ablation P653 

F. Regoli, F. Faletra, M. Acena Ramos, M.C. Dequarti, A. Drasutiene, E. Faragasso, E. Pasotti, 

T. Moccetti, A. Auricchio (Lugano, CH) 

fast reacting electromagnets for remote navigation of the mapping catheter: a validation 

human study P654 

J.L. Merino, J. Shachar, A. Estrada, D. Doiny, J.A. Figueroa, S. Castrejon, D. Filgueiras, M. Ortega, 

D. Johnson, E. Gang (Madrid, ES; Inglewood and Los Angeles, US) 

Entrainment from the right ventricle distinguishes fast-slow AV nodal reentrant tachycardia 

from permanent junctional reciprocating tachycardia. P655 

R. Peinado, M. Arrascaite, E. Gonzalez-Torrecilla, M.A. Arias-Palomares, L. Tercedor, 

D. Filgueiras-Rama, M.A. Pachon, G. Tortajada, D. Garofalo, A. Gomez Gallanti (Madrid, Toledo 

and Granada, ES) 

Catheter ablation with a force monitoring contact system: relationship between pressure 

and lesion in an experimental model. P656 

R. Matia, A.H. Madrid, L. Carrizo, A. Delgado, H. Del Castillo-Carnevalli, S. Fernandez-Santos, 


low long-term rate of recurrences after cryoablation of supraventricular tachycardias P657 

J. Gonzalez-Zuelgaray, F. De Valais, A. Perez, A. Szyszko, C. Muratore, A. Sciegata, L. Hallon 

(Buenos Aires, AR) 

Persistent atrial fibrillation ablation with magnetic robotic system P658 

P. Carmo, P. Adragao, D. Cavaco, F. Costa, G. Santos, R. Quaresma, T. Teixeira, M. Marques, 

M. Abecasis (Lisbon and Carnaxide, PT) 

Radiofrequency catheter ablation of idiopathic ventricular arrhythmias originating from 

coronary vein system P659 

T. Li, X.-Z. Zhan, Y.-M. Xue, X.-H. Fang, H.-T. Liao, S.-L. Wu (Guangzhou, CN) 

Endocardeial voltage mapping in patients with dilatative cardiomyopathy is feasible and 

reveals a distinct scar pattern P660 

M. Zarse, H. Bogossian, H. Suleimann, I. Ninios, D. Mijic, Z. Karosiene, F. Hasan, A. Kloppe, 

B. Lemke (Luedenscheid and Bochum, DE) 

103 

monday 

posters

monday 

posters 


Inadvertently developed ventricular fibrillation during electrophysiologic study and catheter 

ablation; its incidence, cause and prognosis P661 

Y.M. Park, J.Y. Sung, R.S. Lim, K.J. Ko, H.S. Lee, J.E. Ban, J.I. Choi, H.E. Lim, S.W. Park, Y.H. Kim 

(Seoul, KR) 

Precordial QRs amplitude ratio predicts long term outcome after catheter ablation of 

electrical storm due to ventricular tachycardias in patients with arrhythmogenic right 


A. Muessigbrodt, B. Dinov, L. Fiedler, P. Sommer, S. Richter, O. Breithardt, A. Bollmann, 

D. Husser, G. Hindricks, A. Arya (Leipzig, DE) 

Electrophysiologic study and coronary angiography: more adverse events if performed together P663 

S. Fichtner, H. Estner, M. Dzijan-Horn, J. Herber, T. Reents, S. Ammar, V. Semmler, R. Dillier, 

G. Hessling, I. Deisenhofer (Munich, DE) 

Influence of complete ventricular tachycardia non-inducibility after radiofrequency ablation 

on the long term Vt free survival in ischaemic and non-ischaemic dilated cardiomyopathy P664 

B. Dinov, L. Fiedler, R. Schoenbauer, C. Piorkowski, A. Bollmann, S. Rolf, A. Arya, G. Hindricks 

(Leipzig, DE) 

Complications, procedure-related death and intra-hospital mortality after radiofrequency 

ablation of substrate-related ventricular tachycardia P665 

B. Dinov, L. Bertagnolli, L. Fiedler, R. Schoenbauer, C. Piorkowski, A. Bollmann, S. Rolf, 

G. Hindricks, A. Arya (Leipzig, DE) 

P-Wave morphology in focal atrial tachycardia P666 

V. Halianishcha, A. Mrochek, D. Goncharik, A. Chasnoits, O. Kovalenko, A. Savchenko, 

E. Rebeko, L. Plashchinskaya, A. Bandarchuk, S. Sivak (Minsk, BY; New York, US) 


Ventricular conduction disturbance might be the predictor of the recurrence of ventricular 

fibrillation in the patients with idiopathic ventricular fibrillation P667 

M. Watanabe, H. Yokoshiki, H. Mitsuyama, K. Mizukami, H. Tsutsui (Sapporo, JP) 

successful AtP for ventricular tachycardia in non-ischaemic dilated cardiomyopathy is 

associated with lower mortality during long-term follow-up. P668 

G.F.L. Kapel, C. Brouwer, M. De Riva Silva, J. Thijssen, S.R. Piers, A.C. Van Der Heijden, 

C.L. Meuwese, L. Van Erven, M.J. Schalij, K. Zeppenfeld (Leiden, NL) 

Myocardial micro damage associated with defibrillation threshold testing - to test or not to test? P669 

V. Semmler, J. Biermann, B. Haller, C. Jilek, N. Sarafoff, C. Lennerz, H. Vrazic, B. Zrenner, 

S. Asbach, C. Kolb (Munich, Freiburg and Landshut, DE) 

Outcome of patients with advanced heart failure who receive device-based therapy for 

primary prevention of sudden cardiac death: insights from the israeli iCd registry P670 

M. Suleiman (Haifa, IL) 

Cardiac resynchronisation therapy reduces appropriate therapy in iCd patients with primary 

prevention indication P671 

S. Cabrera Gomez, C. Alonso Martin, J. Guerra Ramos, E. Rodriguez Font, F. Mendez Zurita, 

M. Sobre, S. Magnani, X. Vinolas Prat (Barcelona, ES) 

Reduced hyperaemic myocardial perfusion assessed with [15O]H2O PEt predicts inducibility 

of ventricular arrhythmias in ischaemic cardiomyopathy P672 

M.T. Rijnierse, C.P. Allaart, S. De Haan, H.J. Harms, L. Wu, I. Danad, A.C. Van Rossum, 

A.A. Lammertsma, P. Knaapen (Amsterdam, NL) 

104


impaired night-time heart rate adaptation may be prognostic of the arrhythmic risk in 

Heart failure patients. P673 

P. Arsenos, K. Gatzoulis, G. Manis, P. Dilaveris, T. Gialernios, A. Kefala, D. Tsiachris, A. Aggelis, 

S. Archontakis, C. Stefanadis (Athens and Ioannina, GR) 

superiority of night-time extracted heart rate variability indices in comparison to those of 

day-time for ventricular arrhythmia prediction in heart failure patients. P674 

P. Arsenos, K. Gatzoulis, G. Manis, P. Dilaveris, T. Gialernios, A. Kefala, D. Tsiachris, A. Vouliotis, 

S. Archontakis, C. Stefanadis (Athens and Ioannina, GR) 

Fewer lead related complications in subcutaneous implantable defibrillator compared to 

transvenous single- and dual-chamber iCd P675 

J.B. Johansen, R.E. Kirkfeldt, J.C. Nielsen, L. Boersma, R. Knops, L.O. Nordekamp, P. Lambiase, 

N. Carter, H. Reeve, D. Theuns (Odense and Aarhus, DK; Nieuwegein, Amsterdam and 

Rotterdam, NL; London, GB; St. Paul, MN, US) 

Who is suitable for the subcutaneous iCd: incidence and predictors of failed t-wave analysis P676 

L.R.A. Olde Nordkamp, J.L.F. Warnaars, A.A.M. Wilde, R.E. Knops (Amsterdam, NL) 

Very long-term follow-up of patients with surgically corrected congenital heart disease and 

an implantable cardioverter-defibrillator P677 

P. Silva Cunha, M. Martins Oliveira, M. Nogueira Da Silva, A. Agapito, L. Sousa, C. Trigo, 

J. Fragata, R. Cruz Ferreira (Lisbon, PT) 

Performance of fluoroscopy for diagnosing conductor externalization in recalled St. Jude 

Medical Riata defibrillator leads P678 

J.M. Larsen, S. Riahi, J.C. Nielsen, R. Videbaek, J. Haarbo, K.M. Due, D.A.M.J. Theuns, 

J.B. Johansen (Aalborg, Aarhus, Copenhagen, Gentofte and Odense, DK; Rotterdam, NL) 

Evaluation of a young population candidate for subcutaneous iCd - is inability to pacing an 

important limitation? P679 

P. Galvao Santos, D. Cavaco, P. Adragao, F. Costa, P. Carmo, F. Mogado, M. Abecasis, 

M. Mendes (Lisbon, PT) 

Potential eligibility of congenital heart disease patients for subcutaneous implantable 

cardioverter defibrillator based on surface ECG mapping. P680 

M. Zeb, S. Chande, S. Kwok, P. Roberts, J. Morgan (Southampton, GB) 

A novel morphology based algorithm for prediction of antitachycardia pacing success. P681 

R. Matia, A.H. Madrid, G. Sanchez-Huete, C. Pindado, H. Del Castillo-Carnevali, A. Delgado, 

S. Fernandez-Santos, C. Lazaro, C. Moro, J. Zamorano (Madrid, ES) 

Pacing 

tlR-4 expression in explanted tissue during transcutaneous lead removal in 49 patients. P682 

A. Kolodzinska, A. Kutarski, E. Wilczek, M. Grabowski, L. Koperski, M. Kozlowska, B. Gornicka, 

G. Opolski (Warsaw and Lublin, PL) 

Patients with higher standard deviation in daily median respiratory rate are at higher risk of 

worsening Hf in 30 days P683 

J. Boehmer, Q. An, Y. Zhang, A. Shih (Hershey and St Paul, US) 

device explantation due to infection - are we facing a trend towards multirestistant 

microorganisms? P684 

V. Moeller, M. Seifert, T.H. Schau, F. Hoelschermann, C.H. Butter (Bernau bei Berlin, DE) 

Can skin adhesive be used to achieve a similar cosmetic result compared to absorbable 

sutures in skin closure after permanent pacemaker implantation: a randomised controlled trial. P685 

D.H. Brahmbhatt, T.J. Watson, R. Prasad, A. Ladwiniec, I. Rafiq, V. Nayar, D. Chan, R. Price, 

M.R.D. Belham, P.J. Pugh (Cambridge, GB) 

105 

monday 

posters

monday 

posters 


is right ventricular pacing associated with an increased incidence of appropriate implantable 

cardioverter defibrillator (ICD) therapy? P686 

C.M. Seifer, A. Farag (Winnipeg, CA) 

Pacing threshold and site of steroid elution in left ventricular leads P687 

M. Cao, A. Fischer, E. Karst, L. Sloman, M. Desmond, M. Turakhia (Los Angeles, Sylmar and 

Palo Alto, US) 

Cardiac device related infective endocarditis. Usually long way between first symptoms and 

proper treatment P688 

A. Polewczyk, A. Kutarski, A. Tomaszewski, K. Boczar, M. Janion (Kielce and Lublin, PL) 

left heart performance during right ventricular apex pacing in patients after cardiac surgery P689 

D. Novikov, M. Kandinsky, S. Popov, E. Vyskubova, S. Yuriev, A. Samoilov, M. Latkin 

(Krasnodar and Tomsk, RU) 

incidence and predictors of heart failure hospitalisation and death in permanent pacemaker 

patients: a single-center experience over medium-term follow-up P690 

A. Mazza, M.G. Bendini, M. Leggio, U. Riva, C. Ciardiello, R. De Cristofaro, G. Giordano 

(Orvieto, Rome and Milan, IT) 

Impact of anemia in patients who underwent implantable cardioverter defibrillator/ cardiac 

resynchronisation therapy defibrillator implantation P691 

T. Kabutoya, T. Mitsuhashi, H. Watanabe, T. Watanabe, R. Nakagami, Y. Hata, K. Kario 

(Tochigi and Chiba, JP) 

CRT complications - the first year post implant P692 

C.E.P. Brough, C. Mcgee, A. Rao, D.J. Wright (Liverpool, GB) 


Clinical outcomes are worse in patients upgraded to cardiac resynchronisation therapy than 

in primary implants P693 

C. Alonso-Martin, J. Guerra, E. Rodriguez-Font, F. Mendez, S. Magnani, M. Sobre, S. Cabrera, 

M.C. Varela, E. Paz, X. Vinolas (Barcelona, ES) 

is ventricular electrical delay a predictor of arrhythmic outcomes among patients with 

cardiac resynchronisation therapy? P694 

V. Gulati, S. Bhavnani, S.U. Nair, M. Friedman, J. Kluger (Farmington and Hartford, US) 

Cardiac resynchronisation therapy: do patient selection and implant practice vary according 

to the volume of the center ? P695 

R. Matia, A.H. Madrid, L. Almenar, M. Sancho-Tello, I. Fernandez-Lozano, A. Delgado, 

S. Fernandez-Santos, C. Lazaro, C. Moro, J. Zamorano (Madrid and Valencia, ES) 

Acute cardiac resynchronisation (ACCEss): an echo guided lead positioning method: a 

feasibility study. P696 

D. Dan, A. Wickliffe, T. Deering, I. Kosmidou, F. Renesto, S. Cazeau (Piedmont, US; 

Clamart and Paris, FR) 

A novel electrocardiographic predictor of clinical response to cardiac resynchronisation therapy P697 

R. Mollo, I. Coviello, I. Battipaglia, G. Russo, A. Villano, A. Di Franco, G. Careri, A. Sestito, 

G.A. Lanza, F. Crea (Rome, IT) 

A novel fluoroscopic method fo RV-lV interleads measurement and the prediction of CRt 

response P698 

G. Covino, M. Volpicelli, P. Belli, G. Ratti, P. Tammaro, C. Provvisiero, L. Auricchio, C. Fiorentino, 

C. Ciardiello, P. Capogrosso (Naples and Milan, IT) 

106


transseptal endocardial left ventricular lead implantation - a very effective alternative 

method in heart failure patients P699 

L. Geller, L. Molnar, S.Z. Szilagyi, T. Tahin, V. Kutyifa, K. Solymossy, G. Szeplaki, I. Osztheimer, 

E. Zima, B. Merkely (Budapest, HU) 

Assessment of myocardial contractility by sonr sensor in patients undergoing cardiac 

resynchronisation therapy (CRt) P700 

S. Sacchi, I. Ricceri, P. Attana', A. Giomi, A. Rossi, P. Pieragnoli, G. Ricciardi, L. Perrotta, 

M. Piacenti, L. Padeletti (Florence and Pisa, IT) 

introducing a new combined diagnostic imaging strategy to improve the response rate in 

Cardiac Resynchronization therapy P701 

Z. Bakos, H. Markstad, E. Ostenfeldt, M. Carlsson, A. Roijer, R. Borgquist (Lund, SE) 


Maximal aerobic power in top athletes is predicted by heart rate variability and high 

frequency components of the ventricular activation of signal-averaged electrocardiogam 702 (W) 

M. Marocolo, O. Barbosa Neto, D. Schimitz De Freitas, G. Ribeiro Da Mota (Uberaba and 

Juiz de Fora, BR) 

Heart rate turbulence as index for risk stratification in patients with severe sleep apnea 

syndrome and frequent ventricular ectopy without organic heart disease P703 

E. Simeonidou, K. Vlami, K. Ntai, K. Koniari, E. Iliodromitis, M. Anastasiou-Nana (Athens, GR) 

Evaluation of heart rate variability changes in response to the training for a marathon P704 

M. Sturmer, K. Dahl, A. Vinet, V. Jacquemet, B. Dube, O. Mahiddine, G. Becker, T. Kus, 

R. Nadeau (Montreal, CA) 

Gender-related differences in heart rate turbulence in the early phase of acute myocardial 

infarction P705 

B. Sredniawa, S. Cebula, K. Mitrega, A. Wozniak, A. Musialik-Lydka, J. Kowalczyk, Z. Kalarus 

(Zabrze, PL) 

Factors that may influence physical training effects 706 (W) 

C.C. Grant, D.C. Janse Van Rensburg (Pretoria, ZA) 

long-term predictive value of heart rate recovery in patients with chronic heart failure P707 

A. Gwizdala, E. Straburzynska-Migaj, T. Krauze, S. Grajek, R. Ochotny (Poznan, PL) 

Repolarisation duration as a predictor of appropriate iCd interventions in patients with the 

remote myocardial infarction, untreated with amiodarone. P708 

K. Szydlo, A. Filipecki, W. Orszulak, W. Kwasniewski, D. Urbanczyk, M. Trusz-Gluza, 

K. Mizia-Stec (Katowice, PL) 

Echocardiographic right atrial reverse remodeling in long-term follow-up after typical atrial 

flutter ablation. P709 

P. Cabanas Grandio, F. Bisbal, J. Garcia Seara, J.L. Martinez Sande, X.A. Fernandez Lopez, 

A. Berruezo, L. Mont, J.R. Gonzalez Juanatey (Santiago de Compostela and Barcelona, ES) 

time delay from atrial electrical depolarization to mechanical contraction as a marker of 

sinus node dysfunction P710 

D.H. Lee, J.S. Park, J.M. Seo, J.H. Choi, K.I. Park, T.H. Park, M.H. Kim, Y.D. Kim, S.Y. Choi (Busan, KR) 

Oral anticoagulation after cavotricuspid isthmus ablation: when should it be discontinued? P711 

R. Rodriguez-Olivares, R. Cozar Leon, F. Francisco Aparicio, E. Diaz-Infante (Seville, ES) 

107 

monday 

posters

monday 

posters 


Clinical impact of supraventricular tachycardias in patients with chronic thromboembolic 

pulmonary hypertension P712 

S. Havranek, D. Ambroz, D. Wichterle, P. Jansa (Prague, CZ) 

brugada syndrome in pediatric patients. Clinical features and outcome. P713 

M.N. Benjamin, J.A. Olmedo, M.S. Abello, J.M. Moltedo (Ciudad Autonoma de Buenos Aires 

and Buenos Aires, AR) 

Cardiac electrical abnormalities in Qat chewers P714 

A.M. El Mahmoudy (cairo, EG) 

Ambulatory electrocardiogram-based t-wave alternans might be useful to identify patients 

with implantable cardioverter defibrillator at risk for ventricular tachyarrhythmias. P715 

M. Kawasaki, T. Yamada, T. Morita, Y. Furukawa, Y. Iwasaki, A. Kikuchi, M. Fukunami (Osaka, JP) 

Variations of P-P intervals are correlated with variations of R-R intervals from ECG obtained 

in low electromagnetic noise condition P716 

A. Boev, A. Levitchi, D. Josan (Chisinau, MD) 

108

New version 2013 

of the EsC Guidelines on 

Cardiac Pacing & CRT 

Full Text 2013 to be 

first presented at 

EHRA EUROPACE 

on 25 June 08:30 

in Room Rhodes 

Now Available 

109 

Version 

2013 

its pocket guidelines and derivative 

educational material will be available at 

ESC Congress in Amsterdam 

For more information 

www.escardio.org/guidelines 

tuesday 

sessions

tUEsdAy 25 JUnE 2013 - MORNING 

08:30 - 10:00 Main session Crete 

Nightmares in electrophysiology: my worst case ever 

Chairpersons: P. Geelen (Aalst, bE); J.H. svendsen (Copenhagen, dK) 


08:30 Atrial fibrillation. 717 

J. Kautzner (Prague, CZ) 

08:52 Ventricular tachycardia ablation. 718 


09:15 Pacemaker implantation. 719 

L. Van Erven (Leiden, NL) 

09:37 Cardiac resynchronisation implantation. 720 

M.R. Gold (Charleston, US) 

08:30 - 10:00 Main session Rhodes 

The new 2013 ESC Guidelines on pacing and cardiac resynchronisation therapy. 

Chairpersons: K.-H. Kuck (Hamburg, dE); A. Auricchio (lugano, CH) 


08:30 What’s new. 721 

M. Brignole (Lavagna, IT) 

08:48 Update on cardiac pacing. 722 

R. Sutton (Monte Carlo, MC) 

09:06 Update on CRt in patients in sinus rhythm. 723 

V. Delgado (Leiden, NL) 

09:24 Update on CRT in patients in sinus rhythm in patients in atrial fibrillation. 724 


09:42 Update on CRt in patients with heart failure and conventional pacemaker indications. 725 

C. Linde (Stockholm, SE) 

111 

tuesday 

sessions

tUEsdAy 

sEssiOns 

tuesday 25 June 2013 - morning 


Epicardial ventricular tachycardia ablation 

Chairpersons: G. Hindricks (leipzig, dE); R. brugada terradellas (Girona, Es) 


Epicardial ventricular tachycardia approach has besome a key issue for successful ventricular tachycardia 

ablation. It is not yet of common practice in every EP labs. 

08:30 How to obtain epicardial access? 726 

A. Davila (New York, US) 

08:52 How to prevent and manage complications? 727 


09:15 Epicardial mapping and ablation technique. 728 

P. Della Bella (Milan, IT) 

09:37 should ventricular tachycardia ablation only be recommended in centres capable to 

perform epicardial approach? 729 

M.P. Riley (Philadelphia, US) 


The "unknowns" in arrhythmogenic diseases 

Genetic summit 

Chairpersons: d. dobrev (Essen, dE); A. Zaza (Milan, it) 

basic science 

08:30 Loss of function mutations in SCN5A: why so many phenotypes? 730 

S.C. Dudley (Providence, US) 

08:52 Susceptibility loci, polymorphisms and mutations: complexity of genetic influence on 

atrial fibrillation. 731 

S. Kaab (Munich, DE) 

09:15 Epigenetics in arrhythmias: from dnA mathylation to microRnAs. 732 

X. Luo (Montreal, CA) 

09:37 Gene therapy for channelopathies: pros and cons. 733 


112



Lead extraction, extension of the lead management summit (Part I) 

Indications for lead extraction 


Chairpersons: M.G. bongiorni (Pisa, it); C.E.H. Kennergren (Goteborg, sE) 


The goal of these two sessions is to present the latest indications for lead extraction in part I and the 

techniques to achieve safe and successful procedures in Part II. These sessions are case-based and the 

participation of the audience is highly requested. Each presenter will divide their time equally between 

presenting one case that raises a particular topic and then gives a brief presentation of the topic raised 

in the care of that particular patient. 

08:30 When are multiple leads, including superfluous, too many? 734 

D. Klug (Lille, FR) 

08:52 Management of recalled leads. 735 

B.O. Oswald (Vienna, AT) 

09:15 Other class ii indications for lead extraction. 736 

H. Marshall (Birmingham, GB) 

09:37 Extraction of dual coil iCd lead. 737 

B. Wilkoff (Cleveland, US) 

08:30 - 10:00 Oral Abstract session ithaca 

Oral Abstract Session: ablation: technical aspects 

Chairpersons: M. duytschaever (Gent, bE); A. Proclemer (Udine, it) 

08:30 Contact force - the new Paradig for Rf Ablation 738 

P.N. Neuzil, S.D. Dukkipatti, F.C. Cuoko, M.M. Mansour, A.N. Natale, F.M. Marchlinski, 

D.P. Packer, H.L. Lambert, J.B. Bouvier, V.Y.R. Reddy (Prague, CZ; New York, 

Charleston, Boston, Austin, Philadelphia and Rochester MN, US; Geneva, CH) 

08:45 Outcome after substrate-based epicardial catheter ablation of ventricular 

arrhythmias in patients with prior myocarditis 739 

D. Tsiachris, G. Maccabelli, J. Silberbauer, C. Bisceglia, F. Baratto, N. Trevisi, P. Vergara, 

A. Esposito, P. Della Bella (Milan, IT) 

09:00 simultaneous single-beat electrocardiographic mapping of complex arrhythmias 740 

I. Suman Horduna, L. Mantziari, S. Ernst (London, GB) 

09:15 Predictors of recurrence after scar dechanneling in scar-related ventricular tachycardia 741 

J. Fernandez Armenta, A. Berruezo, L. Mont, D. Andreu, D. Penela, R. Everzt, 

L. Cipolletta, J.M. Tolosana, E. Arbelo, J. Brugada (Barcelona, ES) 

113 

tuesday 

sessions

tUEsdAy 

sEssiOns 



Oral Abstract Session: ablation: technical aspects (continued) 

Chairpersons: M. duytschaever (Gent, bE); A. Proclemer (Udine, it) 

09:30 Occurrence of presystolic potentials in various type of outflow tract ventricular 

arhythmias 742 

B. Goncharik, D. Goncharik, A. Mrochek, A. Chasnoits, O. Kovalenko, V. Golenischa, 

T. Burmistrova (Minsk, BY) 

09:45 Relation between QRs duration of frequent ventricular premature complexes and 

brain natriuretic peptide 743 

T. Kitamura, S. Fukamizu, R. Hojo, T. Hayashi, K. Komiyama, Y. Tanabe, T. Tejima, 

H. Sakurada, M. Nishizaki, M. Hiraoka (Tokyo and Yokohama, JP) 

08:30 - 10:00 Main session Mykonos 

Worldwide debatable topics 

Joint session World society of Arrhythmias / EHRA 

Chairpersons: s.-A. Chen (taipei, tW); P.E. Vardas (Heraklion, GR) 


08:30 The global pacemaker/ICD patient card: where are we? 744 

M. Santini (Rome, IT) 

08:48 International patient informed consent: is it feasible? 745 


09:06 few women in electrophysiology: reasons and solutions. 746 

A. Gillis (Calgary, CA) 

09:24 Re use of electrophysiological tools: implantable devices, EP catheters. 747 

C.W. Israel (Bielefeld, DE) 

09:42 Patient awareness campaigns: which priorities? 748 


114



Catheter ablation of outflow tract ventricular tachycardia 

Connecting Continents - JHRs - EHRA 

Chairpersons: K. Okumura (Hirosaki, JP); s. Willems (Hamburg, dE) 


08:30 The surface ECG: clues to find the spot. 749 


08:52 Access to target sites: right, left and epicardial. 750 

H. Tada (Ibaraki Prefecture, JP) 

09:15 Electrogramme criteria for successful ablation. 751 

A. Arya (Leipzig, DE) 

09:37 Complications: incidence and treatment. 752 

H. Hachiya (Bunkyo-Ku, JP) 


Oral Abstract Session: translational view on atrial fibrillation 

Chairpersons: U. Ravens (dresden, dE); s. Hatem (Paris, fR) 

08:30 Characterisation of the inflammatory response following radiofrequency catheter 

ablation of cardiac arrhythmias 753 

G. Szeplaki, O.M. Kovacs, T. Tahin, L. Geller, S.Z. Szilagyi, I. Osztheimer, Z.S. Jenei, 

Z. Prohaszka, B. Merkely (Budapest, HU) 

08:45 Endothelial dysfunction and platelet activation in patients with atrial fibrillation: 

importance of co-morbid conditions 754 

H.S. Lim, S.R. Willoughby, C. Schultz, M. Alasady, D.H. Lau, A.G. Brooks, 

K.C. Roberts-Thomson, G.D. Young, M.I. Worthley, P. Sanders (Adelaide, AU) 

09:00 The substrate of atrial fibrillation associated with heart failure is characterized by a 

reduced atrial excitability despite normal electrical properties of atrial myocytes 755 

V. Algalarrondo, N. Mougenot, A. Jacquet, C. Eichel, A. Coulombe, E. Balse, 

S.N. Hatem (Chatenay-Malabry and Paris, FR) 

09:15 Cardiorenal relation in patients with chronic heart failure and permanent atrial 

fibrillation during treatment by omega-3-unsaturated fatty acids. 756 

N. Koziolova, J. Nikonova, Y. Shilova, A. Agafonov, E. Polyanskaya (Perm, RU) 

09:30 Renal sympathetic denervation provides ventricular rate control but does not 

prevent atrial electrical remodeling during atrial fibrillation. 757 

D. Linz, F. Mahfoud, C. Ukena, M. Hohl, U. Schotten, H.R. Neuberger, K. Wirth, 

M. Böhm (Homburg and Frankfurt/Main, DE; Maastricht, NL) 

09:45 Variability of P-wave morphology as an electrocardiographic marker of atrial 

substrate: a study on patients with hypertrophic cardiomyopathy, patients with atrial 

fibrillation and healthy 758 

Y. Huo, F. Holmqvist, J. Carlson, T. Gaspar, A. Bollmann, G. Hindricks, C. Piorkowski, 

P. Platonov (Lund, SE; Leipzig, DE) 

115 

tuesday 

sessions

tUEsdAy 

sEssiOns 


11:00 - 12:30 special session Crete 

Late Breaking Trial Session I 

Chairpersons: A. Goette (Paderborn, dE); J. brugada terradellas (barcelona, Es) 

11:00 Gap-Af - -AfnEt 1 trial. 759 


11:13 discussant: Gap-Af. 760 

D. Shah (Geneva, CH) 

11:18 Catheter ablation for the treatment of persistent atrial fibrillation: a prospective, 

multicentric, randomized controlled trial of ablation versus antiarrhythmic drugs in 

persistent atrial fibrillation. 761 


11:31 discussant: sARA. 762 

L.V.A. Boersma (Nieuwegein, NL) 

11:36 Clinical evaluation of the Phd function in the PARAdyM CRt device trial. 763 

F. Leyva-Leon (Sutton Coldfield, GB) 

11:49 discussant: ClEPsydRA 764 

I. Garcia Bolao (Pampelone, ES) 

11:54 incidence and risk factors for thromboembolic events after catheter ablation of 

atrial fibrillation: the Leipzig heart center AF ablation registry. 765 

J. Kornej (Leipzig, DE) 

12:07 discussant: the leipzig Heart Center Ablation Registry. 766 


12:12 Painfree smartshock technology: trial primary results: inappropriate shock rates in 

patients with single chamber iCd's using a novel suite of detection algorithms. 767 

A. Meijer (Maastricht, NL) 

12:25 discussant: painfree smartshock technology. 768 





programme. 


116



Ablation of idiopathic ventricular tachycardias and premature ventricular 

complexes 

Chairpersons: E. Wissner (Hamburg, dE); J.-f. leclercq (levallois, fR) 


Indication for idiopathic premature ventricular complexes/ventricular tachycardias ablation in usual 

practice but also from rare sites of origin 

11:00 When to ablate patients with high density premature ventricular complexes? 772 


11:22 Ablation of ventricular tachycardias arising from the right ventricular outflow tract, 

left ventricular outflow tract and aortic cusps. 773 

F. Ouyang (Hamburg, DE) 

11:45 Ablation of ventricular tachycardias arising from the papillary muscle, the tricuspid 

and mitral annulus. 774 

D.J. Wilber (Maywood, US) 

12:07 Ablation fo ventricular tachycardias/premature ventricular complexes arising from 

the great cardiac veins and epicardial sites. 775 

A. Natale (Austin, US) 


Debated issues in channelopathies 


Chairpersons: P. Kirchhof (birmingham, Gb); H. Abriel (bern, CH) 

basic science 

11:00 From in silico to in vitro characterisation of mutations: what is most helpfl for the clinician? 776 

P.G.A. Volders (Maastricht, NL) 

11:22 next generation sequencing: lights and shadows for its use in clinical diagnosis. 777 

J. Ware (London, GB) 

11:45 Epicardial ablation in Brugada Syndrome: ready for prime time? 778 

K. Nademanee (Los Angeles, US) 

12:07 induced pluripotent stem cells derived myocytes: immature cells or suitable models 

for channelopathies? 779 

E. Cerbai (Florence, IT) 

117 

tuesday 

sessions

tUEsdAy 

sEssiOns 



Lead extraction, extension of the lead management summit (Part II) 

State of the art in lead extraction techniques 


Chairpersons: J. Kautzner (Prague, CZ); J. Winter (dusseldorf, dE) 


The goal of these two sessions is to present the latest indications for lead extraction in part I and the 

techniques to achieve safe and successful procedures in Part II. These sessions are case-based and the 

participation of the audience is highly requested. Each presenter will divide their time equally between 

presenting one case that raises a particular topic and then gives a brief presentation of the topic raised 

in the care of that particular patient. 

11:00 Extraction with mechanical sheaths. 780 


11:22 femoral lead extraction. 781 

F.A.L.E. Bracke (Eindhoven, NL) 

11:45 laser assisted lead extraction. 782 

P. Defaye (Grenoble, FR) 

12:07 special approaches to lead extraction. 783 

C.E.H. Kennergren (Goteborg, SE) 


Oral Abstract Session: atrial fibrillation: Clinical Aspects 

Chairpersons: E. Kanoupakis (Heraklion, GR); E. Pokushalov (novosibirsk, RU) 

11:00 Atrial fibrillation ablation patients have long-term stroke rates similar to patients 

without atrial fibrillation regardless of CHADS2 score 784 

T. Bunch, H.T. May, T.L. Bair, B.G. Crandall, J.S. Osborn, J.P. Weiss, J.L. Anderson, 

J.B. Muhlestein, D.L. Lappe, J.D. Day (Murray, US) 

11:15 Atrial fibrillation as a marker of clinical severity in brugada syndrome 785 

N. Cabanelas, E. Arbelo, P. Berne, J.M. Tolosana, A. Berruezo, L. Mont, J. Brugada 

(Barcelona, ES) 

11:30 Progression of atrial fibrillation after a failed initial ablation procedure in patients 

with paroxysmal atrial fibrillation: a randomized comparison of antiarrhythmic drug 

therapy vs re-ablation 786 

E. Pokushalov, A. Romanov, M. De Melis, S. Artyomenko, V. Baranova, D. Losik, 

S. Bairamova, A. Karaskov, S. Mittal, J.S. Steinberg (Novosibirsk, RU; Maastricht, NL; 

New York, US) 

11:45 Physical activity and risk of atrial fibrillation in men 787 

N. Drca, A. Wolk, M. Jensen-Urstad, S.C. Larsson (Stockholm, SE) 

118



Oral Abstract Session: atrial fibrillation: Clinical Aspects (continued) 

Chairpersons: E. Kanoupakis (Heraklion, GR); E. Pokushalov (novosibirsk, RU) 

12:00 How well do electrophysiologists estimate the degree of quality of life impairment 

of their patients with paroxysmal atrial fibrillation? Results from the ANTIPAF Trial 788 

K.-H. Ladwig, A.V. Eisenhart-Rothe, T.H. Meinertz, A. Goette (Munich, Hamburg and 

Paderborn, DE) 

12:15 Costs of complications for stroke prevention in atrial fibrillation patients, comparing 

warfarin to left atrial appendage closure 789 

L. Da Deppo, S. Amorosi, S. Armstrong, R. Peppa, S. Garfield, K. Stein (Milan and 

Genova, IT; Natick, Wayland, MA and St, Paul, US) 

11:00 - 12:30 How-to session Mykonos 

How to solve clinical problems in pacemakers patients 

Chairpersons: M. santini (Rome, it); P.R. Roberts (southampton, Gb) 


11:00 What to do in pacemaker patients with new heart failure? 790 


11:22 What to do in pacemaker patients with syncope? 791 

R. Sutton (Monte Carlo, MC) 

11:45 How to prevent strokes in pacemaker patients. 792 


12:07 Use of remote monitoring to optimise pacemaker therapy. 793 


119 

tuesday 

sessions

tUEsdAy 

sEssiOns 



Catheter ablation of longstanding persistent atrial fibrillation 

Connecting Continents - APHRs - EHRA 

Chairpersons: s.-A. Chen (taipei, tW); f. Gaita (turin, it) 


11:00 Patient selection: how to identify patients with low likelihood for ablation success? 794 

J. Kalman (Victoria, AU) 

11:22 Treatment strategies: pulmonary vein isolation plus...what? 795 

Y.-H. Kim (Seoul, KR) 

11:45 The redi-procedures: what's the strategy? 796 

C. Sticherling (Basel, CH) 

12:07 The re-re-re does: when to give up? 797 



Oral Abstract Session: translational view on ventricular electrophysiology 

Chairpersons: A. Zaza (Milan, it); i. Mavrakis (Heraklion, GR) 

11:00 Optical mapping of voltage and intracellular calcium in cardiac cells and tissues 798 

A.M. Saleh, T. Arafune, T. Yamanaka, I. Sakuma, M. Yamazaki, H. Honjo, K. Kamiya 

(Coburg, DE; Tokyo and Nagoya, JP) 

11:15 3d delayed enhancement magnetic resonance sequences improve conducting 

channel delineation prior to ventricular tachycardia ablation 799 

D. Andreu, J.T. Ortiz, A. Berruezo, J. Fernandez-Armenta, D. Penela, R. Evertz, 

E. Arbelo, J.T. Tolosana, L. Mont, J. Brugada (Barcelona, ES) 

11:30 Chronic dyssynchronous ventricular activation is proarrhythmic 800 

T.R.G. Stams, M. Meine, H.D.M. Beekman, R. Van Der Nagel, M.A. Vos (Utrecht, NL) 

11:45 the effect of autonomic nervous system blockade on remote ischaemic postconditioning 801 

P. Flevari, A. Zoga, I.S. Bibli, E. Iliodromitis, M. Anastasiou-Nana (Athens, GR) 

12:00 serum markers of collagen turnover predict future shocks in iCd recipients with 

dilated cardiomyopathy on optimal treatment 802 

E.K. Kanoupakis, E.K. Kallergis, H.M. Mayrakis, C.G. Goudis, I.S. Saloustros, 

E.K. Koutalas, N.M. Malliaraki, M.M. Milathianaki, G.C. Chlouverakis, P.V. Vardas 

(Heraklion, GR) 

12:15 Cardiac electrographic and morphological changes following status epilepticus: 

comparative therapeutic effects of clonidine, atenolol and diazepam 803 

M.I. Read, J.C. Harrison, D.S. Kerr, I.A. Sammut (Dunedin, NZ) 

120


12:45 - 13:45 satellite symposium Rhodes 

Changing paradigms in electrophysiological arrhythmia treatment 

sponsored by st. Jude Medical 

Chairperson: K. Zeppenfeld (leiden, nl) 

Understand better the benefits & explore the potential of new & innovative methods of identifying 

cardiac arrhythmias & giving treatment. 



12:50 Electrical conductive, index supported Rf ablation and transmurality; Results of Us 

atrial flutter interventional device exemption trial. 805 

L. Chinitz (New York, US) 

13:05 improved therapeutic outcomes in Vt through complex chamber mapping. 806 


13:20 impact of MRi in improving outcomes in the ablation of Vt. 807 


13:35 Conclusion. 808 



AF ablation: transforming complexity into safe, effective and efficient 


Chairpersons: K.-H. Kuck (Hamburg, dE); M. Hocini (Pessac, fR) 

Learn about the new Phased RF system for AF ablation including the technological advances and the 

clinical results. 

Learn about the new Cryoballoon system for AF ablation ranging from the modifications to the balloon 

to the latest clinical experiences and results. 


M. Hocini (Pessac, FR) 

12:50 new Phased Rf system: beyond theory to the power of precision. 810 

A. Verma (Newmarket, CA) 

13:15 new Cryoballoon system: from concept to latest clinical experience. 811 

B. Schumacher (Kaiserslautern, DE) 



121 

tuesday 

sessions

tUEsdAy 

sEssiOns 


12:45 - 13:45 satellite symposium lefkada 

Novel oral anticoagulants during clinical procedures in patients with AF: 

translating promising data into real-life practice 

sponsored by boehringer ingelheim 

Chairpersons: G.y.H. lip (birmingham, Gb); P.E. Vardas (Heraklion, GR) 

To describe the available guidance (specifically the EHRA guidance) and data supporting optimal 

strategies for using NOACs in patients with AF undergoing clinical procedures, focussing on 

cardioversion and ablation. To discuss the practicalities of using NOACs in patients undergoing invasive 

procedures. To use real-world information to provide insights into optimal management strategies. 

12:45 introduction and welcome. 813 


12:50 EHRA guidance for patients undergoing procedures: a useful tool for real-life practice. 814 


13:00 Protecting patients during ablation: what is the optimal anticoagulation strategy? 815 


13:20 safeguarding patients undergoing cardioversion: optimizing your approach to 

anticoagulation. 816 

G.K. Andrikopoulos (Thrakomakedones-Athens, GR) 

13:40 summary and close. 817 



A new paradigm in ICD therapy: clinical perspectives on a novel singlechamber 

ICD system with complete atrial diagnostics 

sponsored by biOtROniK 

Chairperson: b. Merkely (budapest, HU) 

By the end of the symposium, the participants should be able to: Discuss the clinical benefits of this new 

ICD system and specifically of its single-coil, single-pass ICD lead with atrial sensing capability. Describe 

the particular benefit of the atrial sensing capability for early detection of atrial fibrillation when used 

with BIOTRONIK Home Monitoring. 


B. Merkely (Budapest, HU) 

12:55 Clinical value of atrial electrogram in a single-lead ICD? 819 

C. Sticherling (Basel, CH) 

13:20 Home Monitoring: advantages of early detection of atrial fibrillation in ICD patients. 820 

D. Bansch (Hamburg, DE) 


B. Merkely (Budapest, HU) 

122

tUEsdAy 25 JUnE 2013 - AFTERNOON 

12:45 - 13:45 satellite symposium ithaca 

Ground breaking new therapies for electrophysiologists 


Chairpersons: R. Cappato (san donato, it); d.W. davies (london, Gb) 

Goal of this session is to educate the audience on new technologies that are or will soon be available 

to the EP; new technologies that will change the EP practice. The session will focus on the state of the 

technology as well as reviewing the available clinical data. 


R. Cappato (San Donato, IT) 

12:51 Subcutaneous defibrillation. 823 

A. Grace (Cambridge, GB) 

13:09 Through the looking glass - Atrial fibrillation and rotors. 824 

M.J. Wright (London, GB) 

13:27 Rapid, high-resolution electroanatomical mapping. 825 

D.W. Davies (London, GB) 

12:45 - 13:45 satellite symposium Mykonos 

Advances in ablation catheter technology and role of contact force 

sponsored by biosense Webster 

Chairperson: d. shah (Geneva, CH) 

12:45 Acute results of contact force optimized pulmonary vein isolation. 826 

T.J.R. De Potter (Aalst, BE) 

13:00 the use of contact force data results in low acute pulmonary vein electrical 

reconnection rates. 827 

T. Wong (London, GB) 

13:15 Outcome correlations with contact force optimized pulmonary vein isolation. 828 


13:30 tips and tricks in the clinical use of real time contact force measurement. 829 

J.-P. Albenque (Toulouse, FR) 

13:40 Questions and answers. 830 

123 

tuesday 

sessions

tUEsdAy 

sEssiOns 

tuesday 25 June 2013 - afternoon 

12:45 - 13:45 satellite symposium santorini 

Benefits of sleep apnea screening in the management of atrial fibrillation patients 

sponsored by sorin Group and ResMed 

Chairpersons: P. defaye (Grenoble, fR); s. Chatzidou (Athens, GR) 

It is well established that sleep apnea triggers arrhythmias such as non-sustained ventricular tachycardia, 

sinus arrest and 2nd degree AV block. This symposium explores the link between sleep apnea and atrial 

fibrillation (AF) and presents a novel approach for the automatic screening of sleep apnea in patients 

with implantable cardiac devices. Early detection of sleep apnea may result in enhanced treatment 

options and improved patient outcomes. 

12:45 Atrial fibrillation & sleep apnea: clinical mechanism, consequences and patient 

management impact. 831 

N. Zarqane (Monaco, MC) 

13:15 Automated screening of severe sleep apnea in an implantable cardiac device. 832 

J.L. Pepin (Grenoble, FR) 

12:45 - 13:45 satellite symposium Hydra 

New opportunities and new challenges of anticoagulation in atrial fibrillation 

sponsored by daiichi sankyo Europe 

Chairpersons: A.J. Camm (london, Gb); A. Goette (Paderborn, dE) 

To highlight achievements and current challenges in oral anticoagulation. To highlight treatment 

of AF (based on current ESC Guidelines), putting role of anticoagulants into context. To highlight 

current challenges of new oral anticoagulants in clinical practice. To highlight key pharmacokinetic/ 

pharmacodynamics aspects of edoxaban to support once-daily dosing. To explain that ENGAGE AF- 

TIMI 48 is the pivotal Phase III trial investigating the efficacy and safety of edoxaban in patients with AF. 

12:45 Welcome and introductory notes. 833 

A.J. Camm (London, GB); A. Goette (Paderborn, DE) 

12:55 Novel anticoagulants in atrial fibrillation - Recent developments and open questions. 834 

J.-Y. Le Heuzey (Paris, FR) 

13:15 Edoxaban - A new oral anticoagulant in late clinical development. What can we expect? 835 

J. Steffel (Zurich, CH) 

13:35 Panel discussion. 836 

A.J. Camm (London, GB); A. Goette (Paderborn, DE); J.-Y. Le Heuzey (Paris, FR); 

J. Steffel (Zurich, CH) 

13:45 Closing. 837 


124


14:00 - 15:30 symposium Crete 

New tools for atrial fibrillation 

Chairpersons: V.y. Reddy (new york, Us); f. Gaita (turin, it) 


14:00 Cryoballon ablation of pulmonary veins: tools and techniques. 838 

T. Neumann (Bad Nauheim, DE) 

14:22 duty cycled Rf technologies. 839 

F. Halimi (Le Chesnay, FR) 

14:45 PVi using laser ballon. 840 

P. Neuzil (Praha, CZ) 

15:07 Measuring contact force during mapping and Rf: concept and techniques. 841 





programme. 



Ablation of accessory pathways 

Chairpersons: R. sutton (Monte Carlo, MC); P.E. Vardas (Heraklion, GR) 


The objective of the session is to demonstrate the potential complexities of Rf ablation in patients with 

WPW syndrome 

14:00 Asymptomatic pre-excitation? What to do? 845 

E. Hoffmann (Munich, DE) 

14:22 Ablation of coronary sinus associated pathways. 846 

S. Stavrakis (Oklahoma City, US) 

14:45 Ablation of parahisian pathways. 847 


15:07 Repeat procedures for prior ablation failure. 848 


125 

tuesday 

sessions

tUEsdAy 

sEssiOns 



The grey areas in genetic syndromes 


Chairpersons: M. Horie (Ohtsu, JP); E. behr (london, Gb) 

translational 

14:00 Brugada syndrome is due to a depolarisation or a repolarisation defect? 849 

M. Borggrefe (Mannheim, DE) 

14:22 Genetic defect and no phenotype: what should be done? 850 

C. Napolitano (Pavia, IT) 

14:45 When genetic testing SHOULD NOT be performed? 851 

M. Ackerman (Rochester, US) 

15:07 Early repolarisation: normal variant or new genetic disease? 852 

H.V. Huikuri (Oulu, FI) 


Pacing/ICDs/CRT:ECG/EGMs discussion (Part II). 



Two sessions are dedicated to ECGs and EGMs on pacing and defibrillation. The majority of ECG/EGM 

trouble shooting that can be found during pacemaker and ICD visits are covered and discussed. EGMs 

provided by the devices of 5 companies are presented, including remote monitoring data. 

14:00 Hundreds of cases in databank! Presenters: 853 

P. Bordachar (Pessac, FR); S. Garrigue (Bordeaux, FR); S. Reuter (Bordeaux, FR); 

P. Ritter (Pessac, FR) 

14:45 Hundreds of cases in databank! Challengers:. 854 

C.W. Israel (Bielefeld, DE); M. Gasparini (Rozzano, IT) 

126



Oral Abstract Session: optimizing right ventricular and left ventricular pacing 

Chairpersons: M. brignole (lavagna, it); to be announced 

14:00 Achieving very low percentage of ventricular pacing with safe-R pacing mode does 

not prevent atrial fibrillation and remodelling of the left heart chambers compared 

to ddd pacing with long AV delay 855 

B. Thibault, A. Ducharme, C. Simpson, J.F. Sarrazin, C. Stuglin, M. Barrero-Garcia, 

I. Greiss, R. Williams, M. Senaratne, S. Mcnicoll (Montreal, Kingston, Québec city, 

Saskatoon, Trois-Rivières, Montréal, Edmonton and Saint Jérôme, CA) 

14:15 Reduced pacemaker patient mortality associated with remote monitoring 856 

R.K. Thakur, B. Faulknier, J.D. Snell, N. Dalal, M. Richards (Lansing, MI, Charleston WV, 

Sylmar, Ca and Toledo, OH, US) 

14:30 deterioration of left ventricular (lV) systolic function in patients (Pts) treated 

with antibradycardic pacemakers (PM) and rightventricular (RV) stimulation: is the 

stimulation site of importance? 857 

M. Ebert, J. Stockinger, K. Astheimer, T. Blum, C. Restle, T. Arentz, D. Kalusche 


14:45 device infection risk factors for pacemaker implantation: a nationwide 

population-based study 858 

S.P. Hung, P.R. Chen, T.S. Chen (Tao-Yuan and Taoyuan, TW) 

15:00 Feasibility, efficacy and safety of percutaneous retrieval of a leadless cardiac 

pacemaker in an in vivo ovine model. 859 

J. Sperzel, A. Khairkhahan, D. Ligon, S. Zaltsberg (Bad Nauheim, DE; Sunnyvale, US) 

15:15 long term clinical outcome of cardiac resynchronisation therapy according to 

baseline QRs duration: a multi-national, ten-year experience. 860 

M. Gasparini, C. Leclercq, C.-M. Yu, A. Auricchio, J. Steinberg, B. Lamp, A. Curnis, 

C. Klersy, F. Leyva (Rozzano, Brescia and Pavia, IT; Rennes, FR; Hong Kong, HK; 

Lugano, CH; New York, US; Bad Oeynhausen, DE; Birmingham, GB) 


ICD: controversial indications in primary prevention 

Chairpersons: J. Kautzner (Prague, CZ); J.M. Almendral Garrote (Madrid, Es) 


14:00 Repolarisation variability: a useful index in ICD decision making? 861 

M.A. Vos (Utrecht, NL) 

14:22 When to implement an ICD after AMI? 862 

Y.G. Yap (Kuala Lumpur, MY) 

14:45 Is there an indication for primary prevention in patients with chronic kidney disease? 863 

P. Korantzopoulos (Ioannina, GR) 

15:07 the role of dual chamber devices in primary prevention. 864 

F. Arribas (Madrid, ES) 

127 

tuesday 

sessions

tUEsdAy 

sEssiOns 



Understanding complex ECG's: a case based approach 

Connecting Continents - sObRAC - EHRA 

Chairpersons: A.M. lorga filho (sao Jose do Rio Preto, bR); G. Hindricks (leipzig, dE) 


14:00 Case 1. 865 


14:18 Case 2. 866 

J. Atie (Rio De Janeiro, BR) 

14:36 Case 3. 867 

J.L.R.M. Smeets (Nijmegen, NL) 

14:54 Case 4. 868 

T. Rodrigues (Belo Horizonte, BR) 

15:12 Panel. 869 

J. Brugada Terradellas (Barcelona, ES); J. Atie (Rio De Janeiro, BR); 

J.L.R.M. Smeets (Nijmegen, NL); T. Rodrigues (Belo Horizonte, BR) 


Oral Abstract Session: syncope 

Chairpersons: i. deisenhofer (Munich, dE); to be announced 

14:00 syndromes of orthostatic intolerance in syncope and neurohormonal biomarkers: 

systEMA study 870 

A. Fedorowski, S. Juul-Moller, O. Mellander (Malmö, SE) 

14:15 Heart failure is the strongest predictor of mortality in patients presenting with 

unexplained syncope: an ACAP-sElf registry analysis 871 

C. Maniotis, C. Pamidimukala, A. Benjo, B. Pratap, J. Bastawrose, U. Pai, M. Pierce, 

R. Bharathi, E. Herzog, E. Aziz (Athens, GR; New York, US) 

14:30 short and long term outcomes of patients admitted with unexplained syncope using 

a simple novel sElf-pathway 872 

C. Maniotis, C. Pamidimukala, A.M. Benjo, J.H. Bastawrose, B. Pratap, E. Cho, 

S. Mohamed, R. Usmani, E. Herzog, E.F. Aziz (Athens, GR; New York, US) 

14:45 Cerebral blood pressure drops before systemic hemodynamics in reflex syncope, 

a tCd study during prolonged head-up tilt 873 

J.P. Freitas, P. Castro, E. Azevedo, R.M. Santos, M.J. Maciel, F. Rocha-Goncalves (Porto, PT) 

15:00 Brugada syndrome: does syncope has prognostic impact? 874 

H. Dores, F.M. Costa, D. Cavaco, P.G. Santos, M.S. Carvalho, J. Abecasis, P. Carmo, 

F.B. Morgado, P. Adragao, M. Mendes (Lisbon, PT) 

15:15 Misdiagnosis epilepsy. Role of tilt table testing. 875 

J.P. Freitas, I. Rangel, M.J. Maciel, F. Rocha-Goncalves (Porto, PT) 

128


16:30 - 18:00 symposium Crete 

Tailored catheter ablation of atrial fibrillation: toward less arrhythmia 

recurrence. 

Chairpersons: d. shah (Geneva, CH); s. boveda (toulouse, fR) 


The objective of this session is to analyse some causes of arrhythmia recurrence after catheter ablation 

of atrial fibrillation in different groups of patients, and to provide strategies to reduce them. 

16:30 How can we minimise pulmonary vein conduction recurrences? New tools, new evidence. 876 

R. Tilz (Hamburg, DE) 

16:52 The thin red line between paroxysmal and persistent atrial fibrillation. The crucial 

role of patient selection. 877 

C. Herrera Siklody (Vaihingen An Der Enz, DE) 

17:15 Struggling with electrogrammes in persistent atrial fibrillation. What should we ablate? 878 


17:37 Sinus rhythm for everyone? Who should not undergo an atrial ablation? 879 

X. Vinolas Prat (Barcelona, ES) 




programme. 


16:30 - 18:00 debate session naxos 

Systemic effects of atrial fibrillation 

Chairpersons: W.s. teo (singapore, sG); U. lendeckel (Greifswald, dE) 

translational 

16:30 Atrial fibrillation and cardiac function 883 


16:52 Atrial fibrillation and brain function 884 

D.O. Arnar (Reykjavik, IS) 

17:15 Atrial fibrillation and kidney function 885 

F.R. Heinzel (Graz, AT) 

17:37 Atrial fibrillation and psychosocial function 886 

K.-H. Ladwig (Munich, DE) 

129 

tuesday 

sessions

tUEsdAy 

sEssiOns 



Let's discuss my most difficult clinical case 


Chairpersons: V. Probst (nantes, fR); H.J.G.M. Crijns (Maastricht, nl) 

basic science 

16:30 Case by Josep brugada 887 


16:40 Comments from: 888 


16:52 Case by sami Viskin 889 

S. Viskin (Tel Aviv, IL) 


R. Brugada Terradellas (Girona, ES) 

17:14 Case by Carlo napolitano 891 




17:36 Case by Wataru shimizu 893 

W. Shimizu (Osaka, JP) 


A. Leenhardt (Paris, FR) 


Ablation techniques in atrial fibrillation and in VT/VF (Part II). 

Ventricular Arrhythmias: case-based presentations 


Chairpersons: J.M. Almendral Garrote (Madrid, Es); G. Hindricks (leipzig, dE) 


The aim of these two sessions is to discuss in depth the methods to ablate complex arrhythmias and 

the tools used to achieve procedure success. The first session will focus on atrial arrhythmias, and the 

second, on ventricular arrhythmias. 

16:30 tailoring iCd programming to the patient. 895 


17:00 Role of imaging techniques for ventricular arrhythmia ablation. 896 


17:30 When going to epicardium is mandatory for ventricular arrhythmia ablation. 897 


130



Oral Abstract Session: advances in ICD therapy and SCD prevention 

Chairpersons: i. Zupan (ljubljana, si); f. braunschweig (stockholm, sE) 

16:30 Painfree sst trial primary results: low shock rates in patients with dual and triple 

chamber iCds using novel detection algorithms 898 

E. Schloss, A. Auricchio, T. Kurita, A. Meijer, S. Zweibel, F. Alsmadi, C. Leng, C. Garutti, 

J. Raijmakers, L. Sterns (Cincinnati, Hartford and Philadelphia, US; Lugano, CH; 

Osaka, JP; Eindhoven and Maastricht, NL; Riyadh, SA; Victoria, CA) 

16:45 inappropriate shocks in the subcutaneous iCd population: incidence, predictors and 

therapy 899 

L.R.A. Olde Nordkamp, A.A.M. Wilde, N. Carter, P. Lambiase, L. Boersma, 

P. Neuzil, D. Theuns, J. Johansen, H. Reeve, R.E. Knops (Amsterdam, Nieuwegein 

and Rotterdam, NL; St Paul, US; London, GB; Prague, CZ; Odense, DK) 

17:00 Predictors for recurrent sudden cardiac death in cardiac arrest survivors associated 

with coronary vasospasm 900 

K.H. Lee, H.W. Park, J.G. Cho, N.S. Yoon, K.H. Park, D.S. Sim, Y.J. Hong, Y.K. Ahn, 

M.H. Jeong, J.C. Park (Gwangju, KR) 

17:15 five year results of iCd leads implanted in the right ventricular mid-septum versus 

the apex: the septal randomized study 901 

P. Defaye, P.H. Mabo, E. Mouton, M. Burban, J.L. Pasquie, J.M. Dupuis, D. Babuty, 

J.S. Hermida, J.C. Deharo, A. Savoure (Grenoble, Rennes, Montigny le Bretonneux, 

Nantes, Montpellier, Angers, Tours, Amiens, Marseille and Rouen, FR) 

17:30 Clinical characteristics and outcomes of elderly patients treated with implantable 

cardioverter-defibrillator and cardiac resynchronisation therapy in a real world setting 902 

M. Suleiman (Haifa, IL) 

17:45 Risk of sudden cardiac arrest in patients with myocarditis and the use of wearable 

cardioverter defibrillator: a German experience 903 

C. Wan, H.B. Hughes, N.R. Bianco, S.J. Szymkiewicz (Pittsburgh, US) 

131 

tuesday 

sessions

tUEsdAy 

sEssiOns 



Management of patients with ICD 

Chairpersons: A. Auricchio (lugano, CH); s.J. dubner (buenos Aires, AR) 


Important reserach and clinical spects of the growing field of ICD, focussing on its non-invasive 

management and follow up, based in the Consensus paper joint published few month ago. 

16:30 How to reduce inappropriate therapy (MAdit Rit). 904 

M. Stockburger (Nauen, DE) 

16:52 Remote monitoring in CRt-d patients. 905 

J. Steinberg (New York, US) 

17:15 Defibrillation testing: is it necessary? 906 

D. Baensch (Rostock, DE) 

17:37 ICDs and CRT-Ds in the "real world": good value for money? 907 

F. Leyva-Leon (Sutton Coldfield, GB) 


Catheter ablation of atrial fibrillation and concomitant renal ablation: a 

new strategy? 

Connecting Continents - CEPs - EHRA 

Chairpersons: J. Kautzner (Prague, CZ); s. Zhang (beijing, Cn) 

transforming 

16:30 the concept: potential effects of renal ablation on cardiac arrhythmias. 908 

R. Schilling (London, GB) 

16:52 the technologies: tools for renal ablation during Af catheter ablation. 909 

Q. Shan (Nanjing, CN) 

17:15 The outcome: any solid data on renal ablation in AF patients? 910 

E. Pokushalov (Novosibirsk, RU) 

17:37 the future: will renal ablation become a standard treatment for patients with 

hypertension and atrial fibrillation? 911 

Y. Yin (Chongqing, CN) 

132



Oral Abstract Session: novel non-invasive risk marker 

Chairpersons: E. Aliot (Vandoeuvre-les-nancy, fR); i. savelieva (london, Gb) 

16:30 Predictors for arrhythmic and major adverse cardiovascular events in patients with 

hypertrophic cardiomyopathy 912 

S.J. Park, S.H. Lee, K.M. Byeon, Y.K. On, J. Huh, J.S. Kim (Seoul, KR) 

16:45 successful prospective application of a novel surface ECG based marker of 

ventricular arrhythmia risk 913 

W.B. Nicolson, M.I. Smith, G. Chu, P.B. Brown, A.J. Sandilands, P.J. Stafford, 

F.S. Schlindwein, N.J. Samani, G.P. Mccann, G.A. Ng (Leicester, GB) 

17:00 Association of plasma proinflammatory biomarkers and circulating endothelial 

progenitor cells to risk of cardiac arrhythmia among diabetes mellitus patients 914 

A. Berezin, A. Kremzer (Zaporozhye, UA) 

17:15 Magnetic field imaging fails to predict sudden cardiac death or ventricular 

tachyarrhythmias in iCd carriers 915 

K. Kouraki, M. Strauss, A. Skarlos, U. Zeymer, R. Zahn, T. Kleemann 

(Ludwigshafen am Rhein, DE) 

17:30 P-wave characteristics and histological atrial abnormality 916 (W) 

Y. Huo, P. Holmberg, L. Mitrofanova, V. Orshanskaya, F. Holmqvist, P. Platonov 

(Lund, SE; St. Petersburg, RU) 

17:45 novel non invasive detection of arrhythmia substrate using supervised learning 

support vector machine 917 

J.A. Rosengarten, S.M. Dima, C. Panagiotou, P.A. Scott, K.H.O. Chui, E.B. Mazomenos, 

K. Maharatna, N.P. Curzen, J. Morgan (Southampton, GB) 

18:15 - 19:45 special session Kythira 

EHRA General Assembly 

• Discover the newly elected Board members (President-Elect, Secretary and Treasurer) 

for the 2013-2015 term 

• Get a report on EHRA past year’s achievements activities 

All EHRA members 2013 are welcome and encouraged to attend. 

133 

tuesday 

sessions

TUESDAY POSTERS 

Genetics Summit 

The Summit is designed to offer attendees a comprehensive learning 

opportunity that will encompass all aspects of Cardio-genetics of 

Arrhythmias, spanning from basic science to genetic screening to patient 

management. Beside conventional lectures, the programme will include 

a session dedicated to the discussion of clinical cases with involvement 

of the audience. 

On Tuesday in Room Lefkada 

135 

tuesday 

posters

tUEsdAy 25 JUnE 2013 - POSTERS MORNING 


Hot topics in genetics and anticoagulation 

Chairpersons: C. Wolpert (ludwigsburg, dE); s. tzeis (Maroussi, GR) 







family cluster as risk factor for catecholaminergic polymorphic ventricular tachycardia P918 

P.M. Ruiz Hernandez, F. Wanguemert, P. Berne, O. Campuzano, J. Brugada, R. Brugada 

(Las Palmas de Gran Canaria, Barcelona and Girona, ES) 

Clinical and genetic markers in stratification risk of sudden cardiac death in 

hypertrophic cardiomyopathy P919 

Y.N. Belenkov, E.V. Privalova, V.Y. Kaplunova, N.V. Khabarova, G.A. Shakaryants 

(Moscow, RU) 

Genetic variation in two chromosomal regions associated with AF influences local 

gene expression P920 

R.I.R. Martin, E. Glen, D.H. Hall, W.A. Owens, M. Santibanez-Koref, B.D. Keavney 

(Newcastle upon Tyne, GB) 

novel arrhythmia-related mutations in Croatian arrhythmia patients P921 

M. Dembic, S. Brusich, P.L. Hedley, Z. Cubranic, A.L. Carlsen, T.T. Pham, L. Zaputovic, 

M. Christiansen (Copenhagen, DK; Rijeka, HR) 

determination of polymorphism of a gene of alpha2betta adrenoreceptors at 

patients with atrioventricular block P922 

A. Chernova, S.Y.U. Nikulina (Krasnoyarsk, RU) 

did warfarin and antiplatelet reduce the incidence of dementia in patients with atrial 

fibrillation: a nationwide cohort study P923 

M.-T. Liao, L.Y. Lin, J.L. Lin (Hsinchu and Taipei, TW) 

Predictors of left atrium appendage clot detection despite on-target warfarin 

prevention for atrial fibrillation P924 

F. Zoppo, G. Brandolino, A. Berton, N. Frigato, M. Michieletto, A. Zanocco, F. Zerbo, 

E. Bacchiega, A. Lupo, E. Bertaglia (Mirano and Padua, IT) 

Are the CHADS2 and the CHADS2 VASc2 risk scores the same? Result from an 

atrial fibrillation registry in Argentine 925 (W) 

D. Di Toro, C.L.H. Hadid Claudio, S.G. Gallino Sebastian, C.D.L. Labadet Carlos 

(Ciudad Autonoma d3 Buenos Aires, AR) 

Validation of CHA2ds2-VAsc and HAs-blEd scores in Japanese patients with 

non-valvular atrial fibrillation: An analysis of J-RHYTHM Registry P926 

K. Okumura, H. Inoue, H. Atarashi, T. Yamashita, H. Tomita, H. Origasa 

(Hirosaki, Toyama, Tamanagayama and Tokyo, JP) 

Dose modification of rivaroxaban may reduce clinical benefits in patients with atrial 

fibrillation and moderate renal insufficiency compared with warfarin: a meta-analysis P927 

R. Sakurai (Tokyo, JP) 

137 

tuesday 

posters

tuesday 

posters 





between 08:30 - 12:30. 




Dynamics of main ECG characteristics after conversion of persistent atrial fibrillation and 

flutter by new class III antiarrhythmic agent niferidile. P928 

Y.U. Yuricheva, S. Sokolov, S. Golitsyn, E. Maykov, N. Mironov, L. Rosenshtraukh, E. Chazov 

(Moscow, RU) 

Antazoline for rapid termination of atrial fibrillation during ablation of accessory pathways. P929 

R. Piotrowski, T. Krynski, J. Baran, P. Futyma, S. Stec, P. Kulakowski (Warsaw and Rzeszow, PL) 

Chronic amiodarone therapy impairs the function of the superior sinoatrial node in patients 

with atrial fibrillation P930 

H.S. Mun, J. Wi, J.S. Uhm, J. Shim, M.H. Lee, H.N. Pak, B. Joung (Seoul, KR) 

Hyperuricacidemia as an independent Predictor for Paroxysmal Atrial fibrillation P931 

T. Liu, Y. Wu, G. Xu, R. Yuan, G. Li (Tianjin, CN) 

Adherence to anticoagulation guidelines in non-valvular atrial fibrillation patients remains 

poor despite admission to a tertiary cardiology unit P932 

G.S. Kew, M. Tan, T.W. Lim (Singapore, SG) 

Heterogenesity of breakthrough from right atrium to superior vena cava: implication for safe 

superior vena cava isolation P933 

A. Suzuki, Y. Yamauchi, A. Yagishita, H. Sato, T. Miyamoto, T. Obayashi, S. Umezawa, A. Niwa, 

K. Hirao, K. Aonuma (Kanagawa, Tokyo and Ibaraki, JP) 

Mapping and ablation of atrial tachycardia after valve surgery plus mini-MAZE procedure P934 

Y.M. Xue, X.Z. Zhan, H.T. Liao, X.H. Fang, H. Deng, W. Wei, S.L. Wu (Guangzhou, CN) 

long-term success can be achieved with duty-cycled circular multipolar radiofrequency 

ablation after a failed cryoballoon ablation in paroxysmal or persistent atrial fibrillation P935 

A. Kiss, E. Nagy-Balo, I. Edes, Z. Csanadi (Debrecen, HU) 

transseptal approach for ablation of left sided arrhythmias without routine use of 

intracardiac echocardiography P936 

M. Jensen-Urstad, H. Bastani, F. Braunschweig, N. Drca, K. Gudmundsson, G. Kenneback, 

J. Schwieler, F. Tabrizi, J. Tapanainen, P. Insulander (Stockholm, SE) 

Impact of atrial fibrosis on wave propagation in human atrial fibrillation. evidence for regional 

channel, pivot, slow conduction at delayed enhanced sites P937 

A. Jadidi, S. Kim, H. Cochet, H. Lehrmann, C.I. Park, S. Miyazaki, M. Haissaguerre, P. Jais, 

T. Arentz (Bad Krozingen, DE; Saint Paul, US; Bordeaux, FR) 

Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation. 

biochemical assessment of collagen type i turnover P938 

I.S. Saloustros, E.K. Kallergis, E.K. Kanoupakis, H.M. Mayrakis, S.P. Petousis, M.V. Vernardos, 

P.V. Vardas (Heraklion, GR) 

138


Prevalence of unidentified risk factors in patients with apparently lone atrial fibrillation: a 

case-control study P939 

N. Calvo, P. Ramos, S. Montserrat, B. Coll-Vinent, M. Domenech, R. Borras, A. Berruezo, 

M. Sitges, J. Brugada, L. Mont (Barcelona, ES) 

Focal impulse and rotor modulation (FIRM) for atrial fibrillation is successful even in patients 

with unfavorable demographics for conventional ablation P940 

T. Baykaner, P. Clopton, D. Krummen, A. Schricker, G. Lalani, K. Shivkumar, J. Miller, S. Narayan 

(San Diego, Los Angeles and Indianapolis, US) 

short term results of left atrial appendage exclusion with lariat in patients with atrial 

fibrillation and contraindications for anticoagulation P941 

M.G. Chelu, A. Nazeri, S.A. May, H. Afshar-Kharaghan, M. Saeed, M. Razavi, A. Rasekh, 

A. Massumi (Houston, US) 

Atrial fibrillation prevalence, incidence, clinical outcomes and related hospitalisation costs in 

a modern pacemaker population P942 

B. Faulknier, M. Richards, W. Hou, J.D. Snell, N. Dalal, R.K. Thakur (Charleston WV, Toledo, 

OH, Sylmar, Ca and Lansing, MI, US) 

Correlation of vascular wall stiffness with the left atrial size in hypertensive patients with 


L. Mohammadi, V. Podzolkov, A. Tarzimanova, M. Pisarev (Moscow, RU) 

negative affectivity of type d personality predicts the increased recurrences rate risk in lone 

atrial fibrillation patients P944 

E.H. Hatzinikolaou-Kotsakou, E. Reppas, T.H. Beleveslis, G. Moschos, M. Kotsakou, P. Latsios, 

K. Tsakiridis (Thessaloniki, GR) 

Clinical success of conventional vs. contact force-controlled radiofrequency catheter ablation 

of atrial fibrillation: clinical outcome after 12 months P945 

A. Berkowitsch, S. Lehinant, D. Paijitnev, H. Greiss, S. Zaltsberg, C. Hamm, M. Kuniss, 


luminal esophageal temperature predicts esophageal lesions after second-generation 

cryoballoon pulmonary vein isolation P946 

A. Konstantinou, S. Bordignon, B. Schmidt, M. Boehmig, M.C. Boehmer, B. Schulte-Hahn, 

B. Nowak, A.U. Dignass, J.K.R. Chun, A. Fuernkranz (Frankfurt/M, DE) 

Contact force guided pulmonary vein isolation reduces the rate of adenosine-mediated 

pulmonary vein reconnection, OCCAs-Af a multicenter pilot study P947 

A. Jadidi, C.I. Park, H. Puererfellner, C.I. Dechillou, P. Jais, E. Pruvot, J. Albenque, O. Xhaet, 

D. Shah, T. Arentz (Bad Krozingen, DE; Linz, AT; Nancy, Bordeaux and Toulouse, FR; 

Lausanne and Geneva, CH; Yvoir, BE) 

Probucol prevents atrial remodeling by inhibiting reactive oxygen species production and 

nf-kappab activation in alloxan-induced diabetic rabbits P948 

H.Y. Fu, T. Liu, C.L. Liu, G.P. Li, J. Li, L.J. Cheng, X.H. Wang, M. Yuan (Tianjin, CN) 

Pharmacological treatments before and after catheter ablation for atrial fibrillation in Japan P949 

Y. Murakawa, A. Nogami, M. Shoda, K. Inoue, S. Naito, K. Kumagai, Y. Miyauchi, T. Yamane, 

N. Morita, K. Okumura (Kawasaki, Yokohma, Tokyo, Osaka, Maebashi, Fukuoka and Hirosaki, JP) 

the effect of ibutilide on novel indexes of ventricular repolarisation in patients with 

persistent atrial fibrillation P950 

P. Korantzopoulos, K. Letsas, A. Kotsia, G. Baltogiannis, K. Kalantzi, K. Kyrlas, J.A. Goudevenos 

(Ioannina and Athens, GR) 

139 

tuesday 

posters

tuesday 

posters 


Utilization of ablation procedures in the United states P951 

J. Viles-Gonzalez, S. Pant, A. Deshmukh, N.J. Patel, P. Grover, A. Chothani, N. Shah, K. Mehta, 

R.D. Mitrani, H. Paydak (Miami, Little Rock, Staten Island, Washington and Philadelphia, US) 

Plasma copper homeostasis in patients with recent-onset atrial fibrillation and structurally 

normal hearts P952 

M.N. Negreva, A.P. Penev, A.A. Aleksandrova (Varna and Sofia, BG) 

Remotely controlled steerable sheath facilitates circumferential right pulmonary veins 

isolation during atrial fibrillation ablation with magnetic navigation P953 

D. Latcu, A. Errahmouni, S.S. Bun, N. Rijo, E. Allouche, N. Saoudi (Monaco, MC) 

intermitent apneic oxigenation (AO) during radiofrecuency pulmonary vein catheter ablation 

under general anaesthesia: feasibility and acute results. P954 

M.L. Castilla, R. Coulier, M. Rodriguez, J. Almendral, E. Castellanos, M. Ortiz, A. Lopez (Madrid, ES) 

CHA2ds2-VAsc score is associated with the recurrence of atrial arrhythmia after catheter 

ablation for typical atrial flutter P955 

Y.M. Park, D.I. Lee, H.C. Park, J.E. Ban, J.I. Choi, H.E. Lim, S.W. Park, Y.H. Kim (Seoul, KR) 

Effects of electrical stimulation of carotid baroreflex and renal denervation on atrial 

electrophysiology P956 

D. Linz, F. Mahfoud, K. Wirth, H.R. Neuberger, U. Schotten, M. Böhm (Homburg and Frankfurt/ 

Main, DE; Maastricht, NL) 

Sustained atrial fibrillation is sustained by stable rotors, with passive activation into the 

pulmonary veins P957 

G. Lalani, S. Narayan, A. Schricker, D. Krummen (San Diego, US) 

time-course of apelin levels after sinus rhythm restoration in pts with persistent Af P958 

I. Saloustros, E.K. Koutalas, E.K. Kanoupakis, E.K. Kallergis, H.M. Mayrakis, S.P. Petousis, 

M.V. Vernardos, S.M. Maragkoudakis, P.V. Vardas (Heraklion, GR) 

Does atrial fibrillation begets heart failure? P959 

R. Dierckx, R. Houben, M. De Proft, E. Boel, W. Timmermans, F. De Pauw, M. Goethals, 

S. Verstreken, J. Bartunek, M. Vanderheyden (Aalst, BE; Maastricht, NL) 

Amiodarone is associated with higher mortality rates in patients with atrial fibrillation and a 

low CHA2ds2Vasc score. P960 

G. Vanerio, P. Fernandez Banizi, J.L. Vidal Amaral (Montevideo, UY) 

Arrhythmic complications after electrical cardioversion of acute atrial fibrillation P961 

T. Gronberg, I. Nuotio, M. Nikkinen, A. Ylitalo, T. Vasankari, J.E.K. Hartikainen, K.E.J. Airaksinen 

(Turku, Kuopio and Pori, FI) 

n-terminal pro-brain natriuretic peptide plasma level in patients with persistent atrial 

fibrillation: is there a role of this biomarker in arrhythmia recurrence after electrical 

cardioversion ? P962 

F. Imperadore, V. Curci, M. Schinella (Rovereto, IT) 

Why patients with atrial fibrillation and low or moderate thromboembolic risk still develop 

stroke? P963 

N. Diaconu, A. Grosu, C. Gratii, V. Racila, G. Pavlic (Chisinau, MD) 

The true atrial fibrillation burden after the Cox-Maze-III Cryo procedure in high risk patients 

with long-standing persistent atrial fibrillation - first report of event recorder documented 

continuous P964 

T. Hanke, U. Stierle, M. Baldewig, H.-H. Sievers, E.I. Charitos (Luebeck, DE) 

140


Evaluation of the temperature curves characteristics of isolated versus non-isolated 

pulmonary veins using the novel Achieve mapping catheter for cryoablation P965 

R.P. Martins, N. Behar, R. Bacquelin, J. Lacaze-Gadonneix, A. Behagel, P. Mabo, D. Pavin 

(Rennes, FR) 

Magnetically guided irrigated platinum-iridium versus irrigated gold-tip ablation of atrial 

fibrillation: procedural parameters and outcome P966 

K.J. Gutleben, B.G. Muntean, D. Horstkotte, G. Noelker (Bad Oeynhausen, DE) 

incremental prognostic value of the combination of 4q25 and ZfHX3 gene single nucleotide 

polymorphisms in patients who underwent radiofrequency catheter ablation for atrial 

fibrillation P967 

J. Shim, J.H. Park, J. Wi, H.S. Mun, J.S. Uhm, J.Y. Kim, B.Y. Joung, M.H. Lee, H.N. Pak (Seoul, KR) 

Termination of chronic atrial fibrillation by ablation as possibility of reverse remodeling of 

left Atrium P968 

K. Kumagai, Y. Nakatani, N. Tsukada, K. Sasaki, S. Osima (Maebashi, JP) 

serum brain natriuretic peptide predicts the reverse remodeling of the left atrium after 

catheter ablation for atrial fibrillation. P969 

T. Kimura, K. Inagawa, Y. Katsumata, T. Nishiyama, N. Nishiyama, K. Fukumoto, Y. Aizawa, 

Y. Tanimoto, K. Tanimoto, S. Takatsuki (Tokyo, JP) 

Objective quality assessment of atrial fibrillation ablation: a novel scoring system P970 

J.S. Chinitz, R.A. Kulina, S.R. Gangireddy, M.A. Miller, J.S. Koruth, S.R. Dukkipati, V.Y. Reddy, 

A.D.avila (New York, US) 

Impact of atrial fibrillation on platelet gene expression P971 

W. Wysokinski, R.D.M. Mcbane, A.J.T. Tafur, W.Y. Wu, N.A. Ammash, D.G. Grill, J.M. Mruk 

(Rochester, MN and Wichita, KS, US) 

4-year follow-up after ablation of paroxysmal atrial fibrillation: cryoballoon versus 

radiofrequency catheter ablation P972 

M. Kuhne, S. Knecht, B. Schaer, D. Altmann, P. Ammann, S. Osswald, C. Sticherling 

(Basel and St. Gallen, CH) 

Prediction of early recurrence of atrial fibrillation after catheter ablation by CHA2DS2-VASc 

score and association with late recurrences P973 

J. Kornej, J. Kosiuk, A. Arya, C. Piorkowski, P. Sommer, S. Rolf, D. Husser, G. Hindricks, G. Lip, 

A. Bollmann (Birmingham, GB; Leipzig, DE) 

Hybrid ablation of long standing persistent atrial fibrillation utilizing minimally invasive 

surgical and endocardial catheter approach: one year results. P974 

D.E. Pajitnev, M. Kuniss, M. Schoenburg, Z. Szalay, S.W. Zaltsberg, H. Greiss, E. Akkaya, 

T. Walther, C.W. Hamm, T. Neumann (Bad Nauheim, DE) 

Left atrial size in perimitral atrial flutter after extensive encircling pulmonary vein isolation P975 

Y. Kaneko, T. Nakajima, T. Irie, M. Ota, T. Iijima, M. Tamura, T. Iizuka, S. Tamura, A. Saito, 

M. Kurabayashi (Maebashi, Gunma, JP) 

the combined use of adenosine and pacing for pulmonary vein isolation line evaluation 

(APPlE trial) P976 

S.H. Kim, Y.S. Oh, T.S. Kim, W.S. Shin, J.H. Kim, S.W. Jang, M.Y. Lee, T.H. Rho (Seoul, KR) 

A pilot study on the contact sensor equipped catheter in atrial fibrillation ablation. P977 

P. Marchese, M. Gujic, I. Horduna, S. Johar, S. Haldar, D.G. Jones, T. Wong, V. Markides, 

S. Ernst (London, GB) 

141 

tuesday 

posters

tuesday 

posters 


Correspondence between echocardiographic indices of left atrial size and left atrial volume 

derived from 3D electroanatomic mapping in patients with atrial fibrillation P978 

S. Havranek, V. Bulkova, J. Simek, T. Palecek, D. Wichterle (Prague, CZ) 

High bi-atrial organization in patients with long-standing persistent atrial fibrillation 

terminated within the left atrium P979 

A. Buttu, E. Pruvot, A. Forclaz, P. Pascale, S.M. Narayan, P. Maury, A. Rollin, J.M. Vesin 

(Lausanne, CH; San Diego, US; Toulouse, FR) 

Human vs Robot: a comparison of catheter contact force application for Af ablation 

(a MAst-Af substudy) P980 

G.S. Chu, N. Masca, T.P. Almeida, P.D. Brown, F.S. Schlindwein, G.A. Ng (Leicester, GB) 

Optimizing cryo-balloon ablation: what have we learned from online signals visualisation? P981 

D.E. Pajitnev, T. Neumann, S.W. Zaltsberg, H. Greiss, J. Sperzel, E. Akkaya, A. Berkowitsch, 

H.F. Pitschner, C.W. Hamm, M. Kuniss (Bad Nauheim, DE) 

disparate distribution of catheter tissue contact forces at right versus left pulmonary veins in 

patients undergoing pulmonary vein isolation P982 

C.I. Park, H. Lehrmann, R. Weber, C. Keyl, J. Schiebeling, J. Allgeier, C. Herrera-Siklody, 

T. Arentz, A. Jadidi (Freiburg - Bad Krozingen, DE) 

Conduction recovery in patients with recurrent atrial fibrillation after pulmonary vein 

isolation using multi-electrode duty cycled radiofrequency ablation P983 

J. Balt, C. Karadavut, A.A.W. Mulder, J.G.L. Luermans, M.C.E. Wijffels, L.V.A. Boersma 

(Nieuwegein, NL) 

Exercise tolerance can improve with sinus rhythm restoration by the catheter ablation for 

persistent atrial fibrillation. P984 

Y. Katsumata, S. Takatsuki, T. Kimura, N. Nishiyama, K. Fukumoto, K. Tanimoto, T. Sadahiro, 

Y. Ohgino, U. Tamura, K. Fukuda (Tokyo, JP) 

balloon cryoablation is superior to circumferential Rf pulmonary vein ablation in patients 

with paroxysmal atrial fibrillation P985 

A. Wozniak, B. Sredniawa, P. Pruszkowska, O. Kowalski, R. Lenarczyk, J. Kowalczyk, 

A. Sedkowska, S. Pluta, Z. Kalarus (Zabrze, PL) 

Feasibility of percutaneos left atrial appendage occlusion combined with atrial fibrillation 

ablation P986 

S. Grossi, F. Bianchi, A. Sibona Masi, S. Lebini, M.R. Conte (Turin, IT) 

Is septal muscle potentials guided ablation of the left atrial septum beneficial or harmful 

in patients with persistent atrial fibrillation? P987 


Predictors of atrial fibrillation recurrence after catheter ablation P988 

C. Kalil, E. Bartholomay, A. Pires Borges, G. Gazzoni, E. De Lima, R. Moraes, R. Etchepare, 

C. Sussenbach, L.C. Bodanese, R. Kalil (Porto Alegre, BR) 

Improved procedural efficacy of pulmonary vein isolation using the novel second-generation 

cryoballoon P989 

K.R.J. Chun, A. Fuernkranz, S. Bordignon, M. Gunawardene, B. Schulte-Hahn, V. Urban, 

B. Nowak, B. Schmidt (Frankfurt a.M., DE) 

Atrial pacing with active fixation in the coronary sinus is feasible, safe and shows good and 

stable electrical parameters P990 

P.N.W.M. Breuls, J.C.J. Res, L.J.P.M. Van Woerkens, E.J. Van Den Bos, J.T.H. Schmidt 

(Dordrecht and Rotterdam, NL) 

142


Fortuitous cardioversion of cardioversion of atrial fibrillation during ICD implantation P991 

A. Vischer, M. Mutschelknauss, M. Kuhne, S. Osswald, C. Sticherling, B. Schaer (Basel, CH) 

Atrial fibrillation, drugs and tools 

CHA2ds2VAsc score and the thromboembolic risk of electrical cardioversion of acute atrial 


T. Gronberg, J.E.K. Hartikainen, I. Nuotio, A. Ylitalo, M. Nikkinen, K.E.J. Airaksinen 

(Turku, Kuopio and Pori, FI) 

Vacuum therapy in electrocardiology P993 

E. Pilat, R. Mlynarski, A. Mlynarska, J. Wilczek (Katowice, PL) 

Very-long-term monitored atrial tachyarrhythmia and time-dependent risk of ischaemic 

stroke in patients with cardiac implanted electronic devices in the real world P994 

S. Wang, Y.C. Kang, T.S. Cheng (Taoyuan, TW) 


Nonfluoroscopic mapping for supraventricular arrhythmia ablation in pediatric patients. 

initial results in a prospective study. P995 

S. Melo, C. Pisani, F. Darrieux, T. Barbosa, D. Hachul, A. Tanaka, C. Hardy, N. Miura, E. Sosa, 

M. Scanavacca (Sao Paulo, BR) 

Panoramic body surface electrocardiographic mapping of tachyarrhythmias in adult patients 

with congenital heart disease P996 

I. Suman Horduna, L. Mantziari, S. Ernst (London, GB) 

Prospective characterisation of catheter-tissue contact force at the cavotricuspid isthmus in 

an experimental model in pigs. P997 

R. Matia, A.H. Madrid, L. Carrizo, A. Delgado, H. Del Castillo-Carnevali, S. Fernandez-Santos, 


A novel approach for the successful radiofrequency ablation of non-inducible atrial 

tachycardias using bump induction P998 

D.H.J. Elder, N. Grubb, C. Lang (Dundee and Edinburgh, GB) 

first human use of a novel epicardial access needle embedded with a real time pressure/ 

frequency monitoring of thoracic structures to facilitate epicardial access P999 

L. Di Biase, Z. Csanadi, G. Sandorfi, E. Nagy-Balo, P. Santangeli, C. Trivedi, A. Leny, A. Kiss, 

A. Natale, J.D. Burkhardt (Austin, US; Debrecen, HU) 

Accuracy of electrocardiographic algorithms in patients with Wolff-Parkinson-White 

syndrome and left ventricular hypertrophy P1000 

D. Novikov, M. Kandinsky, S. Popov, A. Samoilov, M. Latkin (Krasnodar and Tomsk, RU) 

Common atrial flutter ablation with duty-cycled radiofrequency energy: P1001 

A. Avella, P. De Girolamo, F. Laurenzi, A. Pappalardo (Rome, IT) 

Escaping from the window of interest phenomenon during electroanatomical mapping of 

atrial tachycardias P1002 

E. Lyan, A. Klukvin, G. Gromyko, F. Tursunova, A. Kazakov, A. Merkureva, A. Morozov, 

P. Krasnoperov, S. Yashin (Saint Petersburg, RU) 

the stepwise algorithm using clinical features after ECG differentiation could localize the 

origins of focal atrial tachycardias from the adjacent structures P1003 

J.-S. Uhm, J. Shim, J. Wi, H.S. Mun, H.N. Pak, M.H. Lee, B. Joung (Seoul, KR) 

143 

tuesday 

posters

tuesday 

posters 


Prognostic value of incremental pacing maneuver for long term recurrences after typical 

flutter ablation P1004 

E. Valles Gras, V. Bazan, B. Benito, M.E. Jauregui, J. Bruguera, J. Marti (Barcelona, ES) 

More than 50% of atrial flutter cycle length - a simple algorithm to evaluate isthmus block 

during ablation of atrial flutter. P1005 

P. Insulander, H. Bastani, F. Braunschweig, N. Drca, K. Gudmundsson, G. Kenneback, B. Sadigh, 

J. Schwieler, J. Tapanainen, M. Jensen-Urstad (Stockholm, SE) 

Influence of radiofrequency catheter ablation of idiopathic ventricular tachycardia / 

premature ventricular ectopics form the outflow tracts on quality of life P1006 

D. Goncharik, A. Mrochek, A. Chasnoits, O. Kovalenko, V. Golenischa, T. Burmistrova (Minsk, BY) 

The relationship of congenital diverticulum in right outflow tract (RVOT) and ventricular 

arrhythmia P1007 

K. Cui, J. Jiang, H. Fu, Q. Yang, H. Hu (Chengdu, CN) 

Epicardial ablation of a focal atrial tachycardia from the right atrial appendagge mimicking 

innaproppriate sinus tachycardia P1008 

S. Castrejon Castrejon, D. Doiny, A. Estrada Mucci, J. Figueroa, M. Molina, D. Filgueiras Rama, 

J.L. Lopez Sendon, J.L. Merino Llorens (Madrid, ES) 

Concomitant atrial fibrillation ablation and percutaneous closure of the left atrial appendage: 

a pivotal experience. P1009 

G.M. Fassini, O. Al-Nono, A. Dello Russo, M. Casella, S. Riva, M. Moltrasio, F. Tundo, 

M. Zucchetti, E. Russo, C. Tondo (Milan, IT) 

Safety and efficacy of open irrigated-tip catheter ablation of Wolff-Parkinson-White 

syndrome in children and adolescents. P1010 

S. Gulletta, D. Tsiachris, A. Radinovic, P. Mazzone, C. Bisceglia, N. Trevisi, G. Paglino, B. Bellini, 

S. Sala, P. Della Bella (Milan, IT) 

Peripartum focal atrial tachycardia originating from right atrial appendage with cardiogenic 

shock requiring circulatory support refractory to catheter ablation P1011 

R. Nakamura, A. Mizukami, M. Suzuki, A. Matsumura, Y. Hashimoto (Kamogawa, JP) 

factors of failure or recurrence of AV nodal reentrant tachycardia after ablation P1012 

B. Brembilla-Perrot, J.M. Sellal, J. Schwartz, A. Olivier, P.Y. Zinzius, C. De Chillou, E. Aliot, 

M. Andronache, D. Beurrier (Vandoeuvre-Les-Nancy, FR) 

Groin hematoma after electrophysiological procedures - incidence and predisposing factors P1013 

A. Dalsgaard, C. Jakobsen, S. Riahi, S. Hjortshoj (Aalborg, DK) 

Electrophysiology interventions without the used of femoral via P1014 

G. Rodriguez-Diez, M. Ortiz, M. Cortes, M. Alcantara, R. Robledo-Nolasco (Mexico City, MX) 


Implantable cardioverter-cefibrillators in arrhythmogenic right ventricular cariomyopathy: 

A single Center Experience P1015 

E.H. Hatzinikolaou-Kotsakou, M. Kotsakou, P. Latsios, G. Moschos, T.H. Beleveslis, E. Reppas, 

K. Tsakiridis (Thessaloniki, GR) 

incidence and risk factors for the development of fast ventricular tachycardia in recipients 

of implantable cardioverter defibrillators P1016 

R. Cozar-Leon, E. Diaz-Infante, R. Peinado, B. Prado, M. Gonzalez-Vasserot, E. Macias, 

D. Garofalo, J.M. Cruz (Seville and Madrid, ES) 

144


longterm primary preventive iCd treatment, a single center experience P1017 

F. Gadler, T. Malmkvist (Stockholm and Orebro, SE) 

Suppression of ventricular arrhythmias with flecainide in patients with Andersen-Tawil 

syndrome with KCnJ2 mutation P1018 

K. Miyamoto, H. Kimura, H. Hayashi, M. Ishihara, T. Anzai, S. Yasuda, H. Ogawa, S. Kamakura, 

M. Horie, W. Shimizu (Suita, Osaka and Otsu, JP) 

Prognostic value of electrophysiology studies among iCd recipients in the israeli iCd registry P1019 

J.E. Schliamser, G. Amit, M. Haim, M. Suleiman, A. Militianu, A. Glick, V. Khalameizer, 

N. Gavrielov-Yusim, I. Goldenberg, M. Glikson (Haifa, Beer-Sheva, Petah Tikva, Tel Aviv, 

Ashkelon and Ramat Gan, IL) 

Programmed ventricular stimulation can accurately predict appropriate iCd therapy in 

patients with idiopathic dilated cardiomyopathy P1020 

A.-I. Vouliotis, K. Gatzoulis, D. Tsiachris, S. Archontakis, P. Dilaveris, T. Gialernios, P. Arsenos, 

G. Karystinos, S. Sideris, C. Stefanadis (Athens, GR) 

Results of implantable cardioverter defibrillator in very elderly population P1021 

M. Cortes Garcia, P. Avila, E. De La Cruz, I. Hernandez, J.A. Palfy, A.M. Romero, J.J. Hernandez, 

J. Benezet, J.M. Rubio, J. Farre (Madrid, ES) 

Implantable cardioverter-defibrillator guidelines application in Argentine patients with heart 

failure. A registry from 64 cardiology residencies. P1022 

A.G. Carrizo, E. Fairman, N. Gonzalez, L. Corradi, E. Zaidel, G. Perez, A. Alfie, O. Oseroff 

(Ciudad de Buenos Aires, Ciudad De Buenos Aires and Cordoba, AR) 

Prevalence of externalized conductors in Riata and Riata st silicone iCd leads: results from 

a prospective, multicenter study P1023 

D. Hayes, R. Freedman, A. Curtis, M. Niebauer, G. Neal Kay, J. Dinerman, S. Beau, W. Wong 

(Rochester, Salt Lake City, Buffalo, Cleveland, Birmingham, Huntsville and Little Rock, US) 

Longevity of implantable cardioverter defibrillators in a large multicenter experience. P1024 

M. Gasparini, G. Boriani, A. Proclemer, M. Santini, M. Landolina, M. Biffi, G. Zanotto, A. Gentili, 

S. Bisetti, M. Lunati (Rozzano, Bologna, Udine, Rome, Pavia, Legnago and Milan, IT) 

Pulse width optimisation of ICD defibrillation waveform is both a safe and effective 

programming strategy at time of implant P1025 

P. Nolan, C. Mcfadden, B.D. Macneill, J. Crowley, P.J. Nash, K. Daly (Galway, IE) 

the remote monitoring systems in management of children with brugada syndrome: single 

center experience. P1026 

D. Ricciardi, C. De Asmundis, M. Namdar, J. Rao, M. Rodriguez Manero, F. Bayrak, R. Casado 

K. Wauters, G.B. Chierchia, A. Sarkozy (Brussels, BE) 

Defibrillation efficacy of the single coil screw-in lead Sprint Quattro Secure S 6935 - 

Evaluation during intraoperative testing P1027 

L. Binner, S. Stiller, G. Grossmann, W. Rottbauer, D. Walcher (Ulm, Ravensburg and 

Weissenhorn, DE) 

beta-blockers reduce cardiac mortality among iCd patients presenting with shocks: a 

long-term prospective study. P1028 

J. Jimenez-Candil, C. Ledesma, J. Morinigo, J.C. Rama, A. Martin, C. Martin-Luengo 

(Salamanca, ES) 

Fractal property of self-similarity distinguishes ventricular tachycardia from atrial fibrillation P1029 

M. Mollerus (Duluth, US) 

145 

tuesday 

posters

tuesday 

posters 


Pacing 

impact of cable externalization in feasibility of Riata lead extraction in a tertiary referral P1030 

G. Zucchelli, L. Segreti, D. Levorato, E. Soldati, A. Di Cori, S. Viani, L. Paperini, B. Valente, 

R. De Lucia, M.G. Bongiorni (Pisa, IT; Lisbon, PT) 

Cardiac device-related endocarditis- safety and effectiveness of transvenous leads extraction 

procedures. P1031 


first clinical experience with the new four-pole standard connector for high-voltage iCd 

leads. Results from a multicentric prospective comparative study P1032 

G.B. Forleo, L.P. Papavasileiou, M. Mantica, L. Di Biase, G. Panattoni, M. Santamaria, D. Sergi, 

L. Santini, A. Natale, F. Romeo (Rome, Milan and Campobasso, IT; Athens, GR; Austin, US) 

Pacemakers patients perception of daily life activities and medical follow-up: a french survey P1033 

W. Amara, S. Cheggour, H. Salih, A. Elhraiech, P. Sagnol, J. Taieb, F. Ghanem, B. Lahitton, 

K. Gacem, A. Dompinier (Montfermeil, Avignon, Chalon-sur-Saone, Aix en Provence, 

Chateauroux, Dax and Annecy, FR) 

Pulmonary hypertension in advanced atrioventricular block is related to the duration of 

atrioventricular block and is reversed after pacing P1034 

A.D. Margulescu, B.M.C. Suran, C. Siliste, D. Vinereanu (Bucharest, RO) 

the incidence of cardiac device infections in the modern era. Experience from a single UK 

tertiary centre P1035 

D. Monnery, R. Beadle, A. Patwala (Stoke On Trent, GB) 

Reduction in right ventricular pacing with a new reverse mode switch algorithm: results from 

the iVORy trial P1036 

J.M. Tolosana, D. Gras, J.B. Le Polain De Waroux, P. Le Franc, J. Goetzke, P. Jones, N. Wold, 

R.S. Gardner (Barcelona, ES; Nantes and Rouen, FR; Brussels, BE; Saint Paul, US; Clydebank, GB) 

Cardiac device infections are more frequent in male patients with cardiac resynchronisation 

therapy devices P1037 

S. Yuksel, S. Demircan, A. Erbay, K. Soylu, O. Gulel, M. Sahin (Kurupelit-Samsun, TR) 

Complete heart block: audit of potential safety and cost effectiveness of direct transfer 

of patients needing pacing to a pacing center P1038 

J.M. Mccomb, M. Dewhurst (Newcastle upon Tyne, GB) 

Effects of AV-delay optimisation on hemodynamic parameters and quality of life in patients 

with Vdd-pacemakers P1039 

K.A. Krychtiuk, N. Nuernberg, R. Volker, L. Pachinger, R. Jarai, M.K. Freynhofer, J. Wojta, 

K. Huber, T.W. Weiss (Vienna, AT) 

Abnormal autocapture algorithm phenomenon after pacemaker implant. P1040 

J. Benezet Mazuecos, J.A. Iglesias, J.M. Rubio, M.A. Quinones, P. Sanchez-Borque, E. Macia, 

J. Farre (Madrid, ES) 

Evolution of the acute effect of ventricular activation sequence change induced by right 

ventricular apical pacing on the function of ventricles by echocardiography and radionuclide 

ventriculography P1041 

S. Topal, M. Basara, S.K. Acikgoz, A. Akyel, Y. Alsancak, M. Unlu, H.M. Ozdemir (Ankara, TR) 

limitations of the pacemaker autocapture algorithm: when save energy turns to waste energy. P1042 

J. Benezet Mazuecos, J.A. Iglesias, J.M. Rubio, J.J. De La Vieja, A. Espejo, S. Calle, E. Aguado, 

J. Farre (Madrid, ES) 

146


Evolution of cardiac conduction system abnormalities in paced patients. P1043 

E. Simantirakis, E. Foukarakis, S. Chrysostomakis, E. Arkolaki, S. Petousis, A. Dermitzakis, 

P. Vardas (Heraklion and Iraklion Crete, GR) 

Defibrillators patients perception of daily life activities and medical follow-up: a French survey P1044 

W. Amara, S. Cheggour, A. Elhraiech, H. Salih, J. Taieb, N. Rabah, G. Glerici, F. Ghanem, 

A. Dompinier, P. Bru (Montfermeil, Avignon, Aix en Provence, Evreux, Chateauroux, 

Annecy and La Rochelle, FR) 

Endocardial leads extraction - what has changed during last 7 years - based on experience 

of polish leads registry. P1045 

M. Chudzik, A. Kutarski, P. Mitkowski, A. Maciag, M. Kempa, B. Malecka (Lodz, Lublin, Poznan, 

Warsaw, Gdansk and Krakow, PL) 

transvenous lead extraction: single centre experience of more than 1000 cases. P1046 

O. Al-Razzo, E. Gonzalez, R. Sanchez, A. Hurtado, M. Monteagudo, L. Sartor, J.A. Blazquez, 

U. Ramirez, J. Silvestre, J.M. Mesa (Madrid, ES) 

Advanced techniques for chronic lead extraction. Heading from the laser towards the 

Evolution system. P1047 

P. Mazzone, D. Tsiachris, A. Marzi, G. Paglino, G. Stavropoulos, N. Sora, F. Guarracini, 

P. Vergara, S. Gulletta, P. Della Bella (Milan, IT) 

Over one thousand laser lead extraction: single center experience 1048 (W) 


Drug-related atrioventricular block, is it a benign condition? P1049 

M.A. Akbarzadeh, S. Sayah, Z. Emkanjoo, A. Azhari, R. Mollazadeh, S. Shahrzad (Tehran, IR) 

Dry heart wall perforation - the new epidemy or better diagnosed phenomenon? P1050 

A. Kutarski, A. Tomaszewski, W. Brzozowski, K. Oleszczak, K. Boczar (Lublin, PL) 


CRT-defibrillator long-term survival compared with CRT-pacemaker in patients meeting 

class ia indication for CRt: data from COntAK italian Registry P1051 

F. Zanon, G. Morani, M. Gasparini, A. Spotti, A. Reggiani, F. Solimene, G. Molon, M. Accogli, 

C. Ciardiello, L. Padeletti (Rovigo, Verona, Rozzano, Cremona, Mantova, Mercogliano, 

Negrar-Verona, Tricase, Milan and Florence, IT) 

VistA clinical study: rationale, objectives, and design P1052 

D. Lebedev, V. Lebedeva, E. Zubarev, T. Lubimceva, E. Shlyakhto (Saint Petersburg, RU) 

Relationship between tapse and both renal and left ventricular function in patients 

undergoing cardiac resynchronisation therapy P1053 

P. Pieragnoli, G. Ricciardi, E. Sticchi, F. Ristalli, P. Attana, L. Checchi, C. Fatini, L. Padeletti, 

R. Abbate, A. Michelucci (Florence, IT) 

delayed ECG-based left ventricular activation time and outcome in patients after cardiac 

resynchronisation therapy. P1054 

B. Urbanek, M. Chudzik, I. Cygankiewicz, E. Nowacka, J.K. Wranicz (Lodz, PL) 

trying to predict the unpredictable:device-based daily monitored parameters can predict 

malignant arrhythmic events in patients undergoing cardiac resynchronisation P1055 

R. Lenarczyk, E. Jedrzejczyk-Patej, O. Kowalski, B. Sredniawa, P. Pruszkowska, A. Sokal, 

M. Szulik, M. Mazurek, J. Kowalczyk, Z. Kalarus (Zabrze, PL) 

147 

tuesday 

posters

tuesday 

posters 


Prognosis after implantable cardioverter defibrillator / cardiac resynchronisation therapy 

defibrillator implantation in cardiac sarcoidosis patients P1056 

T. Kabutoya, T. Mitsuhashi, H. Watanabe, T. Watanabe, R. Nakagami, Y. Hata, K. Kario 

(Tochigi and Chiba, JP) 

impact factor of beta1-gly-389-arg adrenergic receptor polymorphism on left ventricular 

remodelling after crt P1057 

A. Fundaliotis, P. Marino, A. Cuko, E. Cassetti, E. Occhetta, M. Moscatiello, C. Pappone, 

G. De Luca (Novara and Cotignola, IT) 

biventricular pacing in patients with hypertrophic obstructive cardiomyopathy: long term 

follow-up P1058 

D. Penela, A. Berruezo, R. Evertz, J. Fernandez-Armenta, E. Arbelo, J.M. Tolosana, M. Sitges, 

X. Alsina, L. Mont, J. Brugada (Barcelona, ES) 

Change of intrinsic AV intervals with increased heart rate associated with exercise and atrial 

pacing: Results of the RAVE study P1059 

M.R. Gold, Y. Yu, J.L. Sturdivant, J. Everidge, P. Kaveney, C. Athill (Charleston, St. Paul and 

San Diego, US) 

narrowing the QRs complex: a new pacing mode in cardiac resynchronisation therapy P1060 

T. Guo, L.M. Zhang, R.J. Li (Kunming, CN) 

Echo-guided upgrading from biventricular to triple site cardiac resynchronisation therapy P1061 

G. Moubarak, P. Ritter, G. Vedrenne, S. Cazeau (Paris and Bordeaux-Pessac, FR) 

transvenous retrieval of foreign objects lost during cardiac device implantation or revision: 

a 10-year experience P1062 

G.M. Calvagna, P. Romeo, F. Ceresa, S. Valsecchi (Taormina, Messina and Milan, IT) 

the Jurdham procedure for left ventricular endocardial CRt: absence of complications at 

medium term follow up . P1063 

S. Worley, N. Lopez Cabanillas, J. Trainini, A. Fischer, L. Cardinali, J.L. Barisani, J. Jazbik, J. De Paz, 

F. Verbal, B. Elencwajg (Lancaster and New York, US; Buenos Aires, AR; Rio de Janeiro, BR; 

Talcahuano, CL) 

differences in mode of death in super responders as compared to negative responders to 

cardiac resynchronisation therapy P1064 

A.C. Van Derh Heijden, U. Hoke, C.J.W. Borleffs, J. Thijssen, J.B. Van Rees, E.T. Van Der Velde, 

M.J. Schalij, L. Van Erven (Leiden, NL) 

Patient-specific computer modeling for analysis of ventricular conduction disorders P1065 

M. Potse, W. Kroon, D. Krause, M. Acena, F. Regoli, R. Murzilli, E. Caiani, F.W. Prinzen, R. Krause, 

A. Auricchio (Lugano, CH; Milan, IT; Maastricht, NL) 

Vectorcardiography for optimizing cardiac resynchronisation therapy in dyssynchronous 

canine hearts. P1066 

M. Strik, P. Houthuizen, L.B. Van Middendorp, S. Ploux, E. Evers, A. Van Hunnik, M. Kuipers, 

A. Auricchio, F.W. Prinzen (Maastricht, NL; Lugano, CH) 

long term outcomes of cardiac triventricular pacing in patients with a high risk of non 

response to cardiac resynchronisation therapy P1067 

A. Duparc, C. Cardin, A. Rollin, E. Thomson, R. Noblemaire, M. Rezai, P. Maury, M. Delay, 

D. Carrie, P. Mondoly (Toulouse, FR) 

Benefit of additional pacing leads in CRT patients with heart failure and short QRS P1068 

I. Kosmidou, D. Dan, A. Wickliffe, T. Deering, F. Zanoni, S. Cazeau (Piedmont, US; 


148


Prediction of the anatomy of coronary sinus branches through angiographical characteristics 

of obtus marginalis branches of left circumflex coronary artery P1069 

B. Candemir, M. Kilickap, O. Akyurek, A.T. Altin, M. Gerede, M. Guldal, C. Erol (Ankara, TR) 

Right-to-left ventricular pacing-lead distance and reverse remodelling in cardiac 

resynchronisation therapy P1070 

F. Zoppo, A. Berton, F. Zerbo, N. Frigato, M. Michieletto, A. Zanocco, A. Lupo, E. Bacchiega, 

G. Brandolino, E. Bertaglia (Mirano and Padua, IT) 

device monitoring of heart failure in CRt-d recipients. A single-center experience with a 

novel multi-vector impedance monitoring system. P1071 

G.B. Forleo, L.P. Papavasileiou, G. Panattoni, V. Schirripa, D.G. Della Rocca, A. Politano, 

K. Mahfouz, L. Santini, D. Sergi, F. Romeo (Rome, IT) 

Prediction of functional recovery after resynchronisation by contractile and coronary flow 

reserve analysis P1072 

A. Djordjevic-Dikic, G. Nikcevic, S. Raspopovic, V. Jovanovic, M. Tesic, G. Milasinovic (Belgrade, RS) 

How effective and safe is the cardiac resynchronisation therapy (CRt) in patients with heart 

failure? Data from the German device registry. P1073 

S. Heiderfazel, C. Ewertsen, J. Senges, D. Andresen (Berlin and Ludwigshafen, DE) 

Right ventricular strain as a predictor of early mortality in cardiac resynchronisation therapy 

patients P1074 

K.V. Nagy, G. Szeplaki, A. Kosztin, A. Apor, C.S. Liptai, L. Molnar, E. Zima, L. Geller, B. Merkely 

(Budapest, HU) 

impact of baseline anemia on long-term clinical outcomes in patients with heart failure 

treated by cardiac resynchronisation therapy P1075 

J. Hosoda, T. Ishikawa, K. Andoh, M. Nobuyoshi, S. Fujii, S. Shizuta, T. Kimura, T. Isshiki 

(Yokohama, Kitakyushu, Kurashiki, Kyoto and Tokyo, JP) 

Cardiac arrhythmias 

trends of cardiac implantable electronic device data during time frames preceding death. 

Results from the HomeGuide Registry. P1076 

A.D.onofrio, G. Buja, P. Vaccaro, L. Vasquez, D. Pecora, A. Vaglio, L. Rossi, L. Giovene, 

F. Chiusso, R.P. Ricci (Naples, Padua, Palermo, Milazzo, Brescia, Venice, Piacenza, Milan and Rome, IT) 

implantable loop recorder: a new tool in the diagnosis of cryptogenic stroke P1077 

M. Garcia Bermudez, J. Merce Klein, X. Ustrell, A. Pellise, R. De Castro, A. Bardaji (Tarragona, ES) 

detection and early intervention in worsening heart failure episodes with home monitoring. 

Results from the homeguide registry. P1078 

G. Zanotto, L. Calo', A. Curnis, G. Mantovani, E. Bertaglia, M. Santamaria, V. Calvi, L. Giovene, 

N. Rovai, R.P. Ricci (Legnago, Rome, Brescia, Desio, Padua, Campobasso, Catania and Milan, IT) 

Atrial fibrillation finder: a new option for remote monitoring of patients with cardiac 

implantable electronic devices P1079 

H. Keilegavlen, S. Faerestrand (Bergen, NO) 

feasibility of using mobile phone technology to record and transmit 12-lead ECGs P1080 

A. Hanley, A. Stack, P. Kelly, G.J. Fahy (Cork and Letterkenny, IE) 

Clinico-laboratory characteristics and long-term outcome of patients presenting with 

idiopathic complex right ventricular ectopy. How often we encounter ARVC/D? P1081 

K.A. Gatzoulis, S. Archontakis, I. Vlasseros, D. Tsiachris, A. Vouliotis, P. Arsenos, S. Sideris, 

P. Dilaveris, I. Kalikazaros, C. Stefanadis (Athens, GR) 

149 

tuesday 

posters

tuesday 

posters 


trends in ablation procedures in greece over the 2008-2012 period: results from the hellenic 

cardiology society ablation registry. P1082 

V.P. Vassilikos, M. Efraimidis, E. Simandirakis, A. Billis (Thessaloniki, Athens and Heraklion, GR) 

Diagnosis, prognosis, treatment 

is the calgary syncope symptom score a useful tool for vasovagal syncope diagnosis in the 

emergency room? P1083 

V. Exposito Garcia, F. Rodriguez Entem, S. Gonzalez Enriquez, B. Arnaez, J.M. Gomez Delgado, 

I. Olavarri, P. Lerena, J.J. Olalla Antolin (Santander, ES) 

Heart rate variability in the first five minutes of the tilt test to predict cardio-inhibitory 

syncopes P1084 

D. Matelot, N. Khodor, A. Hernandez, N. Thillaye-Du-Boullay, G. Carrault, F. Carre (Rennes, FR) 

syncope and hypokalemia with mild long term mild cola consumption P1085 

N. Zarqane, H. Gaid, I. Badea, N. Saoudi (Monaco, MC) 

Prognostic value of echocardiography in risk stratification of patients with syncope in the 

emergency department. P1086 

F. Rodriguez Entem, V. Exposito, S. Gonzalez Enriquez, J.J. Olalla, B. Arnaez, 

J.N. Gomez Delgado, I. Olavarri, P. Lerena (Santander, ES) 

Pre-implant vector check mapping of implantable loop recorders wastes times and does not 

improve outcomes P1087 

S. Velu, S. Ahmad, J. Upright, L. Bradley, L. Head, G. Northwood, S. Petkar (Wolverhampton, GB) 


Clinical and electrophysiological charasteristics of paroxysmal supraventricular tachycardias 

in elderly patients P1088 

P. Avila Alonso, E. Gonzalez-Torrecilla, A. Uribarri, L. Bravo, A. Arenal, F. Atienza, T. Datino, 

J. Hernandez, M. Pelliza, F. Fernandez-Aviles (Madrid, ES) 

Comparison of left ventricular ejection time measured by three different non-invasive methods. P1089 

T. Krauze, D. Przymuszala, M. Bryl, D. Karbowy, J. Tarchalski, K. Barecka, M. Biczysko, J. Piskorski, 

A. Wykretowicz, P. Guzik (Poznan, PL) 

Competitive sports induce phenotypic expression of arrhythmogenic right ventricular 

cardiomyopathy in families of patients with asymptomatic PKP2-mutation carriers P1090 

J.-L. Pasquie, C. Hedon, S. Thomann, O. Alfalasi, F. Massin, F. Cransac, T.T. Cung, J.M. Davy 

(Montpellier, FR) 

Premature ventricular beats in non-compaction cardiomyopathy: consequence of immature 

development of the cardiac conduction system? P1091 

S.C.H. Van Malderen, K. Caliskan, F. Akca, T. Szili-Torok (Rotterdam, NL) 

Resting respiratory rate and the function of the cardiovascular system in patients with an 

implanted defibrillating device and left ventricular ejection fraction up to 40%. P1092 

T. Krauze, M. Bryl, D. Przymuszala, D. Karbowy, J. Tarchalski, M. Biczysko, M. Jastrzebska, 

A. Palasz, J. Piskorski, P. Guzik (Poznan, PL) 

sudden paradoxical changes in repolarisation dynamics may provide a potential substrate for 

ventricular arrhythmias in patients undergoing renal replacement therapy P1093 

A. Talib, N. Sato, K. Abe, N. Yao, M. Matsuki, T. Fujino, T. Hirayama, J. Maruyama, 

Y. Kawamura, N. Hasebe (Asahikawa, JP) 

150


Clinical and prognostic significance of idiopathic intraventricular conduction disturbances in 

young subjects. P1094 

G. Allocca, N. Sitta, M. Centa, A. Cati, E. Marras, L. Sciarra, L. Coro', P. Delise (Conegliano (Tv) 

and Rome, IT) 

Significantly higher peak body surface restitution gradients in patients experiencing 

ventricular arrhythmias P1095 

W.B. Nicolson, M.I. Smith, G. Chu, P.B. Brown, A.J. Sandilands, P.J. Stafford, F.S. Schlindwein, 

N.J. Samani, G.P. Mccann, G.A. Ng (Leicester, GB) 

Ventricular arrhythmias and systolic function in young patients with mitral valve prolapse P1096 

E. Malev, S. Reeva, L. Vasina, A. Pshepiy, E. Zemtsovsky (Saint Petersburg, RU) 

A new stepwise electrocardiographic algorithm for localizing the atrial flutter circuit 

:Usefulness of flutter-wave morphology in leads V1 and I P1097 

K. Sasaki, S. Shingo, M. Kimura, S. Owada, D. Horiuchi, T. Itoh, Y. Ishida, T. Kinjo, K. Okumura 

(Hirosaki, JP) 

diagnosis, treatment and outcomes of neonates and fetuses with complete AV- block single 

centre experience P1098 

R. Bejiqi, R. Bejiqi, R. Retkoceri, H. Bejiqi, N. Zeka (Prishtina, KS) 

Analysis of intra-nocturnal ventricular vepolarization dynamics in early repolarisation 

syndrome: insights into the pathophysiology of sudden cardiac death. P1099 

A. Talib, N. Sato, E. Sugiyama, N. Sakamoto, H. Ota, Y. Tanabe, T. Takeuchi, 

K. Akasaka, Y. Kawamura, N. Hasebe (Asahikawa, JP) 

Prevalence of brugada type ECG pattern and early repolarisation variant in turkish 

population: results from the HAPPy study P1100 

B. Hunuk, O. Cagac, O. Erdogan, A. Kepez, B. Mutlu, M. Degertekin (Istanbul, TR) 

the relationship between t-wave amplitude variability and myocardial viability in patients 

with cardiac resynchronisation therapy P1101 

M. Cvijic, D. Zizek, L. Lezaic, I. Zupan (Ljubljana, SI) 

Comparations of electrocardiographic patterns of ventricular arrhythmias: differences 

between ARVC and idiopathetic RVOt tachycardia. P1102 

L. Ren, Y.-H. Jia, Z. Liu, J.-M. Chu, P.-H. Fang, S. Zhang (Beijing, CN) 

Combinations of qt-prolonging drugs are frequently used in psychiatry P1103 

T. Marynissen, E. Vandael, J. Reyntens, V. Foulon, R. Willems (Leuven and Eeklo, BE) 

Heterogeneity of ventricular repolarisation in patients with end stage renal disease. P1104 

A. Talib, N. Sato, K. Abe, N. Yao, M. Matsuki, T. Fujino, T. Hirayama, J. Maruyama, 

Y. Kawamura, N. Hasebe (Asahikawa, JP) 

U wave variables in body surface potential mapping as risk indicators for ventricular 

arrhythmias in post myocardial infarction patients 1105 (W) 

B. Wang, P. Korhonen, H. Vaananen, H. Hanninen, L. Toivonen (Helsinki and Espoo, FI) 

A description of the arrhythmogenic profile in chronic chagasic cardiomyopathy. is it 

different from other dilated cardiomyopathies? P1106 

D.A. Escobar Gutierrez, J.L. Morales Velazquez, S.R. Nava Townsend, A. Enriquez Silverio, P. 

Iturralde Torres, L.J. Colin Lizalde, M.F. Marquez Murillo, J.F. Gomez Flores, 

M. Levinstein Jacinto, E. Fajardo Flores (Mexico City, MX) 

late high grade arrhythmic complications in acute myocardial infarction: impact on morbidity 

and mortality P1107 

B. Picarra, A.R. Santos, A.F. Damasio, M. Celeiro, A. Bento, J. Aguiar, R.N.S.C.A. Spc (Évora and 

Portugal, PT) 

151 

tuesday 

posters

tuesday 

posters 


incidence and risk factors of ventricular arrhythmias in patients with acute coronary syndrome P1108 

O. Kalejs, A. Maca, I. Zakke, I. Mintale, G. Kamzola, M. Zabunova, E. Silina, A. Udre, S. Jegere, 

A. Erglis (Riga, LV) 

Repolarisation variability as a predictor of appropriate iCd interventions in patients with the 

remote myocardial infarction, untreated with amiodarone. P1109 

K. Szydlo, A. Filipecki, W. Orszulak, W. Kwasniewski, D. Urbanczyk, M. Trusz-Gluza, 

K. Mizia-Stec (Katowice, PL) 

152

tUEsdAy 25 JUnE 2013 - POSTERS AFTERNOON 


Catheter ablation 

Chairpersons: E. bertaglia (Mirano-Venezia, it); M. shkolnikova (Moscow, RU) 


be on display between 14:00 and 18:00. The Presenter should be present throughout the coffee break 





Peri-AV nodal focal atrial tachycardia: ablation from the right, from the left or from 

the non-coronary aortic sinus? P1110 

R. Pap, C. Tutuianu, J. Szilagyi, G. Bencsik, A. Makai, G. Klausz, L. Saghy (Szeged, HU) 

Periprocedural continuation of warfarin with therapeutic international normalized 

ratio reduces silent cerebral thromboembolism in catheter ablation of atrial fibrillation P1111 

A. Aso, T. Nakamura, T. Mori, K. Takenaka, N. Kawamura, K. Numaguchi, E. Mori, 

S. Satoh, K. Hiyamuta (Fukuoka, JP) 

Nonhomogeneous force application during typical flutter ablation explains local 

difficulties in lesion creation P1112 

D. Latcu, S.S. Bun, A. Errahmouni, L. Alkhoury, N. Saoudi (Monaco, MC) 

Does termination of atrial fibrillation during ablation of long standing persistent 

atrial fibrillation predict the outcome at follow-up? Results from a prospective 

randomized study P1113 

L. Di Biase, P. Santangeli, P. Mohanty, J.E. Sanchez, S. Mohanty, R. Bai, R. Horton, 

J.G. Gallinghouse, J.D. Burkhardt, A. Natale (Austin, US) 

Prevalence and risk factors for atrial fibrillation occurring after "successful" ablation 

for intraatrial reentry tachycardia in patients after correction of congenital heart 

disease P1114 

P. Peichl, D. Wichterle, R. Cihak, J. Kautzner (Prague, CZ) 

Predictors of arrhythmia-free survival after single or repeat catheter ablation for 

long-standing persistent atrial fibrillation P1115 

M. Fiala, D. Wichterle, L. Sknouril, V. Bulkova, R. Nevralova, O. Toman, M. Dorda, 

J. Pindor, J. Januska, J. Spinar (Trinec, Prague and Brno, CZ) 

Radiofrequency catheter ablation of ventricular tachycardias in adults with 

congenital heart disease: acute and long term outcome. P1116 

G.F.L. Kapel, T. Reichlin, A.P. Wijnmaalen, S.R. Piers, M.J. Schalij, W.G. Stevenson, 

K. Zeppenfeld (Leiden, NL; Boston, US) 

R-wave duration in lead V2: a new electrocardiographic criterion for differentiating 

left from right coronary cusps tachycardias P1117 

W. Uribe, J. Velasquez, J. Aristizabal, V. Astudillo, E. Medina, J. Marin, A. Miranda, 

J. Bareno, A. Baranchuk, M. Duque (Medellin, CO; Kingston, CA) 

left-sided ablation of ventricular tachycardias in adults with repaired tetralogy of 

fallot: a case series. P1118 

G.F.L. Kapel, T. Reichlin, A.P. Wijnmaalen, U.B. Tedrow, S.R. Piers, M.J. Schalij, 

W.G. Stevenson, K. Zeppenfeld (Leiden, NL; Boston, US) 

153 

tuesday 

posters

tuesday 

posters 


Premature ventricular beat-induced cardiomyopathy characteristics and prognosis 

after radio-frequency ablation P1119 

P. Maury, M. Sadron, F. Sacher, A. Duparc, P. Mondoly, N. Derval, A. Rollin, C. Cardin, 

P. Pascale, M. Hocini (Toulouse and Bordeaux, FR; Lausanne, CH) 

154





between 14:00 - 18:00. 




Preventive effects of rosuvastatin on atrial fibrillation: a meta-analysis of randomized 

controlled trials P1120 

T. Liu, P. Korantzopoulos, L. Li, G. Li (Tianjin, CN; Ioannina, GR) 

Predictors of successful cardioversion with vernakalant in patients with short duration atrial 


N. Mochalina, T. Juhlin, B. Ohlin, J. Carlson, F. Holmqvist, P.G. Platonov (Helsingborg, Malmo and 

Lund, SE) 

Beneficial effects of Losartan for secondary prevention of atrial fibrillation: Long-term follow 

up using analysis of memory function in pacemaker P1122 

E. Takii, M. Ohe, T. Inage, T. Gondo, G. Haraguchi, S. Ito, A. Kumanomido, T. Imaizumi (Kurume, JP) 

Relation of renal dysfunction to the increased risk of stroke and death in female patients with 


Y. Guo, Y.T. Wang, G.Y.H. Lip (Beijing, CN; Birmingham, GB) 

Characterisation of the cardiac neural network during atrial fibrillation ablation: Importance 

of the ligament of marshall P1124 

C. Eickholt, T. Drexel, M. Siekiera, K. Kirmanoglou, D.-I. Shin, M. Martinek, H. Puererfellner, 

T. Rassaf, M. Kelm, C. Meyer (Duesseldorf, DE; Linz, AT) 

The extent of complex fractionated atrial electrograms in the left atrium reflects age-related 

electrical remodeling in patients with persistent atrial fibrillation. P1125 


Assessment of clinical outcome of ablation for long-standing persistent atrial fibrillation with 

or without defragmentation P1126 

F. Akca, L. De Vries, L. Dabiri Abkenari, M. Khan, G. De Ruiter, P. Janse, N. De Groot, 

D. Theuns, T. Szili-Torok (Rotterdam and Amsterdam, NL) 

The efficacy of CPVI in patients with atrial fibrillation and pulmonary vein anatomy variants: 

analysis using multislice tomographyy P1127 

I. Wozniak-Skowerska, M. Skowerski, A. Hoffmann, J. Kolasa, M. Faryan, S. Nowak, T. Skowerski, 

M. Sosnowski, A. Wnuk-Wojnar, K. Mizia-Stec (Katowice, PL) 

Effects of renal sympathetic denervation on the development of atrial fibrillation substrates 

in dogs with pacing-induced heart failure P1128 

Q. Zhao, S. Yu, J. Xiao, Z. Dai, X. Wang, C. Huang (Wuhan, CN) 

Electrophysiological properties of the pulmonary veins and both atria in a pediatric patient 

population P1129 

J.M. Moltedo, M.S. Abello, J. Olmedo, M. Benjamin (Buenos Aires, AR) 

155 

tuesday 

posters

tuesday 

posters 


Increased vascular factor levels in patients with paroxysmal and persistent atrial fibrillation. P1130 

F. Cabrera Bueno, A. Flores Marin, N. Rodriguez Losada, J. Alzueta Rodriguez, 

A. Barrera Cordero, A. Ruiz Salas, J. Fernandez Pastor, J. Pena Hernandez, C. Medina Palomo, 

E. De Teresa Galvan (Malaga, ES) 

CHAds2 and CHA2ds2-VAsc scores predict new onset of Af in pacemaker patients: 

results from the bRAdyCARE trial P1131 

M. Richards, B. Faulknier, Y. Nabutovsky, R. Thakur (Toledo, Charleston, Sunnyvale and 

Lansing, US) 

indexed left atrial volume is superior to left atrial diameter as predictor of lone atrial 

fibrillation recurrence after the pulmonary veins isolation procedure. P1132 

P. Marchese, M. Tritto, F. Gennaro, A. Sanzo, E. Renzullo, P. Moretti, G. Spadacini, G. Bargiggia, 

J. Salerno Uriarte (Ascoli Piceno, Castellanza and Varese, IT) 

A comparative study of quality of life in patients with controlled versus uncontrolled 

ventricular rate in atrial fibrillation (COMPAF) P1133 

W.Y.H. W Isa, S.L. Ng, N.N. Naing, Z. Yusof (Kota Bharu, MY) 

Incidence of stroke in atrial fibrillation: Report from the Montevideo-CASMU Cohort of 


G. Vanerio (Montevideo, UY) 

total thoracoscopic left atrial epicardial radiofrequency ablation of longstanding persistent 

atrial fibrillation in severely symptomatic patients P1135 

J. Probst, L. Jideus, P. Blomstrom, V. Zemgulis, E. Wassberg, S. Lonnerholm, L. Bagge, 

P. Landelius, H. Malmborg, C. Blomstrom Lundqvist (Uppsala, SE) 

Impact of atrial fibrillation termination site and termination mode during catheter ablation on 

arrhythmia recurrence 1136 (W) 

S. Miyazaki, H. Taniguchi, Y. Komatsu, T. Uchiyama, S. Kusa, H. Nakamura, H. Hachiya, Y. Iesaka 

(Tsuchiura, JP) 

Prediction of left atrial appendage thrombi in patients scheduled for catheter ablation of 


D. Wichterle, P. Peichl, B. Aldhoon, R. Cihak, J. Kautzner (Prague, CZ) 

Intravenous flecainide reduces the extension of complex fractionated electrogram areas 

preserving their spatial localization P1138 

A. De Bortoli, L.Z. Sun, E. Solheim, P.I. Hoff, P.M. Schuster, O.-J. Ohm, J. Chen (Bergen, NO) 

The telemonitoring electrocardiogram after catheter ablation for atrial fibrillation. P1139 

T. Kimura, K. Inagawa, Y. Katsumata, T. Nishiyama, N. Nishiyama, K. Fukumoto, Y. Aizawa, 

Y. Tanimoto, K. Tanimoto, S. Takatsuki (Tokyo, JP) 

long-term outcome after cryoballoon pulmonary vein isolation: retrospective analysis in 346 


A. Martin, P.J. Jacon, R.E.M. Moisei, P.D.E. Defaye (Grenoble, FR) 

Geometrical Reverse Remodeling of left Atrium after Atrial fibrillation Ablation. P1141 

F. Bisbal, E. Guiu, P. Cabanas, A. Berruezo, E. Arbelo, B. Vidal, T.M. Caralt, M. Sitges, J. Brugada, 


Cerebral microemboli and its neurological impact in phased versus irrigated radiofrequency 

ablation of atrial fibrillation: results of a prospective, randomised study P1142 

S. Kochhaeuser, M.A.R. Ritter, P.L. Leitz, F.G. Guener, H.H.L. Lohmann, S.Z. Zellerhoff, 

C.K. Korsukewitz, D.A.D. Dechering, L.E. Eckardt, G.M. Moenning (Münster, DE) 

156


five year follow up of patients with structural heart disease undergoing catheter ablation of 

persistent atrial fibrillation using the stepwise approach P1143 

D. Scherr, S. Miyazaki, V. Aurillac-Lavignolle, Y. Komatsu, P. Pascale, L. Roten, S. Knecht, 

K. Ramoul, P. Jais, M. Haissaguerre (Graz, AT; Bordeaux, FR) 

Safety and efficacy of coronary angiography guided mitral isthmus ablation P1144 

Y. Hama, Y.M. Matsudo, T.S. Sekine, M.Y. Yamamoto, T.H. Himi (Kisarazu, JP) 

Catheter force direction angle predicts contact force and impedance fall during ablation for 


A. De Bortoli, L.Z. Sun, E. Solheim, P.I. Hoff, P.M. Schuster, O.-J. Ohm, J. Chen (Bergen, NO) 

Arrhythmia recurrence after pulmonary vein isolation for paroxysmal atrial fibrillation: 

Ablation failure or undiagnosed extra-pulmonary vein foci? P1146 

S. Ammar, A. Buiatti, T. Reents, S. Kathan, R. Dillier, V. Semmler, H. Pavaci, C. Kolb, G. Hessling, 


temporal variability of dominant frequency and complex fractionated atrial electrograms in 

human atrial fibrillation P1147 

I. Watanabe, R. Kogawa, Y. Okumura, K. Nagashima, H. Mano, K. Sonoda, N. Sasaki, 

K. Ohkubo, T. Nakai, A. Hirayama (Tokyo, JP) 

Characterisation of bipolar electrograms recorded at the PV ostia before and after 

pulmonary vein isolation P1148 

B. Berte, M. El Haddad, M. Acena, G. De Meyer, Y. Vandekerckhove, R. Tavernier, 

M. Duytschaever (Bruges and Ghent, BE) 

Characteristics of reconduction after mesh catheter pulmonary vein isolation P1149 

B. Oude Velthuis, Y.J. Stevenhagen, J.M. Van Opstal, J. Van Der Palen, P.F. Van Dessel, 

M.F. Scholten (Enschede, NL) 

Why meticulous analysis of pulmonary vein anatomy prior to ablation can improve 

procedural outcome P1150 

K. Goossens, S. Wijchers, G. Van Langenhove, Y. De Greef, D. Stockman, F. Van Den Branden, 

B. Schwagten (Antwerp, BE) 

Improved efficacy using the new 28mm cryoballoon for pulmonary vein isolation P1151 

E. Wissner, P. Rausch, A. Metzner, A. Bardyszewski, T. Mihalik, A. Rillig, S. Mathew, R. Tilz, 

F. Ouyang, K.H. Kuck (Hamburg, DE; Minneapolis, US) 

long-term outcome and predictors for arrhythmia recurrence after repeat catheter ablation 

of atrial fibrillation in patients who recurred after a single ablation procedure. P1152 

A. Yagishita, Y. Yamauchi, A. Suzuki, H. Sato, T. Obayashi, K. Hirao, K. Aonuma (Tokyo and 

Tsukuba, JP) 

Remote magnetic navigation for ablation of persistent atrial fibrillation: a comparison to 

manual ablation. P1153 

S.S. Bun, R. Tavernier, B. Berte, G. De Meyer, K. Van Beeumen, Y. Vandekerckhove, 

M. Duytschaever (Bruges, BE) 

Predictors of arrhythmia recurrence after an index 3-D radiofrequency ablation of Afib. 

Results of 3 years of follow-up P1154 

A. Ardashev, E. Dolgushina, E. Zhelyakov, A. Konev, V. Ardashev (Moscow, RU) 

One year follow-up after atrial fibrillation ablation: the experience from a French registry P1155 

S. Fazaa, R.A. Providencia, J.P. Cebron, F. Halimi, D. Pavin, F. Anselme, M. Ben Halima, 

D. Defaye, J.P. Albenque, S. Boveda (Toulouse, Nantes, Le Chesnay, Rennes, Rouen and 

Grenoble, FR) 

157 

tuesday 

posters

tuesday 

posters 


Catheter ablation of persistent Af: anatomically-based circumferential PV ablation in 

combination with a potential-guided segmental approach to achieve complete PV isolation - 

long-term outcome P1156 

K. Kettering, F. Gramley (Frankfurt, DE) 

Efficacy of isolation pulmonary vein guilty in the ablation of paroxysmal atrial fibrillation P1157 

J.A. Figueroa, A. Estrada, D. Doiny, S. Castrejon-Castrejon, M. Ortega, D. Filgueiras, J.L. Merino 

(Madrid, ES) 

Real time assessment of pulmonary vein isolation using the novel Achieve mapping catheter 

during cryoablation P1158 

R.P. Martins, N. Behar, R. Bacquelin, J. Lacaze-Gadonneix, A. Behagel, P. Mabo, D. Pavin 

(Rennes, FR) 

the factors associated with pulmonary vein isolation time in patients undergoing catheter 

ablation of atrial fibrillation P1159 

A. Mizukami, M. Suzuki, W. Nagahori, M. Ohno, A. Matsumura, Y. Hashimoto (Kamogawa, JP) 

Catheter-tissue interaction throughout the cardiac and respiratory cycles P1160 

M.J. Wright, D. Haines, E. Harks, H. Belt, S. Fokkenrood, D. Rankin, W.C. Stoffregen, J. Nguyen, 

V. Reddy, P. Jais (London, GB; Royal Oak, San Jose and New York, US; Best and Eindhoven, NL; 

Bordeaux, FR) 

Ablation of atrial fibrillation with Cryoballon or duty-cycled radiofrequency ablation catheter 

(PVAC) - a randomised controlled study comparing the clinical outcome and safety; 

the Af-COR study P1161 

H. Malmborg, S. Lonnerholm, P. Blomstrom, C. Blomstrom-Lundqvist (Uppsala, SE) 

intraatrial pressure measured during Af ablation does not predict recurrence P1162 

J. Hutter, P. Insulander, H. Bastani, F. Braunschweig, N. Drca, K. Gudmundsson, G. Kenneback, 

J. Schwieler, J. Tapanainen, M. Jensen-Urstad (Stockholm, SE) 

impact of additional left atrial lines on Af recurrence in patients undergoing pulmonary vein 

isolation redo procedure P1163 

H.J. Quiroga Ponce, S. Divakaramenon, J.S. Healey, S.J. Connolly, C.A. Morillo (Hamilton, CA) 

Long term follow-up of atrial fibrillation ablation with subcutaneous ECG monitoring device 

insertion: a single centre experience. P1164 

E. Pelissero, S. Manganiello, C. Amellone, M. Giuggia, G. Trapani, B. Giordano, M. Anselmino, 

G. Senatore (Ciriè (Turin) and Turin, IT) 

Myocardial biomarker release comparison using the first and the second generation 28mm 

cryoballoon. P1165 

S. Bordignon, A. Fuernkranz, A. Klemt, M.C. Bohmer, M. Gunawardene, V. Urban, 

B. Schulte-Hahn, B. Nowak, B. Schmidt, K.R.J. Chun (Frankfurt a.M., DE) 

Automatic multilead characterisation of f-wave amplitude enhances prediction of catheter 

ablation outcome in persistent atrial fibrillation P1166 

M. Meo, D.G. Latcu, V. Zarzoso, O. Meste, M. Garibaldi, I. Popescu, N. Saoudi 

(Sophia Antipolis, FR; Monaco, MC) 

Mechanically-mediated pulmonary vein conduction block during Redo procedure: clinical 

utility of adenosine P1167 

E. Lyan, F. Tursunova, A. Morozov, S. Yashin (Saint Petersburg, RU) 

Randomized comparison of continuous and intermittent heparin infusion during catheter 

ablation of atrial fibrillation; interim results of ongoing COHERE (COntinuous HEparin 

infusion REferring to ablat P1168 

Y.S. Oh, S.H. Kim, T.S. Kim, W.S. Shin, J.H. Kim, S.W. Jang, M.Y. Lee, T.H. Rho (Seoul, KR) 

158


Contact force aided compared to standard pulmonary vein isolation in patients with 


S. Fichtner, T. Reents, S. Ammar, V. Semmler, S. Kathan, R. Dillier, A. Buiatti, G. Hessling, 


Atrial balloon dilatation of the septum is an easy and safe method to facilitate the difficult 

transseptal approach P1170 

M. Gwechenberger, B. Richter, M. Marx, T. Binder, H. Goessinger (Vienna, AT) 

High pre-ablation ECG organization in long-standing persistent atrial fibrillation terminated 

within the left atrium P1171 

A. Buttu, J. Van Zaen, A. Viso, A. Forclaz, P. Pascale, P. Maury, A. Rollin, S.M. Narayan, J.M. Vesin, 

E. Pruvot (Lausanne, CH; Toulouse, FR; San Diego, US) 

Catheter stability during pulmonary vein isolation using a contact force sensing catheter P1172 

H. Makimoto, A. Rillig, A. Metzner, S. Mathew, S. Deiss, E. Wissner, P. Rausch, K.-H. Kuck, 

F. Ouyang, R. Tilz (Hamburg, DE) 

Educational value of real-time contact force sensing for pulmonary vein isolation in 

paroxysmal atrial fibrillation catheter ablation P1173 

J.P.A. Albenque, A.B. Bouzeman, S.F. Fazaa, E.M. Marijon, B.C. Casteigh, R.P. Providencia, 

S.A. Ascoeta, N.C. Combes, S.C. Combes, S.B. Boveda (Toulouse, FR) 

Persistence of vein-to-atria conduction in the presence of atria-to-vein conduction block 

during catheter ablation of atrial fibrillation. P1174 

D.G. Doiny, S. Castrejon Castrejon, A. Estrada, J. Figueroa, D. Filgueiras Rama, M. Ortega 

Molina, F. Gutierrez Larraya, J.L. Merino (Madrid, ES) 

Catheter ablation of atrial fibrillation supported by non-fluoroscopic sensor-guided 4D tracking P1175 

S. Rolf, P. Sommer, S. John, T. Gaspar, Y. Huo, A. Arya, S. Richter, C. Piorkowski, G. Hindricks 

(Leipzig, DE) 

Point-by-point electroanatomical mapping of localized source driving atrial fibrillation P1176 

E. Lyan, F. Tursunova, S. Yashin (Saint Petersburg, RU) 

The hybrid thoracoscopic-transcatheter approach is associated with incremental benefits at 

mid-term in patients with persistent atrial fibrillation P1177 

C. Muneretto, G. Bisleri, F. Rosati, L. Bontempi, A. Curnis (Brescia, IT) 


VKORC1 and CyP2C9 genotypes unrelated to bleeding risk in patients receiving long-term 

warfarin therapy P1178 

B. Diug, M. Dooley, J. Lowthian, L. Sheffield, K. Byron, J. Mcneil (Melbourne, AU) 

short term antithrombotic therapy after lAA occlusion. A prospective study. P1179 

B. Schmidt, S. Bordignon, A. Fuernkranz, L. Perotta, K.R.J. Chun (Frankfurt/Main, DE) 

stroke reduction by combining catheter ablation and left atrial appendage closure in high risk 


M.J. Swaans, S. Karadavut, A. Alipour, M.C. Post, B.J.W.M. Rensing, L.V.A. Boersma (Nieuwegein, NL) 

does left atrial appendage closure with a cardiac plug system reduce the stroke risk in 

nonvalvular atrial fibrillation patients? A single-center case series. P1181 

R. Proietti, P. Danna, A. Sagone, A. Arensi, A. Rago, V. Russo, M. Viecca (Milan and Naples, IT) 

159 

tuesday 

posters

tuesday 

posters 



Prediction of fluoroscopy use in cavotricuspid isthmus catheter ablation exclusively guided by 

an electroanatomic system P1182 

R. Macias Ruiz, M. Alvarez, J. Jimenez, T. Barrio, T. Gil, L. Tercedor (Granada, ES) 

Acute catheter ablation of electrical storm in patients with ischaemic heart disease using a 

remote magnetic navigation system P1183 

P.K. Jacobsen, S. Pehrson, A. Karlsdottir, X. Chen (Copenhagen, DK) 

Could Late diastolic potentials predict origin of PVC in normal heart? P1184 

G. Al Mohani, M. Casella, G. Pelargonio, E. Russo, F. Pintus, M. Narducci, A. Di Monaco, 

F. Perna, G. Bencardino, C. Tondo (Rome and Milan, IT) 

the magnitude of the "jump" is valuable to identify the site of successful cryoablation of the 

slow pathway in AV node reentry P1185 

J. Gonzalez-Zuelgaray, A. Perez, A. Szyszko, L. Hallon, C. Muratore, F. De Valais 

(Buenos Aires, AR) 

A zero-fluoroscopy approach to cavotricuspid isthmus catheter ablation:comparative analysis 

of two electroanatomical mapping systems P1186 

R. Macias Ruiz, M. Alvarez, J. Jimenez, T. Barrio, T. Gil, L. Tercedor (Granada, ES) 

Ventricular arrhythmia ablation in patients with left ventricular noncompaction 

cardiomyopathy report of three cases P1187 

I. Suman Horduna, S. Honarbakhsh, L. Mantziari, T. Wong, S. Ernst (London, GB) 

transseptal puncture facilitated with radiofrequency P1188 

J.A. Figueroa, A. Estrada, D. Doiny, S. Castrejon-Castrejon, M. Ortega, M. Toniolo, 

D. Filgueiras, J.L. Merino (Madrid, ES) 

Use of a novel method to rapidly identify the site of origin of ventricular arrhythmias P1189 

A. Li, J. Davis, J. Wierwille, J. Schweitzer, D. Morgan, K. Herold, S. Shorofsky, M. Saba 

(London, GB; College Park, Saint Paul and Baltimore, US) 

increased incidence of dual atrioventricular node physiology with right septal and 

posteroseptal atrioventricular bypass tracts in children and adolescents P1190 

M.J. Kantoch, J. Atallah (Edmonton, CA) 

Ablation within the aortic sinus of Valsalva for the treatment of ventricular arrhythmias: 

the Vietnam Heart institute Experience P1191 

P. Phan, L. Pham T. Pham Q. Nguyen L (Hanoi, VN) 

Electrocardiographic and electrophysiological differences of idiopathic ventricular 

arrhythmias arising from the left coronary cusp versus the aortomitral continuity. P1192 

J.E. Ban, J.E. Choi, H.E. Lim, S.W. Park, Y.H. Kim (Seoul, KR) 

Prognostic value of programmed electrical stimulation after ventricular tachycardia ablation 

in patients with prior myocardial infarction. P1193 

M. De Riva-Silva, S.R.D. Piers, G.F.L. Kapel, K.M. Dyrda, K. Zeppenfeld (Leiden, NL) 

Propofol sedation administered by cardiologists without assisted ventilation is safe for 

patients undergoing catheter ablation for ventricular tachycardia P1194 

H. Servatius, T. Hoefeler, B.A. Hoffmann, A. Sultan, J. Lueker, B. Schaeffer, D. Schreiber, 

M. Knoll, S. Willems, D. Steven (Hamburg, DE) 

the neurohormonal, structural and functional recovery pattern after pcv ablation is 

independent of structural heart disease status in patients with depressed left ventricular 

ejection fraction P1195 

D. Penela, C. Van Huls Van Taxis, L. Aguinaga, J. Fernandez-Armenta, L. Mont, J.M. Tolosana, 

M. Sitges, J. Brugada, K. Zeppenfeld, A. Berruezo (Barcelona, ES; Leiden, NL; Buenos Aires, AR) 

160



Long term follow up of idiopathic ventricular fibrillation: is beta-blocker therapy an effective 

treatment? P1196 

V. Exposito Garcia, F. Rodriguez Entem, S. Gonzalez Enriquez, I. Olavarri, P. Lerena, J. Lucas, 

G. Martin Gorria, D. Iglesias, J.J. Olalla Antolin (Santander, ES) 

statin related reduction in ventricular tachyarrhythmias in patients undergoing iCd 

implantation for primary prevention. P1197 

M. Manfrin, R. Cemin, W. Rauhe (Bolzano, IT) 

Implantable cardioverter-defibrillators and subsequent cancer risk: a nationwide 

population-based cohort study P1198 

S.B. Pedersen, J.C. Nielsen, H.E. Boetker, D.K. Farkas, M. Schmidt, H.T. Soerensen (Aarhus, DK) 

Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac 

conduction disturbances P1199 

G. Moubarak, A. Savoure, B. Godin, B. Borz, M. Mabru, V. Drouin-Garraud, A. Gay, F. Anselme 

(Rouen, FR) 

REVisiOn - registry of ischaemic ventricular dysfunction P1200 

M.S. Rocha, L.A. Machado Cesar, W.A. Hueb, S.F. Siqueira, T.O. Hueb, S.A.D. Nishioka, 

R.A. Teixeira, G.L. Peixoto, R.C. Costa, M. Martinelli (Sao Paulo, BR) 

Actual significance of induced arrhythmias at programmed ventricular stimulation after 

myocardial infarction. P1201 

B. Brembilla-Perrot, J.M. Sellal, J. Schwartz, A. Olivier, O. Selton, P. Louis, 

A. Terrier De La Chaise, H. Blangy, L. Freysz, N. Sadoul (Vandoeuvre-Les-Nancy, FR) 

Are MADIT-2 results still applicable to current post myocardial infarction population? P1202 

M. Svetlosak, H. Bou Ezzeddine, M. Sasov, A. Vachulova, K. Gladisova, L. Urban, V. Bernat, 

P. Hlivak, P. Margitfalvi, R. Hatala (Bratislava, SK) 

Replacement of defibrillators in primary prevention: worthy if no events? P1203 

E. Gonzalez Lopez, V. Castro Urda, J. Toquero Ramos, M. Sanchez Garcia, E. Perez Pereira, 

H.E. Delgado, I. Fernandez Lozano (Madrid, ES) 

Remote monitoring follow-up of 632 iCd/CRt-d recipients: a very low rate of inappropriate 

shocks P1204 

P. Defaye, N. Pellet, C. Vandeneynde, R. Moisei, A. Martin, P. Jacon (Grenoble, FR) 

long term preservation of battery longevity (despite daily transmission load) with home 

monitoring- the tRUst trial P1205 

N. Varma, J. Michalski, A. Epstein, T.R.U.S.T. Investigators (Cleveland, Lake Oswego and 

Philadelphia, US) 

Remote monitoring of implantable cardioverter-defibrillator (ICD): evaluation and analysis P1206 

F. Mendez Zurita, E. Rodriguez F.C. Alonso M.J.M. Guerra, S. Magnani R.M. Sobre, S. Cabrera 

G.X. Vinolas P (Barcelona, ES) 

Remote monitoring of patients with iCd and CRt-d devices P1207 

M.S. Carvalho, F. Costa, H. Dores, P.G. Santos, G. Cardoso, P. Carmo, D. Cavaco, F. Morgado, 

P. Adragao, M. Mendes (Carnaxide, PT) 

Efficiency of remote technical support for the ICD follow up of outpatients. P1208 

M. Biffi, M. Ziacchi, I. Diemberger, M. Mancusi, M. Soranno, P. Battistini, C. Martignani, 

G. Boriani (Bologna, IT; lausanne, CH) 

long-term stability and reliability of direct atrial sensing in single-lead (Vdd) iCd system 

with remote monitoring P1209 

M. Nemeth, L. Melczer, S. Szabados (Pecs, HU) 

161 

tuesday 

posters

tuesday 

posters 


single centre experience of implanted riata and riata st silicone coated leads at the liverpool 

heart and chest hospital P1210 

M.J. Ng Kam Chuen, D.J. Wright, S. Hughes, S. Belchambers, M. Sendegaya, A. Rao (Liverpool, GB) 

Pacing 

salvage treatment of infected cardiovascular implantable electronic devices by a novel 

therapeutic system P1211 

M. Topaz, M. Kazatsker, Y. Oron, G. Keren, N.N. Carmel, A. Silberman, G. Topaz, S. Meisel, 

D.S. Blondheim, A. Shotan (Hadera and Tel Aviv, IL) 

Ultrasound guided venous access for pacemaker and defibrillator leads: randomized trial P1212 

M. Liccardo, G. Sibilio, T. Crisci, A.P. Marino, A. Borrino, C. Carbone, G. Salzano, C. Ciardiello, 

P. Nocerino (Pozzuoli, Milan and Napoli, IT) 

Use of transesophageal echocardiography during lead extraction procedure P1213 

F. Regoli, M. Acena, M.C. Dequarti, T. Cassina, G. Casso, T. Moccetti, E. Pasotti, A. Auricchio 

(Lugano, CH) 

Cardiac device algorithms for optimal outcomes in patients with sick sinus syndrome P1214 

J. Curry (Darlington, GB) 

Minimizing ventricular pacing in patients without prior history of atrial fibrillation is safe and 

may even help prevent new onset of atrial fibrillation. P1215 

B. Thibault, J.F. Andrade, M. Dubuc, K. Dyrda, P. Khairy, L. Macle, L. Rivard, D. Roy, M. Talajic, 

P.G. Guerra (Montreal, CA) 

does steroid eluting proximal electrodes in left ventricular coronary sinus quadripolar leads 

improve chronic pacing thresholds. P1216 

A. Lin, E. Schotzko, L. Foerster, J. Schell, J. Sommer, C. Bounds, P. Yang (Chicago and Minneapolis, US) 

Can we assess the risk of pacing capture threshold changes for a standard pacing lead during 

magnetic resonance imaging? A role for computer modeling P1217 

C.P. Naehle, G. Engel, H.F. Tse, J.J. Hunt, B.J. Peterson (Bonn, DE; East Palo Alto and 

Mounds View, US; Hong Kong, HK) 

Clinical outcome of patients with device endocarditis and cardiac vegetations undergoing 

lead extraction 1218 (W) 


single operator experience on different active screw-in MR conditional permanent 

pacemaker leads P1219 

C.G. Wollmann, K. Thudt, P. Vock, H. Mayr (St. Polten, AT) 

stim report - program for the simple direct comparison of sequential pacemaker information P1220 

D.Y. Volkov, D. Lopin, S. Rashkovskiy (Kharkiv, UA) 

sleep apnea syndrome prevalence in unselected recently implanted pacemaker patients P1221 

J.L. Pepin, R. Tamisier, I. De La Cruz, N. Grau, J. Abad, V. Mercier, P. Defaye 

(Grenoble and Clamart, FR; Seville, Barcelona and Badalona, ES) 

A single-center experience in transvenous coronary sinus lead extraction and 

re-implantation. technical issues and alternative re-implantation approaches. P1222 

D. Tsiachris, P. Mazzone, D. Zagari, G. Paglino, S. Gulletta, G. Stavropoulos, A. Marzi, P. Vergara, 

J. Silberbauer, P. Della Bella (Milan, IT) 

Pacing from bachmanns bundle region can reduce unnecessary right ventricular pacing P1223 

M. Didenko, G. Pasenov, M. Rezvantsev, G. Khubulava (Saint-Petersburg, RU) 

162


the chronical effects of different right ventricular site pacing on left ventricular synchrony 

using phase analysis from Gated myocardial perfusion imaging P1224 

H.X. Zhang, J.G. Zou, X.F. Hou, Z. Chen, H.P. Wu (Nanjing, CN) 

Unnecessary lead's loops in tricuspid valve - can we observe it only? P1225 

A. Kutarski, B. Malecka, A. Zabek, K. Boczar (Lublin and Krakow, PL) 

the optimal sensing in arial tachyarrhythmia s study (OsAt) P1226 

W.G. De Voogt, S. Pakarinen, J. Ruiter, G.S. De Ruiter, E.P. Viergever, L.H.R. Bouwels 

(Amsterdam, Alkmaar, Gouda and Nijmegen, NL; Helsinki, FI) 

Transvenous pacemaker and implantable cardioverter defibrillator lead extraction in patients 

with infected cardiac vegetation of all sizes, including large. long term outcomes. P1227 

E.V. Dovellini, L. Giurlani, P. Corsi, G. Cerisano, P. Buonamici, N. Carrabba, R. Valenti, 

D. Antoniucci (Florence, IT) 

Clinical outcome of hemodialysis patient undergoing laser lead extraction 1228 (W) 


Atrial lead location plays an important role to avoid unnecessary ventricular pacing not only 

during atrial pacing but also during atrial sensing P1229 

C. Suga, T. Hirahara, Y. Sugawara, J. Nakajima, J. Ako, S. Momomura, T. Nakai, T. Yamada, 

K. Enta, K. Tanaka (Saitama, Tokyo, Osaka and Kasukabe, JP) 

Pacemaker infections revisited- a 40-years singel center experience P1230 

T.S. Tischer, W. Voss, I. Wendig, J. Ortak, J. Lauschke, R. Schneider, D. Baensch (Rostock, DE) 

PACINCHAGAS - study of mortality risk stratification in patients with Chagas' 

cardiomyopathy and permanent pacemaker P1231 

G.L. Peixoto, R.O. Madia, M.M. Saccab, M.M. Lensi, S.F. Siqueira, S.A.D. Nishioka, 

A.A.A. Pedrosa, R.A. Teixeira, R. Costa, M. Martinelli (Sao Paulo, BR) 

Rf lead heating of mri-conditional pacemaker systems P1232 

Y. Liu, D. Li, J. Chen (Houston, US) 

systematic echocardiography before permanent pacing - essential but rarely performed, 

a single centre audit P1233 

S. Badiani, S. Chandran, N. Liow, C. Sugihara, H. Patel, N. Sulke, S. Furniss, G. Lloyd, 

N. Patel (Eastbourne, GB) 

Comparison of different approaches of atrioventricular junction ablation and pacemaker 

implantation in patients with atrial fibrillation P1234 

N. Arenja, B. Schaer, C. Sticherling, S. Osswald, M. Kuehne (Basel, CH) 

the change of atrioventricular hemodynamic interactions affected by the difference of atrial 

pacing site and during atrial pacing and during atrial sensing P1235 

T. Hirahara, C. Suga, Y. Sugawara, J. Ako, S. Momomura (Saitama, JP) 

long term follow-up of Vdd pacemaker leads and Vdd pacing in pediatric population P1236 

S. Rosenheck, J. Banker, Z. Sharon, A. Weiss (Jerusalem, IL) 


Quantitative analysis of dyssynchrony assessed by multidetector computed tomography can 

predict clinical outcome after cardiac resynchronisation therapy P1237 

T. Onishi, Y. Koyama, K. Inoue, K. Iwakura, K. Tanaka, Y. Toyoshima, N. Tanaka, H. Nakanishi, 

Y. Sotomi, K. Fujii (Osaka, JP) 

Endothelial progenitor cells in patients scheduled for cardiac resynchronisation therapy: 

relationship with left ventricular remodeling. P1238 

A. Michelucci, F. Cesari, G. Ricciardi, P. Pieragnoli, A.M. Gori, E. Sticchi, F. Ristalli, G. Grifoni, 

L. Padeletti, R. Abbate (Florence, IT) 

163 

tuesday 

posters

tuesday 

posters 


Role of cystatin-c in patients scheduled for cardiac resynchronisation therapy P1239 

E. Sticchi, G. Ricciardi, P. Pieragnoli, F. Ristalli, I. Ricceri, C. Fatini, L. Padeletti, G.F. Gensini, 

R. Abbate, A. Michelucci (Florence, IT) 

left ventricular conduction delay and biventricular pacing delay in cardiac resynchronisation 

therapy responder and non-responder P1240 

M. Heinke, B. Ismer, H. Kuehnert, B. Gorissen, D. Mueller, G. Dannberg, H.R. Figulla 

(Offenburg and Jena, DE) 

stability of the left ventricular evoked response signal from pacing cathode in bipolar 

lV pacing leads P1241 

D. Mahajan, G. Kalahasty, C. Schulze, M. Giudici, M. Vloka, R. Shankar, K.A. Ellenbogen 

(St Paul, Richmond, Yardley, Iowa City and Wauwatosa, US) 

Short-term clinical benefit of CRT optimisation: Equivalence of methods P1242 

B. Degand, A. Capucci, G. Frohlig, H. Hartog, M. Martino, J. Silvestre (Poitiers, FR; Piacenza 

and Saluggia, IT; Homburg, DE; Utrecht, NL; Madrid, ES) 

devolving complex cardiac device service implantation from tertiary to secondary care 

significantly improves referral rates for ICD and CRT. P1243 

D.H. Brahmbhatt, R. Prasad, N.M. Hiari, A. Santasieri, D.P. Dutka, P.J. Pugh (Cambridge, GB) 

Long term survival benefit in 301 elderly patients receiving cardiac resynchronisation 

therapy: 8 year follow-up at a single center P1244 

F.A. Mcgrew, E.E. Johnson, M.A. Coppess, B. Hamilton, J. Foon, S. Charlton, J.J. Sims 

(Memphis and Moundsview, US) 

long-term clinical impact of acute effects of cardiac resynchronisation therapy assessed with 

gated myocardial perfusion sPECt P1245 

N. Kanamori, H. Furusho, S. Matsuo, T. Kusayama, A. Chikata, S. Kaneko, M. Yamagishi, 

M. Takamura (Kanazawa, JP) 

Optimizing cardiac resynchronisation therapy programming with echocardiography: 

Is there an added value? Randomized Controlled Clinical Trial POBREE P1246 

N. Cortez-Dias, D. Silva, S. Sobral, A. Bernardes, J. Silva-Marques, A. Magalhaes, S. Goncalves, 

C. Coelho, L. Carpinteiro, J. Sousa (Lisbon, PT) 

Association of leukocytosis and septic pulmonary embolism in patients with device infection 1247 (W) 


Active fixation leads in coronary veins for providing resynchronisation therapy. A case series. P1248 

V.H. Tan, D.V. Exner (Calgary, CA) 

A cardiac resynchronisation therapy method to augment ventricular contraction using 

polymer based actuators and mitral regurgitation reduction with devices over left ventricular 

endocardial pace-wire P1249 

M. Arokiaraj, L. Guerrero, R. Levine, I. Palacios (Pondicherry, IN; Boston, US) 

fluoroscopy is inaccurate for assessment of left ventricular lead position in cardiac 


A. Sommer, C. Gerdes, P.T. Mortensen, M.B. Kronborg, B.L. Noergaard, J.C. Nielsen (Aarhus, DK) 

impact of left ventricular lead position on the outcome of cardiac resynchronisation therapy P1251 

A. Hassan, S. Raffa, M. Brunnelli, J.C.H. Geller (Alexandria, EG; Bad Berka, DE) 

impact of right ventricular function on the outcome of cardiac resynchronisation therapy P1252 

A. Hassan, A. Farah, S. Raffa, M. Brunnelli, J.C.H. Geller (Alexandria, EG; Bad Berka, DE) 

Variation in cardiac vein system associates with the coronary artery calcium - a venous - 

atherosclerosis paradox? P1253 

R. Mlynarski, A. Mlynarska, J. Wilczek, M. Sosnowski (Katowice, PL) 

164


Evolution of a novel approach to CRt: left ventricular endocardial pacing through the 

interventricular septum P1254 

T.R. Betts, J. Gamble, K. Wong, K. Rajappan, Y. Bashir (Oxford, GB) 

Reliability and reproducibility of QRs duration measurement by one-lead ECG as a part of 

standard thransthoracic echocardiography P1255 

O. Suchanek, T. Prothero, J. Newton, T. Betts (Oxford, GB) 

novel armrest for radiation protection during device implantation P1256 

A.E. Tuinenburg, M. Meine, F.H. Wittkampf, N. Jongejan, M.S. Koster, P.A. Doevendans (Utrecht, NL) 

Hemodynamic response to biventricular pacing is influenced by the effect of right ventricular 

pacing: an acute pressure-volume loop study P1257 

L. Wu, G.J. De Roest, C.C. De Cock, M.L. Hendriks, A.C. Van Rossum, C.P. Allaart 

(Amsterdam, NL) 

interventricular conduction time in predicting response to cardiac resynchronisation therapy P1258 

A.D.onofrio, G.Q. Villani, G. Botto, M. Mantica, M. Rillo, E. Occhetta, R. Verlato, G. Molon, 

C. Ciardiello, C.D. Dicandia (Naples, Piacenza, Como, Milan, Taranto, Novara, Camposampiero, 

Negrar-Verona and Lecce, IT) 

the impact of supraventricular tachyarrhythmia on the long-term clinical outcome in 

patients undergoing cardiac resynchronisation therapy: insight from the CUbiC registry P1259 

M. Yahata, T. Doi, S. Shizuta, T. Kimura, M. Hayano, K. Inoue, S. Fujii, K. Ando, M. Nobuyoshi, 

T. Isshiki (Kyoto, Maebashi, Osaka, Kurashiki, Kokura and Tokyo, JP) 

Multisite left ventricular pacing gives greater benefit in patients with lower response to 

biventricular pacing P1260 

C.A. Rinaldi, W. Kranig, C. Leclercq, S. Kacet, T. Betts, P. Bordachar, K.J. Gutleben, A.J. Keel, 

K. Ryu, T. Naqvi (London and Oxford, GB; Bad Rothenfelde and Bad Oeynhausen, DE; 

Rennes, Lille and Bordeaux, FR; Sylmar and Los Angeles, US) 


Serum potassium in acute myocardial infarction: controversial or case closed? P1261 

L.V. Paiva, S. Barra, P. Dinis, R. Providencia, J. Nascimento, A. Leitao-Marques (Coimbra, PT) 

The prognostic significance of the N-terminal of brain natriuretic peptide and troponin I in 

the diagnosis of palpitations in the emergency department P1262 

A. Erdem, T. Ocak, A. Duran, U.Y. Tekelioglu, S. Ozturk, S.S. Ayhan, M.F. Ozlu, H. Kocoglu, 

M. Yazici (Bolu, TR) 

decreasing in number of ventricular extrasystoles obtained from telemonitoring predicts 

heart failure progression in patients with cardioverter-defibrillator with resynchronisation 

therapy. P1263 

B. Urbanek, M. Chudzik, J.K. Wranicz (Lodz, PL) 

cost saving and safety of iCd remote monitoring in the "real world": a single centre experience P1264 

F. Caravati, V. Cremona, F. Zuffada, C. Minoia, R. De Ponti, J.A. Salerno-Uriarte (Varese and 

Gallarate, IT) 

do we encounter echocardiographic abnormalities among patients presenting with idiopathic 

complex right ventricular ectopy compared to those observed in ARVC/D? P1265 

S. Archontakis, K.A. Gatzoulis, I. Vlasseros, P. Arsenos, D. Tsiachris, A. Vouliotis, S. Sideris, 

G. Karistinos, I. Kalikazaros, C. Stefanadis (Athens, GR) 

165 

tuesday 

posters

tuesday 

posters 



Predictors of cardiac and undetermined syncope - 5 years experience of a syncope unit P1266 

P. Sousa, N. Marques, J. Chin, J. Amado, R. Candeias, I. Jesus (Faro, PT) 

natural history of a cardio-inhibitory response to non-pharmacological tilt-testing in 

subjects with neuromediated syncope. long-term (10 years) single-center experience P1267 

L. Romero-Ayala, R. Frank, G. Varas, J. Tonet, F. Hidden-Lucet, A. De Sisti, M.F. Marquez Murillo 

(Paris, FR; Mexico City, MX) 

Yhe role of reduced arterial baroreflex sensitivity in predicting reflex syncope during 

head-up tilt testing P1268 

S. Laranjo, C. Tavares, J. Gomes, E. Oliveira, S. Silva, M.M. Oliveira, R.C. Ferreira, I. Rocha 

(Lisbon, PT) 

Does atypical syncope matter in relation to age? P1269 

N.R. Petix, A. Del Rosso, V. Guarnaccia, A. Zipoli (Empoli, IT) 

dynamic ECG and signal-averaged ECG changes in patients with arrhythmogenic right 


M.H. Bae, Y. Cho, W.S. Choi, S.Y. Jang, J.H. Kim, J.H. Lee (Daegu and Gumi, KR) 

Copeptin and vasovagal syncope P1271 

P. Flevari, D. Leftheriotis, G. Giannakakis, M. Dafni, S. Lagou, T. Giakoumakis, K. Dima, 

M. Anastasiou-Nana (Athens, GR) 

Basic science in arrhythmias 

Human left atrial mechanoelectric feedback P1272 

R. Pap, G. Agoston, G. Bencsik, A. Makai, A. Varga, T. Forster, L. Saghy (Szeged, HU) 

functional and topographic concordance of right atrial neural structures inducing sinus 

tachycardia P1273 

C. Eickholt, K. Mischke, D. Pauza, N. Marx, D.-I. Shin, M. Kelm, C. Meyer (Duesseldorf 

and Aachen, DE; Kaunas, LT) 

Adenosine sensitivity of retrograde fast pathway conduction in patients with slow-fast 

atrioventricular nodal reentrant tachycardia: a prospective study P1274 

E. Efimova, S. Riahi, Y. Huo, A. Bollmann, M. Esato, T. Gaspar, P. Sommer, C. Piorkowski, 

G. Hindricks, A. Arya (Leipzig, DE; Aalborg, DK; Yamaguchi, JP) 

the features of electrophysiological disorders in HCM patients with different clinical variants 

of the course. P1275 

Y.N. Belenkov, E.V. Privalova, V.Y. Kaplunova, N.V. Khabarova, G.A. Shakaryants, V.O. Stebakova 

(Moscow, RU) 

the role of endocardial biopsy in Vt treatment. P1276 

R.B. Tatarskiy, D.S. Lebedev, V.V. Grohotova (Saint-Petersburg, RU) 

Effect of hydro alcoholic extract of linseeds and lettuce seed on biochemical factors of 

cardiovascular diseases and atherosclerosis in rabbits. P1277 

H. Jowhari, H.Kargar, A.Karimnia, A.Manteghi, M.Yazdani (Darab, Jahrom, Fasa and Firoozabad, IR) 

isotropic computational reconstruction of the human foetal electrocardiogram. P1278 

E. Pervolaraki, R.A. Anderson, M.N. Paley, A.V. Holden (Leeds, Edinburgh and Sheffield, GB) 

166



sudden cardiac death correlated to Wolff-Parkinson-White syndrome in association with 

hypertrophic cardiomyopathy P1279 

L. De Paula Van Der Steld, M.S. Rocha (Salvador, BR) 

Prevalence of early repolarisation in congenital long Qt syndrome. A combination of early 

and delayed repolarisation P1280 

P. Maury, M. Audoubert, A. Rollin, C. Cardin, A. Duparc, P. Mondoly, M. Sadron, M. Delay 

(Toulouse, FR) 

new electrocardiographic criteria for the diagnosis of Andersen-tawil P1281 

P. Kukla, E.K. Biernacka, A. Baranchuk, M. Saj, R. Ploski, D. Di Toro, M. Jagodzinska, 

M. Jastrzebski (Gorlice, Warsaw and Cracow, PL; Ontario, CA; Buenos Aires, AR) 

Usefulness of external loop recorder with auto-trigger function for patients with 

symptomatic paroxysmal atrial fibrillation P1282 

K. Tanno, M. Kikuchi, H. Ito, N. Watanabe, Y. Minoura, T. Adachi, T. Asano, Y. Kobayashi (Tokyo, JP) 

Markers for risk to develop atrial fibrillation based on a new electrocardiographic tool P1283 

A. Viso, M. Acena, R. Leber, A. Cabasson, L. Kappenberger, A. Auricchio, J.M. Vesin 

(Lausanne, Lugano and Baar, CH; Nice, FR) 

Usefulness of tpeak-tend interval to distinguish arrhythmogenic right ventricular 

cardiomyopathy from idiopathic right ventricular outflow tachycardia P1284 

K. Yalin, E. Golcuk, E.B. Karaayvaz, A. Elitok, A.K. Bilge, K. Adalet (Istanbul, TR) 

Clinically important prehospital electrocardiography findings of a public health system in a 

developing country 1285 (W) 

E.R.F.L. Moraes, A.A. De Paola, A.A.E. Rodrigues, C. Cirenza, L.P.R. Barros, E.M. Barros Junior, 

A.C. Carvalho (Sao Paulo, BR) 

RR interval changes during obstructive sleep apnea episodes in hypertrophic cardiomyopathy P1286 

T. Konecny, N. Covassin, J.Y. Park, S.H. Hai, K. Zidova, S.R. Ommen, S.J. Asirvatham, 

D.L. Packer, A.P. Brady, V.K. Somers (Rochester, US; Brno, CZ) 

A new formula for the evaluation of the Qt interval in patients with left bundle branch block P1287 

H. Bogossian, I. Ninios, F. Hasan, D. Mijic, Z. Karosiene, A. Kloppe, B. Lemke, M. Zarse 

(Luedenscheid, Bochum and Witten, DE) 

Clinical and electrocardiographical features of left sided arrhythmogenic ventricular 

cardiomyopathy P1288 

J. Jimenez Jaimez, T. Barrio, T. Gil Jimenez, E. Lopez Moreno, M. Alvarez, R. Macias, L. Tercedor 

(Granada and Marbella. Málaga, ES) 

Acute improvement of P wave dispersion after transcatheter aortic valve implantation P1289 

M. Turfan, M.A. Vatankulu, O. Sonmez, E. Sevgili, A. Tasal, M. Ergelen, O. Goktekin (Istanbul, TR) 

Changes in ventricular repolarisation after 5-days of head-down bed-rest immobilization P1290 

A. Pellegrini, J. Bolea, P. Laguna, P. Vaida, E.G. Caiani (Milan, IT; Zaragoza, ES; Bordeaux, FR) 

Electrocardiographic features in hypertrophic cardiomyopathy: a correlation study based on 

cardiac magnetic resonance findings P1291 

A. Lebreiro, M. Vasconcelos, E. Martins, A. Sousa, T. Pinho, A. Madureira, M. Campelo, 

S. Amorim, J. Silva-Cardoso, M.J. Maciel (Porto, PT) 

Effect of exercise on t-wave alternans predictive power for the occurrence of ventricular 

arrhythmias P1292 

L. Burattini, S. Man, C.A. Sweene (Ancona, IT; Leiden, NL) 

167 

tuesday 

posters

tuesday 

posters 


ECG-based screening of young athletes of a first division Belgian soccer team. P1293 

B. Berte, J. Elices, L. Timmers, F. Van Heuverswyn, A. Neyrinck, R. Stroobandt, J. De Neve, 

Y. Vandekerckhove, R. Tavernier, M. Duytschaever (Bruges and Ghent, BE) 

differences in retrograde P wave morphology during tachycardia between slow-slow form of 

AVnRt and AVRt through posteroseptal accessory pathway P1294 

Y. Nakatani, K. Kumagai, K. Mizumaki, K. Nishida, T. Sakamoto, Y. Yamaguchi, N. Kataoka, 

S. Naito, H. Inoue (Maebashi and Toyama, JP) 

in healthy humans low frequency variability of Qt interval witnesses sympathetic drive to 

ventricles over and above RR waving P1295 

R.M. Negoescu, S. Dinca Panaitescu, D.D. Ionescu (Bucharest and Craiova, RO; Toronto, CA) 

Application of QRs scoring system for appropriate therapy risk assessment in patients with 

implantable cardioverter defibrillator and coronary artery disease P1296 

G. Gromyko, A. Kazakov, S. Chetverikov, M. Didenko, G. Pasenov, S. Yashin (Saint Petersburg 

and Khanty-Mansiysk, RU) 

Mad honey: so sweet pass out... P1297 

U.O. Turk, E. Tuncer, E. Alioglu (Izmir, TR) 

depressed low frequency power of heart rate variability is associated with increased pulse 

pressure and decreased diastolic blood pressure in heamodialysis patients P1298 

D. Poulikakos, D.B. Banerjee, M.M. Malik (London, GB) 

Workflow and economic benefits of seamless implantable device interrogation report 

transfer with the electronic health record systems P1299 

D. Goldman, C.M. Movsowitz, D.B.S. Selsky, L.D. Diederich (Boca Raton, Philadelphia, 

Austin and Fort Collins, US) 

time delay from atrial electrical depolarization to mechanical contraction as a marker for 


D.H. Lee, J.S. Park, J.M. Seo, J.H. Choi, K.I. Park, T.H. Park, M.H. Kim, Y.D. Kim, S.Y. Choi 

(Busan, KR) 

Age-related differences of patients with supraventricular tachycardia P1301 

B. Brembilla-Perrot, J.M. Sellal, J. Schwartz, A. Olivier, E. Aliot, C. De Chillou, D. Beurrier, 

P.Y. Zinzius (Vandoeuvre-Les-Nancy, FR) 

168

WEDNESDAY SESSIONS 

Late Breaking Trials 

Due to the exceptionally high quality level of abstracts submitted for the 

Late Breaking Trials session we felt obliged to add a second session to 

give more time to present the latest information on trials, registries and 

other relevant information in the field of Arrhythmias. These sessions will 

include discussants to add an objective view to each abstract. 

On Tuesday in Room Crete 

and Wednesday in Room Lefkada 

169 

wednesday 

sessions

WEdnEsdAy 26 JUnE 2013 - MORNING 


How can cardiac imaging help in ablating atrial fibrillation? 

Chairpersons: f. Halimi (le Chesnay, fR); P. Geelen (Aalst, bE) 


Overview of how modern imaging modalities can help in selecting patients for atrial fibrillation ablation 

and help in performing the ablation. 

08:30 Rotational LA angiography and 3-D image-integrated enhanced fluoroscopy for 

ablation of atrial fibrillation. 1302 

T.J.R. De Potter (Aalst, BE) 

08:52 Role of MRI for LA substrate analysis in atrial fibrillation. 1303 

N. Marrouche (Salt Lake City, US) 

09:15 Role of intracardiac echo in ablating atrial fibrillation. 1304 

L. Di Biase (Austin, US) 

09:37 Use of a novel anatomical mapping tool of atrial fibrillation. 1305 



Thoracoscopic ablation of longstanding persistent AF – bail out in failed 

catheter ablation or as primary procedure? 

Chairpersons: C. blomstrom-lundqvist (Uppsala, sE); l. Pison (Maastricht, nl) 

translational 

08:30 Recent insights in atrial fibrillation mechanisms - implications for ablation techniques. 1306 


08:52 Overview and result of transvenous ablation techniques for long standing persistent 

atrial fibrillation. 1307 


09:15 Overview and result of thoracoscopic epicardial ablation techniques for long 

standing persistent atrial fibrillation. 1308 

M. La Meir (Maastricht, NL) 

09:37 The staged hybrid procedure - when and why? 1309 

A. Curnis (Brescia, IT) 

171 

wednesday 

sessions

WEdnEsdAy 

sEssiOns 

wednesday 26 June 2013 - morning 


Risk stratification of primary electrical diseases in the ICD era: changing horizons 

Connecting Continents 

Chairpersons: W. shimizu (Osaka, JP); P.G.A. Volders (Maastricht, nl) 


08:30 brugada syndrome and early-repolarisation syndrome. 1310 

T. Aiba (Suita, JP) 

08:48 inherited preexcitation. 1311 

E. Sternick (Nova Lima, BR) 

09:06 long-Qt syndrome. 1312 

M. Shkolnikova (Moscow, RU) 

09:24 Catecholaminergic polymorphic Vt and short-Qt syndrome. 1313 


09:42 Concluding remarks. 1314 


08:30 - 10:00 Oral Abstract session Mykonos 


Chairpersons: R. Mantovan (Mestre, it); R. bosch (ludwigsburg, dE) 



08:30 Ablation of atrial fibrillation benefits the outcomes of stroke and all-cause mortality 

as compared with antiarrhythmic drug therapy: a meta-analysis 1315 

Y.Y. Chen, Y.-J. Lin, K.-L. Chien, S.-A. Chen (Taipei, TW) 

08:38 Very low incidence of permanent complications in atrial fibrillation catheter ablation 1316 

E. Bertaglia, G. Stabile, A. Pappone, S. Themistoclakis, C. Tondo, V. De Sanctis, 

M. Tritto, F. Solimene, M. Grimaldi, C. Pappone (Padua, Naples, Cotignola, 

Mestre-Venice, Milan, Castellanza, Mercogliano and Acquaviva Delle Fonti, IT) 

08:46 Long-term efficacy and safety of two different rhythm control strategies in elderly 

patients with symptomatic persistent atrial fibrillation 1317 

A. Blandino, E. Toso, M. Scaglione, M. Anselmino, F. Ferraris, D. Sardi, A. Battaglia, 

F. Gaita (Turin and Asti, IT) 

172


08:30 - 10:00 Oral Abstract session Mykonos 


Chairpersons: R. Mantovan (Mestre, it); R. bosch (ludwigsburg, dE) 



08:54 Patients with atrial fibrillation and left ventricular hypertrophy have significantly 

increased mortality when treated with rhythm control strategy: a post-hoc analysis 

from AffiRM trial 1318 

P. Grover, N. Shah, N. Patel, A. Chothani, K. Mehta, A. Deshmukh, A.O. Badheka, 

H. Paydak, J. Coffey, J. Viles-Gonzalez (Miami, Staten Island, Washington, Philadelphia 

and Little Rock, US) 

09:02 endogenous t-PA is an independent predictor of adverse cardiovascular events and 

all cause death in patients with atrial fibrillation 1319 

M.K. Freynhofer, D.F. Draxler, S.C. Gruber, V. Bruno, T. Hoechtl, B. Fellner, J. Wojta, 

I. Pabinger-Fasching, K. Huber, C. Ay (Vienna, AT) 

09:10 thromboembolic complications, mortality and arrhythmia recurrence 6 to 10 years 

after catheter ablation of atrial fibrillation. 1320 

E. Tessitore, N. Tran, P. Gentil-Baron, A.S. Jannot-Berthier, C.I. Park, H. Burri, 

H. Sunthorn, F. Mach, D. Shah (Geneva, CH; New York, US) 

09:19 left atrial volume and symmetry changes as predictors of long-term success after 

catheter ablation of atrial fibrillation. 1321 

S. Nedios, E. Koutalas, S. Pastromas, J. Kosiuk, P. Sommer, A. Arya, S. Rolf, D. Husser, 

G. Hindricks, A. Bollmann (Leipzig, DE) 

09:27 Digoxin does not influence outcome in patients with permanent atrial fibrillation: 

data of the RACE ii study 1322 

B.A. Mulder, D.J. Van Veldhuisen, H.J.G.M. Crijns, M. Rienstra, J.L. Hillege, J.G.P. Tijssen, 

M.P. Van Den Berg, M.A. Alings, I.C. Van Gelder (Groningen, Amsterdam and Breda, NL) 

09:35 High incidence of ischaemic strokes and left atrial thrombi after left atrial appendage 

isolation for treatment of atrial tachyarrhythmias 1323 

A. Rillig, R.R. Tilz, A. Arya, A. Metzner, S. Mathew, E. Wissner, H. Makimoto, 

P. Wohlmuth, K.H. Kuck, F. Ouyang (Hamburg, DE) 

09:43 total epicardial adipose tissue volume is associated with outcome of pulmonary vein 

isolation for atrial fibrillation. 1324 

H. Kawakami, K. Satomi, I. Nakajima, K. Miyamoto, Y. Yamada, H. Okamura, T. Noda, 

T. Aiba, S. Kamakura, W. Shimizu (Suita, JP) 

09:51 Dabigatran versus warfarin in patients undergoing percutaneous atrial fibrillation 

ablation: a meta-analysis of 3.010 patients. 1325 

R.A. Providencia, S. Combes, A. Bouzeman, B. Casteigt, S. Fazaa, H. Hireche, L. Riahi, 

S. Boveda, N. Combes, J.P. Albenque (Toulouse, FR) 

173 

wednesday 

sessions

WEdnEsdAy 

sEssiOns 


08:30 - 10:00 Meet the Experts santorini 

From deciphering molecular pathogenesis to developing targeted new therapies 

Chairpersons: M. Anastasiou-nana (Athens, GR); s.C. dudley (Providence, Us) 

translational 

08:30 Genetics and molecular mechanisms of pathogenesis in cardiomyopathies and 

arrhythmias. 1326 

D. Sanoudou (Athens, GR) 

08:48 Ubiquitination and sUMOylation of ion channels. 1327 

H. Abriel (Bern, CH) 

09:06 imaging approaches in deciphering arrhythmogenesis. 1328 

M. Mongillo (Padova, IT) 

09:24 Identification and validation of novel therapeutic targets in arrhythmias. 1329 

S.E. Lehnart (Gottingen, DE) 

09:42 stem cells from bench side to fdA approval. 1330 

I. Terrovitis (Athens, GR) 

08:30 - 10:00 Main session Hydra 

Pathophysiological insights provided by EUTRAF: Progressive electrical 

uncoupling as determinant of AF chronification 

Chairpersons: A.J. Camm (london, Gb); s. Hatem (Paris, fR) 

basic science 

This session focuses on translational aspects of electrical uncoupling between muscle bundles providing 

the basis for conduction block and enhanced dissociation of electrical dissociation in the atria. Myocytefibroblast 

interactions have attracted a lot of attention in recent years as did the heterogeneity of the 

electrophysiological properties of atrial myocytes. This symposium will not only discuss the molecular 

mechanisms of altered fibroblast behavior and fibroblast-myocyte interactions but will also aim at 

translation of these findings to the organ-level and patients using non-invasive imaging techniques. 

08:30 Profibrotic and prohypertrophic signalling in atrial fibrillation 1331 


08:52 ROS signalling in atrial fibrillation 1332 

S.N. Reilly (Oxford, GB) 

09:15 Channel trafficking and cell-cell coupling in atrial fibrillation. 1333 

S. Hatem (Paris, FR) 

09:37 Towards a classification of atrial fibrillation based on the electrophysiological phenotype. 1334 


174



Late Breaking Trials session II 

Chairpersons: K.-H. Kuck (Hamburg, dE); A. Auricchio (lugano, CH) 

11:00 CitAdEl/CEntURiOn study interim analysis: use of an antibacterial envelope is 

associated with very low 90-day CiEd infection rates 1335 

C. Henrikson (Porland, US) 

11:13 discussant: CitAdEl/CEntURiOn 1336 


11:18 Optimal antitachycardia therapy in iCd patients without pacing indications 1337 

C. Kolb (Munchen, DE) 

11:31 discussant: Optimal antitachycardia therapy. 1338 

M.J. Schalij (Voorschoten, NL) 

11:36 Trends in management of patients with atrial fibrillation in 5 European countries. 1339 


11:49 discussant: PREfER in Af. 1340 

J. Camm (London, GB) 

11:54 Validation of the clinical diagnosis of neurally-mediated syncope. 1341 

M. Brignole (Lavagna, IT) 

12:07 discussant: issUE-3 1342 


12:12 Radio-frequency ablation for sustained monomorphic ventricular tachycardia in 

patients with structural heart disease without implantation of a defibrillator. 1343 

P. Maury (Toulouse, FR) 

12:25 discussant: RfAVt. 1344 



Ablation of complex fractionated atrial electrogrammes 

Chairpersons: E.P. Gerstenfeld (san francisco, Us); P. sanders (Adelaide, AU) 

translational 

The objective of the session is to present electrophysiology mechanisms of triggers and substrat of 

atrial fibrillation 

11:00 Origin of signal fractionation and complex atrial electrogrammes: a marker of 

arrhythmogenic substrate or something else? 1345 

L. Saghy (Szeged, HU) 

11:22 Manual vs. automatic algorhythms to properly record fractionated atrial electrogrammes. 1346 

S.-A. Chen (Taipei, TW) 

11:45 The role of CFAE ablation in paroxysmal and persisten atrial fibrillation. 1347 

A. Verma (Newmarket, CA) 

12:07 is rotor mapping correlated with fractionated electrogrammes? 1348 

S. Narayan (San Diego, US) 

175 

wednesday 

sessions

WEdnEsdAy 

sEssiOns 



Arrhythmias and valvular heart disease 

Connecting Continents - GHRs / EHRA 

Joint session GHRs / EHRA 

Chairpersons: f. bokhari (Jeddah, sA); R. sutton (Monte Carlo, MC) 

transforming 

11:00 MitraClip and cardiac arrhythmias. 1349 


11:22 tAVi and cardiac arrhythmias. 1350 

S.A. Alkaabi (Abu Dhabi, AE) 

11:45 Catheter ablation of Vt in valvular heart disease. 1351 

A. Arya (Leipzig, DE) 

12:07 iCd implantation in patients with valvular heart disease. 1352 

A. Alsheikh-Ali (Dubai, AE) 


How to optimise CRT-D programming 

Chairpersons: b. Wilkoff (Cleveland, Us); J. brugada terradellas (barcelona, Es) 


This session focuses on how to optimize programming of contemporary ICDs 

11:00 What can we learn from echocardiography and imaging modalities? 1353 

W. Jung (Villingen-Schwenningen, DE) 

11:22 Optimal programming in patients with atrial fibrillation. 1354 

F.R. Heinzel (Graz, AT) 

11:45 individualising programming: tricks and tips and pitfalls. 1355 

L. Jordaens (Rotterdam, NL) 

12:07 Early detection of lead problems-role of remote monitoring and patient alerts. 1356 

J.O. Schwab (Bonn, DE) 

176



Oral Abstract Session: prolonged rhythm monitoring for detection of 

atrial fibrillation 

Chairpersons: R. Hatala (bratislava, sK); to be announced 

11:00 Atrial fibrillation burden estimates derived from intermittent rhythm monitoring are 

unreliable estimators of the true atrial fibrillation burden 1357 

E. Charitos, P.D. Ziegler, U. Stierle, H.H. Sievers, T. Hanke (Luebeck, DE; Minneapolis, US) 

11:15 diagnostic yield of extended-time external loop recording for the detection of 

paroxysmal atrial fibrillation in patients with cryptogenic stroke 1358 

S. Deelawar, J.C. Manegold, M. Kalyani, W.N. Tschishow, D. Ridjab, J. Buddecke, 

B. Lamp, C.W. Israel (Bielefeld, DE) 

11:30 Atrial fibrillation remote management and stroke incidence in patients with cardiac 

implantable electronic devices. Results from the homeguide registry. 1359 

D. Vaccari, L. Morichelli, B. Villari, G. Zingarini, A. Di Girolamo, G. Piraino, E. Pisano', 

F. Chiusso, A. Gargaro, R.P. Ricci (Montebelluna, Rome, Benevento, Perugia, Trapani, 

Palermo, Lecce and Milan, IT) 

11:45 CHADS2 and CHA2DS2-VASc scores to predict new-onset atrial fibrillation in 

heart failure patients candidates to cardiac resynchronisation therapy (CRt) 1360 

A. Paoletti Perini, S. Bartolini, P. Pieragnoli, G. Ricciardi, G. Vergaro, F. Michelotti, 

B. Sassone, G. Mascioli, M. Emdin, L. Padeletti (Florence, Pisa, Bergamo and Bologna, IT) 

12:00 AbEl risk score: a predictor of cryptogenic ischaemic stroke and transient 

ischaemic attack recurrence 1361 

C. Galvao Braga, J. Pinho, S. Rocha, A.F. Santos, A. Cabreiro, A. Gomes, S. Magalhaes, 

C. Ferreira, A. Correia (Braga and Porto, PT) 

12:15 Incidence and prognosis of paroxysmal atrial fibrillation occurring during head-up tilt test 1362 

S.J. Park, S.H. Lee, K.M. Byeon, Y.K. On, J. Huh, J.S. Kim (Seoul, KR) 

177 

wednesday 

sessions

WEdnEsdAy 

sEssiOns 


12:45 - 13:45 special Event Crete 

Awards and Closing Ceremony 

Chairpersons: A. Auricchio (lugano, CH); A. Goette (Paderborn, dE) 

12:45 summary EUROPACE 2013. 1363 

J.M. Morgan (Stockbridge, GB) 

12:50 Pioneer in clinical Electrophysiology Lecture: "The spectrum of atrial fibrillation." 1364 

L. Kappenberger (Lausanne, CH) 

13:15 Best clinical abstract: "Does atrial pacing lead to atrial fibrillation in patients with 

sick sinus syndrome? Insights from the DANPACE trial." 1365 

S. Hjortshoj, S. Riahi, J.C. Nielsen, F. Skjoeth, S. Lundbye-Christensen, H.R. Andersen 

(Aalborg and Aarhus, DK) 

13:25 Best basic science abstract: "Superresolution analysis identifies proliferative changes 

of excitable membranes (t-tubules) during cardiac remodeling leading to orphaning 

of Ca2+ release sites and prolonged action potentials." 1366 


13:35 Announcement: training fellowships winners. 


13:35 Announcement: academic Research fellowship winner. 


13:35 “iCd-for-life“ selected countries. 1367 


13:40 farewell address EHRA president. 1368 


178

See you at Esc congrEss 2013 

www.escardio.org/ESC2013 

179 

For more information 

Visit the ESC-EHRA stand H3-B250 

The largest gathering of cardiovascular professionals in the world 

5 days of scientific sessions • 145 CV topics • 400+ ESC sessions • 27 000+ healthcare professionals from 150+ countries 

• 10 000 abstracts submitted • 130 industry sponsored sessions • 200 exhibiting companies • + unique & unlimited opportunities to network! 

ESC CongRESS 2013 

european Society of Cardiology 

22 000+ fans 

#eSCcongress2013 

12 500+ followers 

Bring your Arrhythmias & Pacing 

congress experience full circle 

participating in ESC Congress 2013 

In Village 1, you will find: 

Latest update on indications for ablation, 

post-procedure management, genetics in 

the management of arrhythmias 

New insights on electrical devices and 

cardiac sudden death 

Practical sessions on sport and arrhythmias, 

management of syncope and patient 

management programmes, etc 

Presentation of the new 2013 ESC Clinical 

Practice Guidelines 

AdVAnCE PRogRAmmE 

AVAilABlE onlinE 

www.escardio.org/ESC2013programme 

Register before 31 July at 

www.escardio.org/ESC2013 

escardiodotorg 

EUROPEAN 

SOCIETY OF 

CARDIOLOGY ® 

wednesday 

posters

WEdnEsdAy 26 JUnE 2013 - POSTERS MORNING 



Chairpersons: A. Curnis (brescia, it); C. tondo (Milan, it) 







A 10-year prospective study of estimated glomerular filtration rate and outcomes in 

patients with atrial fibrillation: The Loire Valley Atrial Fibrillation Project P1369 

A. Banerjee, J.M. Halimi, P. Vourc'h, C.R. Andres, S. Taillandier, G.Y.H. Lip, L. Fauchier 

(Birmingham, GB; Tours, FR) 

long-term (>10 years) clinical results and electroanatomic correlations of persistent 

atrial fibrillation ablation with a hybrid approach in patients with valvular heart disease P1370 

E. Ebrille, M. Scaglione, D. Caponi, L. Garberoglio, L. Vivada, A. Barbone, R. Gallotti, 

F. Gaita (Turin, Asti and Rozzano, IT) 

Similar heart rates between atrial fibrillation and sinus rhythm in asymptomatic 

populations justify large scale screening to improve the detection of atrial fibrillation P1371 

G.H. Mairesse, C. Scavee, N. Claes, P. Goethals, J. Vijgen, I. Blankoff, M. Goethals, 

Y. Vandekerkhove (Arlon, Brussels, Hasselt, Charleroi, Overpelt and Bruges, BE) 

Utilization trends for left atrial appendage closure in the United states from 2005-2010 P1372 

A. Chothani, P. Grover, N. Shah, N. Patel, A. Deshmukh, K. Mehta, A.O. Badheka, 

H. Paydak, J. Coffey, J. Viles-Gonzalez (Washington, Miami, Staten Island, Little Rock 

and Philadelphia, US) 

Myocardial septal substrate for reentrant ventricular tachycardia in patients with 

advanced infranodal conduction disease and/or complete heart block. P1373 

M. Nageh-Armanios, K. Poon, J. Turner, P. Hebbar, S. Ji, J. Wu (Los Angeles, US) 

Cryoablation of AVnRt in children and adolescents: the earlier is the procedure the 

better are the results P1374 

D. Righi, M.S. Russo, C. Di Mambro, M.S. Silvetti, R. Palmieri, L.M. Santucci, S. Placidi, 

M. Prosperi, F. Drago (Rome, IT) 

Extrapolation of heart failure and atrial fibrillation risk reduction with SafeR: 

AnsWER trial results P1375 

P. Defaye, S. Boveda, J. Gutierrez, J. Brachmann, F. Garcia, J. Moreno, P. Siot, 

M. Stockburger (Grenoble, Toulouse and Clamart, FR; Ferrol, Santiago de Compostela 

and Madrid, ES; Coburg and Berlin, DE) 

High right ventricular pacing burden increases the incidence of new-onset atrial 


B. Faulknier, M. Richards, X. Min, J. Snell, R.K. Thakur (Charleston, Toledo, Sylmar and 

Lansing, US) 

181 

wednesday 

posters

wednesday 

posters 


Detection of atrial fibrillation in pacemaker clinic and improvement of 

antithrombotic treatment. P1377 

M.C. Salazar Ramirez, F. Cota Delgado, M.C. Carballo Ruiz, L. Ruiz Del Fresno, 

A. Garcia Alcantara, M.V. De La Torre Prados (Malaga, ES) 

Impact of Bachmann's bundle on rapid pacing of atrial fibrillation from the septum area P1378 

N. Virag, A. Rusu, J.-M. Vesin, L. Kappenberger (Tolochenaz and Lausanne, CH) 

182





between 08:30 - 12:30. 




Effective control of atrial fibrillation with low dose amiodarone P1379 

F.A. Mcgrew, J. Foon, S. Charlton, T.A. Charlton, J.J. Sims (Memphis and Moundsview, US) 

Atrial fibrillatory rate response to different antiarrhythmic drugs in persistent human atrial 


S. John, M. Stridh, L. Soernmo, J. Salmas, J. Kornej, D. Husser, A. Bollmann (Leipzig, DE; Lund, SE) 

High prevalence of undiagnosed sick sinus syndrome in patients undergoing atrial fibrillation 

ablation: role of implantable loop recorder. P1381 

E. Pelissero, S. Manganiello, C. Amellone, G. Trapani, M. Giuggia, B. Giordano, M. Anselmino, 

G. Senatore (Ciriè (Turin) and Turin, IT) 

initial experience using percutaneous left atrial appendage occluders. Clinical indications and 

short term follow-up. P1382 

P. Mazzone, D. Tsiachris, F. Guarracini, A. Marzi, S. Sala, G. Paglino, S. Stavropoulos, N. Sora, 


Differences in rotor distribution for paroxysmal and persistent atrial fibrillation P1383 

D.E. Krummen, A.A. Schricker, G.G. Lalani, T. Baykaner, W.-J. Rappel, S.M. Narayan 

(San Diego, US) 

Correlation between contact force and pulmonary veins reconnection after atrial fibrillation 

ablation P1384 

P. Carmo, P. Adragao, F. Morgado, D. Cavaco, G. Santos, F. Costa, R. Quaresma, M. Mendes 

(Carnaxide, PT) 

Atrial defibrillation threshold of internal cardioversion, which is measured before performing 

catheter ablation for atrial fibrillation, can be a predictor of recurrence of atrial fibrillation. P1385 

K. Sawasaki, T. Satoh, H. Fukushima, M. Harada, M. Kobayashi, M. Mutoh (Hamamatsu, JP) 

Predictors of acute pulmonary vein reconnection and dormant conduction during pulmonary 

vein isolation for treatment of atrial fibrillation P1386 

E. Lyan, A. Klukvin, G. Gromyko, A. Kazakov, A. Morozov, F. Tursunova, A. Merkureva, 

P. Krasnoperov, S. Yashin (Saint Petersburg, RU) 

Red wine antioxidant resveratrol reduces af susceptibility in heart failure rabbit model by 

mechanisms of Pi3K/AKt/enos pathway activation. P1387 

E. Chong, S.L. Chang, S.A. Chen (Singapore, SG; Taipei, TW) 

Proinflammatory capacity of epicardial adipose tissue may be associated with prevalent atrial 


T. Mazurek, M. Kobylecka, J. Skubisz-Gluchowska, J. Kochman, K. Filipiak, L. Krolicki, G. Opolski 

(Warsaw, PL) 

Autoimmune dermatological disorders are associated with increased risk of developing atrial 

fibrillation - a case control study. P1389 

J.J. Hai, R.M. Melduni, B.J. Gersh, M.R. Pittelkow, S.S. Cha, K.R. Bailey, H.C. Lee 

(Rochester MN, US) 

183 

wednesday 

posters

wednesday 

posters 


Predicting the outcomes following acute ischaemic stroke in atrial fibrillation: impact of the 

CHAds2, CHA2ds2-VAsC and HAs-blEd scores in a secondary prevention population P1390 

V. Padjen, T. Potpara, G.Y.H. Lip, I. Berisavac, M. Polovina, D. Jovanovic, L.J. Beslac-Bumbasirevic 

(Belgrade, RS; Birmingham, GB) 

Does the mineralcorticoid receptor blockade prevent atrial fibrillation in patients with 

congestive heart failure? P1391 

A. Kisheva, Y.T. Yotov, L.G. Mircheva, O.G. Kunchev, A. Angelov (Varna, BG) 

Von Willebrand factor and oxidised low density lipoprotein are predictors of the ischaemic 

and thromboembolic cardiovascular events in patients with atrial fibrillation P1392 

M. Polovina, T. Potpara, M. Licina, M.C. Ostojic (Belgrade, RS) 

Clinical characteristics and outcomes of catheter ablation of paroxysmal atrial fibrillation in 

young patients P1393 

T.-S. Kim, S.-H. Kim, W.-S. Shin, J.-H. Kim, S.-W. Jang, Y.-S. Oh, M.Y. Lee, T.-H. Rho, 

G.-B. Nam, K.-J. Choi (Seoul, KR) 

Diagnosis of unknown atrial fibrillation among 65+ years patients in general practice using 

a specific AF symptoms questionnaire (PROFIL FA) P1394 

Z. Khoueiry, F. Roubille, C. Heroum, P. Lambert, D. Caumette, A. Avignon, C. Jeandel, 

J.-M. Davy (Montpellier, Sète and Paris, FR) 

Safety and long-term efficacy of surgical ablation of atrial fibrillation, a single center experience. P1395 

J. Mansourati, S. Ropars, P. Castellant, M. Fatemi, J. Abalea, E. Bezon (Brest, FR) 

sinus rhythm restoration and antiarrhythmic drugs withdrawal independently predict 

functional improvement after catheter ablation for long-standing persistent atrial fibrillation P1396 

M. Fiala, D. Wichterle, L. Sknouril, V. Bulkova, R. Nevralova, O. Toman, M. Dorda, J. Pindor, 

J. Januska, J. Spinar (Trinec, Prague and Brno, CZ) 

Nine-fold reduction in X-ray time & dose by optimized fluoroscopy and 3-D visualisation 

techniques during pulmonary vein ablation P1397 

A. Jadidi, H. Lehrmann, C.I. Park, R. Weber, J. Schiebeling-Roemer, J. Allgeier, 

C.I. Herrera Siklody, T. Arentz (Bad Krozingen, DE) 

left atrial roof and mitral isthmus block during ablation for long-standing persistent Af P1398 

M. Fiala, D. Wichterle, L. Sknouril, V. Bulkova, O. Toman, J. Pindor, R. Labrova, J. Januska, 

J. Spinar (Trinec, Prague and Brno, CZ) 

Remote magnetic with open-irrigated catheter versus manual navigation for ablation of atrial 

fibrillation: a systematic review and meta-analysis. P1399 

R. Proietti, A. Sagone, L. Di Biase, P. Santangeli, L. Tagliabue, V. Pecoraro, M. Viecca, L. Moja, 

A. Natale (Milan, IT; Austin, US) 

Elevated E of Ep is an independent predictor of clinical recurrence after catheter ablation of 


H.S. Mun, J. Wi, J.S. Uhm, J. Shim, B. Joung, M.H. Lee, H.N. Pak (Seoul, KR) 

Cryoablation versus radiofrequency ablation of paroxysmal atrial fibrillation: Data from a 

french registry. P1401 

R.A. Providencia, P. Defaye, D. Pavin, F. Anselme, J.P. Cebron, N. Combes, S. Combes, F. Halimi, 

J.P. Albenque, S. Boveda (Toulouse, Grenoble, Rennes, Rouen, Nantes and Le Chesnay, FR) 

A simple technique for predicting roofline block with high specificity and sensitivity P1402 

C.R. Hayes, C. Wong, K. Rajappan, Y. Bashir, T.R. Betts, K. Wong (oxford and belfast, GB) 

intra-tissue ablation & visualisation system to monitor lesion formation P1403 

M.J. Wright, D. Haines, E. Harks, A. Kolen, B. Movassaghi, D. Rankin, W.C. Stoffregen, 

J. Nguyen, V. Reddy, P. Jais (London, GB; Royal Oak and San Jose, US; Best and Eindhoven, NL; 

Bordeaux, FR) 

184


Catheter ablation of Af: three-dimensional tEE provides an excellent overview over the left 

atrial anatomy prior to an ablation procedure - long-term outcome P1404 

K. Kettering, F. Gramley, S. Von Bardeleben (Frankfurt and Mainz, DE) 

Continuous uninterrupted Dabigatran versus Warfarin for catheter ablation of atrial fibrillation P1405 

T. Riexinger, A. Luik, M. Brinkmeier, M. Merkel, C. Schmitt (Karlsruhe, DE) 

transthoracic epicardial ablation of mitral isthmus: initial experience for the treatment of 

recurrent perimitral flutter. P1406 

F. Bisbal, A. Berruezo, N. Calvo, J. Fernandez-Armenta, H.M. Zeljko, D. Andreu, L. Mont, 

J. Brugada (Barcelona, ES) 

direct access to expert health allied professionals reduces re-hospitalisation after catheter 

ablation for atrial fibrillation. P1407 

L. Di Biase, P. Santangeli, B. Thomas, C. Williams, K. Zedlitz, R. Bai, P. Mohanty, S. Beheiry, 

J.D. Burkhardt, A. Natale (Austin and San Francisco, US) 

Mapping of the left sided phrenic nerve course in patients undergoing left atrial catheter 

ablations P1408 

M. Huemer, A.W. Wutzler, A.S.P. Parwani, P.A. Attanasio, W.H. Haverkamp, L.H.B. Boldt 

(Berlin, DE) 

Usefulness of the unipolar filtered electrogram amplitude and morphology during PV 

isolation: compared to bipolar filtered electrogram 1409 (W) 

I. Watanabe, H. Mano, Y. Okumura, K. Nagashima, M. Kofune, N. Sasaki, R. Kogawa, 

K. Ohkubo, T. Nakai, A. Hirayama (Tokyo, JP) 

ECG and echocardiographic changes after linear ablation at the superior left atrial septum P1410 

M. Brunelli, A. Grosse, S. Raffa, M.-A. Secknus, M. Frommhold, K. Hanazawa, T. Baldauf, 

V. Disha, J.C. Geller (Bad Berka, DE) 

Utility of magnetic resonance imaging of left atrium to predict outcome of catheter ablation 

for atrial fibrillation. P1411 

M. Sramko, P. Peichl, R. Maxian, J. Tintera, R. Cihak, D. Wichterle, J. Kautzner (Prague, CZ) 

serum C-terminal peptide from pro-collagen-i level and outcome after catheter ablation 

for atrial fibrillation in patients with left ventricular systolic dysfunction P1412 

L. Bravo, T.D. Datino, A.A. Arenal, J.D. Diez, F.A. Atienza, E.G.T. Gonzalez Torrecilla, P.A. Avila, 

M.P. Pelliza, F.F.A. Fernandez Aviles (Madrid and Pamplona, ES) 

development of real time analytical methods for detection of pulmonary vein lesion 

formation using duty cycled radiofrequency ablation with multi-electrode catheters P1413 

A. Strunk, L. Boersma (Carlsbad, US; Nieuwegein, NL) 

Impact of electroanatomical mapping during catheter ablation of atrial fibrillation guided 

by intracardiac echocardiography P1414 

C. Tutuianu, C. Iorgulescu, R. Pap, G. Bencsik, G. Klausz, J. Szilagyi, A. Makai, L. Saghy 

(Szeged, HU) 

Ectopic electrical activity in right atrial veins of patients with atrial fibrillation undergoing 

pulmonary vein ablation; prevalence and patients characteristics. P1415 

A. Kostopoulou, E. Livanis, P. Kourkoveli, K. Farsalinos, J. Rassias, G. Theodorakis (Athens, GR) 

spectral analysis of baseline and post-ablation electrocardiogram in patients with inducible 

atrial fibrillation after catheter ablation predicts sinus rhythm maintenance P1416 

S. Stavrakis, J.W. Dyer, B.J. Scherlag, Z. Khan, R. Lazzara, S.S. Po (Oklahoma City, US) 

Complications of transseptal catheterization for different cardiac procedures P1417 

G. Katritsis, G.C.M. Siontis, E. Giazitzoglou, N. Fragakis, D.G. Katritsis (Bristol, GB; 

Ioannina, Athens and Thessaloniki, GR) 

185 

wednesday 

posters

wednesday 

posters 


Atrial fibrillation ablation: predictors of recurrence, does paroxysmal AF rule the outcome? P1418 

F. Moscoso Costa, P. Adragao, D. Cavaco, P. Santos, H. Dores, P. Carmo, G. Cardoso, L. Barao, 

C. Soares, M. Mendes (Lisbon, PT) 

left atrial dissociated capture of pulmonary vein muscle as proof of proximal isolation with 

a circular multielectrode radiofrequency ablation catheter: incidence and characteristics P1419 

M. Brunelli, S. Raffa, A. Grosse, K. Hanazawa, M. Frommhold, M. Laubscher, N. Memisovic, 

J.C. Geller (Bad Berka, DE) 

Does acute reconnection following PVI predict chronic reconnection? P1420 

J.-P. Albenque, M. Mansour, J. Ruskin, P. Neuzil, W. Saliba, S. Kalbfleisch, M. Mangrum, 

S. Walczak, D. Harari, K.-H. Kuck (Toulouse, FR; Boston, Cleveland, Columbus and 

Charlottesville, US; Prague, CZ; Geneva, CH; Hamburg, DE) 

Incidence and predictors of success in patients with persistent atrial fibrillation undergoing 

repeat ablation 1421 (W) 

D. Scherr, S. Miyazaki, V. Aurillac-Lavignolle, P. Pascale, Y. Komatsu, S. Knecht, L. Roten, 

M. Hocini, P. Jais, M. Haissaguerre (Graz, AT; Bordeaux, FR) 

technical evolution of cryoballoon pulmonary vein isolation in patients with paroxysmal 

atrial fibrillation - first experience with the new artic front advance cryoballoon P1422 

S. Hoenig, A. Kypta, T. Lambert, K. Saleh, C. Steinwender (Linz, AT) 

Propofol use in patients with atrial fibrillation and cardiac sodium channel mutations P1423 

R. Dietrich, L. Fiedler, A. Bollmann, C. Ingram, D. Darbar, V. Adams, D.M. Roden, G. Hindricks, 

D. Husser (Leipzig, DE; Nashville, US) 

Results of catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy - comparison 

between primary and secondary hypertrophy P1424 

A. Muessigbrodt, J. Kosiuk, E. Koutalas, S. Pastromas, A. Bollmann, G. Hindricks (Leipzig, DE) 

Reduction in embolic events with Multipolar duty-Cycled Radiofrequency isolation of the 

pulmonary veins using the modified version of the GENius ablator P1425 

E. Nagy-Balo, A. Kiss, M. Clemens, L. Lanczi, E. Berenyi, I. Edes, Z. Csanadi (Debrecen, HU) 

Comparison of efficacy of cryo-balloon ablation performed with achieve mapping catheter 

and a standard spiral catheter lasso: two years outcome P1426 

A. Berkowitsch, D. Paijitnev, H. Greiss, S. Zaltsberg, S. Lehinant, E. Akkaya, M. Kuniss, 


Impact of the left atrial contours acquired from the right ventricular outflow tract on 

cartosound merge during radiofrequency catheter ablation of atrial fibrillation P1427 

K. Nakamura, S. Naito, Y. Nakatani, N. Tsukada, T. Sasaki, M. Hayano, S. Nishiuchi, K. Kaseno, 

K. Kumagai, S. Oshima (Maebashi, JP) 

Long-term course after atrial fibrillation ablation in patients with impaired left ventricular 

systolic function: the importance of rhythm and rate control. P1428 

S. Nedios, P. Sommer, J. Kosiuk, N. Kanagkinis, A. Arya, S. Richter, D. Husser, G. Hindricks, 

A. Bollmann, S. Rolf (Leipzig, DE) 

Risk of silent cerebral lesions comparing irrigated radiofrequency current ablation with the 

cryo balloon and the laser balloon P1429 

B. Schmidt, M. Gunawardene, S. Bordignon, A. Fuernkranz, V. Urban, B. Schulte-Hahn, 

B. Nowak, K.R.J. Chun (Frankfurt a.M., DE) 

Atrial fibrillation ablation using magnetic navigation: comparison with conventional approach 

during long term follow up. P1430 

P. Adragao, D. Cavaco, F. Moscoso Costa, H. Dores, P. Santos, P. Carmo, K. Santos, A. Soares, 

F. Morgado, L. Parreira (Lisbon, PT) 

186


Catheter-tissue contact force at different anatomical sites in pulmonary vein isolation: 

how to improve the tissue contact force? P1431 

M. Zucchetti, A. Dello Russo, M. Casella, E. Russo, G. Izzo, F. Costa, L. Di Biase, 

C. Carbucicchio, A. Natale, C. Tondo (Milan and Pomezia, IT; Austin, US) 

Reduction of radiation exposure during ablation of atrial fibrillation P1432 

J. Lauschke, R. Schneider, C. Schneider, I. Akin, C. Nienaber, D. Baensch (Rostock, DE) 

Clinical experience with catheter ablation of a broad spectrum of arrhythmias using 

a remote magnetic navigation system P1433 

P.K. Jacobsen, S. Pehrson, A. Karlsdottir, X. Chen (Copenhagen, DK) 

Selection of persistent atrial fibrillation patients in whom pulmonary vein isolation is 

sufficient to maintain sinus rhythm P1434 

K. Inoue, K. Tanaka, Y. Toyoshima, N. Tanaka, H. Nakanishi, T. Onishi, K. Iwakura, K. Fujii 

(Osaka, JP) 

Catheter ablation of Af: long-term follow-up results of radiofrequency catheter ablation for 

redo procedures after pulmonary vein isolation with the cryoballoon technique P1435 

K. Kettering, F. Gramley (Frankfurt, DE) 

Clinical impact of radiofrequency ablation catheter using contact force sensing on pulmonary 

vein isolation: an italian single centre experience. P1436 

L. Rebellato, D. Muser, D. Facchin, P. Gallo, M. Toniolo, E. Daleffe, A. Proclemer (Udine, IT) 


Elevation of bnP may be the predictor of left atrial thrombus in patients with persistent 

atrial fibrillation even if low CHA2DS2VASc score P1437 

S. Suzuki, Y. Murakami, K. Nakasuka, S. Sekimoto, K. Miyata, M. Inomata, T. Yoshida, N. Tamai, 

T. Saeki, S. Ito (Nagoya, JP) 

novel oral anticoagulants in a real-world-cohort of patients undergoing catheter ablation of 


J. Koch, G. Hindricks, S. John, S. Kircher, P. Sommer, A. Bollman, A. Arya, C. Piorkowski, C. Eitel 

(Leipzig, DE) 

Comparison of predicted dose vs. actual dose using pharmacogenomic algorithms in 

483 patients on long term warfarin therapy. P1439 

B. Diug, L. Sheffield, M. Dooley, J. Lowthian, J. Mcneil (Melbourne, AU) 

safety of periprocedural anticoagulation with dabigatran versus acenocumarol in patients 

undergoing atrial fibrillation catheter ablation P1440 

N. Calvo, H. Arguedas, M. Garcia-Yebenes, L. Moreno, A. Esteban, I. Garcia-Bolao (Pamplona, ES) 


first-line ablation site in patients with advanced stage of arrhythmogenic right ventricular 


T. Kobayashi, S. Kamakura, K. Satomi, T. Noda, K. Miyamoto, Y. Yamada, H. Okamura, T. Aiba, 

S. Yasuda, W. Shimizu (Suita, Osaka, JP) 

Impact of echocardiography-derived left atrial fibrosis parameter on the outcome of 

catheter ablation for atrial fibrillation 1442 (W) 

I. Watanabe, N. Sasaki, Y. Okumura, M. Kofune, K. Nagashima, H. Mano, K. Sonoda, R. Kogawa, 

T. Nakai, A. Hirayama (Tokyo, JP) 

Outcomes of repeated catheter ablation using magnetic navigation or conventional ablation P1443 

F. Akca, D. Theuns, L. Dabiri Abkenari, N. De Groot, L. Jordaens, T. Szili-Torok (Rotterdam, NL) 

187 

wednesday 

posters

wednesday 

posters 


radiofrequency ablation of ebstein's anomaly with supraventricular tachycardias P1444 

W. Wei, X.Z. Zhan, Y.M. Xue, X.H. Fang, H.T. Liao, H. Deng, Y.H. Liang, S.L. Wu 

(Guangzhou, CN) 

the use of a contact force-sensing catheter for the ablation of ventricular tachycardia P1445 

F. Akca, L. Dabiri Abkenari, R. Bhagwandien, S. Van Malderen, N. De Groot, T. Szili-Torok 

(Rotterdam, NL) 

Ablation of typical atrial flutter without discontinuation of oral anticoagulation. P1446 

S. Castrejon-Castrejon, D. Filgueiras Rama, A. Estrada Mucci, J. Figueroa, M. Ortega Molina, 

D. Doiny, J.L. Lopez Sendon, J.L. Merino Llorens (Madrid, ES) 

Automatic focal tachycardia ablation by using a non-contact multielectrode mapping catheter. 

initial experience. P1447 

J.J. Ferrer Hita, A. Rodriguez-Gonzalez, R.A. Juarez-Prera, P. Jorge-Perez, 

M. Carrillo Perez-Tome, G.E. Blanco-Palacios, I. Laynez-Cerdena (Santa Cruz de Tenerife, ES) 

Procedural endpoints in catheter ablation of ventricular tachycardia: should all inducible 

ventricular tachycardia be targeted in all patients? P1448 

A. Sultan, J. Luker, B. Hoffmann, H. Servatius, B. Schaffer, D. Schreiber, M. Knoll, T. Rostock, 

S. Willems, D. Steven (Hamburg, Stuttgart and Mainz, DE) 

Efficacy of endocardial and epicardial ablation approach for post myocarditis ventricular 

tachycardia P1449 

A. Sanzo, F. Gennaro, P. Moretti, E. Renzullo, G. Spadacini, J.A. Salerno-Uriarte, M. Tritto 

(Castellanza and Varese, IT) 

low recurrence rate after nodal reentrant tachycardia cryoablation with 8 mm tip catheter 

and prolonged applications P1450 

E. Castellanos Martinez, J. Almendral, N. Antonio, M. Ortiz (Madrid, ES; Coimbra, PT) 

Risk factors of recurrence and complication in radiofrequency catheter ablation of 

atrioventricular reentrant tachycardia P1451 

T. Chen, Y. Lin, T. Wang (Taoyuan, TW) 

intraprocedure recovery of accessory pathways conduction during radiofrequency ablation P1452 

M.S. Abello, J. Olmedo, J.M. Moltedo, M. Benjamin, N. Schnetzer, K. Alonso (Buenos Aires, AR) 

Endocardial or epicardial ventricular tachycardia in patients with non-ischaemic 

cardiomyopathy? The role of 12-lead ECG criteria in clinical practice P1453 

S.R.D. Piers, M. De Riva Silva, G.F.L. Kapel, M.J. Schalij, K. Zeppenfeld (Leiden, NL) 

Cryoablation induces a similar transient blood clotting activation but a lower endothelial 

activation when compared with radiofrequency ablation P1454 

P. Pieragnoli, G. Carrassa, G. Ricciardi, L. Perrotta, L. Checchi, A. Michelucci, R. Priora, 

R. Abbate, G.F. Gensini, L. Padeletti (Florence, IT) 

Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular 

dysplasia/cardiomyopathy P1455 

J. Huang, X.H. Fang, X.Z. Zhan, Y.M. Xue, Q.H. Zhang, C.H. Chen, T. Liu, S.L. Wu 

(Guangzhou, CN) 


impact of statin therapy on the occurrence of ventricular arrhythmias in iCd patients: 

do statins have antiarrhythmic properties? P1456 

T. Kleemann, M. Strauss, K. Kouraki, R. Zahn (Ludwigshafen, DE) 

188


statins prevent iCd therapy regardless of the etiology of the cardiomyopathy. P1457 

H.R. Poghosyan, S.V. Jamalyan (Yerevan, AM) 

Identification of arrhythmogenic substrate by ce-CMR in post-MI patients with relatively 

preserved left ventricular ejection fraction and nonsustained ventricular tachycardia P1458 

K. Yalin, E. Golcuk, H. Buyukbayrak, R. Yilmaz, M. Dursun, A.K. Bilge, K. Adalet (Istanbul, TR) 

Prognostic value of Microvolt t-Wave Alternans in a real-world iCd population. P1459 

K. Kraaier, M.A.G.M. Olimulder, P.F.H.M. Van Dessel, A.A.M. Wilde, M.F. Scholten 

(Enschede and Amsterdam, NL) 

no evidence of externalized conductors in optim iCd leads: imaging data from the optimum 

registry P1460 

P. Friedman, F. Hamati, K. Gleed (Hyannis, Johnson City and Omaha, US) 

Prognostic value of programmed ventricular stimulation in ischaemic and dilated 

cardiomyopathy patients with preserved systolic function P1461 

D. Tsiachris, K. Gatzoulis, A. Vouliotis, P. Dilaveris, P. Arsenos, S. Sideris, I. Skiadas, 

I. Kallikazaros, C. Stefanadis (Athens, GR) 

sudden cardiac death of patients with implanted anti-arrhythmic devices P1462 

A.N. Osadchii, D. Lebedev, V. Marinin, E. Kurnikova (Saint Petersburg, RU) 

Anxiety, depression and alexitimia in iCd recipients P1463 

F. Caravati, A. Buzzi, M. Diurni, E. Coppola, R. De Ponti, S. Vender, J.A. Salerno-Uriarte 

(Varese, IT) 

Would enhanced ICD programming reduce ICD shocks and improve survival? P1464 

C. Bonanno, M. Paccanaro, R. Ometto (Vivenza and Vicenza, IT) 

Remote monitoring of iCd leads with care link system. A multicenter, prospective, 

observational study P1465 

A. Quesada Dorador, V. Palanca, J. Martinez Ferrer, J. Alzueta, I. Fernandez Lozano, M. Alvarez, 

S. Morell, N. Basterra, I. Anguera (Valencia, Alava, Malaga, Madrid, Granada, Navarra and 

Barcelona, ES) 

Arrhythmic storm in iCd recipients with ischaemic vs dilated cardiomyopathy. 

A comparative study. P1466 

C. Maniotis, A.G. Manolis, S. Nikolidakis, N. Souvaliotis, E. Oikonomou, Z.S. Kyriakides 

(Athens, GR) 

demonstration of the inverse relationship between age and rates of inappropriate iCd therapy P1467 

W.B. Nicolson, A.E. Nicolson, M.I. Smith, A.J. Sandilands, D.T. Chin, P.J. Stafford, W.I. Loke, 

R.K. Pathmanathan, J.D. Skehan, G.A. Ng (Leicester and Cardiff, GB) 

impact of remote monitoring systems in management of patients with arrhythmogenic 

cardiac disease - results from a single center experience P1468 

D. Ricciardi, M. Namdar, A. Gargaro, M. Rodriguez Manero, R. Casado, C. De Asmundis, 

V. Calabrese, G.B. Chierchia, A. Sarkozy, P. Brugada (Brussels, BE; Milan and Rome, IT) 

Screening for externalization in Riata and Riata ST defibrillator leads reveals high rate of 

electrical failure in 8-french leads P1469 

N. Badenco, C. Himbert, G. Duthoit, X. Waintraub, T. Zerah, T. Chastre, E. Gandjbakhch, 

F. Hidden-Lucet (Paris, FR) 

Case series: Transvenous defibrillator lead extraction in patients with left ventricular assist 

devices P1470 

H. Kawata, U. Birgersdotter-Green, T. Baykaner, J. Patel, R. Joshi, T. Mcgarry, G. Feld, 

V. Pretorius (San Diego, US) 

189 

wednesday 

posters

wednesday 

posters 


Pacing 

screening of severe sAs patients using a transthoracic impedance-derived pacemaker algorithm P1471 

P. Defaye, J. Leal Del Ojo, J. Marti, R. Villuendas, J.L. Pepin, J. Senechal, P. Bru (Grenoble, 

Clamart and La Rochelle, FR; Seville, Barcelona and Badalona, ES) 

Riata iCd lead extraction at single center experience P1472 

C. Balabanoff, Y. Okamoto, R. Carrillo (Miami, US; Okayama, JP) 

Mechanical lead damage during transcutaneous lead removal P1473 

M. Budnik, A. Kolodzinska, A. Kutarski, M. Grabowski, I. Jarzyna, G. Opolski (Warsaw, 

Lublin and warsaw, PL) 

Permanent left ventricular apical cardiac pacing in children: long-term follow-up P1474 

P. Kubus, R.A. Gebauer, T. Matejka, Z. Bandzuchova, J. Brazdil, J. Janousek (Prague, CZ; 

Leipzig, DE) 

Recapture of venous access using extraction of functional or abandoned lead for new lead 

implantation in case of innominate / subclavian vein occlusion P1475 

A. Kutarski, A. Zabek, K. Boczar, M. Polewczyk (Lublin, Krakow and Warsaw, PL) 

Novel active fixation left ventricular lead provides precise placement: 6 month results from 

a multicenter clinical study P1476 

F. Gadler, A. Hussin, O. Razali, Y. Khaykin, A. Verma, R. Yee (Stockholm, SE; Kuala Lumpur, MY; 

Newmarket and London, CA) 

Real-world acute performance of the first mri safe pacemaker lead: a report from the 

surescan post-approval study P1477 

G.M. Milasinovic, S.C. Compton, B.R. Ramza, E.P. Pouliot, F.B. Quartieri (Belgrade, RS; 

Anchorage, Kansas City and Minneapolis, US; Reggio Emilia, IT) 

lead removal of recalled iCd leads 1478 (W) 


The efficacy of guidewire technique in cephalic cut-down approach and the predictors of 

successful insertion of two leads via cephalic vein in dual-chamber pacemaker implantation P1479 

T. Hasegawa, S. Higuchi, Y. Yamasaki, Y. Yasuhara, A. Endo, N. Hirata, T. Takahashi, 

S. Nakagawa, S. Ui, H. Mitamura (Tokyo and Fuchu, JP) 

Worsening of left ventricular function late after right ventricular pacemaker implantation: 

impact of left ventricular pacing on reverse remodelling P1480 

B. Bellmann, C.H. Hausdorf, A.N. Napp, M.Z. Zink, C.G. Gemein, G.R. Rakauskas, N.M. Marx, 

P.S. Schauerte (Aachen, DE) 

Cardiac related infective endocarditis- transvenous leads extraction in patients with 

vegetations over 2 cm P1481 


Atrioventricular decoupling prevention with the safer pacing mode P1482 

S. Boveda, P. Defaye, L. Fauchier, J. Sipoetz, C. Romeyer, J. Moreno, M. Rolando, M. Stockburger 

(Toulouse, Grenoble, Tours and Saint-Etienne, FR; Vienna, AT; Madrid, ES; Saluggia, IT; Berlin, DE) 

The insufficiency of left anterior oblique and the usefulness of right anterior oblique 

projection for correct localization of CT-verified right ventricular lead into the midseptum P1483 

P. Osmancik, P. Stros, D. Herman, K. Curila, R. Petr (Prague, CZ) 

Prognostic significance of right ventricular lead position in patients with permanent pacemaker P1484 

T. Tsutsumi, K. Honda, Y. Imamura, T. Matsumoto, T. Uchida, A. Yamada (Iizuka, JP) 

Patient characteristics and device implant practices in south Africa P1485 

A. Chin, I. Dannheimer, C. Badenhorst, I. Ebrahim, M. Bennett, R. Routier, S. Oosthuizen, 

F. Lorgat (Cape Town, Pretoria, Olivedale and Johannesburg, ZA) 

190


Single sheath lead extraction - efficacious and safe. P1486 

E.S. Platou, T.M. Knutsen, T. Steen (Oslo, NO) 

Complicated lead extraction procedures: Role of the femoral snare approach as bail-out 

procedure P1487 

C.T. Starck, D. Huerlimann, J. Steffel, F. Schoenrath, I.E. Caliskan, V. Falk (Zurich, CH) 


MRi assessment of mechanical dyssynchrony in patients with heart failure and narrow QRs P1488 

S. Amraoui, M. Sohal, Z. Chen, E. Sammut, H. Bordachar, A. Rinaldi, G. Carr-White 

(Bordeaux-Pessac, FR; London, GB) 

Cardiac resynchronisation therapy in ischaemic patiens with narrow qrs: the narrow-crt study P1489 

C. Muto, F. Solimene, P. Gallo, M. Nastasi, C. La Rosa, M. Rillo, R. Sangiuolo, C. Ciardiello, 

R. Ospizio, B. Tuccillo (Naples, Mercogliano, Bari, Taranto and Milan, IT) 

Resynchronization improves arterial reactivity and reduces aortic pulse wave velocity and 

peripheral wave reflections: smooth-muscle relaxation the link between CRT and arterial 

changes P1490 

Y. Zocalo, D. Bia, G. Varela, J.B. Gonzalez-Moreno, F. Calleriza, R. Armentano, W. Reyes-Caorsi 

(Montevideo, UY) 

facilitation of coronary sinus cannulation by a Cs assist catheter in cardiac resynchronisation 

therapy patients P1491 

L. Wang, S. Yuan, J. Brandt (Lund, SE) 

Predictors of appropriate device therapy for ventricular arrhythmias in patients with cardiac 


T. Kobayashi, T. Noda, I. Nakajima, K. Miyamoto, Y. Yamada, H. Okamura, K. Satomi, T. Aiba, 

S. Kamakura, W. Shimizu (Suita, Osaka, JP) 

Adherence to guidlines for implantation of implantable defibrillators (ICD) or biventricular 

pacemakers/defibrillators (CRT-D) P1493 

O.C. Grebe, F. Ziayee, P. Skurzewski, T. Leitsch, E.G. Vester (Dusseldorf, DE) 

Comparison of one year follow up in safety, efficacy and complication rate of a novel 

quadripolar lead with conventional bipolar leads in patients after CRt-d implantation P1494 

D. Mijic, A. Kloppe, Z. Karosiene, I. Ninios, H. Bogossian, M. Zarse, B. Lemke (Ludenscheid 

and Bochum, DE) 

Cost-utility analysis of remote monitoring in heart failure patients with implantable 

defibrillators: results from the EVOLVO study. P1495 

M. Lunati, A. Curnis, M. Marzegalli, M. Landolina, P. Zanaboni, S. Bisetti, F. Borghetti, G. Borghi, 

C. Masella, G.B. Perego (Milan, Brescia, Pavia and Milan, IT; Tromsø, NO; Milan, IL) 

transseptal conduction is an important factor for cardiac resynchronisation therapy in the 

dyssynchronous canine heart. P1496 

M. Strik, C.J.M. Van Deursen, L.B. Van Middendorp, A. Van Hunnik, M. Kuiper, A. Auricchio, 


Electrical remodeling in hearts with iatrogenic lbbb P1497 

E.B. Engels, P. Houthuizen, F.W. Prinzen (Maastricht, NL) 

Optimal versus standard CRT optimisation significantly impacts acute response with respect 

to lPEi reduction P1498 

D. Dan, A. Wickliffe, T. Deering, I. Kosmidou, P. Milpied, F. Zanoni, S. Cazeau (Piedmont, US; 


191 

wednesday 

posters

wednesday 

posters 


serum apelin as a predictor of right ventricular dysfunction P1499 

A. Kosztin, G. Szeplaki, K.V. Nagy, A. Apor, C.S. Liptai, L. Molnar, E. Zima, L. Geller, B. Merkely 

(Budapest, HU) 

Can we distinguish between proximal and distal left bundle branch block? a 

vectorcardiographic analysis. P1500 

E.B. Engels, P. Houthuizen, F.W. Prinzen (Maastricht, NL) 

High-density epicardial activation mapping as a guide during videothoracoscopic left 

ventricular lead placement P1501 

R. Polasek, I. Skalsky, J. Hanuliakova, T. Martinca, D. Wichterle, P. Kucera, T. Roubicek, J. Pirk, 

J. Kautzner (Liberec and Prague, CZ) 

intraoperative differences between ischaemic and non-ischaemic cardiomyopathy during 

CRt implantation P1502 

A. Hassan, A. Farah, S. Raffa, M.A. Ohlow, J.C.H. Geller (Alexandria, EG; Bad Berka, DE) 

Mechanical ventricular activation patterns in patients with systolic dysfunction evaluated 

using an accurate non-fluoroscopic 3D navigation system and echocardiography P1503 

H. Razavi, O.A. Breithardt, K. Ryu, C. Eitel, G. Hindricks, C. Piorkowski (Sylmar, US; Leipzig, DE) 

Upgrade CRt: characteristics of the non-responders P1504 

A. Hassan, A. Farah, M.A. Urlow, M. Brunnelli, J.C.H. Geller (Alexandria, EG; Bad Berka, DE) 

Atrial fibrillation in CRT patients: is there an impact of the AV- and VV-delay? P1505 

V. Puetz, I. Seifert, D. Schmitz, C.K. Naber, O. Bruder (Essen, DE) 

The success of cardiac resynchronisation therapy in patients with atrial fibrillation according 

to the atrioventricular node ablation P1506 

V. Lebedeva, T. Lubimceva, M. Trukshina, D. Lebedev (Saint Petersburg, RU) 

Cardiac reshyncronization therapy in Chagas disease,results of 2 years of follow up in 

82 patients P1507 

J.R. Castro Dorticos, S. Dos Santos Galvao Filho, J. Velasco Pucci, J. Medeiros De Vasconcelos, 

R. Cardoso Jung Batista, B. Papelbaum, C. Duarte, L. Laite, R. Marrero, C.K. Lins (Guadalajara, ES; 

Sao Paulo, BR; Havana, CU) 

QRs axis deviation predicts outcome in patients treated with CRt P1508 

L. Perrotta, R. Bani, G. Ricciardi, P. Pieragnoli, L. Di Biase, A. Natale, A. Valleggi, M. Emdin, 

G. Mascioli, L. Padeletti (Florence, Pisa and Bergamo, IT; Austin, US) 

low QlV to QRs ratio in non-responders to CRt predicts mortality and need of heart 

transplantation P1509 

K. Sedlacek, D. Grieco, D. Wichterle, J. Kautzner (Prague, CZ) 

Identification of patients at high risk of heart failure decompensation by a multiple diagnostic 

parameters device - development of a device-based algorithm from the ClEPsydRA 

population P1510 

M. Gold, F. Leyva, J. Brugada, J. Dumont, A. Auricchio (Charleston, US; Birmingham, GB; 

Barcelona, ES; Clamart, FR; Lugano, CH) 

long-term results after cardiac resynchronisation therapy with or without surgical 

revascularization in patients with ischaemic heart failure and left ventricle dyssynchrony. P1511 

A. Romanov, E. Pokushalov, S. Artyomenko, N. Shirokova, A. Karaskov, S. Mittal, J.S. Steinberg 

(Novosibirsk, RU; New York, US) 

targeting the lV-lead outside scar tissue in patients with ischaemic cardiomyopathy: 

evaluating cardiac resynchronisation therapy with pressure-volume loops P1512 

G.J. De Roest, L. Wu, P.P. Delnoy, C.C. De Cock, M.L. Hendriks, A.C. Van Rossum, 

C.P. Allaart (Amsterdam and Zwolle, NL) 

192



Mutation of desmoplakin gene and assessment of right ventricle function in patients 

with arrhythmogenic right ventricular cardiomyopathy P1513 

Q.H. Zhang, S.L. Wu, C.H. Chen, J. Huang, H.H. Tan (Guangzhou, CN) 

Compliance with wearable cardioverter-defibrillator use in a european cohort of patients P1514 

N. Bianco, H. Hughes, C. Wan, S. Szymkiewicz (Pittsburgh, US) 

Outpatient clinic workload for remote monitoring of patients with cardiac electronic 

implantable devices. Results from the HomeGuide registry. P1515 

R.P. Ricci, L. Morichelli, A.D.onofrio, L. Calo', D. Vaccari, G. Zanotto, A. Curnis, G. Buja, 

N. Rovai, A. Gargaro (Rome, Naples, Montebelluna, Legnago, Brescia, Padua and Milan, IT) 

diagnostic umtsefulness of prolonged and real-ime rhythm monitoring using mobile phone P1516 

Y.S. Oh, S.H. Kim, T.S. Kim, W.S. Shin, J.H. Kim, S.W. Jang, M.Y. Lee, T.H. Rho (Seoul, KR) 

Influence of high doses of omega-3-polyunsaturated fat acids on heart rate turbulence in 

acute phase of myocardial infarction P1517 

A.G. Nikishin, T.A. Nurbaev, M.M. Pirnazarov, N.T. Yakubbekov, S.Y. Abdullaeva, M.S. Hasanov, 

A.V. Malikov (Tashkent, UZ) 


long term follow-up of patients with syncope of unknown etiology after implantable loop 

recorder explantation without reaching a diagnosis: do we need longer observation period? P1518 

V. Exposito Garcia, F. Rodriguez Entem, S. Gonzalez Enriquez, P. Lerena, B. Arnaez, 

J.M. Gomez Delgado, I. Olavarri, J.J. Olalla Antolin (Santander, ES) 

Lack of sympathetic reserve as a cause of nitroglycerin-evoked reflex syncope P1519 

S. Laranjo, M. Oliveira, C. Tavares, S. Santos, E. Oliveira, R.C. Ferreira, I. Rocha (Lisbon, PT) 

Adenosine test in patients with unexplained syncope. Are there any place for this indication P1520 

G. Albina, F. Scazzuso, R. Laino, V. Sammartino, D. Belardi, A. Klein, L. Gomez, A. Giniger 

(CABA, AR) 

diabetes or previous conduction disturbances in syncope - Which better predicts 

pacemaker implantation in patients with implantable loop recorders P1521 

M. Fernandes, V.H. Pereira, V. Sanfins, J. Portugues, A. Alves, F. Canario-Almeida, B. Rodrigues, 

I. Quelhas, A. Lourenco (Guimaraes, PT) 

Validation of clinical decision rules for syncope in the emergency department P1522 

F. Rodriguez Entem, V. Exposito, S. Gonzalez Enrriquez, J.J. Olalla, B. Arnaez, 

J.M. Gomez Delgado, I. Olavarri, P. Lerena (Santander, ES) 

Basic science in arrhythmias 

Efficacy of the Valsalva manoeuvre and electrophysiological properties of the atrioventricular 

node. P1523 

D. Michalkiewicz, K. Makowski, K. Krzyzanowski, Z. Orski, G. Kaminski (Warsaw, PL) 

Contribution of the double atrial potentials to the occurrence of paroxysmal atrial 

fibrillation in the left sided Wolff-Parkinson-White syndrome. P1524 

K. Blaszyk, W. Seniuk, M. Wasniewski, A. Gwizdala, K. Malaczynska-Rajpold, M. Michalak, 

S. Grajek (Poznan, PL) 

Morphometric characteristics of the right atrium and bachmanns bundle region: implications 

for atrial pacing P1525 

M. Didenko, D. Starchik, S. Natarova, G. Pasenov, G. Khubulava (Saint-Petersburg, RU) 

193 

wednesday 

posters

wednesday 

posters 


Age related variations in the His bundle potential amplitude P1526 

O. Cenusa, J. Perez Rodon, I. Roca Lique, N. Rivas Gandara, D. Garcia Dorado, A. Moya 

Mitjans (Barcelona, ES) 

Mutations of desmoglein-2 in chinese with arrhythmogenic right ventricular dysplasia/ 


W.L. Liu, X.L. Qiu, D.Y. Hu, T.G. Zhu, C.L. Li (Beijing, CN) 

Electrophysiological and hemodynamic effects of vernakalant and flecainide in 

dyssynchronous canine hearts P1528 

L.B. Van Middendorp, M. Strik, P. Houthuizen, M. Kuiper, J.G. Maessen, A. Auricchio, 


Age and fasting glucose dependent trends of electrophysiological parameters in patients 

with atrioventricular nodal re-entrant tachycardia P1529 

I. Morozov, E. Bizyaeva, E. Korobkov, I. Rakovskaya, G. Oleynik, N. Furman, L. Malinova 

(Saratov, RU) 

ivabradine maintaines sinus rhythm and reverses tachycardiomyopathy due to incessant 

focal atrial tachycardia P1530 

A. Almusaad, S. Shaaban, M. Mukhtar, S. Alshuhri (Riyadh, SA) 


Age-related variability of P-wave morphology in healthy subjects 1531 (W) 

Y. Huo, F. Holmqvist, J. Carlson, R. Havmoeller, P. Platonov (Lund and Stockholm, SE) 

PQ segment depression in short QT syndrome: A novel diagnostic ECG marker? P1532 

E. Tulumen, C. Giustetto, R. Schimpf, C. Wolpert, P. Maury, O. Anttonen, C. Scrocco, 

C. Veltmann, F. Gaita, M. Borggrefe (Mannheim and Ludwigsburg, DE; Turin, IT; Toulouse, FR; 

Lahti, FI) 

localizing the origin of ventricular tachycardia by phase domain analysis of the surface ECG 

in humans and computational models P1533 

D. Calvo Cuervo, L. Martinez, J. Saiz, F. Atienza, J.M. Rubin, J. Jalife, R. Sebastian, A. Ferrer, 

O. Berenfeld (Oviedo, Valencia and Madrid, ES; Ann Arbor, US) 

Revisit of typical counterclockwise atrial flutter wave in the ECG: electroanatomic studies 

on the determinants of the morphology P1534 

K. Sasaki, S. Sasaki, M. Kimura, S. Owada, D. Horiuchi, T. Itoh, Y. Ishida, K. Okumura (Hirosaki, JP) 

Is myotonic dystrophy part of the Brugada syndrome ? Results of ajmaline challenge in 

steinert disease P1535 

P. Maury, M. Audoubert, F. Raczka, A. Rollin, C. Cardin, A. Duparc, P. Mondoly, M. Sadron, 

M. Delay, P. Cintas (Toulouse and Montpellier, FR) 

An automated algorithm for quantification of myocardial scar with the Selvester QRS score 

with or without electrocardiogram confounders P1536 

G. Giannakakis, P. Flevari, M. Dafni, D. Leftheriotis, E. Iliodromitis, M. Anastasiou-Nana 

(Athens, GR) 

baseline QRs fragmentation is a risk marker in brugada syndrome P1537 

C. Sousa, A. Lebreiro, S.M. Oliveira, F. Medeiros, A. Parada, R. Garcia, C. Frutuoso, J. Campos, 

M.J. Maciel (Porto, PT) 

Significant differences in the qrs width between males and females after repaired tetralogy 

of fallot P1538 

B. Borchert, D. Boethig, P. Beerbaum, S. Sarikouch (Hannover, DE) 

194


Atrial conduction time, left atrial mechanical and electromechanical functions in patients 

with polycystic ovary syndrome P1539 

E. Gazi, M. Gencer, V. Hanci, A. Temiz, B. Altun, A. Barutcu, A.N.C. Gungor, S. Hacivelioglu, 

A. Uysal, A.Y. Colkesen (Canakkale, TR) 

fragmented QRs complexes in adult patients with repaired tetralogy of fallot: a correlation 

study with cardiovascular magnetic resonance P1540 

A. Lebreiro, C. Cruz, T. Pinho, A. Madureira, I. Ramos, M.J. Maciel (Porto, PT) 

Oscillation product on a standard 12-lead electrocardiogram can improve diagnosis of 

cardiac tamponade P1541 

S. Kumar, M. Saint-Jour, N. Warrier, M. Milcevic, A. Innasimuthu, A. Budzikowski, J. Kassotis 

(New York, US) 

baseline ECG parameters in turkish population: results from the HAPPy study P1542 

B. Hunuk, O. Cagac, A. Kepez, B. Mutlu, O. Erdogan, M. Degertekin (Istanbul, TR) 

Abnormal repolarisation discrimination by an innovative t-wave frequency index P1543 

C. Giuliani, L. Burattini (Ancona, IT) 

Are the ECG features able to predict which is the culprit artery in patients with inferior 

myocardial infarction? P1544 

P. Sousa, N. Marques, R. Candeias, S. Pereira, J. Mimoso, V. Brandao, I. Jesus (Faro, PT) 

Tachyarrhythmias at extreme high-altitudes - is it norm or pathology already? P1545 

P. Krzyzak (Warsaw, PL) 

Noninvasive arrhythmia risk stratification in patients (pts) with non-ischaemic dilated 

cardiomyopathy (nidCM) and malignant ventricular tachyarrhythmias (MVt). P1546 

L. Lepska, P. Zagozdzon, G. Raczak, M. Dudziak (Gdansk, PL) 

Clinical pictures of sudden cardiac arrest in the patients with congenital heart disease P1547 

A. Miyazaki, H. Sakaguchi, H. Ohuchi, K. Yasuda, S. Yazaki, E. Tsuda, O. Yamada (Suita, JP) 

diagnostic approach in cathecolaminergic polymorphic ventricular tachycardia P1548 

J. Jimenez Jaimez, T. Gil-Jimenez, M. Lopez Perez, M. Alvarez, R. Macias Ruiz, T. Barrio Lopez, 

L. Tercedor (Granada and Marbella. Málaga, ES) 

A case report of type 1 brugada ECG exercise induced. P1549 

A. Previti, P. Carvalho, G.P. Varalda, D. Giachino, G. Mandrile, G. Colombatti, C. Rolando, 

R. Pozzi (Orbassano, IT) 

195 

wednesday 

posters

LISTS 

Sessions by Topic .....................................................................................................................................................................................................Page 199 

Sessions by Category ..............................................................................................................................................................................Page 200 

Chairpersons .............................................................................................................................................................................................................................Page 204 

Speakers ......................................................................................................................................................................................................................................................Page 206 

Authors ...........................................................................................................................................................................................................................................................Page 210 

Industry Partners ................................................................................................................................................................................................Page 240 

197 

INDEX

SeSSIonS by ToPIC - name/Page number 

ablation: 36, 40, 42, 65, 66, 67, 82, 85, 112, 117, 120, 125, 129, 132, 171, 175 

antiarrhythmic drugs (atrial Fibrillation): 124 

anticoagulation: 73, 75, 78, 87, 122 

basic Science: 174 

Catheter ablation (atrial Fibrillation): 63, 76, 121, 172 

Cellular electrophysiology: 33, 34, 41, 45, 66, 70, 80, 84, 112, 117, 118, 126, 130, 181 

Computer modelling: 68, 72 

CrT & Heart Failure: 63, 70, 71, 79, 111, 176 

Devices (Pacing): 88, 124 

eCg (Cardiac arrhythmias, non invasive): 100 

electrocardiography – non Invasive electrophysiology: 37, 69, 115, 128 

genetics (basic Science in arrhythmias): 137 

guidelines & Consensus paper: 71 

ICD & Telemedicine: 37, 39, 41, 68, 80, 81, 127, 130, 132, 172, 176 

Imaging modalities: 82, 171 

Indications (resynchronization therapy): 77 

Leads (Pacing): 76 

mechanism (basic Science in arrhythmias): 115, 120 

miscellaneous: 25, 35, 40, 45, 46, 52, 65, 69, 78, 82, 92, 101, 111, 116, 123, 125, 129, 133, 138, 155, 175, 178, 183 

molecular biology: 129, 174 

monitoring tools: 74, 75, 177 

nursing and allied Professional: 33, 35, 43 

Others (Cardiac arrhythmias, non invasive): 38, 42, 133 

Primary prevention (Sudden cardiac death and implantable defibrillators): 41, 91, 122, 131 

Results (Catheter ablation /except atrial fibrillation): 113, 153 

results (Pacing): 127 

results (resynchronization therapy): 51, 73, 81, 87 

Syncope: 128 

Syncope / Pacing / Lead extraction: 34, 36, 38, 40, 79, 83, 113, 114, 118, 119, 126 

Technical and imaging aspects (resynchronization therapy): 85, 77 

Tools: catheters, sources, mapping, navigators (Catheter ablation /except atrial): 121, 123 

199 

INDEX

INDEX 

SeSSIonS by CATegory - name/Page number 


Flash abstract presentations: atrial fibrillation ablation ............................................................................................................................................................................................................................................................ 63 

Oral Abstract Session: outcomes in CRT ........................................................................................................................................................................................................................................................................................................... 81 

Flash abstract presentations: cardiac resynchronisation therapy/Implantable cardioverter-defibrilator/Pacing .............................................. 85 

Oral Abstract Session: ablation: technical aspects ............................................................................................................................................................................................................................................................................ 113 

Oral Abstract Session: translational view on atrial fibrillation .................................................................................................................................................................................................................................. 115 

Oral Abstract Session: translational view on ventricular electrophysiology................................................................................................................................................................................ 120 

Oral Abstract Session: atrial fibrillation: Clinical Aspects ................................................................................................................................................................................................................................................... 118 

Late Breaking Trial Session I ............................................................................................................................................................................................................................................................................................................................................................. 116 

Oral Abstract Session: syncope ............................................................................................................................................................................................................................................................................................................................................... 128 

Oral Abstract Session: optimizing right ventricular and left ventricular pacing ..................................................................................................................................................................... 127 

Oral Abstract Session: novel non-invasive risk marker ........................................................................................................................................................................................................................................................... 133 

Oral Abstract Session: advances in ICD therapy and SCD prevention ................................................................................................................................................................................................ 131 

Flash abstract presentations: atrial fibrillation ablation ............................................................................................................................................................................................................................................................ 172 

Oral Abstract Session: prolonged rhythm monitoring for detection of atrial fibrillation................................................................................................................................. 177 

Late Breaking Trials session II......................................................................................................................................................................................................................................................................................................................................................... 175 

basic Science 

Mechanical stress and cell function ................................................................................................................................................................................................................................................................................................................................... 33 

Molecular mechanisms in cardiomyopathies ................................................................................................................................................................................................................................................................................................. 34 

Channelopathies ....................................................................................................................................................................................................................................................................................................................................................................................................... 41 

Carmeliet-Coraboeuf-Weidmann lecture ......................................................................................................................................................................................................................................................................................................... 45 

Microcompartments in cell function............................................................................................................................................................................................................................................................................................................................... 66 

Experimental models of proarrhythmia.................................................................................................................................................................................................................................................................................................................. 70 

Gap junctions in myocardial disease ............................................................................................................................................................................................................................................................................................................................... 80 

Calcium-store stability and arrhythmias ................................................................................................................................................................................................................................................................................................................. 84 

Gap junctions under cardiac ischaemia ..................................................................................................................................................................................................................................................................................................................... 84 

The «unknowns» in arrhythmogenic diseases ........................................................................................................................................................................................................................................................................................... 112 

Debated issues in channelopathies .................................................................................................................................................................................................................................................................................................................................... 117 

Let’s discuss my most difficult clinical case ......................................................................................................................................................................................................................................................................................................... 130 

Pathophysiological insights provided by EUTRAF: Progressive electrical uncoupling as determinant of AF chronification .... 174 


Καρδιακες αρρυθμιες σε ασθενεις που νοσηλευονται στη στεφανιαια μοναδα .................................................................................................................................................. 33 

Cardiac arrhythmias in the coronary care unit 

Cardiac lead engineering: designing for the future to improve reliability, performance, and extractability .............................................................. 34 

Νεωτερα δεδομενα σε καθιερωμενες θεραπειες - New developments in established therapies ................................................................................................. 35 

Special consideration of ventricular tachycardia ablation in patients with arrhythmogenic right ventricular dysplasia ...................... 36 

Quality of care and data........................................................................................................................................................................................................................................................................................................................................................................... 36 

Preventing and managing device and procedure complications ............................................................................................................................................................................................................................ 39 

In the Cath Lab Session ............................................................................................................................................................................................................................................................................................................................................................................. 35 

Devices and antiarrhythmic drugs ....................................................................................................................................................................................................................................................................................................................................... 42 

Implantable cardioverter defibrillator given for rare indications ......................................................................................................................................................................................................................... 41 

What can the implanter do to avoid lead extraction or to make it easier? .................................................................................................................................................................................. 40 

Atrial fibrillation: do we know what to advise patients?......................................................................................................................................................................................................................................................... 43 


Improving outcomes in AF patients in Europe: 10 years (German) Atrial Fibrillation Network (AFNET) ................................................................. 45 

European-wide surveys on the practice and real world status in clinical electrophysiology ..................................................................................................................... 65 

Clues to successful catheter ablation of ventricular tachycardia: overcoming frequent hurdles ........................................................................................................ 67 

Mapping and ablation of focal atrial tachycardias ................................................................................................................................................................................................................................................................................. 65 

Ablation techniques in atrial fibrillation and in VT/VF (Part II). Atrial fibrillation: case-based presentations .......................................................... 130 

Difficult tracings with interactive discussions ............................................................................................................................................................................................................................................................................................... 69 

Atrial fibrillation management in 2013: what do the Guidelines tell us and how do they compare? ........................................................................................ 71 

200


Managing cardiac resynchronisation therapy patients (Part I) - When the situation is tricky ................................................................................................................. 70 

Techno Live Session .......................................................................................................................................................................................................................................................................................................................................................................................... 69 

Device and lead infections ................................................................................................................................................................................................................................................................................................................................................................... 79 

Managing cardiac resynchronisation therapy patients (Part II) – The future is now!................................................................................................................................................. 79 


Case session: Lead extraction in challenging cases .......................................................................................................................................................................................................................................................................... 83 

Ablation of ventricular complex substrates ..................................................................................................................................................................................................................................................................................................... 85 

Pacing/ICDs/CRT:ECG/EGMs discussion (Part I). ............................................................................................................................................................................................................................................................................... 83 


Epicardial ventricular tachycardia ablation .......................................................................................................................................................................................................................................................................................................... 112 

Catheter ablation of outflow tract ventricular tachycardia ............................................................................................................................................................................................................................................. 115 

Lead extraction, extension of the lead management summit (Part I) Indications for lead extraction ................................................................................ 113 

The new 2013 ESC Guidelines on pacing and cardiac resynchronisation therapy. ........................................................................................................................................................ 111 

Nightmares in electrophysiology: my worst case ever............................................................................................................................................................................................................................................................. 111 

Worldwide debatable topics .......................................................................................................................................................................................................................................................................................................................................................... 114 

Ablation of idiopathic ventricular tachycardias and premature ventricular complexes ........................................................................................................................................ 117 

How to solve clinical problems in pacemakers patients ........................................................................................................................................................................................................................................................ 119 

Catheter ablation of longstanding persistent atrial fibrillation .................................................................................................................................................................................................................................. 120 

Lead extraction, extension of the lead management summit (Part II) State of the art in lead extraction techniques...................... 118 


New tools for atrial fibrillation .................................................................................................................................................................................................................................................................................................................................................... 125 

Ablation of accessory pathways ............................................................................................................................................................................................................................................................................................................................................... 125 

ICD: controversial indications in primary prevention ................................................................................................................................................................................................................................................................. 127 

Understanding complex ECG’s: a case based approach ....................................................................................................................................................................................................................................................... 128 

Pacing/ICDs/CRT:ECG/EGMs discussion (Part II). ............................................................................................................................................................................................................................................................................. 126 


Tailored catheter ablation of atrial fibrillation: toward less arrhythmia recurrence. ................................................................................................................................................... 129 

Management of patients with ICD ..................................................................................................................................................................................................................................................................................................................................... 132 

Ablation techniques in atrial fibrillation and in VT/VF (Part I). Atrial fibrillation: case-based presentations ............................................................ 66 


How can cardiac imaging help in ablating atrial fibrillation? ............................................................................................................................................................................................................................................ 171 

Risk stratification of primary electrical diseases in the ICD era: changing horizons .................................................................................................................................................... 172 

How to optimise CRT-D programming .................................................................................................................................................................................................................................................................................................................. 176 

Transforming 

Remote monitoring of patients with ICD............................................................................................................................................................................................................................................................................................................ 37 

Autonomic function .......................................................................................................................................................................................................................................................................................................................................................................................... 38 

How to ablate ventricular tachycardia: new tools and approaches................................................................................................................................................................................................................ 40 

What the electrophysiologists need to know about renal denervation ............................................................................................................................................................................................. 42 

New technologies in the treatment of complex arrhythmias.................................................................................................................................................................................................................................... 67 

How to measure? ................................................................................................................................................................................................................................................................................................................................................................................................... 68 

Clinical challenges of patients with ICD and CRT-D .................................................................................................................................................................................................................................................................... 71 

State of the art lecture: ICD therapy and telemedicine ........................................................................................................................................................................................................................................................ 68 

EHRA document ..................................................................................................................................................................................................................................................................................................................................................................................................... 69 

Assessment of left-ventricular dyssynchrony ................................................................................................................................................................................................................................................................................................ 72 

Reduce ICD shocks: improve quality of life ..................................................................................................................................................................................................................................................................................................... 81 

State of the art lecture: novel anticoagulants in atrial fibrillation ........................................................................................................................................................................................................................ 78 

State of the art lecture: atrial fibrillation ablation ................................................................................................................................................................................................................................................................................ 82 

Catheter ablation of atrial fibrillation and concomitant renal ablation: a new strategy? ..................................................................................................................................... 132 

Arrhythmias and valvular heart disease................................................................................................................................................................................................................................................................................................................... 176 

201 

INDEX

INDEX 


Translational 

New types antiarrhythmic drugs for atrial fibrillation................................................................................................................................................................................................................................................................. 38 

Scientific Projects of new e-Cardiology nucleus members ............................................................................................................................................................................................................................................ 37 

State of the art lecture: cardiac resynchronisation therapy ........................................................................................................................................................................................................................................... 63 

Translational session on Brugada’s syndrome.............................................................................................................................................................................................................................................................................................. 80 

Multimodality imaging of cardiac arrhythmias ............................................................................................................................................................................................................................................................................................ 82 

The grey areas in genetic syndromes ........................................................................................................................................................................................................................................................................................................................... 126 

Systemic effects of atrial fibrillation .................................................................................................................................................................................................................................................................................................................................. 129 

Thoracoscopic ablation of longstanding persistent AF – bail out in failed catheter ablation or as primary procedure? ................. 171 

From deciphering molecular pathogenesis to developing targeted new therapies ...................................................................................................................................................... 174 

Ablation of complex fractionated atrial electrogrammes .................................................................................................................................................................................................................................................. 175 

Moderated Posters 

New challenges in cardiac pacing .......................................................................................................................................................................................................................................................................................................................................... 51 

ICD therapy: current issues and future strategies.............................................................................................................................................................................................................................................................................. 91 

J-wave syndromes and arrhythmia complication after TAVI ........................................................................................................................................................................................................................................ 100 

Hot topics in genetics and anticoagulation ........................................................................................................................................................................................................................................................................................................ 137 

Catheter ablation .................................................................................................................................................................................................................................................................................................................................................................................................... 153 

Atrial fibrillation.......................................................................................................................................................................................................................................................................................................................................................................................................... 181 

Poster Session 

Poster session Sunday 8:30 to Monday 18:00............................................................................................................................................................................................................................................................................................. 25 

On behalf of the ESC Working Group on Cardiac Cellular Electrophysiology 

Poster session 1 ......................................................................................................................................................................................................................................................................................................................................................................................................... 52 






Satellite Symposium 

ICD therapy: patient selection, device technology and clinical results .................................................................................................................................................................................................... 44 

Innovations in the diagnosis and treatment of cardiac arrhythmias .............................................................................................................................................................................................................. 44 

Will percutaneous mitral valve repair impact your management of patients with mitral regurgitation? ......................................................................... 77 

AF: a riddle wrapped in a mystery inside an enigma? .................................................................................................................................................................................................................................................................. 76 

Home Monitoring of cardiac devices: clinic efficiencies and improved patient outcomes ............................................................................................................................. 75 

Left atrial appendage closure for risk reduction of AF related stroke: what every electrophysiologist should know.......................... 75 

Reducing stroke risk: early AF detection and new anticoagulants ................................................................................................................................................................................................................... 74 

Fresh perspectives on hemodynamic ambulatory optimisation in CRT .............................................................................................................................................................................................. 77 

Manage every lead - From implantation to extraction ............................................................................................................................................................................................................................................................ 76 

Improved patient and economic outcomes with advanced HF solutions ........................................................................................................................................................................................ 73 

Novel oral anticoagulants for stroke prevention in atrial fibrillation: understanding our way forward .............................................................................. 73 

CRT Care Pathway: from patient selection to clinical outcome.......................................................................................................................................................................................................................... 87 

Status quo: antithrombotic management in atrial fibrillation...................................................................................................................................................................................................................................... 87 

AF ablation: transforming complexity into safe, effective and efficient .................................................................................................................................................................................................. 121 

Changing paradigms in electrophysiological arrhythmia treatment............................................................................................................................................................................................................... 121 

A new paradigm in ICD therapy: clinical perspectives on a novel single-chamber ICD system with complete ............................................ 122 

atrial diagnostics 

Benefits of sleep apnea screening in the management of atrial fibrillation patients .................................................................................................................................................... 124 

Ground breaking new therapies for electrophysiologists .................................................................................................................................................................................................................................................. 123 

New opportunities and new challenges of anticoagulation in atrial fibrillation ..................................................................................................................................................................... 124 

Novel oral anticoagulants during clinical procedures in patients with AF: translating promising data into real-life practice .............. 122 

Advances in ablation catheter technology and role of contact force......................................................................................................................................................................................................... 123 

202


Special Session 

Women competence session - State of the art in interventional electrophysiology ................................................................................................................................................ 45 

Inaugural Session...................................................................................................................................................................................................................................................................................................................................................................................................... 46 

Honorary Lectures.............................................................................................................................................................................................................................................................................................................................................................................................. 78 

The ESC Working Group on Cardiac Cellular Electrophysiology General Assembly ........................................................................................................................................... 82 

EPIC Advances: updated guidelines and clinical trials shaping the future of device and EP therapy .......................................................................................... 88 

EHRA General Assembly...................................................................................................................................................................................................................................................................................................................................................................... 133 

Awards and Closing Ceremony ............................................................................................................................................................................................................................................................................................................................................... 178 

203 

INDEX

INDEX 

ChAIrPerSonS - name/Page number 

A 

Abriel H.: 117 

Aliot E.: 133 

Almendral Garrote J.M.: 67, 76, 127, 130 

Anastasiou-Nana M.: 174 

Arenal Maiz A.: 40 

Arentz T.: 69 

Arribas F.: 40 

Auricchio A.: 71, 77, 78, 111, 132, 175, 178 

b 

Behr E.: 126 

Benitah J-P.: 66 

Bertaglia E.: 153 

Blomstrom-Lundqvist C.: 36, 45, 65, 85, 171 

Bokhari F.: 176 

Bongiorni M.G.: 40, 88, 113 

Bordachar P.: 51 

Bosch R.: 172, 173 

Boveda S.: 129 

Braunschweig F.: 131 

Breithardt G.: 68 

Brignole M.: 127 

Brugada Terradellas J.: 80, 116, 176 

Brugada Terradellas R.: 112 

Bruining N.: 82 

Burri H.: 77 

Butter C.: 83 

C 

Camm A.J.: 74, 124, 174 

Cappato R.: 63, 64, 123 

Capucci A.: 38 

Cerbai E.: 66 

Chatzidou S.: 124 

Chen S-A.: 82, 114, 120 

Corrado D.: 36 

Crijns H.J.G.M.: 130 

Curnis A.: 181 

D 

Daubert J.C.: 81 

Davies D.W.: 123 

de Chillou C.: 67 

Defaye P.: 85, 124 

Deharo J-C.: 79 

Deisenhofer I.: 128 

Della Bella P.: 40 

Dobrev D.: 86, 112 

Dubner S.J.: 87, 132 

Dudley S.C.: 174 

Duytschaever M.: 113, 114 

204 

e 

Efremidis M.: 38 

Ernst S.: 88 

g 

Gaita F.: 42, 120, 125 

Geelen P.: 111, 171 

Gerstenfeld E.P.: 175 

Goette A.: 73, 116, 124, 178 

Gomez A.: 33 

Grace A.: 72 

Guerra G.: 67 

h 

Halimi F.: 69, 171 

Hansen R.: 84 

Hatala R.: 42, 177 

Hatem S.: 115, 174 

Hatzina I.: 35 

Heidbuchel H.: 37 

Helland J.: 34 

Hindricks G.: 71, 75, 112, 128, 130 

Hinterbuchner L.: 39 

Hocini M.: 121 

Horie M.: 126 

Husser D.: 100 

I 

Israel C.W.: 77 

K 

Kaab S.: 34 

Kanoupakis E.: 118, 119 

Kappenberger L.: 68, 81 

Kautzner J.: 44, 65, 118, 127, 132 

Kennergren C.E.H.: 34, 76, 113 

Kirchhof P.: 69, 74, 117 

Kletsiou E.: 33, 43 

Kottkamp H.: 67 

Krstacic G.: 37 

Kuck K.-H.: 44, 77, 82, 87, 111, 121, 175 

L 

Lambrinou E.: 39 

Le Heuzey J-Y.: 78 

Leclercq C.: 73 

Leclercq J-F.: 117 

Lehnart S.E.: 41 

Lendeckel U.: 129 

Lewalter T.: 43 

Lip G.Y.H.: 122

L 

Lorga Filho A.M.: 128 

Lunati M.: 65 

M 

Malik M.: 82 

Mantovan R.: 172, 173 

Mavrakis I.: 120 

Merkely B.: 122 

Mont L.: 51 

Morgan J.M.: 36, 41, 78, 87 

Murgatroyd F.D.: 44 

n 

Naebauer M.: 44 

Napolitano C.: 41, 80 

o 

Okumura K.: 115 

O’neill M.: 66 

Oto A.: 39 

Oyarzun R.: 81 

P 

Padeletti L.: 71, 87 

Pison L.: 171 

Pistolas D.: 33 

Pokushalov E.: 42, 118, 119 

Priori S.G.: 45 

Probst V.: 130 

Proclemer A.: 113, 114 

Pruvot E.: 66 

Q 

Quesada Dorador A.: 71 

r 

Rafla S.M.: 38 

Rasmussen L.H.: 78 

Ravens U.: 45, 115 

Raviele A.: 69 

Reddy V.Y.: 125 

Rinaldi C.A.: 79 

Ritter P.: 70, 79 

Roberts P.R.: 119 

ChAIrPerSonS - name/Page number 

205 

S 

Sanders P.: 175 

Santini M.: 63, 119 

Savelieva I.: 133 

Schmidt G.: 68, 72 

Scott L.R.: 85, 86 

Shah D.: 123, 129 

Shimizu W.: 172 

Shkolnikova M.: 153 

Simantirakis E.: 63 

Smith G.L.: 32 

Stamatopoulou E.: 35 

Steinbach K.: 84 

Stellbrink C.: 85, 86 

Sticherling C.: 91 

Sutton R.: 127, 176 

Svendsen J.H.: 37, 65, 111 

T 

Teo W.S.: 129 

Tondo C.: 75, 181 

Tzeis S.: 41, 137 

V 

van der Velde E.T.: 37, 68 

Vardas P.E.: 73, 87, 114, 122, 125 

Viskin S.: 91 

Volders P.G.A.: 172 

Vos M.A.: 70 

W 

Wilders R.: 80 

Wilkoff B.: 40, 70, 79, 176 

Willems S.: 36, 115 

Winter J.: 118 

Wissner E.: 117 

Wolpert C.: 81, 137 

Z 

Zaza A.: 80, 112, 120 

Zeppenfeld K.: 121 

Zhang S.: 132 

Zupan I.: 42, 131 

INDEX

INDEX 

SPeAKerS - name/InDex number 

A 


Ackerman M.: 851 

Aguinaga Arrascue L.E.: 480 

Aiba T.: 1310 

Albenque J-P.: 829 

Alevizaki A.: 84 

Alkaabi S.A.: 1350 

Alsheikh-Ali A.: 1352 

Ammann P.: 470 

Andrikopoulos G.K.: 816 

Antonakos V.: 100 

Antz M.: 502 

Arentz T.: 331 

Arnar D.O.: 884 

Arribas F.: 168, 864 

Arya A.: 751, 1351 

Athanasakis E.: 99 

Atie J.: 866, 869 

Auricchio A.: 300, 411 

b 

Baensch D.: 906 

Baldus S.: 413 

Bansch D.: 820 

Batsikas K.: 102 

Bauer A.: 120 

Baxter W.: 88, 93 

Bazzino O.: 444 

Benoit A.: 135 

Berruezo Sanchez A.: 109, 479, 1344 

Berul C.: 145 

Betts T.R.: 395 

Biffi M.: 169, 432, 790 

Blomstrom-Lundqvist C.: 352, 766 

Boengler K.: 478 

Boersma L.V.A.: 394, 762 

Bollmann A.: 341 

Bongiorni M.G.: 132, 183, 317, 510, 780 

Bordachar P.: 147, 469, 853 

Borggrefe M.: 344, 849, 888 

Boriani G.: 148, 354, 388 

Bosch R.: 176 

Botto G.L.: 385 

Boveda S.: 357, 464 

Brachmann J.: 389, 793, 1336 

Bracke F.A.L.E.: 467, 781 

Braunschweig F.: 118 

Breithardt G.: 173 

Brignole M.: 721, 1341 

Brugada Terradellas J.: 149, 353, 749, 865, 869, 887 

Brugada Terradellas R.: 890 

Bruining N.: 339 

206 

Burri H.: 151, 498 

Butter C.: 412, 414, 1349 

C 

Cabrera J.A.: 124 

Calkins C.: 106, 372, 848 

Calovic Z.: 383 

Camm A.J.: 128, 178, 371, 386, 390, 424, 738, 833, 836, 

837, 1340 

Cappato R.: 822 

Carbucicchio C.: 445 

Carrillo R.G.: 111, 401 

Cerbai E.: 779 

Charpentier F.: 155 

Chen S-A.: 1346 

Chinitz L.: 805 

Chronaki C.E.: 123 

Chung M.: 509 

Cooke D.: 89, 93 

Crijns H.J.G.M.: 129 

Curnis A.: 466, 1309 

D 

Darius H.: 503 

Daubert J.C.: 115, 495 

Davies D.W.: 825 

Davila A.: 726 

De Potter T.J.R.: 826, 1302 

Defaye P.: 402, 782 

Deisenhofer I.: 508, 878 

Delgado V.: 723 

Delhaas T.: 377 

Della Bella P.: 728, 806, 897 

Delmar M.: 476 

Di Biase L.: 1304 

Dobrev D.: 160 

Dubuc M.: 335 

Dudley S.C.: 730 

e 

Ehrlich J.R.: 161 

Eisner D.A.: 179 

Ernst S.: 181 

Ernst S.: 506 

F 

Fernandez Lozano I.: 359, 443, 745 

Francis D.: 299, 375 

Fynn S.P.: 316

g 

Gaita F.: 407 

Garcia-Bolao J.I.: 764 

Garrigue S.: 469, 853 

Gasparini M.: 854 

Giakis N.: 85 

Gillis A.: 370, 746 

Glikson M.: 350 

Goette A.: 175, 378, 501, 833, 836, 1331 

Gold M.R.: 367, 720 

Gorenek B.: 162 

Grace A.: 823 

Gras D.: 496 

Guzik P.: 122 

h 

Hachiya H.: 752 

Haissaguerre M.: 482 

Halimi F.: 839 

Hansen A.: 361 

Haqqani H.M.: 107 

Hatala R.: 1307, 1367 

Hatem S.: 1333 

Haverkamp W.: 150 

Heidbuchel H.: 351, 369, 380, 814, 1305 

Heinzel F.R.: 885, 1354 

Henrikson C.: 1335 

Herrera Siklody C.: 877 

Hindricks G.: 397, 400 

Hocini M.: 325, 809 

Hoffmann E.: 508, 845 

Hohnloser S.H.: 379, 416, 815 

Huikuri H V.: 460, 852 

Husser D.: 180 

I 

Israel C W.: 470, 747, 792, 854, 985 

J 

Jansens J L.: 430 

Jordaens L.: 1355 

Jung W.: 116, 1353 

K 

Kaab S.: 152, 731 

Kachenoura N.: 119 

Kalman J.: 315, 794 

Kantelhardt J.W.: 340 

Kappenberger L.: 1364 

Kautzner J.: 717 

Keane D.T.J.: 406 

Kennergren C.E.H.: 783 


207 

Kim Y-H.: 795 

Kirchhof P.: 177, 387, 504, 1339 

Klug D.: 468, 734 

Knecht S.: 324 

Kolb C.: 374 

Kolb C.: 1337 

Korantzopoulos P.: 863 

Kornej J.: 765 

Kottkamp H.: 454, 718, 722 

Kuck K-H.: 415, 505, 759, 812, 1368 

Kutarski A.: 465 

L 

La Meir M.: 1308 

Ladwig K-H.: 886 

Landolina M.: 346 

Laugwitz K-L.: 154 

Le Heuzey J-Y.: 130, 834, 836 

Leclercq C.: 133, 298, 431, 724, 768 

Lederer W.J.: 79 

Leenhardt A.: 894 


Lemke B.: 497 



Leyva-Leon F.: 763, 907 

Linde C.: 345, 725 

Lip G.Y.H.: 165, 320, 373, 417, 813 

Lombardi F.: 121 

Luo X.: 732 

M 

Mabo P.: 360 

Malik M.: 125 

Marin F.: 419 

Marinskis G.: 114, 318 

Marrouche N.: 461, 1303 

Marshall H.: 736 

Marshall M.: 92, 93 

Maury P.: 1343 

Meijer A.: 767 

Meine M.: 171 

Meissner A.: 404 

Merino J.L.: 338, 1342 

Merkely B.: 818, 821 

Miller J.P.: 90, 93 

Mitkowski P.: 144 

Mongillo M.: 1328 

Mont L.: 333, 761 

Morgan J.M.: 499, 1363 

Murgatroyd F.D.: 172, 408 

INDEX

INDEX 


n 

Nademanee K.: 441, 778 

Napolitano C.: 850, 891, 1313 

Narayan S.: 1348 

Natale A.: 455, 775 

Nattel S.: 423 

Neuberger H-R.: 158 

Neumann T.: 838, 847 

Neuzil P.: 840 

Nielsen M.S.: 477 

o 

Oliveira M.M.: 409 

O’neill M.: 323 

Orchard C.: 326 

Osca Asensi J.: 384 

Osswald B.: 403 

Oswald B.O.: 735 

Oto A.: 159 

Ouyang F.: 773 

P 

Padeletti L.: 494 

Pap R.: 313 

Pepin J.L.: 832 

Petryka J.: 376 

Pichlmaier A.: 427 

Piorkowski C.: 140, 453, 797 

Pison L.: 319 

Platou E.S.: 112 

Pokushalov E.: 910 

Poole J.: 507 

Postema P.G.: 439 

Pozzer D.L.: 481 

Prinzen F.W.: 301 

Priori S.G.: 153, 440, 733, 1314 

Probst V.: 438 

Proclemer A.: 322, 410 

r 

Rammou P.: 87 

Reddy V.Y.: 392 

Regoli F.: 146 

Reilly S.N.: 1332 

Reuter S.: 469, 853 

Ricci R.P.: 399 

Riley M.P.: 108, 729 

Ritter P.: 469, 853 

Rodrigues T.: 868, 869 

Roy A.: 91, 93 

Rozkovec A.: 110 

Russo A.: 509 

208 

S 

Sacher F.: 332, 727, 807, 896 

Saghy L.: 1345 

Sanoudou D.: 94, 1326 

Santini M.: 744 

Sapp J.L.: 337 

Savelieva I.: 418 

Schalij M.J.: 1338 

Schilling R.: 134, 908 

Schmidt B.: 141 

Schmidt G.: 127 

Schotten U.: 452, 1306, 1334 

Schumacher B.: 811 

Schuster T.: 342 

Schwab J.O.: 170, 1356 

Sejersted O.M.: 471 

Shah D .: 760, 828, 841 

Shan Q.: 909 

Shimizu W.: 893 

Shkolnikova M.: 1312 

Simantirakis E.: 101 

Smeets J.L.R.M.: 867, 869 

Sohail M.R.: 428 

Soldati E.: 463 

Sommer P.: 382 

Stamatopoulou E.: 86 

Stavrakis S.: 156, 846 

Stefanadis C.: 157 

Steffel J.: 835, 836 

Steinbeck G.: 174 

Steinberg J.: 905 

Sternick E.: 1311 

Steven D.: 334 

Sticherling C.: 796, 819 

Stix G.: 405 

Stockburger M.: 904 

Sutton R.: 722, 791 

Svendsen J.H.: 429 

T 

Tada H.: 750 

Tascini C.: 425 

Terrovitis I.: 1330 

Tilz R.: 876 

Tondo C.: 391, 396 

Trayanova N.: 139 

Traykov V.B.: 314 

Tsiftsidou E.: 164 

U 

Uribe W.: 442

V 

Valente B.: 426 

Van Dam P.: 459 

van Dijk J.G.: 126 

Van Erven L.: 143, 719 

Van Gelder I.C.: 131, 358, 883 

Van Rijen H.V.M.: 433, 475 

Van Welsenes G.H.: 366 

Vanhees L╩;E.M.: 166 

Vardas P.E.: 381, 500, 817 

Varma N.: 117, 343, 398, 810 

Verma A.: 810, 1347 

Vinolas Prat X.: 879 

Virmani R.: 393 

Viskin S.: 889 

Vitali Serdoz L.: 507 

Volders P.G.A.: 776 

Vos M.A.: 861 


209 

W 

Wagner E.: 1366 

Walfridsson U.: 167 

Ware J.: 777 

Wilber D.J.: 774 

Wilkoff B.: 737 

Willems S.: 142 

Wissner E.: 336 

Wolpert C.: 163, 368, 892 

Wong T.: 827 

Wright M.J.: 824 

y 

Yap Y.G.: 862 

Yin Y.: 911 

Z 

Zarqane N.: 831 

Zeppenfeld K.: 182, 462, 804, 808 

Zimmermann M.: 355 

INDEX

INDEX 

AUThorS - name/InDex number 

A 

Abad J.: P1221 

Abalea J.: P1395 

Abbate R.: P1053, P1238, P1239, 

P1454 

Abd El Aziz A.: P279 

Abdollah H.: P251 

Abdullaeva S.Y.: P1517 

Abe K.: P1093, P1104 

Abecasis J.: 874 

Abecasis M.: P574, P658, P679 

Abello M.S.: P713, P1452, P1129 

Abraham P.: P271 


Abu-Taha I.: 1 

Accardi F.: P246 

Accogli M.: P1051 

Acena M.: 484, P1065, P1148, P1213, 

P1283, P282, P644 

Acena Ramos M.: P653 

Acikgoz S.K.: P1041 

Acosta G.: P584 

Acsai K.: 82 

Adachi T.: P1282 

Adalet K.: P1284, P1458, P284 

Adamopoulos S.: P520 

Adams V.: P1423 

Adragao P.: 874, P1207, P1384, P1418, 

P1430, P537, P574, P658, P679 

Afshar-Kharaghan H.: P941 

Agafonov A.: 756 

Agapito A.: P677 

Agarwal S.: P186 

Agarwal S.K.: P205 

Ageev F.T.: P613 

Aggelis A.: P673 

Agoston G.: P1272 

Aguado E.: P1042 

Aguiar J.: P1107 

Aguinaga L.: P1195 

Aguirre J.M.: P558 

Ahmad S.: P1087 

Ahmed Ali A : 

P279 

Ahn Y.K.: 900, P236 

Aiba T.: 1324, P1441, P1492 

Aidietis A.: P47 

Aidonidis I.: 2 

Aime E.: P602 

Airaksinen K.E.J.: P961, P992 

Aizawa Y.: P1139, P969 

Akasaka K.: P1099 

Akbarzadeh M.A.: P1049 

Akca F.: P1091, P1126, P1443, P1445, 

P222 

Akin I.: P1432 

Akkaya E.: P1426, P529, P974, P981 

Ako J.: P1229, P1235 

Akyel A.: P1041 

Akyurek O.: P1069 

Al Jefairi N.Y.J.: P581 

Al Mohani G.: P1184 

Alasady M.: 754 

Albat B.A.: P622 

Albayrak S.: P289 

Albenque J.: P947 

Albenque J.P.: 1325, P1155, P1401 

Albenque J.-P.: P1420 

Albenque J.P.A.: P1173, P532 

Albert T.A.: P260 

Albina G.: P1520 

Alcantara M.: P1014 

Aldhoon B.: P1137 

Aleksandrova A.A.: P199, P952 

Alessandrini F.: P582 

Alfalasi O.: P1090 

Alfalasi O.A.: P622 

Alfie A.: P1022 

Algalarrondo V.: 755 

Alings M.A.: 1322 

Alioglu E.: P1297 

Aliot E.: P1012, P1301 

Alipour A.: P1180 

Alkhoury L.: P1112 

Allaart C.P.: P1257, P1512, P672 

Allan A.: 3 

Allgeier J.: 305, 306, P1397, P216, 

P218, P643, P982 

Allocca G.: P1094 

Allouche E.: P953 

Almeida T.P.: P980 

Almenar L.: P695 

Almendral J.: P1450, P954 

Almusaad A.: P1530 

Al-Nono O.: P1009 

Alonso A.: P205 

Alonso K.: P1452 

Alonso M.C.: P1206 

Alonso-Martin C.: P671, P693 

Alper Alkoc O.: P289 

Alper T.: P238 

Al-Razzo O.: P1046 

Alsancak Y.: P1041 

Alshuhri S.: P1530 

Alsina X.: P1058 

Alsmadi F.: 898 

210 

Altin A.T.: P1069 

Altmann D.: P972 

Altun B.: P1539 

Alvares Pereira M.: P639 

Alvarez M.: P1182, P1186, P1288, 

P1465, P1548, P599 

Alves A.: P1521 

Alzand B.S.N.: P647 

Alzueta J.: P1465 

Alzueta- Rodriguez F.J.: P258, P263 

Alzueta Rodriguez J.: P1130, P265, 

P270 

Amado J.: P1266 

Amara W.: P1033, P1044, P286 

Ambroz D.: P712 

Amellone C.: P1164, P1381, P246 

Amit G.: P1019 

Ammann P.: P972 

Ammar S.: P1146, P1169, P533, P663 

Ammash N.A.: P971 

Amorim S.: P1291 

Amorosi S.: 789 

Amraoui S.: P1488, P197 

An Q.: P683 

Anastasiou-Nana M.: 801, P1271, 

P1536, P703 

Andersen H.R.: 1365 

Anderson J.L.: 784 

Anderson K.: P193 

Anderson R.A.: P1278 

Ando K.: P1259 

Andoh K.: P1075 

Andrade J.F.: P1215 

Andreka P.: P271 

Andres C.R.: P1369 

Andresen D.: P1073 

Andreu D.: 483, 741, 799, P1406, 

P641 

Andrikopooulos G.: P515 

Andronache M.: P1012 

Angelov A.: P1391 

Anguera I.: P1465, P512 

Anselme F.: P1155, P1199, P1401, 

P260, P602 

Anselmino M.: 1317, P1164, P1381 

Antonelli D.: P264 

Antonio N.: P1450, P277, P278 

Antoniucci D.: P1227, P253 

Anttonen O.: P1532 

Anzai T.: P1018 

Aonuma K.: 450, P1152, P933 

Apor A.: P1074, P1499 

Appendino M.: P528

Arafune T.: 798 

Aragon M.: P196, P626 

Aranega-Jimenez A.A.-J.: P632 

Arantes C.: P639 

Arbelo E.: 489, 741, 785, 799, P1058, 

P1141, P641 

Archontakis S.: P1020, P1081, P1265, 

P673, P674 

Ardashev A.: P1154 

Ardashev V.: P1154 

Arenal A.: P1088, P223, P553 

Arenal A.A.: P1412 

Arenja N.: P1234 

Arensi A.: P1181 

Arentz A.: 306 

Arentz T.: 305, 857, P1397, P216, 

P218, P266, P545, P643, P937, P947, 

P982 

Argnani S.: P280 

Arguedas H.: P1440 

Arheden H.: 485 

Arias Palomares M.A.: P275 

Arias-Palomares M.A.: P655 

Ariff B.: P203 

Aristizabal J.: P1117, P534 

Arkolaki E.: 490, P1043 

Armentano R.: P1490 

Armstrong S.: 789 

Arnaez B.: P1083, P1086, P1518, 

P1522 

Arokiaraj M.A.R.K.: P1249 

Arrascaite M.: P655 

Arribas F.: P563, P567 

Arribas Ynsaurriaga F.: P250 

Arseneau D.: P226 

Arsenos P.: P1020, P1081, P1265, 

P1461, P673, P674 

Artyomenko S.: 310, 311, 786, P1511 

Arya A.: 1321, 1323, P1175, P1274, 

P1428, P1438, P524, P535, P646, 

P662, P664, P665, P973 

Asano T.: P1282 

Asbach S.: P515, P669 

Ascoeta S.A.: P1173 

Asirvatham S.J.: P1286 

Askar S.F.: P48 

Askar S.F.A.: P46 

Aslantas Y.: P289 

Aso A.: P1111 

Assali A.A.: P619 

Astheimer K.: 857 

Astudillo V.: P1117 

Atallah J.: P1190 


Atarashi H.: P926 

Athill C.: P1059, P269 

Atienza F.: P1088, P1533, P223, P553 

Atienza F.A.: P1412 

Attana P.: P1053 

Attana’ P.: P700 

Attanasio P.A.: P1408 

Audoubert M.: P1280, P1535 

Augello G.: P522 

Auricchio A.: 446, 484, 860, 898, 

P1065, P1066, P1213, P1283, P1496, 

P1510, P1528, P282, P593, P644, 

P653, P69 

Auricchio L.: P698 

Aurillac-Lavignolle V.: P1143, P1421 

Avella A.: P1001, P212 

Avignon A.: P1394 

Avila Alonso P.: P1088 

Avila P.: P1021, P223, P553 

Avila P.A.: P1412 

Ay C.: 1319 

Ayala-Paredes F.: P226, P285 

Aydin M.A.: P210 

Ayers L.: P281 

Ayhan S.: P290 

Ayhan S.S.: P1262 

Azevedo E.: 873 

Azevedo P.: P639 

Azhari A.: P1049 

Aziz E.: 871 

Aziz E.F.: 872 

b 

Babuty D.: 901, P585 

Bacchiega E.: P1070, P924 

Bacova B.: 436 

Bacquelin R.: P1158, P965 

Badea I.: P1085 

Badenco N.: P1469 

Badenhorst C.: P1485 

Badheka A.: P648 

Badheka A.O.: 1318, P1372 

Badiani S.: P1233 

Bodanese L.C.: P988 

Badra M.: P226, P285 

Bae M.H.: P1270 

Baensch D.: P1230, P1432 

Bagge L.: P1135 

Baggio Jr J.M.: P562 

Bai R.: P1113, P1407 

Bai W.: P203 

Bailey K.R.: P1389 

Bair T.L.: 784 

211 

Bairamova S.: 310, 786 

Bakos Z.: 485, P701 

Balabanoff C.: P1048, P1218, P1228, 

P1247, P1472, P1478, P256 

Baldauf T.: P1410 

Baldewig M.: P964 

Baldinger S.H.: P513 

Balse E.: 755 

Balt J.: P983 

Balt J.C.: P542 

Baltogiannis G.: P950 

Balykova L.A.: P243 

Balzer J.: P642 

Ban J.E.: P1125, P661, P955, P987 

Ban J.E.: P1192 

Bandarchuk A.: P666 

Bandzuchova Z.: P1474 

Banerjee A.: P1369 

Banerjee D.B.: P1298 

Bani R.: P1508 

Banker J.: P1236, P555 

Barake W.: P638 

Baran J.: P929 

Baranchuk A.: P1117, P1281, P534, 

P638 

Baranchuk A.M.: P251 

Baranova V.: 310, 786 

Barao L.: P1418 

Baratto F.: 739, P220 

Barbieri A.: P198 

Barbone A.: P1370 

Barbosa A.J.: P277 

Barbosa Neto O.: P293, P294, P60, 

P702 

Barbosa T.: P995 

Barboza A.: P626 

Barbuti A .: 362 

Bardaji A.: P1077 

Bardyszewski A.: 309, P1151 

Barecka K.: P1089, P578 

Bareno J.: P1117, P534 

Bargiggia G.: P1132 

Barinova I.V.: P613 

Barisani J.L.: P1063 

Barker D.: P511 

Barra S.: P1261, P637 

Barrera A.: P567 

Barrera-Cordero A.: P258, P263, 

P1130 

Barrero-Garcia M.: 855 

Barrio Lopez T.: P1548 

Barrio T.: P1182, P1186, P1288 

Barros Junior E.M.: P1285 

INDEX

INDEX 


Barros L.P.R.: P1285 

Bartelings M.M.: P600 

Bartholomay E.: P988 

Bartolini S.: 1360, P590 

Bartunek J.: P959 

Barutcu A.: P1539 

Basara M.: P1041 

Bashir Y.: P1254, P1402, P539 

Bastani H.: P1005, P1162, P936 

Bastawrose J.: 871 

Bastawrose J.H.: 872 

Basterra N.: P1465 

Batlle M.: 489 

Battaglia A.: 1317, P528 

Battipaglia I.: P697 

Battistini P.: P1208 

Battle M.: P629 

Baykaner T.: P1383, P1470, P940 

Bayrak F.: P1026 

Bazan V.: P1004, P233 

Beadle R.: P1035 

Beau S.: P1023 

Bebarova M.: 4 

Becker G.: P610, P704 

Beekman H.D.M.: 800, P74, P76 

Beerbaum P.: P1538 

Begley D.A.: P186 

Behagel A.: P1158, P965 

Behar N.: P1158, P965 

Beheiry S.: P1407 

Bejiqi H.: P1098 

Bejiqi R.: P1098, P1098 

Bekke R.: 365 

Belardi D.: P1520 

Belardinelli L.: P64 

Belchambers S.: P1210 

Belenkov Y.N.: P1275, P919 

Beleveslis T.H.: P1015, P944 

Belham M.R. D.: P685 

Belli P.: P698 

Bellini B.: P1010 

Bellmann B.: P1480 

Bello D.B.: P260 

Belotti G.: P580 

Belt H.: P1160 

Belvito C.: P259 

Ben Halima M.: P1155 

Bencardino G.: P1184 

Bencsik G.: P1110, P1272, P1414 

Bendini M.G.: P690 

Benezet J.: P1021 

Benezet Mazuecos J.: P1040, P1042, 

P601 

Benito B.: P1004, P233 

Benjamin M.: P1452 

Benjamin M.N.: P713, P1129 

Benjo A.: 871 

Benjo A.M.: 872 

Bennadji A.: P561 

Bennett M.: P1485 

Benova T.: 436 

Bental T.: P239 

Bental T.B.: P619 

Bento A.: P1107 

Berenfeld O.: P1533 

Berenyi E.: P1425 

Berezin A.: 914 

Bergmann T.: 448 

Berisavac I.: P1390 

Berkowitsch A.: P1426, P945, P981 

Berman L.M.: P591 

Bernardes A.: P1246 

Bernat V.: P1202 

Berne P.: 785, P604, P918 

Berne P.M.: P641 

Berrio T.: P599 

Berruezo A.: 312, 483, 489, 741, 785, 

799, P1058, P1141, P1195, P1406, 

P542, P709, P939 

Bertaglia E.: 1316, P1070, P1078, 

P522, P924 

Bertagnolli L.: P665 

Berte B.: P1148, P1153, P1293 

Bertero G.: P224 

Bertini M.: P580 

Berton A.: P1070, P924 

Bertoncelli D.B.: P195 

Bertuccio G.: P244 

Beslac-Bumbasirevic L.J.: P1390 

Betts T.: P1255, P1260, P539 

Betts T.R.: P1254, P1402 

Beurrier D.: P1012, P1301 

Bezon E.: P1395 

Bhagwandien R.: P1445 

Bharathi R.: 871 

Bhavnani S.: P694 

Bia D.: P1490 

Bianchi F.: P986 

Bianco N.: P1514 

Bianco N.R.: 903 

Bibli I.S.: 801 

Biczysko M.: P1089, P1092 

Bieganowska K.: P560 

Bierhuizen M.F.A.: P68 

Biermann J.: P515, P669 

Biernacka E.K.: P1281 

212 

Biffi M.: P1024, P1208, P273, P580, 

P585 

Bilge A.K.: P1284, P1458, P284 

Bilinska M.: P560 

Billis A.: P1082 

Binder T.: P1170 

Bingen B.O.: P46, P48 

Binner L.: P1027 

Birgersdotter-Green U.: P1470, P257, 

P583 

Birk E.: P234, P235 

Birnie D.: 450 

Bisbal F.: 312, P1141, P1406, P641, 

P709 

Bisceglia C.: 739, P1010, P220 

Bisetti S.: P1024, P1495, P268 

Bisleri G.: P1177 

Bitay M.: P52 

Bizyaeva E.: P1529 

Blaha M.: P568 

Blanco-Palacios G.E.: P1447 

Blandino A.: 1317, P224, P528 

Blangy H.: P1201 

Blank A.C.: P586 

Blankoff I.: P1371 

Blankova Z.N.: P613 

Blaszyk K.: P1524 

Blazquez J.A.: P1046 

Blich M.: P237, P62 

Block M.: P531 

Bloise R.: P62, P66 

Blom N.A.: P600 

Blomstrom Lundqvist C.: P1135 

Blomstrom P.: P1135, P1161 

Blomstrom-Lundqvist C.: P1161 

Blondheim D.S.: P1211 

Blum T.: 857, P266 

Boczar K.: P1031, P1050, P1225, 

P1475, P1481, P191, P192, P688 

Bodalski R.: P560 

Boehm M.: 757, P72, P956 

Boehmer J.: P683 

Boehmer M.C.: P946 

Boehmig M.: P946 

Boel E.: P959 

Boem A.: 492, P261 

Boersma L.: 899, P1413, P642, P675 

Boersma L.V.A.: P1180, P542, P983 

Boethig D.: P1538 

Boetker H.E.: P1198 

Boev A.: P716 

Bogaard K.: P591 

Bogats G.: P52

Bogossian H.: P1287, P1494, P254, 

P660 

Bohmer M.C.: P1165 

Boldt L.H.B.: P1408 

Bolea J.: P1290 

Bollman A.: P1438 

Bollmann A.: 1321, 758, P1274, P1380, 

P1423, P1424, P1428, P255, P524, 

P535, P646, P662, P664, P665, P973 

Bolognesi M.G.: P195 

Bonanno C.: P1464 

Bongiorni M.G.: 492, P1030, P246, 

P261, P549, P556 

Bontempi L.: P1177, P262 

Borchert B.: P1538 

Bordachar H.: P1488 

Bordachar P.: P1260 

Bordignon S.: P1165, P1179, P1429, 

P946, P989 

Borggrefe M.: P1532, P184, P75 

Borghetti F.: P1495 

Borghi G.: P1495 

Borgquist R.: 485, P245, P603, P701 

Boriani G.: 446, P1024, P1208, P207, 

P268 

Borleffs C.J.W.: 447, P1064 

Borowiec A.: P272 

Borras R.: P939 

Borrego L.: P558 

Borrino A.: P1212 

Borz B.: P1199 

Botelho A.M.: P637 

Botto G.: P1258, P207 

Bou Ezzeddine H.: P1202 

Bouallouche S.: P286 

Bougherbal R.: P286 

Boulos M.: P237, P62 

Bounds C.: P1216, P273 

Bourgonje V.J.A.: P76 

Bouvier J.B.: 738 

Bouwels L.H.R.: P1226 

Bouzeman A.: 1325 

Bouzeman A.B.: P1173, P532 

Boveda S.: 1325, P1155, P1375, P1401, 

P1482 

Boveda S.B.: P1173, P532 

Brachmann J.: P1375 

Bradley L.: P1087 

Brady A.P.: P1286 

Braga C.: P639 

Brahmbhatt D.H.: P1243, P281, P685 

Brandao V.: P1544 

Brandolino G.: P1070, P924 


Brandt J.: P1491, P245 

Braun J.: P211 

Braunschweig F.: P1005, P1162, P936 

Bravo L.: P1088, P1412, P553 

Brazdil J.: P1474 

Breithardt O.: P662 

Breithardt O.A.: P1503 

Brembilla-Perrot B.: P1012, P1201, 

P1301 

Breuls P.N.W.M.: P990 

Breur J.M.P.J.: P586 

Brinkmeier M.: P1405 

Brisben A.: P274 

Brombin C.: P547 

Brooks A.G.: 754 

Brough C.E.P.: P692 

Brouwer C.: P668 

Brown P.B.: 913, P1095 

Brown P.D.: P980 

Brscic E.: P244 

Bru P.: P1044, P1471 

Bruckheimer E.: P234, P235 

Bruder O.: P1505 

Brugada J.: 312, 483, 489, 741, 785, 

799, P1058, P1141, P1195, P1406, 

P1510, P542, P563, P604, P641, P918, 

P939 

Brugada P.: P1468, P295 

Brugada R.: P604, P918 

Bruguera J.: P1004, P233 

Bruhm A.: P533 

Brunckhorst C.B.: P513 

Brunelli M.: P1410, P1419 

Brunnelli M.: P1251, P1252, P1504 

Bruno V.: 1319 

Brusich S.: P921 

Bryl M.: P1089, P1092, P578 

Brzozowski W.: P1050, P579 

Bucchi A.: 5 

Bucx J.: P531 

Buddecke J.: 1358 

Budnik M.: P1473 

Budzelaar F.: P214 

Budzikowski A.: P1541 

Buettner E.: P57 

Buiatti A.: P1146, P1169, P533 

Buiten M.S.: P240, P516 

Buja G.: P1076, P1515, P246 

Bukowska A.: P71, P78 

Bulkova V.: P1115, P1396, P1398, 

P217, P978 

Bulur S.: P289 

Bulur S..: P289 

213 

Bun S.S.: P1112, P953 

Bun S.S.: P1153 

Bunch T.: 784 

Buonamici P.: P1227 

Burattini L.: P1292, P1543 

Burban M.: 901 

Burchard A.: 309 

Burkhardt J.D.: P1113, P1407, P999 

Burmistrova T.: 742, P1006 

Burri H.: 1320, P573, P581 

Burton F.L.: P51, P54 

Busch M.: P71 

Butter C.H.: P684 

Buttu A.: P1171, P979 

Buyukbayrak H.: P1458 

Buzzi A.: P1463 

Byeon K.M.: 1362, 912 

Byron K.: P1178 

C 

Cabanas Grandio P.: P709 

Cabanas P.: 312, P1141, P641 

Cabanelas N.: 785 

Cabasson A.: P1283 

Cabreiro A.: 1361, P606 

Cabrera Bueno F.: P1130, P265, P270 

Cabrera G S.: P1206 

Cabrera Gomez S.: P671 

Cabrera S.: P693 

Cagac O.: P1100, P1542 

Caiani E.: P1065 

Caiani E.G.: P1290, P593 

Cakmak N.: P238 

Calabrese V.: P1468 

Caldwell J.: 328 

Caldwell J.C.: P638 

Caliskan I.E.: P1487 

Caliskan K.: P1091 

Calle S.: P1042 

Calleriza F.: P1490 

Calloe K.: 6 

Calo L.: P522 

Calo’ L.: P1078, P1515 

Calovic Z.: 486, P188 

Calvagna G.M.: P1062 

Calvi V.: P1078, P620, P621 

Calvo Cuervo D.: P1533, P223 

Calvo N.: P1406, P1440, P939 

Calzolari V.: P522 

Campbell A.M.: P54 

Campelo M.: P1291 

Campos J.: P1537 

Campuzano O.: P604, P918 

INDEX

INDEX 


Canario-Almeida F.: P1521 

Canavese G.: P244 

Candeias R.: P1266, P1544 

Candemir B.: P1069 

Canevese F.: P259 

Canteli A.: P575 

Cao M.: 451, P687 

Capkova V.: P568 

Capodanno D.: P621 

Capogrosso P.: P698 

Caponi D.: P1370, P224, P528 

Capucci A.: P1242 

Caralt T.M.: P1141 

Caravati F.: P1264, P1463 

Carballo Ruiz M.C.: P1377 

Carbone C.: P1212 

Carbucicchio C.: P1431, P204, P221 

Cardin C.: P1067, P1119, P1280, 

P1535, P283, P561 

Cardinali L.: P1063 

Cardoso G.: P1207, P1418, P537 

Cardoso Jung Batista R.: P1507 

Careri G.: P697 

Carlsen A.L.: P921 

Carlson J.: 758, P1121, P1531, P535 

Carlsson M.: 485, P701 

Carmel N.N.: P1211 

Carminati C.: P593 

Carmo P.: 874, P1207, P1384, P1418, 

P1430, P537, P574, P658, P679 

Carnero G.: P242 

Carpinteiro L.: P1246 

Carrabba N.: P1227 

Carrassa G.: P1454 

Carrault G.: P1084 

Carre F.: P1084 

Carrie D.: P1067, P283 

Carrilho-Ferreira P.: P597 

Carrillo Perez-Tome M.: P1447 

Carrillo R.: P1048, P1218, P1228, 

P1247, P1472, P1478, P256 

Carrizo A.G.: P1022 

Carrizo L.: P229, P656, P997 

Carr-White G.: P1488 

Carter N.: 899, P675 

Carvalho A.C.: P1285 

Carvalho M.: P56 

Carvalho M.S.: P1207 

Carvalho M.S.: 874 

Carvalho P.: P1549 

Carvalho S.: P537 

Casado R.: P1026, P1468 

Casado-Arroyo R.: P295 

Casella M.: P1009, P1184, P1431, 

P204, P221, P549 

Cassetti E.: P1057 

Cassina T.: P1213 

Casso G.: P1213 

Casteigh B.C.: P1173 

Casteigt B.: 1325 

Castel A.: 489 

Castella M.: P542 

Castellanos E.: P954 

Castellanos Martinez E.: P1450 

Castellant P.: P1395 

Castilla M.L.: P954 

Castrejon Castrejon S.: P1008, P1174, 

P652, P1157, P1188, P629 

Castrejon S.: P202, P559, P631, P654 

Castrillo C.: P575 

Castro Dorticos J.R.: P1507 

Castro P.: 873 

Castro Urda V.: P1203, P187 

Cati A.: P1094 

Caumette D.: P1394 

Cavaco D.: 874, P1207, P1384, P1418, 

P1430, P537, P574, P658, P679 

Cazeau S.: P1061, P1068, P1498, 

P595, P696 

Cebron J.P.: P1155, P1401 

Cebula S.: P612, P705 

Cekirdekci E.: P238 

Celeiro M.: P1107 

Cemin R.: P1197 

Centa M.: P1094 

Cenusa O.: P1526, P584 

Cerbai E.: P64, P67 

Ceresa F.: P1062 

Cerini M.: P262 

Cerisano G.: P1227, P253 

Cesari F.: P1238 

Cha S.S.: P1389 

Cha Y.-M.: 96 

Chai Q.: 96 

Chan D.: P685 

Chande S.: P680 

Chandran S.: P1233 

Chang S.L.: P1387 

Chang S.-L.: P608 

Chang Y.: P260 

Chang Y.-C.: P608 

Charitos E.: 1357, P292, P607 

Charitos E.I.: P964 

Charlton S.: P1244, P1379 

Charlton T.A.: P1379 

Chasnoits A.: 742, P1006, P666 

214 

Chastre T.: P1469 

Chaumont J.: P226 

Chazov E.: P928 

Checchi L.: P1053, P1454 

Checchinato C.: P244 

Cheggour S.: P1033, P1044 

Chelu M.G.: P941 

Chen C.H.: P1455, P1513 

Chen G.: P200 

Chen J.: 304, P1138, P1145, P1232 

Chen P.R.: 858 

Chen S.: P200 

Chen S.A.: P1387, P297 

Chen S.-A.: 1315, P608 

Chen T.: P1451 

Chen T.S.: 858 

Chen X.: P1183, P1433 

Chen Y.Y.: 1315 

Chen Z.: P1224, P1488 

Cheng L.: P194 

Cheng L.J.: P58, P948 

Cheng T.S.: P994 

Cherkashin D.: P628 

Chernova A.: P922 

Chetverikov S.: P1296 

Chevalier P.C.: P632 

Chien K.-L.: 1315 

Chierchia G.B.: P1026, P1468, P295 

Chikata A.: P1245, P634 

Chilukoti R.K.: P71 

Chin A.: P1485 

Chin D.T.: P1467 

Chin J.: P1266 

Chinitz J.S.: P970 

Chiusso F.: 1359, P1076 

Chlouverakis G.C.: 802 

Cho E.: 872 

Cho J.G.: 900, P236 

Cho Y.: P1270 

Choi J.I.: P1125, P661, P955, P987 

Choi J.E.: P1192 

Choi J.H.: P1300, P710 

Choi K.-J.: P1393 

Choi S.Y.: P1300, P710 

Choi W.S.: P1270 

Chong E.: P1387, P297 

Chong E.R.I.C.: P608 

Chorro J.: P230 

Chothani A.: 1318, P1372, P648, P951 

Christe G.C.: P632 

Christiansen M.: P921 

Chrysostomakis S.: P1043 

Chrysostomakis S.I.: 490

Chu G.: 913, P1095 

Chu G.S.: P980 

Chu J.-M.: P1102 

Chudzik M.: P1045, P1054, P1263 

Chui K.H.O.: 917 

Chun J.K.R.: P946 

Chun K.R.J.: P1165, P1179, P1429, 

P989 

Chung F.-P.: P608 

Chwyczko T.: P272 

Ciaccio C.: 486 

Ciardiello C.: P1051, P1212, P1258, 

P1489, P690, P698 

Ciconte G.: P577 

Cihak R.: P1114, P1137, P1411, P548 

Cintas P.: P1535 

Cipolletta L.: 741 

Cireddu M.: P630 

Cirenza C.: P1285 

Claes N.: P1371 

Claus P.: P296, P557 

Clemens M.: P1425 

Clopton P.: 302, P940 

Cochet H.: P545, P937 

Codner P.C.: P619 

Coelho C.: P1246 

Coffey J.: 1318, P1372 

Colantoni C.: P220 

Colchero T.: P275 

Colin Lizalde L.J.: P1106 

Colkesen A.Y.: P1539 

Coll-Vinent B.: P939 

Colombatti G.: P1549 

Colombo S.: P547 

Coluccia G.: P556 

Combes N.: 1325, P1401 

Combes N.C.: P1173, P532 

Combes S.: 1325, P1401 

Combes S.C.: P1173, P532 

Combescure C.: P573 

Compier M.G.: P211, P527 

Compton S.C.: P1477 

Conde D.: P196, P626 

Connolly S.J.: P1163 

Connors S.: 493 

Contardi D.: P602 

Conte G.: P295 

Conte M.R.: P986 

Conti S.: P620, P621 

Coppess M.A.: P1244 

Coppini R.: P64, P67, 81 

Coppola E.: P1463 

Coresh J.: P205 


Corici C.: P52 

Coro’ L.: P1094 

Corradi L.: P1022 

Correia A.: 1361, P606, P639 

Corsi C.: P280 

Corsi P.: P1227 

Cortes Garcia M.: P1021 

Cortes M.: P1014, P576 

Cortez-Dias N.: P1246, P597 

Costa F.: P1207, P1384, P1431, P574, 

P658, P679 

Costa F.M.: 874 

Costa R.: P1231 

Costa R.C.: P1200 

Costabel J.P.: P196, P626 

Cota Delgado F.: P1377 

Coulier R.: P954 

Coulombe A.: 755 

Coutu B.: 493 

Covassin N.: P1286 

Coviello I.: P697 

Covino G.: P698 

Cowie M.: 448 

Cozar Leon R.: P711 

Cozar-Leon R.: P1016 

Cramer M.J.: P267 

Crandall B.G.: 784 

Cransac F.: P1090 

Cransac F.C.: P622 

Crea F.: P697 

Cremona V.: P1264 

Crijns H.J.G.M.: 1322, P184 

Crisci T.: P1212 

Cristovao J.: P278 

Crocini C.: P67 

Cron C.: P561 

Crowley J.: P1025, P248 

Cruz C.: P1540 

Cruz Ferreira R.: P677 

Cruz J.M.: P1016 

Crystal E.: 493 

Csanadi Z.: P1425, P213, P935, P999 

Csillik A.: P271 

Cubranic Z.: P921 

Cui K.: P1007 

Cuko A.: 486, P1057, P188 

Cung T.T.: P1090 

Cung T.T.C.: P622 

Cuoko F.C.: 738 

Curci V.: P962 

Curila K.: P1483 

Curnis A.: 446, 860, P1078, P1177, 

P1495, P1515, P262 

215 

Curry J.: P1214 

Curtis A.: 448, P1023 

Curzen N.P.: 917, 95 

Cvijic M.: P1101 

Cygankiewicz I.: P1054 

Czajkowski M.: P191, P192, P579 

Czarnecka D.: P589 

D 

Da Deppo L.: 789 

Dabiri Abkenari L.: P1126, P1443, 

P1445 

Dabrowski R.: P272 

Daci S.: P623 

Dafni M.: P1271, P1536 

Dagan T.: P234, P235 

Dahl K.: P704 

Dai Z.: P1128 

Dal Monte A.: P280 

Dalal N.: 451, 856, P942 

Daleffe E.: P1436 

Dallaglio P.: P512 

Dalsgaard A.: P1013 

Daly K.: P1025, P248 

Daly R.C.: 96 

Damasio A.F.: P1107 

Dan D.: P1068, P1498, P595, P696 

Danad I.: P672 

Danielsen T.K.: 7 

Danna P.: P1181 

Dannberg G.: P1240 

Dannheimer I.: P1485 

Darbar D.: P1423 

Darma A.: P255 

Darrieux F.: P995 

Datino T.: P1088, P553 

Datino T.D.: P1412 

Daubert J.C.: P564 

Dauwe D.: P557 

Davies W.: P203 

D’avila A.: P523, P970 

Davis J.: P1189 

Davy J.M.: P1090 

Davy J.-M.: P1394 

Davy J.M.D.: P622 

Day J.: 303 

Day J.D.: 784 

De Asmundis C.: P1026, P1468 

De Bie M.K.: P516 

De Boer T.: P63 

De Boer T.P.: P68 

De Bortoli A.: 304, P1138, P1145 

De Buck S.: P557, P647 

INDEX

INDEX 


De Caralt T.M.: 312 

De Castro R.: P1077 

De Chillou C.: P1012, P1301 

De Cobelli F.: P220 

De Cock C.C.: P1257, P1512 

De Cristofaro R.: P690 

De Ferrari G.M.: P184 

De Girolamo P.: P1001 

De Girolamo P.G.: P212 

De Greef Y.: P1150, P538, P642 

De Groot N.: P1126, P1443, P1445 

De Haan S.: P672 

De Juan J.: P631 

De La Cruz E.: P1021 

De La Cruz I.: P1221 

De La Torre Prados M.V.: P1377 

De La Vieja J.J.: P1042 

De Lima E.: P988 

De Lima G.G.: P227 

De Luca G.: P1057 

De Lucia R.: 492, P1030, P261, P556 

De Melis M.: 786, P531 

De Meyer G.: P1148, P1153 

De Neve J.: P1293 

De Pablos L.: P629 

De Paola A.A.: P1285 

De Paula Van Der Steld L.: P1279 

De Pauw F.: P959 

De Paz J.: P1063 

De Ponti R.: P1264, P1463 

De Proft M.: P959 

De Riva Silva M.: P1453, P527, P668 

De Riva-Silva M.: P1193 

De Roest G.J.: P1257, P1512 

De Ruiter G.: P1126 

De Ruiter G.S.: P1226 

De Sanctis V.: 1316 

De Simone A.: P246 

De Sisti A.: P1267 

De Teresa Galvan E.: P1130 

De Teresa-Galvan E.: P258, P263 

De Valais F.: P1185, P657 

De Voogt W.G.: P1226 

De Vries A.A. F.: P48, P46 

De Vries L.: P1126 

Debruyne P.: P642 

Dechering D.A.D.: P1142 

Dechillou C.I.: P947 

Deelawar S.: 1358 

Deering T.: P1068, P1498, P595, P696 

Defaye D.: P1155 

Defaye P.: 901, P1204, P1221, P1375, 

P1401, P1471, P1482 

Defaye P.D.E.: P1140 

Degand B.: P1242 

Degertekin M.: P1100, P1542 

Deharo J.C.: 901 

Deisenhofer I.: P1146, P1169, P533, 

P663 

Deiss S.: P1172, P215, P526 

Dejong P.M.: P251 

Del Castillo-Carnevalli H.: P229, 

P656, P681, P997 

Del Greco M.: P549 

Del Maschio A.: P220 

Del Rosso A.: P1269 

Deladi S.: 307 

Delay M.: P1067, P1280, P1535, P283 

Delgado A.: P229, P656, P681, P695, 

P997 

Delgado H.: P187 

Delgado H.E.: P1203 

Delgado R.: P202, P629 

Delise P.: P1094 

Della Bella P.: 739, P1010, P1047, 

P1222, P1382, P220, P225, P523, 

P547, P577, P630 

Della Rocca D.G.: P1071 

Dello Russo A.: P1009, P1431, P204, 

P221, P549 

Delnoy P.P.: P1512 

Dembic M.: P921 

Demir M.: P208 

Demircan S.: P1037 

Denegri M.: P66 

Deneke T.: P543, P642 

Deng C.Y.: 435 

Deng H.: 435, P1444, P934 

Denollet J.: P267 

Dequarti M.C.: P1213, P653 

Derejko P.: P560 

Dermitzakis A.: P1043 

Derval N.: P1119, P197 

Deshmukh A.: 1318, P1372, P648, 

P951 

Deshmukh P.: P193 

Desmond M.: P687 

Dewhurst M.: P1038 

Di Biase L.: P1032, P1113, P1399, 

P1407, P1431, P1508, P204, P221, 

P999 

Di Cori A.: 492, P1030, P261, P556 

Di Donna P.: P224, P528 

Di Franco A.: P697 

Di Girolamo A.: 1359 

Di Grazia A.: P620, P621 

216 

Di Mambro C.: P1374 

Di Monaco A.: P1184 

Di Toro D.: P1281, P925 

Diaconu N.: P206, P963 

Dias Da Silva V.J.: P293 

Diaz Anton B.: P250 

Diaz-Infante E.: P1016, P711 

Dicandia C.D.: P1258 

Didenko M.: P1223, P1296, P1525 

Diederich L.D.: P1299 

Diemberger I.: P1208 

Dierckx R.: P959 

Dietrich R.: P1423 

Dietrichs E.S.: 8 

Diez J.D.: P1412 

Dignass A.U.: P946 

Dilaveris P.: P1020, P1081, P1461, 

P673, P674 

Dillier R.: P1146, P1169, P533, P663 

Dima K.: P1271 

Dima S.M.: 917 

Dinca Panaitescu S.: P1295 

Dinerman J.: P1023 

Dinis P.: P1261, P637 

Dinov B.: P662, P664, P665 

Diotallevi P.: P580 

Disha V.: P1410 

Diug B.: P1178, P1439 

Diurni M.: P1463 

Divakaramenon S.: P1163 

Djordjevic-Dikic A.: P1072 

Doering M.: P255 

Doesch C.: P75 

Doevendans P.A.: P1256, P267 

Doi T.: P1259 

Doiny D.: P1157, P1188, P202, P559, 

P629, P631, P654, P1008, P1446, 

P652 

Doiny D.G.: P1174 

Dolgushina E.: P1154 

Domenech M.: P939 

Dominguez Rodriguez F.: P187 

Dompinier A.: P1033, P1044 

D’onofrio A.: P1076, P1258, P1515 

Dooley M.: P1178, P1439 

Dorda M.: P1115, P1396 

Dores H.: 874, P1207, P1418, P1430, 

P537 

Dorman H.G.R.: P565 

Dos Santos Galvao Filho S.: P1507 

Dovellini E.V.: P1227, P253 

Drago F.: P1374 

Drasutiene A.: P653

Draxler D.F.: 1319 

Drca N.: 787, P1005, P1162, P936 

Drexel T.: P1124 

Dries E.: 327 

Drouin-Garraud V.: P1199 

Duarte C.: P1507 

Dube B.: P704 

Dubuc M.: P1215 

Ducharme A.: 855 

Dudley S.C.: P66 

Dudziak M.: P1546 

Due K.M.: P247, P678 

Dukkipati S.R.: P970 

Dukkipatti S.D.: 738 

Dumont J.: P1510 

Dumotier B.M.P.: 9 

Duparc A.: P1067, P1119, P1280, 

P1535, P283, P561 

Dupuis J.M.: 901 

Duque M.: P1117, P534 

Duran A.: P1262 

Dursun M.: P1458 

Duru F.: P513 

Duthoit G.: P1469 

Dutka D.P.: P1243 

Dutka D.P.: P281 

Duytschaever M.: P1148, P1153, 

P1293 

Dyer J.W.: P1416 

Dyrda K.: P1215 

Dyrda K.M.: P1193, P527 

Dzhordzhikiya T.: P598 

Dziarmaga M.: P578 

Dzijan-Horn M.: P663 

e 

E Molina C .: 474 

Ebert M.: 857, P266 

Ebrahim I.: P1485 

Ebrille E.: P1370, P224, P528 

Eckardt L.E.: P1142 

Ector J.: P566, P647 

Eddy S.: P274 

Edes I.: P1425, P213, P935 

Efimova E.: P1274 

Efraimidis M.: P1082 

Ehara N.: P614 

Eichel C.: 755 

Eickholt C.: P1124, P1273 

Eidelman G.: P223 

Eisenhart-Rothe A.V.: 788 

Eitel C.: P1438, P1503 

Ekinozu I.: P289 


El Haddad M.: P1148 

El Mahmoudy A.M.: P714 

Elder D.H. J.: P998 

Elencwajg B.: P1063 

Elhraiech A.: P1033, P1044, P286 

Elices J.: P1293 

Elitok A.: P1284, P284 

Ellenbogen K.: 303 

Ellenbogen K.A.: P1241, P274 

Elmaghawry M.: P262 

Elsik M.: P186 

Elvas L.: P277, P278 

Emdin M.: 1360, P1508 

Emkanjoo Z.: P1049 

Endo A.: P1479 

Engel G.: P1217 

Engels E.B.: P1497, P1500 

Enriquez Silverio A.: P1106 

Enta K.: P1229 

Epstein A.: P1205 

Erbay A.: P1037 

Erdem A.: P1262 

Erdem A.L.I.M.: P290 

Erdogan O.: P1100, P1542 

Erer B.: P238 

Ergelen M.: P1289 

Erglis A.: P1108 

Ernst S.: 740, P1187, P550, P977, P996 

Erol C.: P1069 

Errahmouni A.: P1112, P953 

Ertel E.: 10 

Esato M.: P1274 

Escobar Gutierrez D.A.: P1106 

Espejo A.: P1042 

Esposito A.: 739, P220 

Esteban A.: P1440 

Estner H.: P663 

Estrada A.: P1157, P1174, P1188, 

P202, P559, P629, P631, P654, P1008, 

P1446, P652 

Etchepare R.: P988 

Etienne Y.: P587 

Everidge J.: P1059, P269 

Evers E.: P1066 

Evertz R.: 483, 799, P1058 

Everzt R.: 741 

Ewertsen C.: P1073 

Exner D.V.: 493, P1248 

Exposito Garcia V.: P1083, P1196, 

P1518, P575 

Exposito V.: P1086, P1522 

217 

F 

Fabritz L.: 83 

Facchin D.: P1436 

Faerestrand S.: P1079 

Fahy G.J.: P1080 

Fairman E.: P1022 

Fajardo Flores E.: P1106 

Faletra F.: P644, P653 

Falk V.: P1487 

Fan P.: P64 

Fang P.-H.: P1102 

Fang X.H.: P1444 

Fang X.H.: P1455, P611, P934 

Fang X.I.A.N.-H.: P659 

Farag A.: P686 

Faragasso E.: P644, P653 

Farah A.: P1252, P1502, P1504 

Farkas D.K.: P1198 

Farkowski M.M.: P231 

Farre J.: P1021, P1040, P1042, P601 

Farsalinos K.: P1415 

Faryan M.: P1127, P525 

Fassini G.: P204, P630 

Fassini G.M.: P1009 

Fatemi M.: P1395, P587 

Fatini C.: P1053, P1239 

Fauchier L.: P1369, P1482 

Faulknier B.: 856, P1131, P1376, P185, 

P942 

Faustino A.C.: P637 

Favale S.: P246 

Fazaa S.: 1325, P1155 

Fazaa S.F.: P1173, P532 

Fedorowski A.: 870 

Fei H.W.: P611 

Feld G.: P1470, P257, P583 

Feldman A.: P264 

Felix S.B.: P71 

Fellner B.: 1319 

Fernandes M.: P1521 

Fernandez Armenta J.: 741 

Fernandez Aviles F.F.A.: P1412 

Fernandez Banizi P.: P960 

Fernandez De La Concha J.: P265, P270 

Fernandez Lopez X.A.: P709 

Fernandez Lozano I.: P1203, P1465, 

P187 

Fernandez Pastor J.: P1130 

Fernandez-Armenta J.: 312, 483, 799, 

P1058, P1195, P1406 

Fernandez-Aviles F.: P1088, P553 

Fernandez-Lozano I.: P265, P270, 

P695 

INDEX

INDEX 


Fernandez-Pastor J.: P258, P263 

Fernandez-Perez I.: P263 

Fernandez-Portales J.: P512 

Fernandez-Santos S.: P229, P656, 

P681, P695, P997 

Fernandez-Velasco M.: P11 

Ferrantini C.: P64, P67 

Ferraris F.: 1317 

Ferreira C.: 1361, P606 

Ferreira L.G.: P562 

Ferreira M.J.: P277 

Ferreira R.C.: P1519 

Ferreira R.C.: P1268 

Ferrer A.: P1533 

Ferrer Hita J.J.: P1447 

Ferrero A.: P230 

Fiala M.: P1115, P1396, P1398, P217 

Fichtner S.: P1169, P663 

Fiedler L.: P1423, P662, P664, P665 

Figueroa J.: P1174, P202, P1008, 

P1446, P652 

Figueroa J.A.: P1157, P1188, P629 

Figueroa J.A.: P559, P631, P654 

Figulla H.R.: P1240 

Fijorek K.: P589 

Filgueiras D.: P1157, P1188, P202, 

P559, P629, P631, P654 

Filgueiras Rama D.: P655 , P1174, 

P652, P1008, P1446 

Filipecki A.: P1109, P708 

Filipiak K.: P1388 

Fiorentino C.: P698 

Fischer A.: 451, P1063, P687 

Fischer H.: 484 

Flevari P.: 801, P1271, P1536 

Flore V.: P566 

Flores Marin A.: P1130 

Foerster L.: P1216, P273 

Fogelman R.: P234, P235 

Fokkenrood S.: P1160 

Foldesi C.: P271 

Folino F.: P246 

Fonarow G.: 448 

Fontenla A.: P563, P567 

Fontenla Cerezuela A.: P250 

Fontes M.S. C.: P12, P68 

Foon J.: P1244, P1379 

Footz T.F.: P632 

Forclaz A.: P1171, P645, P979 

Ford J.: P50 

Forleo G.B.: P1032, P1071 

Forster T.: P1272 

Fortmueller L.: 83 

Foukarakis E.: P1043 

Foulon V.: P1103 

Fragakis N.: P1417, P624 

Fragata J.: P677 

Francisco Aparicio F.: P711 

Francisco J.: P584 

Frank R.: P1267 

Freedberg A.N.: P264 

Freedman R.: P1023 

Freitas J.P.: 873, 875 

Freund M.W.: P586 

Freynhofer M.K.: 1319 

Freynhofer M.K.: P1039 

Freysz L.: P1201 

Friedman M.: P694 

Friedman P.: P1460 

Frigato N.: P1070, P924 

Frisk M.: P13 

Frohlig G.: P1242 

Fromer M.: P645 

Frommhold M.: P1410, P1419 

Frutuoso C.: P1537 

Fu H.: P194 

Fu H.U.A.: P1007 

Fu H.Y.: P58, P948 

Fuernkranz A.: P1165, P1179, P1429, 

P946, P989 

Fujii K.: P1237, P1434 

Fujii S.: P1075, P1259 

Fujimoto T.: P617 

Fujino T.: P1093, P1104 

Fukamizu S.: 743 

Fukuda K.: P984 

Fukuhara R.: P554 

Fukumoto K.: P1139, P969, P984 

Fukunami M.: P617, P715 

Fukushima H.: P1385 

Fundaliotis A.: P1057 

Furman N.: P1529 

Furniss S.: P1233 

Furukawa Y.: P541, P614, P617, P715 

Furusho H.: P1245, P634 

Futyma P.: P929 

Fynn S.P.: P186 

g 

Gabbarini F.: P224 

Gabus V.: P645 

Gacem K.: P1033 

Gadiyaram V.: P583 

Gadler F.: P1017, P1476 

Gaid H.: P1085 

Gaita F.: 1317, P1370, P1532, P224, P528 

218 

Gajendragadkar P.: P186 

Gali W.L.: P562 

Galizio N.: P242 

Gallinghouse J.G.: P1113 

Gallino Sebastian S.G.: P925 

Gallo P.: P1436, P1489 

Gallotti R.: P1370 

Galvao Braga C.: 1361, P606 

Galvao Santos P.: P574, P679 

Gamble J.: P1254 

Gandjbakhch E.: P1469 

Gang E.: P631, P654 

Gangireddy S.R.: P970 

Gao G.: P66 

Garberoglio L.: P1370 

Garbis S.: 95 

Garcia Alcantara A.: P1377 

Garcia Bermudez M.: P1077 

Garcia Dorado D.: P1526 

Garcia F.: P1375 

Garcia Guerrero J.J.: P265, P270 

Garcia Lunar I.: P187 

Garcia R.: P1537 

Garcia Seara J.: P709 

Garcia-Alberola A.: P563, P567 

Garcia-Bolao I.: P1440 

Garcia-Castelo A.: P625 

Garcia-Dorado D.: P584 

Garcia-Fermandez J.: P223 

Garcia-Seara J.: P625 

Garcia-Yebenes M.: P1440 

Gardner R.S.: P1036 

Garfield S.: 789 

Gargano A.: P242 

Gargaro A.: 1359, P1468, P1515 

Garibaldi M.: P1166 

Garofalo D.: P1016, P655 

Garutti C.: 898 

Garweg C.: P647 

Gaspar A.: P639 

Gaspar T.: 758, P1175, P1274 

Gasparini M.: 446, 450, 860, P1024, 

P1051, P207, P268 

Gatzoulis K.: P1020, P1461, P673, 

P674 

Gatzoulis K.A.: P1081, P1265 

Gavazzi A.: P184 

Gavrielov-Yusim N.: P1019 

Gay A.: P1199 

Gazi E.: P1539 

Gazzoni G.: P988 

Gebauer R.A.: P1474 

Geller J.C.: P1410, P1419

Geller J.C.H.: P1251, P1252, P1502, 

P1504 

Geller L.: 308, 449, 753, P1074, 

P1499, P699 

Gemein C.G.: P1480 

Gemein C.H.: P47 

Gencer M.: P1539 

Gennaro F.: P1132, P1449 

Gensas C.S.: P227 

Gensini G.F.: P1239, P1454 

Gentil-Baron P.: 1320 

Gentili A.: P1024 

Gerdes C.: P1250, P596 

Gerede M.: P1069 

Germanov A.: P635 

Gersh B.J.: P1389 

Ghanem F.: P1033, P1044 

Giachino D.: P1549 

Giakoumakis T.: P1271 

Gialernios T.: P1020, P673, P674 

Giannakakis G.: P1271, P1536 

Giannelli L.: 486 

Giazitzoglou E.: P1417 

Giese A.: P78 

Gil Jimenez T.: P1288, P599 

Gil T.: P1182, P1186 

Gil-Jimenez T.: P1548 

Giniger A.: P1520, P196, P626 

Giomi A.: P700 

Giordano B.: P1164, P1381 

Giordano G.: P690 

Giorgi D.: P580 

Giovene L.: P1076, P1078 

Giudici M.: P1241, P274 

Giuggia M.: P1164, P1381 

Giuliani C.: P1543 

Giurlani L.: P1227, P253 

Giustetto C.: P1532 

Gkouziouta A.: P520 

Gladisova K.: P1202 

Gleed K.: P1460 

Glen E.: P920 

Glerici G.: P1044 

Glick A.: P1019 

Glikson M.: P1019, P585 

Glock Y.: P561 

Godin B.: P1199 

Goessinger H.: P1170 

Goethals M.: P1371, P959 

Goethals P.: P1371 

Goette A.: 788, P71, P78 

Goetzke J.: P1036 

Goktekin O.: P1289 


Golcuk E.: P1284, P1458, P284 

Gold M.: P1510 

Gold M.R.: P1059, P269 

Gold M.R.: 451 

Goldenberg G.: P239 

Goldenberg G.G.: P619 

Goldenberg I.: P1019 

Goldman D.: P1299 

Golenischa V.: 742, P1006 

Golitsyn S.: P928 

Golovchiner G.: P239 

Golovchiner G.G.: P619 

Gomes A.: 1361, P606 

Gomes G.G.: P562 

Gomes J.: P1268 

Gomez Delgado J.M.: P1083, P1518, 

P1522 

Gomez Delgado J.N.: P1086 

Gomez Flores J.F.: P1106 

Gomez Gallanti A.: P655 

Gomez L.: P1520 

Goncalves L.: P278 

Goncalves S.: P1246, P597 

Goncharik B.: 742 

Goncharik D.: 742, P1006, P666 

Gondo T.: P1122 

Gonzalez E.: P1046 

Gonzalez Enriquez S.: P1083, P1086, 

P1196, P1518, P575 

Gonzalez Enrriquez S.: P1522 

Gonzalez J.: P242 

Gonzalez Juanatey J.R.: P625, P709 

Gonzalez Lopez E.: P1203, P187 

Gonzalez N.: P1022 

Gonzalez Torrecilla E.G.T.: P1412 

Gonzalez V.: P230 

Gonzalez-Ferrer J.: P558 

Gonzalez-Moreno J.B.: P1490 

Gonzalez-Torrecilla E.: P1088, P223, 

P553, P655 

Gonzalez-Vasserot M.: P1016 

Gonzalez-Zuelgaray J.: P1185, P657 

Goossens K.: P1150 

Gopi A.: P552 

Gorbunova I.A.: P243 

Gori A.M.: P1238 

Gorissen B.: P1240 

Gornicka B.: P682 

Goudevenos J.A.: P950 

Goudis C.G.: 802 

Grabowski M.: P1473, P682 

Grace A.A.: P186 

Graf D.: P645 

219 

Grajek S.: P1524, P707 

Gramley F.: P1156, P1404, P1435 

Grammatico A.: P207, P268 

Grant C.C.: P609, P706 

Gras D.: P1036 

Gratii C.: P206, P963 

Grau N.: P1221 

Greason K.L.: 96 

Grebe O.C.: P1493 

Greensmith D.: P14 

Greiss H.: P1426, P529, P945, P974, 

P981 

Greiss I.: 855 

Grieco D.: P1509 

Grifoni G.: P1238 

Grigoryan S.V.: P627 

Grill D.G.: P971 

Grimaldi M.: 1316 

Groeneveld M.: P516 

Grohotova V.V.: P1276 

Gromyko G.: P1002, P1296, P1386 

Gronberg T.: P961, P992 

Groppi F.G.: P195 

Grosse A.: P1410, P1419 

Grossi S.: P986 

Grossmann G.: P1027 

Grosu A.: P206, P963 

Grover P.: 1318, P1372, P648, P951 

Grubb N.: P998 

Grubb S.: 473 

Gruber S.C.: 1319 

Gu L.: P66 

Guarnaccia V.: P1269 

Guarracini F.: P1047, P1382, P577 

Guasch E.: 489 

Gudmundsson K.: P1005, P1162, P936 

Guener F.G.: P1142 

Guerra J.: P693 

Guerra J.M.: P1206 

Guerra P.G.: P1215 

Guerra Ramos J.: P671 

Guerrero D.: P595 

Guerrero L.: P1249 

Guiu E.: 312, P1141, P641 

Gujic M.: P550, P977 

Gulati V.: P694 

Guldal M.: P1069 

Gulel O.: P1037 

Gulletta S.: P1010, P1047, P1222, 

P577 

Gunawardene M.: P1165, P1429, P989 

Gungor A.N.C.: P1539 

Guo J.P.: P252 

INDEX

INDEX 


Guo T.: P1060 

Guo Y.: P1123 

Gurkan K.: P238 

Gutierrez J.: P1375 

Gutierrez Larraya F.: P1174 

Gutleben K.J.: P1260, P228, P966 

Guy-Moyat B.G.M.: P532 

Guzik P.: P1089, P1092, P578 

Gwechenberger M.: P1170 

Gwizdala A.: P1524, P707 

h 

Ha A.: 493 

Haarbo J.: P247, P678 

Hachiya H.: P1136, P649 

Hachul D.: P995 

Hacivelioglu S.: P1539 

Hadid Claudio C.L.H.: P925 

Haegeli L.M.: P513 

Haemers P.: P296 

Hai J.J.: P1389 

Hai S.H.: P1286 

Haim M.: P1019, P239 

Haim M.H.: P619 

Haines D.: 307, P1160, P1403, P214 

Haissaguerre M.: P1143, P1421, P197, 

P216, P545, P937 

Hala P.: P605 

Haldar S.: P977 

Halianishcha V.: P666 

Halimi F.: P1155, P1401 

Halimi J.M.: P1369 

Hall D.H.: P920 

Haller B.: P669 

Hallon L.: P1185, P657 

Hama Y.: P1144 

Hamati F.: P1460 

Hamdy A.M.A.L.: P279 

Hamilton B.: P1244 

Hamm C.: P945 

Hamm C.W.: P529, P974, P981 

Hammoudi N.: P286 

Hanazawa K.: P1410, P1419 

Hanci V.: P1539 

Hanke T.: 1357, P292, P607, P964 

Hanley A.: P1080 

Hanninen H.: P1105 

Hanuliakova J.: P1501 

Harada M.: P1385 

Haraguchi G.: P1122 

Harari D.: P1420 

Hardy C.: P995 

Harks E.: 307, P1160, P1403, P214 

Harms H.J.: P672 

Harrison J.C.: 803 

Hartikainen J.E.K.: P961, P992 

Hartog H.: P1242 

Hasan F.: P1287, P254, P660 

Hasanov M.S.: P1517 

Hasebe N.: P1093, P1099, P1104 

Hasegawa T.: P1479, P616 

Hashimoto Y.: P1011, P1159 

Hassan A.: P1251, P1252, P1502, 

P1504 

Hata Y.: P1056, P691 

Hatala R.: 436, P1202, P564 

Hatem S.N.: 755 

Hatzinikolaou-Kotsakou E.H.: P1015, 

P944 

Hausdorf C.H.: P1480 

Hautmann M.: P543 

Haverkamp W.H.: P1408 

Havmoeller R.: P1531 

Havranek S.: P217, P605, P712, P978 

Hayano M.: P1259, P1427 

Hayashi H.: P1018 

Hayashi T.: 743 

Hayashida K.: P536 

Hayat S.: P203 

Hayes C.R.: P1402 

Hayes D.: P1023 

Hayes D.L.: P260 

Head L.: P1087 

Healey J.S.: 493, P1163 

Hebbar P.: P1373 

Heck P.M.: P186 

Hedley P.L.: P921 

Hedon C.: P1090 

Hegyi B.: P15 

Heidbuchel H.: P557, P566, P647 

Heiderfazel S.: P1073 

Heinke M.: P1240 

Heiss G.: P205 

Hell S.W.: 329 

Hendriks M.L.: P1257, P1512 

Herber J.: P663 

Herman D.: P1483 

Hermida J.S.: 901 

Hernadez-Hernadez J.: P553 

Hernandez A.: P1084 

Hernandez I.: P1021 

Hernandez J.: P1088 

Hernandez J.J.: P1021 

Hernandez Madrid A.: P265, P270 

Hernandez-Torres F.: P632 

Herold K.: P1189 

220 

Heroum C.: P1394 

Herrera Siklody C.: P218, P643 

Herrera Siklody C.I.: P1397 

Herrera-Siklody C.: P982 

Herzog E.: 871, 872 

Hessling G.: P1146, P1169, P533, P663 

Heukers R.: P70 

Hiari N.M.: P1243 

Hidden-Lucet F.: P1267, P1469 

Higuchi S.: P1479, P616 

Hillege J.L.: 1322 

Himbert C.: P1469 

Himi T.H.: P1144 

Hindricks G.: 1321, 758, P1175, P1274, 

P1423, P1424, P1428, P1438, P1503, 

P255, P524, P646, P662, P664, P665, 

P973 

Hirahara T.: P1229, P1235 

Hirao K.: P1152, P933 

Hiraoka M.: 743 

Hirata N.: P1479 

Hirayama A.: P1147, P1409, P1442, 

P544 

Hirayama T.: P1093, P1104 

Hireche H.: 1325 

Hiyamuta K.: P1111 

Hjortshoj S.: 1365, P1013 

Hlianishcha V.: P291 

Hlivak P.: P1202 

Ho J.: P219 

Hocini M.: P1119, P1421, P197 

Hoechtl T.: 1319 

Hoefeler T.: P1194 

Hoelschermann F.: P684 

Hoenig S.: P1422 

Hoff P.I.: 304, P1138, P1145 

Hoffmann A.: P1127, P525 

Hoffmann B.: P1448, P530 

Hoffmann B.A.: P1194, P210, P540 

Hohl M.: 757, P72 

Hoijer C.-J.: P245 

Hojo R.: 743 

Hoke U.: 447, P1064 

Holden A.V.: P1278 

Holmberg P.: 916 

Holmqvist F.: 758, 916, P1121, P1531, 

P245 

Homuth G.: P71 

Honarbakhsh S.: P1187 

Honda K.: P1484 

Hong Y.J.: 900, P236 

Honjo H.: 798 

Hopman W.: P638

Horduna I.: P550, P977 

Horie M.: P1018, P77 

Horiuchi D.: P1097, P1534 

Horstkotte D.: P228, P966 

Hortigon-Vinagre M.: 363 

Horton R.: P1113 

Horvath A.: P49, P52 

Hosoda J.: P1075 

Hou W.: P942 

Hou X.F.: P1224 

Houben R.: P959 

Houthuizen P.: P1066, P1497, P1500, 

P1528, P69 

Houtman M.: P63, P65 

Houtman M.J.C.: P70 

Hrachovina M.: P605 

Hu D.Y.: P1527 

Hu H.: P1007 

Huang C.: P1128 

Huang J.: P1455, P1513, P611 

Huang N.: P608 

Hubay M.: P222 

Huber K.: 1319, P1039 

Hueb T.O.: P1200 

Hueb W.A.: P1200 

Huebert V.: P274 

Huemer M.: P1408 

Huerlimann D.: P1487 

Hughes H.: P1514 

Hughes H.B.: 903 

Hughes S.: P1210, P511 

Huh J.: 1362, 912 

Hummel J.: 303 

Hung S.P.: 858 

Hunt J.J.: P1217 

Hunuk B.: P1100, P1542 

Huo Y.: 758, 916, P1175, P1274, P1531 

Hurtado A.: P1046 

Husser D.: 1321, P1380, P1423, P1428, 

P524, P535, P646, P662, P973 

Hussin A.: P1476 

Hutter J.: P1162 

Hynes S.: P248 

I 

Iesaka Y.: P1136, P649 

Iglesias D.: P1196 

Iglesias J.A.: P1040, P1042 

Iijima T.: P975 

Iitsuka K.: P572 

Iizuka T.: P975 

Iliodromitis E.: 801, P1536, P703 

Imaizumi T.: P1122 


Imamura Y.: P1484 

Imazio M.: P244 

Imperadore F.: P962 

Inagawa K.: P1139, P969 

Inage T.: P1122 

Ingram C.: P1423 

Innasimuthu A.: P1541 

Inomata M.: P1437 

Inoue H.: P1294, P232, P926 

Inoue K.: P1237, P1259, P1434, P949 

Inoue Y.: P572 

Insulander P.: P1005, P1162, P936 

Ionescu D.D.: P1295 

Iorgulescu C.: P1414 

Irie T.: P975 

Ishida Y.: P1097, P1534 

Ishihara M.: P1018 

Ishikawa T.: P1075 

Ismer B.: P1240 

Israel C.W.: 1358 

Isshiki T.: P1075, P1259 

Ito H.: P1282 

Ito S.: P1122, P1437 

Itoh H.: P77 

Itoh T.: P1097, P1534 

Iturralde Torres P.: P1106 

Iwakura K.: P1237, P1434 

Iwasaki Y.: P617, P715 

Izquierdo De Francisco M.: P230 

Izzo G.: P1431, P204, P221 

J 

Jacobsen P.K.: P1183, P1433 

Jacon P.: P1204 

Jacon P.J.: P1140 

Jacquemet V.: P704 

Jacquet A.: 755 

Jadidi A.: 305, 306, P1397, P216, P218, 

P545, P643, P937, P947, P982 

Jafri M.S.: 329 

Jagodzinska M.: P1281 

Jais P.: 307, P1143, P1160, P1403, 

P1421, P197, P214, P216, P545, P937, 

P947 

Jakobsen C.: P1013 

Jalife J.: P1533 

Jamalyan S.V.: P1457 

Jamil-Copley S.: P203 

Janak D.: P605 

Jang J.J.H.: P615, P618 

Jang S.W.: P976 

Jang S.Y.: P1270 

Jang S.W.: P1168, P1516, P551 

221 

Jang S.-W.: P1393 

Janicek R.: P61 

Janion M.: P1031, P1481, P688 

Jankowska A.: P231 

Jannot-Berthier A.S.: 1320 

Janousek J.: P1474 

Jansa P.: P712 

Janse P.: P1126 

Janse Van Rensburg D.C.: P706 

Janse Vanrensburg D.C.: P609 

Janssens S.: P557 

Januario Nogueira E.: P293 

Januska J.: P1115, P1396, P1398, P217 

Jarai R.: P1039 

Jarkovska D.: P16 

Jarzyna I.: P1473 

Jastrzebska M.: P1092 

Jastrzebski M.: P1281, P589 

Jauregui M.E.: P1004, P233 

Jazbik J.: P1063 

Jeandel C.: P1394 

Jedrzejczyk-Patej E.: P1055 

Jegere S.: P1108 

Jenei Z.S.: 308, 753 

Jensen-Urstad M.: 787, P1005, P1162, 

P936 

Jeong M.H.: 900, P236 

Jespersen T.: P55 

Jesuraj M.L.: P552 

Jesus I.: P1266, P1544 

Ji S.: P1373 

Jia Y.-H.: P1102 

Jiang J.I.A.N.: P1007 

Jideus L.: P1135 

Jilek C.: P669 

Jimenez J.: P1182, P1186 

Jimenez Jaimez J.: P1288, P1548, P599 

Jimenez-Candil J.: P1028, P512 

Jimenez-Lopez J.: P275 

Joensen A.M.: P636 

Johansen J.: 899 

Johansen J.B.: P675 

Johansen J.B.: P190, P247, P678 

Johar S.: P977 

John S.: P1175, P1380, P1438 

Johnson D.: P654 

Johnson E.E.: P1244 

Jones D.G.: P977 

Jones P.: P1036 

Jones S.: P519 

Jongbloed M.R.: P600 

Jongejan N.: P1256 

Jordaens L.: P1443, P523 

INDEX

INDEX 


Jorgensen O.D.: P190 

Jorge-Perez P.: P1447 

Josan D.: P716 

Joshi R.: P1470, P257, P583 

Jost N.L.: P52 

Joung B.: P1003, P1400, P930 

Joung B.Y.: P967 

Jovanovic D.: P1390 

Jovanovic V.: P1072, P571 

Jowhari H.: P1277 

Juarez-Prera R.A.: P1447 

Juhlin T.: P1121 

Jukema J.W.: P240, P516 

Junqueira Jr L.F.: P562 

Juul-Moller S.: 870 

K 

Kabeya Y.: P616 

Kabutoya T.: P1056, P691 

Kacet S.: P1260 

Kaczmarek J.: P578 

Kadmon U.: P239 

Kaji S.: P614 

Kalahasty G.: P1241, P274 

Kalantzi K.: P950 

Kalarus Z.: P1055, P612, P705, P985 

Kalbfleisch S.: P1420 

Kalejs O.: P1108 

Kalikazaros I.: P1081, P1265 

Kalil C.: P988 

Kalil R.: P988 

Kalinin V.: P598 

Kalleinen N.: P559 

Kallergis E.K.: 802, P569, P938, P958 

Kallikazaros I.: P1461 

Kalusche D.: 857, P266 

Kalyani M.: 1358 

Kamakura S.: 1324, P1018, P1441, 

P1492 

Kamakura S.K.: P518 

Kaminski G.: P1523 

Kamiya K.: 798 

Kammeraad J.A.: P586 

Kamycka E.: P525 

Kamzola G.: P1108 

Kanagaratnam P.: P203 

Kanagkinis N.: P1428 

Kanal M.: P260 

Kanamori N.: P1245, P634 

Kandinsky M.: P1000, P689 

Kaneko S.: P1245, P634 

Kaneko Y.: P975 

Kang Y.C.: P994 

Kanoupakis E.K.: 802, P569, P938, P958 

Kantoch M.J.: P1190 

Kapel G.F. L.: P1118 

Kapel G.F.L.: P1116, P1193, P1453, 

P600, P668 

Kaplan A.: P602 

Kaplunova V.Y.: P1275, P919 

Kappenberger L.: P1283, P1378, P73 

Kaptsiukh T.: P291 

Karaayvaz E.B.: P1284, P284 

Karadavut C.: P983 

Karadavut S.: P1180 

Karaskov A.: 310, 311, 786, P1511 

Karavolias G.: P520 

Karbowy D.: P1089, P1092, P578 

Kardos A.: P271 

Kardys I.: P591 

Kargar H.: P1277 

Karimnia A.: P1277 

Kario K.: P1056, P691 

Karistinos G.: P1265 

Karlsdottir A.: P1183, P1433 

Karosiene Z.: P1287, P1494, P254, 

P660 

Karst E.: P687 

Karystinos G.: P1020 

Kaseno K.: P1427 

Kassotis J.: P1541 

Kataoka N.: P1294, P232 

Kathan S.: P1146, P1169, P533 

Kato M.: P572 

Katritsis D.: 311, P624 

Katritsis D.G.: P1417 

Katritsis G.: P1417 

Katsianis A.: P520 

Katsumata Y.: P1139, P969, P984 

Kautzner J.: P1114, P1137, P1411, 

P1501, P1509, P523, P548, P568 

Kaveney P.: P1059, P269 

Kawakami H.: 1324 

Kawamura M.: P77 

Kawamura N.: P1111 

Kawamura Y.: P1093, P1099, P1104 

Kawasaki M.: P617, P715 

Kawata H.: P1470, P257, P583 

Kazakov A.: P1002, P1296, P1386 

Kazatsker M.: P1211 

Kazbanov I.V.: P46 

Kazmierczak J.: P521 

Keavney B.D.: P920 

Keceoglu S.: P208 

Keel A.J.: P1260 

Kefala A.: P673, P674 

222 

Keilegavlen H.: P1079 

Kelder J.C.: P542 

Kelly P.: P1080 

Kelm M.: P1124, P1273 

Kempa M.: P1045 

Kenneback G.: P1005, P1162, P936 

Kepez A.: P1100, P1542 

Keren G.: P1211 

Kerr D.S.: 803 

Kettering K.: P1156, P1404, P1435 

Kettlewell S.: P51 

Kew G.S.: P932 

Keyl C.: 305, 306, P982 

Khabarova N.V.: P1275, P919 

Khairkhahan A.: 859 

Khairy P.: P1215 

Khalameizer V.: P1019 

Khan F.Z.: P186, P281 

Khan M.: P1126 

Khan Z.: P1416 

Khaykin Y.: P1476 

Khodor N.: P1084 

Khoueiry Z.: P1394 

Khoury A.: P237 

Khubulava G.: P1223, P1525 

Kiedrowicz R.M.: P521 

Kikuchi A.: P617, P715 

Kikuchi M.: P1282 

Kilickap M.: P1069 

Kim J.H.: P1270, P976 

Kim J.H.: P1168, P1516, P551 

Kim J.-H.: P1393 

Kim J.S.: 1362, 912 

Kim J.Y.: P967 

Kim K.: P614 

Kim K.D.H.: P615, P618 

Kim M.H.: P1300, P710 

Kim S.: P203, P216, P545, P937 

Kim S.H.: P1168, P1516, P976 

Kim S.H.: P551, P615, P618 

Kim S.-H.: P1393 

Kim T.S.: P976 

Kim T.S.: P1168, P1516, P551 

Kim T.-S.: P1393 

Kim Y.H.: P1125, P661, P955, P987 

Kim Y.D.: P1300, P710 

Kim Y.H.: P1192 

Kimman G.P.: P591 

Kimua H.: P77 

Kimura H.: P1018 

Kimura M.: P1097, P1534 

Kimura T.: P1075, P1139, P1259, P969, 

P984

Kinjo T.: P1097 

Kinoshita M.: P614 

Kircanski B.: P571 

Kircher S.: P1438 

Kirchhof P.: 83 

Kirkfeldt R.: P190 

Kirkfeldt R.E.: P675 

Kirkwood G.: P53 

Kirmanoglou K.: P1124 

Kis Z.: P271 

Kisheva A.: P1391 

Kiss A.: P1425, P213, P935, P999 

Kistamas K.: P17 

Kitai T.: P614 

Kitamura T.: 743 

Kittnar O.: P605 

Klausz G.: P1110, P1414 

Klautz R.J. M.: P48 

Klautz R.J.M.: P211 

Kleemann T.: 915, P1456, P249, P288 

Klein A.: P1520 

Klein H.: P184 

Klein N.: P515 

Klein P.: P211 

Klein R.: P205 

Klemt A.: P1165 

Klersy C.: 860, P644 

Klimas K.: P578 

Kloppe A.: 450, P1287, P1494, P254, 

P515, P660 

Kluger J.: P694 

Klukvin A.: P1002, P1386 

Knaapen P.: P672 

Knecht S.: P1143, P1421, P201, P972 

Knezl V.: 436 

Knoll M.: P1194, P1448, P530, P540 

Knops R.: P675 

Knops R.E.: 899, P676 

Knutsen T.M.: P1486 

Ko K.J.: P661 

Kobayashi M.: P1385 

Kobayashi T.: P1441, P1492 

Kobayashi Y.: P1282 

Kobori A.: P541, P614 

Kobylecka M.: P1388 

Koch J.: P1438 

Kochhaeuser S.: P1142 

Kochman J.: P1388 

Kocoglu H.: P1262 

Koestler C.M.: 96 

Kofune M.: P1409, P1442, P544 

Koga Y.: P536 

Kogawa R.: P1147, P1409, P1442, P544 


Kohajda Z.S.: P49, P52 

Kohjitani H.: P614 

Kohl T.: 329 

Koivisto A.P.: P49 

Koivumaki J.: P18 

Kok G.J.M.: P68 

Kokinas K.C.: P624 

Kolasa J.: P1127, P525 

Kolb C.: P1146, P515, P533, P669 

Kolen A.: P1403 

Kolodzinska A.: P1473, P682 

Komatsu Y.: P1136, P1143, P1421 

Komiyama K.: 743 

Komolyatova V.N.: P243 

Kondo K.: P572 

Konecny T.: P1286 

Konev A.: P1154 

Koniari K.: P703 

Konstantinou A.: P946 

Kontaraki I.: 490 

Koperski L.: P682 

Koppikar S.: P638 

Korantzopoulos P.: P1120, P950 

Korhonen P.: P1105 

Kormos A.: P19 

Kornej J.: P1380, P646, P973 

Kornowski R.K.: P619 

Korobkov E.: P1529 

Korsukewitz C.K.: P1142 

Koruth J.S.: P970 

Kosiuk J.: 1321, P1424, P1428, P255, 

P524, P646, P973 

Koskelainen T.: P49 

Kosmidis G R.: P20 

Kosmidou I.: P1068, P1498, P595, 

P696 

Koster M.S.: P1256 

Kostopoulou A.: P1415, P520 

Kosztin A.: 449, P1074, P1499 

Kotsakou M.: P1015, P944 

Kotsia A.: P950 

Kouraki K.: 915, P1456, P249, P288 

Kourkoveli P.: P1415 

Koutalas E.: 1321, P1424, P255, P524 

Koutalas E.K.: 802, P569, P958 

Kovacs O.M.: 308, 753 

Kovalenko O.: 742, P1006, P666 

Kowal R.C.: 303 

Kowalczyk J.: P1055, P612, P705, 

P985 

Kowalik I.: P272 

Kowalski O.: P1055, P985 

Kowsar A.: P602 

223 

Koyama Y.: P1237 

Koziolova N.: 756, P640 

Kozlowska M.: P682 

Kraaier K.: P1459, P565 

Krahn A.D.: 493 

Kramarz E.: P287 

Kranig W.: P1260 

Krasnoperov P.: P1002, P1386 

Krause D.: P1065 

Krause R.: 484, P1065 

Krauze T.: P1089, P1092, P578, P707 

Kremzer A.: 914 

Krivolapov S.: P594 

Krolicki L.: P1388 

Kronborg M.B.: P1250, P596 

Kroon W.: 484, P1065 

Krueger M.: P514 

Kruemel F.: P602 

Krug J.: P543 

Krum H.: 450 

Krummen D.: 302, P633, P940, P957 

Krummen D.E.: P1383, P219 

Krusche C.: 83 

Kruse M.L.: P227 

Krychtiuk K.A.: P1039 

Krynski T.: P929 

Krzyzak P.: P1545 

Krzyzanowski K.: P1523 

Kubus P.: P1474 

Kucera P.: P1501 

Kuchmin A.: P628 

Kuck K.H.: 1323, 309, P1151, P215, 

P514 

Kuck K.-H.: P1172, P1420, P526 

Kudlicka J.: P605 

Kuehne M.: P1234, P201 

Kuehnert H.: P1240 

Kuhne M.: P972, P991 

Kuiper M.: P1496, P1528, P69 

Kuipers M.: P1066 

Kujira K.: P554 

Kukla P.: P1281 

Kulakowski P.: P929 

Kulina R.A.: P970 

Kumagai K.: P1294, P1427, P232, 

P949, P968 

Kumanomido A.: P1122 

Kumar C.: 451 

Kumar S.: P1541 

Kunchev O.G.: P1391 

Kuniss M.: P1426, P529, P945, P974, 

P981 

Kuptsov V.: P598 

INDEX

INDEX 


Kurabayashi M.: P975 

Kurita T.: 898 

Kurnikova E.: P1462 

Kurushko T.: P291 

Kus T.: P610, P704 

Kusa S.: P1136, P649 

Kusano K.: P518 

Kusayama T.: P1245, P634 

Kusniek J.: P239 

Kutarski A.: P1031, P1045, P1050, 

P1225, P1473, P1475, P1481, P191, 

P192, P579, P682, P688 

Kuteszko R.: P231 

Kutyifa V.: 449, P699 

Kwan K.J.: P615, P618 

Kwasniewski W.: P1109, P708 

Kwok S.: P680 

Kypta A.: P1422 

Kyriakides Z.S.: P1466 

Kyriakou P.: P624 

Kyrlas K.: P950 

L 

La Rosa C.: P1489 

Labadet Carlos C.D.L.: P925 

Labartkava E.: P598 

Labrova R.: P1398 

Lacaze-Gadonneix J.: P1158, P965 

Lacko S.: P605 

Lado M.: P625 

Ladwig K.-H.: 788 

Ladwiniec A.: P685 

Lagou S.: P1271 

Laguna P.: P1290 

Lahitton B.: P1033 

Lahoda D.: P193 

Laino R.: P1520 

Laite L.: P1507 

Lakshmanadoss U.: P193 

Lalani G.: P940, P957 

Lalani G.G.: P1383 

Lalukota K.: P552 

Lambardi M.F.: P196, P626 

Lambert H.L.: 738 

Lambert P.: P1394 

Lambert T.: P1422 

Lambiase P.: 899, P675 

Lammertsma A.A.: P672 

Lamp B.: 1358, 860 

Lanczi L.: P1425 

Landelius P.: P1135 

Landolina M.: 446, P1024, P1495, 

P207, P268 

Lang C.: P998 

Lanza G.A.: P697 

Lappe D.L.: 784 

Laranjo S.: P1268, P1519, P56, P600 

Larkin S.E.: 95 

Larsen J.M.: P247, P678 

Larsson S.C.: 787 

Latcu D.: P1112, P953 

Latcu D.G.: P1166 

Latkin M.: P1000, P689 

Latsios P.: P1015, P944 

Lau D.H.: 754 

Lau T.-W.: 96 

Laubscher M.: P1419 

Laucevicius A.: P47 

Laurenzi F.: P1001, P212 

Lauschke J.: P1230, P1432 

Lawless M.: P21 

Laynez-Cerdena I.: P1447 

Lazaro C.: P229, P656, P681, P695, 

P997 

Lazzara R.: P1416 

Le Franc P.: P1036 

Le Gal G.: P587 

Le Polain De Waroux J.B.: P1036 

Leal Del Ojo J.: P1471 

Lebedev D.: P1052, P1462, P1506, 

P276, P588, P594 

Lebedev D.S.: P1276 

Lebedeva V.: P1052, P1506, P276, 

P588 

Leber R.: P1283 

Lebini S.: P986 

Lebreiro A.: P1291, P1537, P1540, 

P558 

Leclercq C.: 446, 860, P1260, P564 

Leclercq F.L.: P622 

Lederer W.J.: 329 

Ledesma C.: P1028, P512 

Lee D.I.: P1125, P955, P987 

Lee D.H.: P1300, P710 

Lee H.: 96 

Lee H.S.: P661 

Lee H.C.: P1389 

Lee J.H.: P1270 

Lee K.: 448 

Lee K.H.: 900, P236 

Lee K.L.L.: 450 

Lee M.Y.: P976 

Lee M.H.: P1003, P1400, P930, P967 

Lee M.Y.: P1168, P1393, P1516, P551 

Lee S.H.: 1362, 912 

Leftheriotis D.: P1271, P1536 

224 

Leggio M.: P690 

Lehinant S.: P1426, P945 


Lehrmann H.: 305, 306, P1397, P216, 

P218, P545, P643, P937, P982 

Leiria T.L.L.: P227 

Leitao-Marques A.: P1261, P637 

Leitsch T.: P1493 

Leitz P.L.: P1142 

Lemke B.: 450, P1287, P1494, P254, 

P660 

Lenarczyk R.: P1055, P985 

Lendeckel U.: P71, P78 

Lendvai Z.: P222 

Leng C.: 898 

Lennerz C.: P515, P669 

Lensi M.M.: P1231 

Leny A.: P999 

Lepska L.: P1546 

Lerena P.: P1083, P1086, P1196, 

P1518, P1522 

Letsas K.: P950 

Leube R.: 83 

Levijoki J.: P49 

Levin V.: 487 

Levine R.: P1249 

Levinstein Jacinto M.: P1106 

Levinstein M.: P295 

Levitchi A.: P716 

Levorato D.: 492, P1030, P261, P556 

Levya F.: 448 

Lewalter T.: P531 

Leyse E.: P295 

Leyva F.: 446, 488, 860, P1510, P189 

Lezaic L.: P1101 

Li A.: P1189, P519 

Li C.L.: P1527 

Li D.: P1232 

Li G.: P1120, P194, P931 

Li G.P.: P58, P948 

Li J.: P194, P58, P948 

Li L.: P1120 

Li R.J.: P1060 

Li T.: P659 

Liang B.: P22 

Liang Y.H.: P1444 

Liao H.T.: P1444 

Liao H.O.N.G.-T.: P659 

Liao H.T.: P934 

Liao M.-T.: P923 

Liccardo M.: P1212 

Licina M.: P1392, P209 

Ligon D.: 859

Lilli A.: P590 

Lim H.E.: P1125, P661, P955, P987 

Lim H.E.: P1192 

Lim H.S.: 754 

Lim P.B.: P203 

Lim R.S.: P661 

Lim T.W.: P932 

Lin A.: P1216 

Lin C.: P608 

Lin J.L.: P923 

Lin L.Y.: P923 

Lin Y.: P1451 

Lin Y.J.: P297 

Lin Y.-J.: 1315, P608 

Linde C.: 448 

Linde- Estrella A.: P258, P263 

Ling T.-Y.: 96 

Linke J.: P78 

Lins C.K.: P1507 

Linz D.: 757, P72, P956 

Liotta C.: P620, P621 

Liow N.: P1233 

Lip G.: P646, P973 

Lip G.Y.H.: P1123, P1369, P1390 

Lipari A.: P262 

Liptai C.S.: P1074, P1499 

Litterfeldt I.: P245 

Little W.: 448 

Liu C.: P194, P58 

Liu C.L.: P948 

Liu S.: P200 

Liu T.: P1120, P1455, P194, P58, P611, 

P931, P948 

Liu W.L.: P1527 

Liu Y.: P1232 

Liu Z.: P1102 

Livanis E.: P1415, P520 

Lloyd G.: P1233 

Lo L.-W.: P608 

Lo M.-T.: P608 

Locantore E.: P262 

Loew L.: P67 

Lohmann H.H.L.: P1142 

Loke W.I.: P1467 

Lonnerholm S.: P1135, P1161 

Looi K.L.: P186 

Loose S.: P50 

Lopez A.: P954 

Lopez Cabanillas N.: P1063 

Lopez F.: P205 

Lopez Gil M.: P250 

Lopez Moreno E.: P1288, P599 

Lopez Perez M.: P1548 


Lopez-Sanchez F.: P275 

Lopez-Sendon J.L.: P202, P1008, 

P1446, P652 

Lopin D.: P1220 

Lorentzen L.A.S.S.E.: P55 

Lorgat F.: P1485 

Losik D.: 310, 786 

Louch W.: 80 

Louis P.: P1201 

Lourenco A.: P1521 

Lowthian J.: P1178, P1439 

Lubimceva T.: P1052, P1506, P276 

Lucas J.: P1196 

Lucca E.: P259 

Lueker J.: P1194, P210 

Luermans J.G.L.: P983 

Luescher T.F.: P513 

Luik A.: P1405 

Luise R.: P246 

Luker J.: P1448, P530, P540 

Lunati M.: 446, P1024, P1495, P207, 

P268 

Lundbye-Christensen S.: 1365, P636 

Lupo A.: P1070, P924 

Luther S.: 329 

Luzi M.: P246 

Lyan E.: P1002, P1167, P1176, P1386 

Lyubimtseva T.: P588 

M 

Maack C.: P72 

Mabo P.: P1158, P564, P965 

Mabo P.H.: 901 

Mabru M.: P1199 

Maca A.: P1108 

Maccabelli G.: 739, P220, P225, P547, 

P630 

Mach F.: 1320 

Machado Cesar L.A.: P1200 

Macia E.: P1040, P601 

Maciag A.: P1045, P231, P272 

Macias E.: P1016 

Macias R.: P1288, P599 

Macias Ruiz R.: P1182, P1186, P1548 

Maciel M.J.: 873, 875, P1291, P1537, 

P1540, P558 

Macle L.: P1215 

Macneill B.D.: P1025, P248 

Madeja Z.: P525 

Madia R.O.: P1231 

Madrazo I.: P575 

Madrid A.H.: P229, P656, P681, P695, 

P997 

225 

Madureira A.: P1291, P1540 

Maessen J.G.: P1528, P69 

Maffessanti F.: P593 

Magalhaes A.: P1246, P597 

Magalhaes S.: 1361, P606 

Magnani R S.: P1206 

Magnani S.: P671, P693 

Mahajan D.: P1241, P274 

Maharatna K.: 917 

Mahfoud F.: 757, P72, P956 

Mahfouz K.: P1071 

Mahiddine O.: P704 

Mairesse G.H.: P1371 

Majewski J.: P543 

Makai A.: P1110, P1272, P1414 

Makarov L.M.: P243 

Makaryan Y.S.: P627 

Makimoto H.: 1323, P1172, P526 

Makita N.: P77 

Makiyama T.: P77 

Makowski K.: P1523, P287 

Malaczynska-Rajpold K.: P1524 

Malecka B.: P1045, P1225, P191, P192 

Maleckar M.M.C.: P23 

Malek I.: P568 

Malev E.: P1096 

Malhotra A.: P539 

Malik J.: P605 

Malik M.M.: P1298 

Malikov A.V.: P1517 

Malinova L.: P1529 

Malliaraki N.M.: 802 

Malmborg H.: P1135, P1161 

Malmkvist T.: P1017 

Man S.: P1292 

Mancusi M.: P1208 

Mandrile G.: P1549 

Manegold J.C.: 1358 

Manfrin M.: P1197 

Manganiello S.: P1164, P1381 

Mangrum M.: P1420 

Maniotis C.: 871, 872, P1466 

Manis G.: P673, P674 

Mano H.: P1147, P1409, P1442, P544 

Manolis A.G.: P1466 

Manotheepan R.: P24 

Manounis T.: P602 

Mansour M.: P1420 

Mansour M.M.: 738 

Mansourati J.: P1395, P587 

Manteghi A.: P1277 

Mantica M.: P1032, P1258 

Mantovani G.: P1078, P602 

INDEX

INDEX 


Mantziari L.: 740, P1187, P996 

Maounis E.: P520 

Maragkoudakis S.M.: P569, P958 

Marai I.: P237 

Marasini M.: P224 

Marcheix B.: P561 

Marchese P.: P1132, P550, P977 

Marchetti G.: P198 

Marchlinski F.M.: 738 

Margheri M.: P280 

Margitfalvi P.: P1202 

Margulescu A.D.: P1034 

Marijon E.M.: P1173, P532 

Marin J.: P1117, P534 

Maring C.: P266 

Marinin V.: P1462 

Marin-Neto J.A.: P562 

Marino A.P.: P1212 

Marino P.: P1057 

Marino V.: P221 

Marinskis G.: P47 

Markides V.: P977 

Markstad H.: 485, P701 

Marocolo Junior M.: P293 

Marocolo M.: P294 

Marocolo M.: P60, P702 

Marques J.: P639 

Marques M.: P658 

Marques N.: P1266, P1544 

Marquez Murillo M.F.: P1106, P1267 

Marras E.: P1094 

Marrero R.: P1507 

Marshall H.: 488 

Marti J.: P1004, P1471, P233 

Martignani C.: P1208 

Martin A.: P1028, P1140, P1204 

Martin D.O.: 450 

Martin Gorria G.: P1196 

Martin R.I.R.: P920 

Martinca T.: P1501 

Martinek M.: P1124 

Martinelli M.: P1200, P1231 

Martinenghi N.: P242 

Martinez A.: P230 

Martinez Ferrer J.: P1465 

Martinez L.: P1533 

Martinez Sande J.L.: P709 

Martinez-Ferrer J.: P563, P567 

Martin-Luengo C.: P1028, P512 

Martino M.: P1242 

Martins E.: P1291 

Martins J.: P639 

Martins Oliveira M.: P677 

Martins R.: P277, P278 

Martins R.P.: P1158, P965 

Maruyama J.: P1093, P1104 

Marx M.: P1170 

Marx N.: P1273 

Marx N.M.: P1480 

Marynissen T.: P1103, P566 

Marzegalli M.: P1495 

Marzi A.: P1047, P1222, P1382, P577 

Masca N.: P980 

Mascioli G.: 1360, P1508, P259 

Masella C.: P1495 

Massin F.: P1090 

Massin F.M.: P622 

Massumi A.: P941 

Matejka T.: P1474 

Matelot D.: P1084 

Mathew S.: 1323, P1151, P1172, P215, 

P526 

Matia R.: P229, P656, P681, P695, 

P997 

Matsudo Y.M.: P1144 

Matsuki M.: P1093, P1104 

Matsumoto T.: P1484 

Matsumura A.: P1011, P1159 

Matsuo S.: P1245 

Maury P.: P1067, P1119, P1171, P1280, 

P1532, P1535, P283, P561, P645, P979 

Maxian R.: P1411 

May H.T.: 784 

May S.A.: P941 

Maykov E.: P928 

Mayordomo Gomez S.: P250 

Mayr H.: P1219 

Mayrakis H.M.: 802, P569, P938, 

P958 

Mazomenos E.B.: 917 

Mazurek M.: P1055 

Mazurek T.: P1388 

Mazza A.: P690 

Mazzocca G.: P580 

Mazzone P.: P1010, P1047, P1222, 

P1382, P577 

Mcbane R.D.M.: P971 

Mccann G.P.: 913, P1095 

Mccomb J.M.: P1038 

Mcfadden C.: P1025 

Mcgarry T.: P1470, P257, P583 

Mcgee C.: P692 

McGlynn K.: P25 

Mcgrew F.A.: P1244, P1379 

Mcneil J.: P1178, P1439 

Mcnicoll S.: 855 

226 

Mcspadden L.C.: 486, P188 

Mechakra A.: P632 

Medeiros De Vasconcelos J.: P1507 

Medeiros F.: P1537 

Medeiros-Domingo A.: P513 

Medina E.: P1117, P534 

Medina Palomo C.: P1130 

Medina-Palomo C.: P258, P263 

Mehta K.: 1318, P1372, P648, P951 

Meijer A.: 898 

Meine M.: 800, P1256, P267 

Meinertz T.H.: 788 

Meisel S.: P1211 

Mejia E.: P567 

Mejia Martinez E.: P250 

Melczer L.: P1209 

Melduni R.M.: P1389 

Melek M.: P208 

Mellander O.: 870 

Melo S.: P995 

Memisovic N.: P1419 

Memmi M.: P62 

Mendes M.: 874, P1207, P1384, P1418, 

P574, P679 

Mendez F.: P693 

Mendez Zurita F.: P1206, P671 

Meo M.: P1166 

Merce Klein J.: P1077 

Mercier V.: P1221 

Merino J.L.: P1157, P1174, P1188, 

P202, P559, P629, P631, P654 

Merino Llorens J.L.: P1008, P1446, 

P652 

Merkel M.: P1405 

Merkely B.: 308, 449, 753, P1074, 

P1499, P222, P699 

Merkureva A.: P1002, P1386 

Mesa J.M.: P1046 

Messano L.: P582 

Meste O.: P1166 

Metzner A.: 1323, 309, P1151, P1172, 

P215, P526 

Meuwese C.L.: P668 

Meyer C.: P1124, P1273 

Meyyappan C.: P189 

Miake J.: P572 

Michael K.: P638 

Michael K.A.: P251 

Michalak M.: P1524 

Michalkiewicz D.: P1523 

Michalski J.: P1205, P517 

Michaud G.F.: P523 

Michelotti F.: 1360, P259

Michelucci A.: P1053, P1238, P1239, 

P1454, P253 

Michieletto M.: P1070, P924 

Mihajlovic N.: 307 

Mihalik T.: P1151 

Mijic D.: P1287, P1494, P254, P660 

Milasinovic G.: P1072, P184, P571 

Milasinovic G.M.: P1477 

Milathianaki M.M.: 802 

Milcevic M.: P1541 

Militianu A.: P1019 

Miller J.: 302, 303, P633, P940 

Miller M.A.: P970 

Milnes J.: P50 

Milpied P.: P1498, P595 

Mimoso J.: P1544 

Min X.: P1376, P185 

Mine D.: P536 

Minoia C.: P1264 

Minoura Y.: P1282 

Mintale I.: P1108 

Miranda A.: P1117 

Mircheva L.G.: P1391 

Mironov N.: P928 

Mischke K.: P1273 

Miszczak-Knecht M.: P560 

Mitamura H.: P1479, P616 

Mitkowski P.: P1045 

Mitrani R.D.: P648, P951 

Mitrega K.: P705 

Mitrofanova L.: 916 

Mitroi C.: P187 

Mitsuhashi T.: P1056, P691 

Mitsuyama H.: P667 

Mittal S.: 310, 311, 786, P1511 

Miura N.: P995 

Miyamoto K.: 1324, P1018, P1441, 

P1492 

Miyamoto T.: P554, P933 

Miyata K.: P1437 

Miyauchi Y.: P949 

Miyazaki A.: P1547 

Miyazaki S.: P1136, P1143, P1421, 

P649, P937 

Mizia-Stec K.: P1109, P1127, P525, 

P708 

Mizukami A.: P1011, P1159 

Mizukami K.: P667 

Mizumaki K.: P1294, P232 

Mizuno H.: P547 

Mlcek M.: P605 

Mllat G.M.: P632 

Mlynarska A.: P1253, P993 


Mlynarski R.: P1253, P993 

Moccetti T.: P1213, P282, P653 

Mochalina N.: P1121 

Moeller V.: P684 

Moenning G.M.: P1142 

Mogado F.: P679 

Mohamed Fereig Hamed H.: P279 

Mohamed S.: 872 

Mohammadi L.: P943 

Mohanty P.: P1113, P1407 

Mohanty S.: P1113 

Moisei R.: P1204 

Moisei R.E.M.: P1140 

Moja L.: P1399 

Molina Martin De Nicolas J.: P250 

Mollazadeh R.: P1049 

Mollerus M.: P1029 

Mollo R.: P697 

Molnar L.: 449, P1074, P1499, P699 

Molon G.: P1051, P1258 

Moltedo J.M.: P1452, P713, P1129 

Moltrasio M.: P1009 

Momomura S.: 448, P1229, P1235 

Mondoly P.: P1067, P1119, P1280, 

P1535, P283, P561 

Monnery D.: P1035 

Mont L.: 312, 483, 489, 741, 785, 799, 

P1058, P1141, P1195, P1406, P542, 

P709, P939 

Mont L.L.: P641 

Monteagudo M.: P1046 

Monteforte N.: P62 

Montserrat S.: P939 

Moody W.E.: P189 

Moraes E.R.F.L.: P1285 

Moraes R.: P988 

Morales Velazquez J.L.: P1106 

Morales-Portano J.D.: P576 

Morani G.: P1051, P592 

Moreira N.: P277, P278 

Morel E.M.: P632 

Morell S.: P1465, P230 

Moreno J.: P1375, P1482, P558 

Moreno L.: P1440 

Moretti P.: P1132, P1449 

Morgado F.: P1207, P1384, P1430, 

P537, P574 

Morgado F.B.: 874 

Morgan D.: P1189 

Morgan J.: 917, P680 

Morgan J.M.: 95 

Mori E.: P1111 

Mori T.: P1111 

227 

Morichelli L.: 1359, P1515 

Morillo C.A.: P1163 

Morimoto S.M.: P518 

Morinigo J.: P1028, P512 

Morita N.: P949 

Morita T.: P617, P715 

Moro C.: P229, P656, P681, P695, 

P997 

Morosato M.: P592 

Morozov A.: P1002, P1167, P1386 

Morozov I.: P1529 

Morris D.J.: P219 

Mortensen P.T.: P1250, P596 

Moscatiello M.: P1057, P188 

Moschos G.: P1015, P944 

Moscoso Costa F.: P1418, P1430, 

P537 

Mostertz J.: P71 

Moubarak G.: P1061, P1199 

Mougenot N.: 755 

Mouton E.: 901 

Movassaghi B.: P1403 

Movsowitz C.M.: P1299 

Moya A.: P584 

Moya Mitjans A.: P1526 

Mrochak A.: P531 

Mrochek A.: 742, P1006, P666 

Mruk J.M.: P971 

Mueller D.: P1240 

Mueller J.: P50 

Mueller-Burri A.: P513 

Muessigbrodt A.: P1424, P662 

Mugelli A.: P64 

Mugnai G.: P592 

Muhlestein J.B.: 784 

Mukhtar M.: P1530 

Mulder A.A.W.: P983 

Mulder B.A.: 1322 

Mun H.S.: P1003, P1400, P930, P967 

Muneretto C.: P1177 

Muntean B.G.: P228, P966 

Murakami Y.: P1437 

Murakawa Y.: P949 

Muratore C.: P1185, P657 

Murzilli R.: P1065 

Muser D.: P1436 

Musialik-Lydka A.: P612, P705 

Mustafa D.: P519 

Mutlu B.: P1100, P1542 

Muto C.: P1489 

Mutoh M.: P1385 

Mutschelknauss M.: P991 

Mysuta M.: P242 

INDEX

INDEX 


n 

Naber C.K.: P1505 

Nabih M.: P279 

Nabutovsky Y.: P1131 

Nadeau R.: P704 

Naehle C.P.: P1217 

Nagahori W.: P1159 

Nagamoto Y.: P536 

Nagashima K.: P1147, P1409, P1442, 

P544 

Nageh-Armanios M.: P1373 

Nagy K.V.: P1074 

Nagy K.V.: P1499 

Nagy V.K.: 449 

Nagy-Balo E.: P1425, P213, P935, 

P999 

Naing N.N.: P1133 

Nair S.U.: P694 

Naito S.: P1294, P1427, P232, P949 

Naito T.: P617 

Nakagami R.: P1056, P691 

Nakagawa S.: P1479, P616 

Nakai T.: P1147, P1229, P1409, P1442, 

P544 

Nakajima I.: 1324, P1492 

Nakajima J.: P1229 

Nakajima T.: P975 

Nakamura H.: P1136, P649 

Nakamura K.: P1427 

Nakamura R.: P1011 

Nakamura T.: P1111 

Nakanishi H.: P1237, P1434 

Nakasuka K.: P1437 

Nakatani Y.: P1294, P1427, P232, 

P968 

Nalos L.: P63, P70 

Nalos L.: 364 

Nalos L.: P26 

Nam G.-B.: P1393 

Namdar M.: P1026, P1468, P295 

Napolitano C.: P62, P66 

Napp A.N.: P1480 

Naqvi T.: P1260 

Narayan S.: 302, 303, P633, P940, 

P957 

Narayan S.M.: P1171, P1383, P219, 

P979 

Nardi S.: P642 

Narducci M.: P1184 

Narsimhan C.: P552 

Nascimento J.: P1261, P637 

Nash P.J.: P1025, P248 

Nastasi M.: P1489 

Natale A.: P1032, P1113, P1399, 

P1407, P1431, P1508, P204, P221, 

P523, P549, P999 

Natale A.N.: 738 

Natarova S.: P1525 

Nava Townsend S.R.: P1106 

Nayar V.: P281, P685 

Nazeri A.: P941 

Neal Kay G.: P1023 

Nedios S.: 1321, P1428, P255, P524 

Negoescu R.M.: P1295 

Negreva M.N.: P199, P952 

Negro A.: P528 

Nemeth M.: P1209 

Nentwich K.: P543 

Neshati Z.: P46 

Neshati Z.N.: P48 

Neuberger H.R.: 757, P956 

Neugebauer A.: P623 

Neumann T.: P1426, P529, P945, 

P974, P981 

Neuzil P.: 899, P1420, P605 

Neuzil P.N.: 738 

Neves J.: P574 

Nevralova R.: P1115, P1396 

Newton J.: P1255, P539 

Neyrinck A.: P1293 

Ng G.A.: 913, P1095, P1467, P980 

Ng Kam Chuen M.J.: P1210 

Ng Kam Chuen M.J.: P511 

Ng S.L.: P1133 

Nguyen J.: 307, P1160, P1403, P214 

Nguyen L V.I.E.T.: P1191 

Nickel A.: P72 

Nicolson A.E.: P1467 

Nicolson W.B.: 913, P1095, P1467 

Niebauer M.: P1023 

Nielsen J.C.: 1365, P1198, P1250, 

P190, P247, P596, P675, P678 

Nienaber C.: P1432 

Nieuwenhuis S.: P68 

Nikcevic G.: P1072, P571 

Nikishin A.G.: P1517 

Nikkinen M.: P961, P992 

Nikolidakis S.: P1466 

Nikoloz B.: P259 

Nikonova J.: 756, P640 

Nikulina S.Y.U.: P922 

Ninios I.: P1287, P1494, P254, P660 

Nishida K.: P1294, P232 

Nishioka S.A.D.: P1200, P1231 

Nishiuchi S.: P1427 

Nishiyama N.: P1139, P969, P984 

228 

Nishiyama T.: P1139, P969 

Nishizaki M.: 743 

Niwa A.: P933 

Noblemaire R.: P1067, P283 

Nobuyoshi M.: P1075, P1259 

Nocerino P.: P1212 

Noda T.: 1324, P1441, P1492 

Noelker G.: P228, P966 

Noergaard B.L.: P1250, P596 

Nogami A.: P949 

Nogueira Da Silva M.: P677 

Nohr E.A.: P190 

Nolan P.: P1025, P248 

Nordekamp L.O.: P675 

Northwood G.: P1087 

Novak M.: P217 

Novikov D.: P1000, P689 

Nowacka E.: P1054 

Nowak B.: P1165, P1429, P946, P989 

Nowak S.: P1127, P525 

Ntai K.: P703 

Nuernberg N.: P1039 

Nuhrich J.: P530, P540 

Numaguchi K.: P1111 

Nunez J.: P230 

Nuotio I.: P961, P992 

Nurbaev T.A.: P1517 

Nuyens D.: P557, P566, P647 

o 

Obayashi T.: P1152, P933 

Ocak T.: P1262 

Occhetta E.: P1057, P1258 

Ochotny R.: P707 

Ogawa H.: P1018 

Ogura K.: P572 

Oh Y.S.: P976 

Oh Y.S.: P1168, P1516, P551 

Oh Y.-S.: P1393 

Ohe M.: P1122 

Ohgino Y.: P984 

Ohkubo K.: P1147, P1409 

Ohlin B.: P1121 

Ohlow M.A.: P1502 

Ohm O.-J.: 304, P1138, P1145 

Ohno M.: P1159 

Ohno S.: P77 

Ohuchi H.: P1547 

Oikonomou E.: P1466 

Okamoto Y.: P1048, P1218, P1228, 

P1247, P1472, P1478, P256 

Okamura H.: 1324, P1441, P1492 

Okisheva E.: P241

Okumura K.: P1097, P1534, P926, 

P949 

Okumura Y.: P1147, P1409, P1442, 

P544 

Olague Ros J.: P265, P270 

Olalla Antolin J.J.: P1083, P1196, 

P1518, P575 

Olalla J.J.: P1086, P1522 

Olavarri I.: P1083, P1086, P1196, 

P1518, P1522 

Olde Nordkamp L.R.A.: 899, P676 

Olesen M.: P55 

Oleszczak K.: P1050 

Oleynik G.: P1529 

Olimulder M.A.G.M.: P1459 

Oliveira E.: P1268, P1519 

Oliveira M.: P1519 

Oliveira M.M.: P56 

Oliveira M.M.: P1268 

Oliveira S.M.: P1537 

Olivier A.: P1012, P1201, P1301 

Olivotto I.: P64 

Olmedo J.: P1452 

Olmedo J.A.: P713, P1129 

Oloriz Sanjuan T.: P630 

Ometto R.: P1464 

Ommen S.R.: P1286 

Omura M.: P77 

On Y.K.: 1362, 912 

Onder E.L.I.F.: P289 

Onishi T.: P1237, P1434 

Oosterhoff P.: P76 

Oosthuizen S.: P1485 

Opolski G.: P1388, P1473, P682 

Orczykowski M.: P560 

Origasa H.: P926 

Oron Y.: P1211 

Orshanskaya V.: 916 

Orski Z.: P1523 

Orszulak W.: P1109, P708 

Ortak J.: P1230 

Ortega M.: P1157, P1188, P202, P559, 

P629, P631, P654 

Ortega Molina M.: P1174, P1008, 

P1446, P652 

Ortiz J.T.: 483, 799 

Ortiz M.: P1014, P1450, P576, P954 

Osadchii A.N.: P1462 

Osborn J.S.: 784 

Oseroff O.: P1022 

Oshima S.: P1427 

Osima S.: P968 

Osmancik P.: P1483 


Ospizio R.: P1489 

Osswald S.: P1234, P201, P972, P991 

Ostenfeld E.: 485 

Ostenfeldt E.: P701 

Ostojic M.C.: P1392, P209 

Osztheimer I.: 308, 753, P699 

Ota H.: P1099 

Ota M.: P975 

Otero-Ravina F.: P625 

Otsomaa L.: P49 

Oude Velthuis B.: P1149, P565 

Ouyang F.: 1323, 309, P1151, P1172, 

P215, P526 

Overvad K.: P636 

Owada S.: P1097, P1534 

Owens W.A.: P920 

Ozdemir H.M.: P1041 

Ozlu F.: P290 

Ozlu M.F.: P1262 

Ozturk S.: P1262, P290 

P 

Pabinger-Fasching I.: 1319 

Paccanaro M.: P1464 

Pache G.: P545 

Pachinger L.: P1039 

Pachon M.: P275 

Pachon M.A.: P655 

Packer D.L.: P1286 

Packer D.P.: 738 

Padeletti L.: 1360, P1051, P1053, 

P1238, P1239, P1454, P1508, P207, 

P268, P522, P590, P700 

Padjen V.: P1390 

Paglino G.: P1010, P1047, P1222, 

P1382, P577 

Pagnoni C.: P262 

Pagourelias E.: P624 

Pai U.: 871 

Paijitnev D.: P1426, P945 

Paiva L.V.: P1261, P637 

Pajitnev D.E.: P529, P974, P981 

Pak H.N.: P1003, P1400, P930, P967 

Pakarinen S.: P1226 

Palacios I.: P1249 

Palanca V.: P1465 

Palasz A.: P1092 

Palazzo A.: P242 

Palecek T.: P978 

Paley M.N.: P1278 

Palfy J.A.: P1021 

Palmieri R.: P1374 

Pamidimukala C.: 871, 872 

229 

Panagiotou C.: 917 

Panattoni G.: P1032, P1071 

Pandozi C.: P522 

Panfilov A.V.: P46 

Pant S.: P951 

Paoletti Perini A.: 1360, P590 

Pap R.: P1110, P1272, P1414 

Papavasileiou L.P.: P1032, P1071 

Papavassiliu T.: P75 

Papelbaum B.: P1507 

Paperini L.: 492, P1030, P261, P556 

Papp J.G.Y.: P49, P52 

Pappalardo A.: P1001, P212 

Pappone A.: 1316 

Pappone C.: 1316, 486, P1057, P188, 

P522 

Parada A.: P1537 

Parisi Q.: P582 

Park C.I.: 1320, 305, 306, P1397, 

P216, P218, P643, P937, P947, P982 

Park H.C.: P1125, P955, P987 

Park H.W.: 900 

Park H.Y.: P236 

Park J.S.: P1300, P710 

Park J.C.: 900, P236 

Park J.H.: P967 

Park J.Y.: P1286 

Park K.H.: 900, P236 

Park K.I.: P1300, P710 

Park P.K.S.: P615, P618 

Park S.W.: P1125, P661, P955, P987 

Park S.J.: 1362, 912, 96 

Park S.W.: P1192 

Park T.H.: P1300, P710 

Park Y.M.: P1125, P661, P955, P987 

Parkash R.: 493 

Parlitz U.: 329 

Parreira L.: P1430 

Parwani A.S.P.: P1408 

Pascale P.: P1119, P1143, P1171, P1421, 

P645, P979 

Pasenov G.: P1223, P1296, P1525 

Pasotti E.: P1213, P282, P653 

Pasquie J.L.: 901 

Pasquie J.-L.: P1090 

Pasquie J.L.P.: P622 

Passini E.: P59 

Pastromas S.: 1321, P1424, P524 

Patel H.: P1233 

Patel J.: P1470, P257, P583 

Patel N.: 1318, 491, P1233, P1372, 

P648 

Patel N.J.: P951 

INDEX

INDEX 


Pathmanathan R.K.: P1467 

Patrianakos A.P.: 490 

Patwala A.: P1035 

Pauza D.: P1273 

Pavaci H.: P1146 

Pavin D.: P1155, P1158, P1401, P965 

Pavlic G.: P206, P963 

Pavlovic S.: P571 

Pavon R.: P563 

Pavone F.S.: P67 

Paydak H.: 1318, P1372, P648, P951 

Paz E.: P693 

Pecora D.: P1076 

Pecoraro V.: P1399 

Pedersen S.B.: P1198 

Pedersen S.S.: P267 

Pedrosa A.A.A.: P1231 

Pego M.: P277, P278 

Pehrson S.: P1183, P1433 

Peichl P.: P1114, P1137, P1411, P548 

Peinado R.: P1016, P655 

Peixoto G.L.: P1200, P1231 

Pelargonio G.: P1184, P549 

Pelissero E.: P1164, P1381 

Pellegrini A.: P1290 

Pellet N.: P1204 

Pellise A.: P1077 

Pelliza M.: P1088, P553 

Pelliza M.P.: P1412 

Pelzmann B.: P27 

Pena Hernandez J.: P1130 

Pena- Hernandez J.L.: P258, P263 

Pena J.L.: P563 

Penela D.: 483, 741, 799, P1058, 

P1195 

Penev A.P.: P199, P952 

Pepin J.L.: P1221, P1471 

Peppa R.: 789 

Pereferrer D.: P567 

Perego G.B.: P1495 

Pereira S.: P1544 

Pereira V.H.: P1521 

Perez A.: P1185, P657 

Perez G.: P1022 

Perez Pereira E.: P1203, P187 

Perez Rodon J.: P1526 

Perez-Castellano N.: P558 

Perez-Rodon J.: P584 

Perez-Villacastin J.: P558 

Perna F.: P1184 

Perotta L.: P1179 

Perrotta L.: P1454, P1508, P590, 

P700 

Pervolaraki E.: P1278 

Pescher M.: P63 

Peters N.: P203 

Peterson B.J.: P1217 

Petix N.R.: P1269 

Petkar S.: P1087 

Petousis S.: P1043 

Petousis S.P.: P569, P938, P958 

Petr R.: P1483 

Petretta A.: P188 

Pfeiffer B.: P623 

Pham Q K.H.A.N.H.: P1191 

Pham T L.I.N.H.: P1191 

Pham T.T.: P921 

Phan P.: P1191 

Philippon F.: 493 

Phlips T.: P647 

Piacenti M.: P549, P700 

Picarra B.: P1107 

Pieragnoli P.: 1360, P1053, P1238, 

P1239, P1454, P1508, P590, P700 

Pierce M.: 871 

Piers S.R.: P1116, P1118, P668 

Piers S.R.D.: P1193, P1453, P546, 

P650, P651 

Pijnappels D.A.: P48 

Pijnappels D.A.: P46 

Pilat E.: P993 

Pindado C.: P229, P656, P681, P997 

Pindor J.: P1115, P1396, P1398, P217 

Pinho J.: 1361, P606 

Pinho T.: P1291, P1540 

Pintus F.: P1184 

Piorkowski C.: 758, P1175, P1274, 

P1438, P1503, P646, P664, P665, 

P973 

Piot C.P.: P622 

Piotrowski R.: P929 

Piraino G.: 1359 

Pires L.M.: P227 

Pires Borges A.: P988 

Pirk J.: P1501 

Pirnazarov M.M.: P1517 

Piroth Z.: P271 

Pisani C.: P995 

Pisano E.: P246 

Pisano’ E.: 1359 

Pisarev M.: P943 

Pisati M.S.P.: P195 

Piskorski J.: P1089, P1092, P578 

Pitschner H.F.: P981 

Pittelkow M.R.: P1389 

Placidi S.: P1374 

230 

Plashchinskaya L.: P666 

Platonov P.: 758, 916, P1531, P535 

Platonov P.G.: P1121 

Platonov P.G.: P245, P603 

Platou E.S.: P1486 

Plaza I.: P202, P559 

Ploski R.: P1281 

Ploux S.: P1066 

Pluta S.: P985 

Po S.S.: P1416 

Podzolkov V.: P943 

Poggesi C.: P64, P67 

Poghosyan H.R.: P1457 

Pokushalov E.: 310, 311, 786, P1511, 

P531 

Polasek R.: P1501 

Polewczyk A.: P1031, P1481, P688 

Polewczyk M.: P1475 

Politano A.: P1071 

Pollesello P.: P49 

Polovina M.: P1390, P1392, P209 

Polyanskaya E.: 756, P640 

Poon K.: P1373 

Popescu I.: P1166 

Popov S.: P1000, P594, P689 

Porta A.: P584 

Portugues J.: P1521 

Post M.C.: P1180 

Potpara T.: P1390, P1392, P209 

Potse M.: 484, P1065 

Poulet C.: P57 

Poulikakos D.: P1298 

Pouliot E.P.: P1477 

Poulos A.: P520 

Pozzi R.: P1549 

Prado B.: P1016 

Prasad R.: P1243, P685 

Prat S.: 312 

Pratap B.: 871, 872 

Pretorius G.: P583 

Pretorius V.: P1470, P257 

Previti A.: P1549 

Price R.: P685 

Prieto E.: P559 

Prinzen F.: 484 

Prinzen F.W.: P1497, P1500 

Prinzen F.W.: P1065, P1066, P1496, 

P1528, P69 

Priora R.: P1454 

Priori S.: P66 

Priori S.G.: P62 

Privalova E.V.: P1275, P919 

Probst J.: P1135

Proclemer A.: 446, P1024, P1436, 

P207, P268 

Prohaszka Z.: 308, 753 

Proietti R.: P1181, P1399 

Prosperi M.: P1374 

Prothero T.: P1255 

Providencia R.: P1261, P637 

Providencia R.A.: 1325, P1155, P1401 

Providencia R.P.: P1173 

Provvisiero C.: P698 

Pruiti G.P.: P620, P621 

Pruszkowska P.: P1055, P985 

Pruvot E.: P1171, P645, P947, P979 

Przybylski A.: P560 

Przymuszala D.: P1089, P1092, P578 

Pshepiy A.: P1096 

Pucci A.: P580 

Puchol A.: P275 

Puererfellner H.: P1124, P947 

Puetz V.: P1505 

Pugh P.J.: P1243, P685 

Pugh P.J.: P281 

Pulido M.: P558 

Purerfellner H.: P531 

Pytkowski M.: P231, P272 

Q 

Qiu X.L.: P1527 

Quaresma R.: P1384, P658 

Quartieri F.: P580 

Quartieri F.B.: P1477 

Quelhas I.: P1521 

Quesada Dorador A.: P1465 

Quinones M.A.: P1040, P601 

Quiroga Ponce H.J.: P1163 

Qureshi N.A.: P203 

r 

Raaijmakers A.J.A.: P68 

Rabah N.: P1044 

Rabajoli F.: P244 

Racila V.: P206, P963 

Rackauskas G.: P47 

Raczak G.: P1546 

Raczka F.: P1535 

Radinovic A.: P1010, P225 

Radosinska J.: 436 

Radovanovic N.: P571 

Raffa S.: P1251, P1252, P1410, P1419, 

P1502 

Rafiq I.: P685 

Rago A.: P1181 

Raijmakers J.: 898 


Raimondo C.: P528 

Rajappan K.: P1254, P1402, P539 

Rakauskas G.R.: P1480 

Rakovskaya I.: P1529 

Rama J.C.: P1028 

Ramirez U.: P1046 

Ramkisoensing A.A.: P46 

Ramos I.: P1540 

Ramos P.: P641, P939 

Ramos V.: P639 

Ramoul K.: P1143 

Ramza B.R.: P1477 

Rana O.R.: P47 

Rancoita P.: P630 

Rangel I.: 875 

Rankin D.: 307, P1160, P1403, P214 

Rao A.: P1210, P511, P692 

Rao F.: 435 

Rao J.: P1026 

Rappel W.-J.: P1383, P219 

Rasekh A.: P941 

Rashkovskiy S.: P1220 

Raspopovic S.: P1072, P184, P571 

Rassaf T.: P1124 

Rassias J.: P1415, P520 

Ratti G.: P698 

Rauhe W.: P1197 

Rausch P.: 309, P1151, P1172, P215, 

P526 

Ravens U.: P50, P57 

Raweh A.: P262 

Razali O.: P1476 

Razavi H.: P1503 

Razavi M.: P941 

Read M.I.: 803 

Rebeko E.: P666 

Rebellato L.: P1436 

Reddy V.: 303, 307, P1160, P1403, 

P214 

Reddy V.Y.: P970 

Reddy V.Y.R.: 738 

Redfearn D.: P638 

Redfearn D.P.: P251 

Reents T.: P1146, P1169, P533, P663 

Reeva S.: P1096 

Reeve H.: 899, P675 

Reggiani A.: P1051 

Regoli F.: 484, P1065, P1213, P282, 

P593, P644, P653 

Reichlin T.: P1116, P1118 

Ren L.: P1102 

Renesto F.: P696 

Rensing B.J.W.M.: P1180 

231 

Renzullo E.: P1132, P1449 

Reppas E.: P1015, P944 

Res J.C. J.: P990 

Restle C.: 857, P266 

Retkoceri R.: P1098 

Revishvili A.: P598 

Reyes-Caorsi W.: P1490 

Reynolds D.W.: 491 

Reyntens J.: P1103 

Rezai M.: P1067, P283 

Rezvantsev M.: P1223 

Rho T.H.: P976 

Rho T.H.: P1168, P1516, P551 

Rho T.-H.: P1393 

Riahi L.: 1325 

Riahi S.: 1365, P1013, P1274, P247, 

P636, P678 

Ribani M.A.: P198 

Ribeiro Da Mota G.: P294, P60, P702 

Ribeiro Mota G.: P293 

Ribeiro S.: P597 

Ricapito M.: P285 

Ricceri I.: P1239, P700 

Ricci R.: P207, P268 

Ricci R.P.: 1359, P1076, P1078, P1515 

Ricciardi D.: P1026, P1468 

Ricciardi G.: 1360, P1053, P1238, 

P1239, P1454, P1508, P590, P700 

Richards M.: 856, P1131, P1376, P185, 

P942 

Richter B.: P1170 

Richter S.: P1175, P1428, P255, P662 

Ridjab D.: 1358 

Rieger G.: P531 

Rienstra M.: 1322 

Riexinger T.: P1405 

Righi D.: P1374 

Rigopoulos A.G.: P623 

Rijnierse M.T.: P672 

Rijo N.: P953 

Rillig A.: 1323, 309, P1151, P1172, 

P215, P526 

Rillo M.: P1258, P1489 

Rinaldi A.: P1488 

Rinaldi C.A.: P1260 

Ristalli F.: P1053, P1238, P1239 

Ritter M.A.R.: P1142 

Ritter P.: P1061 

Riva S.: P1009 

Riva U.: P690 

Rivard L.: P1215 

Rivas Gandara N.: P1526 

Rivas N.: P584 

INDEX

INDEX 


Rivaud M.: 97 

Rivera S.: P226, P285 

Rivolta I.: P28 

Rix T.A.: P636 

Roberts P.: P680 

Roberts-Thomson K.C.: 754 

Robledo-Nolasco R.: P1014, P576 

Robles F.: P242 

Roca Lique I.: P1526 

Roca Luque I.: P584 

Rocha I.: P1268, P1519, P56 

Rocha M.S.: P1200, P1279 

Rocha S.: 1361, P606 

Rocha-Goncalves F.: 873, 875 

Rockweiler H.: P585 

Roden D.M.: P1423 

Rodrigues A.A.E.: P1285 

Rodrigues B.: P1521 

Rodriguez Entem F.: P1083, P1086, 

P1196, P1518, P1522, P575 

Rodriguez F E.: P1206 

Rodriguez Font E.: P671 

Rodriguez Losada N.: P1130 

Rodriguez M.: P954 

Rodriguez Manero M.: P1026, P1468, 

P295, P625 

Rodriguez-Capitan J.: P263 

Rodriguez-Diez G.: P1014, P576 

Rodriguez-Font E.: P693 

Rodriguez-Gonzalez A.: P1447 

Rodriguez-Olivares R.: P711 

Rodriguez-Padial L.: P275 

Roijer A.: 485, P701 

Rolando C.: P1549 

Rolando M.: P1482 

Rolf S.: 1321, P1175, P1428, P524, 

P646, P664, P665, P973 

Rollin A.: P1067, P1119, P1171, P1280, 

P1535, P283, P561, P645, P979 

Romano S.A.: P620, P621 

Romanov A.: 310, 311, 786, P1511 

Romeo F.: P1032, P1071 

Romeo P.: P1062 

Romero A.M.: P1021 

Romero R.: P567 

Romero-Ayala L.: P1267 

Romeyer C.: P1482 

Roncuzzi R.: P198 

Ronsoni R.: P227 

Ropars S.: P1395, P587 

Rosati F.: P1177 

Rosengarten J.A.: 917, 95 

Rosenheck S.: P1236, P555 

Rosenshtraukh L.: P928 

Roslan R.: P29 

Rossi A.: P700 

Rossi L.: P1076 

Rossi L.R.: P195 

Rossios K.: P624 

Rostock T.: P1448 

Roten L.: P1143, P1421 

Rotmans J.: P516 

Rotmans J.I.: P240 

Rottbauer W.: P1027 

Roubicek T.: P1501 

Roubille F.: P1394 

Roudijk R.: P550 

Routier R.: P1485 

Roux J.F.: P226, P285 

Roux Y.: P645 

Rovai N.: P1078, P1515 

Roy D.: P1215 

Rubanenko A.: P635 

Rubin J.M.: P1533, P223 

Rubino I.: P280 

Rubio Alonso B.: P250 

Rubio J.M.: P1021, P1040, P1042, 

P601 

Rudic B.: P75 

Ruiter J.: P1226 

Ruiter J.H.: P591 

Ruiz Del Fresno L.: P1377 

Ruiz Hernandez P.M.: P604, P918 

Ruiz Salas A.: P1130 

Ruiz-Granell R.: P230 

Ruskin J.: P1420 

Russo E.: P1009, P1184, P1431, P204, 

P221, P549 

Russo G.: P697 

Russo M.S.: P1374 

Russo V.: P1181 

Rusticali G.R.: P195 

Rusu A.: P1378, P73 

Rutledge C.: P66 

Ryabceva O.Y.: P613 

Ryu K.: 451, 486, P1260, P1503, P188 

S 

Saba M.: P1189, P519 

Saccab M.M.: P1231 

Sacchi S.: P700 

Sacconi L.: P67 

Sacher F.: P1119, P197 

Sadahiro T.: P984 

Sadamatsu K.: P536 

Sadigh B.: P1005 

232 

Sadoul N.: P1201 

Sadredini M.: P30 

Sadron M.: P1119, P1280, P1535, P561 

Saeed M.: P941 

Saeki T.: P1437 

Saghy L.: P1110, P1272, P1414 

Sagie A.S.: P619 

Sagnol P.: P1033 

Sagone A.: P1181, P1399 

Saguner A.M.: P513 

Saha S.: P585 

Sahin M.: P1037 

Saint-Jour M.: P1541 

Saito A.: P975 

Saiz J.: P1533 

Saj M.: P1281 

Sakaguchi H.: P1547 

Sakamoto N.: P1099 

Sakamoto T.: P1294, P232 

Sakhtivel S.: 83 

Sakuma I.: 798 

Sakurada H.: 743 

Sakurai R.: P927 

Sala L.: P31 

Sala S.: P1010, P1382, P577 

Salazar Ramirez M.C.: P1377 

Saleh A.M.: 798 

Saleh K.: P1422 

Salerno Uriarte J.: P1132 

Salerno-Uriarte J.A.: P1264, P1449, 

P1463 

Salgado Aranda R.: P250 

Salgado R.: P563 

Salghetti F.: P262 

Salguero Bodes R.: P250 

Saliba W.: P1420 

Salih H.: P1033, P1044 

Salmas J.: P1380 

Saloustros I.: P569, P958 

Saloustros I.S.: 802, P938 

Salzano G.: P1212 

Samani N.J.: 913, P1095 

Sambelashvili A.: 450, 487 

Sammartino V.: P1520 

Sammut E.: P1488 

Sammut I.A.: 803 

Samoilov A.: P1000, P689 

Sanchez Garcia M.: P1203, P187 

Sanchez J.E.: P1113 

Sanchez R.: P1046 

Sanchez-Borque P.: P1040, P601 

Sanchez-Gomez J.M.: P230 

Sanchez-Huete G.: P681

Sancho-Tello M.: P695 

Sanders P.: 754 

Sandilands A.J.: 913, P1095, P1467 

Sandorfi G.: P999 

Sanfins V.: P1521 

Sangiuolo R.: P1489 

Sankaranarayanan R.: P32 

Santamaria M.: P1032, P1078, P582 

Santangeli P.: P1113, P1399, P1407, 

P999 

Santasieri A.: P1243 

Santibanez-Koref M.: P920 

Santinelli V.: 486 

Santini L.: P1032, P1071 

Santini M.: 446, P1024, P207, P268 

Santos A.F.: 1361, P606 

Santos A.R.: P1107 

Santos G.: P1384, P658 

Santos K.: P1430 

Santos L.: P597 

Santos P.: P1418, P1430, P537 

Santos P.G.: 874, P1207 

Santos R.M.: 873 

Santos S.: P1519 

Santucci L.M.: P1374 

Sanzo A.: P1132, P1449 

Saoudi N.: P1085, P1112, P1166, P953 

Saporito D.: P580 

Sarabanda A.: P562 

Sarafoff N.: P669 

Sardi D.: 1317 

Sargento L.: P597 

Sarikouch S.: P1538 

Sarkozy A.: P1026, P1468, P295 

Sarrazin J.F.: 855 

Sartiani L.: P33 

Sartor L.: P1046 

Sasaki K.: P1097, P1534, P968 

Sasaki N.: P1147, P1409, P1442, P544 

Sasaki S.: P1534 

Sasaki T.: P1427 

Sasaki Y.: P541, P614 

Sasov M.: P1202, P564 

Sassone B.: 1360 

Sato H.: P1152, P933 

Sato N.: P1093, P1099, P1104 

Sato Y.: P554 

Satoh S.: P1111 

Satoh T.: P1385 

Satomi K.: 1324, P1441, P1492 

Savchenko A.: P666 

Savenkova G.: P594 

Saviano M.: 486, P188 


Savoure A.: 901, P1199 

Sawasaki K.: P1385 

Sayah S.: P1049 

Saygili E.: P47 

Scaglione M.: 1317, P1370, P224, P528 

Scanavacca M.: P995 

Scavee C.: P1371 

Scazzuso F.: P1520 

Schad C.: P210 

Schade A.: P543 

Schaeffer B.: P1194, P210 

Schaer B.: P1234, P972, P991 

Schaffer B.: P1448, P530, P540 

Schalij M.J.: P48 

Schalij M.J.: 447, P1064, P1116, P1118, 

P1453, P211, P240, P46, P516, P527, 

P546, P600, P650, P651, P668 

Schau T.H.: P684 

Schauerte P.: P47 

Schauerte P.S.: P1480 

Schell J.: P1216, P273 

Scherlag B.J.: P1416 

Scherr D.: P1143, P1421 

Schiebeling J.: 305, 306, P982 

Schiebeling-Roemer J.: P1397, P216, 

P218, P545, P643 

Schimitz De Freitas D.: P294, P60, P702 

Schimpf R.: P1532, P75 

Schinella M.: P962 

Schirripa V.: P1071 

Schlaepfer J.: P645 

Schliamser J.E.: P1019 

Schlindwein F.S.: 913, P1095, P980 

Schloss E.: 898 

Schmidt B.: P1165, P1179, P1429, 

P946, P989 

Schmidt E.B.: P636 

Schmidt J.T.H.: P990 

Schmidt M.: P1198 

Schmitt C.: P1405 

Schmitt M.: P260 

Schmitz D.: P1505 

Schneider C.: P1432 

Schneider R.: P1230, P1432 

Schnetzer N.: P1452 

Schoenbauer R.: P664, P665 

Schoenberg S.O.: P75 

Schoenburg M.: P529, P974 

Schoenmakers M.: P76 

Schoenrath F.: P1487 

Scholten M.F.: P1149, P1459, P565 

Schotten U.: 757, P72, P956 

Schotzko E.: P1216, P273 

233 

Schreiber D.: P1194, P1448, P210, 

P530, P540 

Schricker A.: P940, P957 

Schricker A.A.: P1383 

Schulte-Hahn B.: P1165, P1429, P946, 

P989 

Schultz C.: 754 

Schulze C.: P1241, P274 

Schur P.: 305 

Schurr P.: P218, P643 

Schuster P.M.: 304, P1138, P1145 

Schwagten B.: P1150, P538 

Schwartz J.: P1012, P1201, P1301 

Schwartz P.J.: P184 

Schweitzer J.: P1189 

Schwieler J.: P1005, P1162, P936 

Schwitter J.: P260 

Sciarra L.: P1094 

Sciegata A.: P657 

Scott P.A.: 917, 95 

Scrima G.: P244 

Scrocco C.: P1532 

Sebastian R.: P1533 

Secknus M.-A.: P1410 

Sedkowska A.: P985 

Sedlacek K.: P1509 

Seggewiss H.: P623 

Segreti L.: 492, P1030, P261, P556 

Seifer C.M.: P686 

Seifert I.: P1505 

Seifert M.: P684 

Sekimoto S.: P1437 

Sekine T.S.: P1144 

Selek S.: P289 

Sellal J.M.: P1012, P1201, P1301 

Selsky D.B.S.: P1299 

Selton O.: P1201 

Semmler V.: P1146, P1169, P533, 

P663, P669 

Senaratne M.: 855 

Senatore G.: P1164, P1381 

Sendegaya M.: P1210 

Senechal J.: P1471 

Senges J.: P1073 

Seniuk W.: P1524 

Seo J.M.: P1300, P710 

Seredenina E.M.: P613 

Sergi D.: P1032, P1071 

Sergio Castrejon-Castrejon S.C.C.: 

P1446 

Serpytis P.: P47 

Servatius H.: P1194, P1448, P210, 

P530, P540 

INDEX

INDEX 


Sestito A.: P697 

Severi S.: P280, P59 

Sevgili E.: P1289 

Shaaban S.: P1530 

Shachar J.: P631, P654 

Shah D.: 1320, 305, P218, P523, P581, 

P643, P947 

Shah N.: 1318, P1372, P648, P951 

Shah T.: P205 

Shahrzad S.: P1049 

Shakaryants G.A.: P1275, P919 

Shankar R.: P1241 

Sharadha K.: P552 

Sharon Z.: P1236, P555 

Sharrett R.: P205 

Shchukin Y.: P635 

Sheffield L.: P1178, P1439 

Shih A.: P683 

Shilova Y.: 756, P640 

Shim J.: P1003, P1400, P930, P967 

Shimizu W.: 1324, P1018, P1441, 

P1492 

Shin D.-I.: P1124, P1273 

Shin S.S.H.: P615, P618 

Shin W.S.: P976 

Shin W.S.: P1168, P1516, P551 

Shin W.-S.: P1393 

Shingo S.: P1097 

Shiomi T.: P536 

Shirahama N.: P536 

Shirokova N.: 311, P1511 

Shirota K.: P572 

Shivkumar K.: 302, 303, P633, P940 

Shizuta S.: P1075, P1259 

Shlyakhto E.: P1052 

Shoda M.: P949 

Shome S.: P274 

Shorofsky S.: P1189 

Shotan A.: P1211 

Sibilio G.: P1212 

Siboldi A.: P224 

Sibona Masi A.: P986 

Sideris S.: P1020, P1081, P1265, P1461 

Sidorenko I.: P291 

Sieira J.: P295 

Siekiera M.: P1124 

Sievers H.H.: 1357, P292, P607 

Sievers H.-H.: P964 

Sikkel MB.: P34 

Silberbauer J.: 739, P1222, P220 

Silberman A.: P1211 

Silina E.: P1108 

Siliste C.: P1034 

Silva Cortes R.: P293 

Silva Cunha P.: P677 

Silva D.: P1246, P597 

Silva Marques J.: P597 

Silva S.: P1268 

Silva-Cardoso J.: P1291 

Silva-Marques J.: P1246 

Silvestre J.: P1046, P1242 

Silvetti M.S.: P1374 

Sim D.S.: 900, P236 

Simandirakis E.: P1082 

Simantirakis E.: P1043 

Simantirakis E.N.: 490 

Simek J.: P217, P978 

Simeonidou E.: P703 

Simpson C.: 855, P638 

Simpson C.S.: P251 

Sims J.J.: P1244, P1379 

Singh S.: P602 

Siontis G.C.M.: P1417 

Siot P.: P1375 

Sipoetz J.: P1482 

Siqueira S.F.: P1200, P1231 

Sitges M.: 483, 489, P1058, P1141, 

P1195, P939 

Sitta N.: P1094 

Sivak S.: P666 

Skalsky I.: P1501 

Skarlos A.: 915, P249 

Skeberis V.: P624 

Skehan J.D.: P1467 

Skiadas I.: P1461 

Skibsbye L.: P35 

Skjoeth F.: 1365 

Sknouril L.: P1115, P1396, P1398 

Skogestad J.: P36 

Skopal J.: P222 

Skowerski M.: P1127 

Skowerski T.: P1127 

Skubisz-Gluchowska J.: P1388 

Skurzewski P.: P1493 

Sloman L.: P687 

Sloman L.S.: 451 

Smetak M.R.: P219 

Smid J.: P184 

Smith G.L.: P54 

Smith G.L.: P51 

Smith M.I.: 913, P1095, P1467 

Smolis-Bak E.: P272 

Snell J.: P1376, P185 

Snell J.D.: 451, 856, P942 

Soares A.: P1430, P537 

Soares C.: P1418, P574 

234 

Soares F.: P277, P278 

Sobral S.: P1246 

Sobre M.: P1206, P671, P693 

Soerensen H.T.: P1198 

Soernmo L.: P1380 

Sohal M.: P1488 

Sokal A.: P1055 

Sokolov S.: P928 

Soldati E.: 492, P1030, P261, P556 

Solheim E.: 304, P1138, P1145 

Soliman E.Z.: P205 

Solimene F.: 1316, P1051, P1489 

Solloso A.: P575 

Solymossy K.: P699 

Solzbach U.: P515 

Som Z.: P271 

Somers V.K.: P1286 

Sommer A.: P1250, P596 

Sommer J.: P1216, P273 

Sommer P.: 1321, P1175, P1274, 

P1428, P1438, P524, P535, P646, 

P662, P973 

Sommer T.: P260 

Sonmez O.: P1289 

Sonoda K.: P1147, P1442, P544 

Sopov O.: P598 

Sora N.: P1047, P1382, P577 

Soranno M.: P1208 

Sosa E.: P995 

Sosnowski M.: P1127, P1253 

Sotomi Y.: P1237 

Souckova L.: P217 

Sousa A.: P1291 

Sousa C.: P1537 

Sousa J.: P1246, P597 

Sousa L.: P677 

Sousa P.: P1266, P1544 

Souvaliotis N.: P1466 

Soylu K.: P1037 

Spadacini G.: P1132, P1449 

Spaziano M.: P610 

Spc R.N.S.C.A.: P1107 

Spears D.: P62 

Sperzel J.: 859, P981 

Spinar J.: P1115, P1396, P1398 

Spinelli V.: P37 

Spinnler M.T.: P244 

Spitzer S.G.: P642 

Spotti A.: P1051 

Sramko M.: P1411 

Sredniawa B.: P1055, P612, P705, 

P985 

Sridevi C.: P552

Stabile G.: 1316, P522 

Stack A.: P1080 

Stafford P.J.: 913, P1095, P1467 

Stams T.R.G.: 800, P76 

Starchik D.: P1525 

Starck C.T.: P1487 

Starling R.: 450 

Stary-Weinzinger A.: P63 

Stavrakis S.: 491, P1416 

Stavropoulos G.: P1047, P1222 

Stavropoulos S.: P1382 

Stebakova V.O.: P1275 

Stec S.: P929 

Steeds R.P.: P189 

Steen T.: P1486 

Stefanadis C.: P1020, P1081, P1265, 

P1461, P673, P674 

Steffel J.: P1487 

Stegemann B.: P189 

Stein K.: 789 

Steinberg J.: 303, 860 

Steinberg J.S.: 310, 311, 786, P1511 

Steinwender C.: P1422 

Stengl M.: P38 

Sterlinski M.: P272 

Sterns L.: 898 

Stettler C.: P581 

Stevanello C.: P592 

Steven D.: P1194, P1448, P210, P530, 

P540 

Stevenhagen Y.J.: P1149, P565 

Stevenson W.G.: P1116, P1118 

Sticchi E.: P1053, P1238, P1239 

Sticherling C.: P1234, P201, P972, P991 

Stierle U.: 1357, P292, P607, P964 

Stiller S.: P1027 

Stockburger M.: P1375, P1482 

Stockinger J.: 857, P266 

Stockman D.: P1150, P538 

Stoffregen W.C.: 307, P1160, P1403, 

P214 

Straburzynska-Migaj E.: P707 

Strasberg B.: P239 

Strasberg B.S.: P619 

Strauss M.: 915, P1456, P249, P288 

Stridh M.: P1380 

Strik M.: P1066, P1496, P1528, P69 

Stroobandt R.: P1293 

Stros P.: P1483 

Strunk A.: P1413 

Stuebner D.: P535 

Stuglin C.: 855 

Sturdivant J.L.: P1059, P269 


Sturmer M.: P610, P704 

Suchanek O.: P1255 

Suga C.: P1229, P1235 

Sugawara Y.: P1229, P1235 

Sugihara C.: P1233 

Sugiyama E.: P1099 

Suleiman M.: 902, P1019, P237, P670 

Suleimann H.: P660 

Sulimov V.: P241 

Sulke N.: P1233 

Sultan A.: P1194, P1448, P210, P530, 

P540 

Suman Horduna I.: 740, P1187, P996 

Sun L.Z.: 304, P1138, P1145 

Sung J.Y.: P661 

Sunthorn H.: 1320, P581 

Suran B.M.C.: P1034 

Sussenbach C.: P988 

Suzuki A.: P1152, P933 

Suzuki M.: P1011, P1159 

Suzuki S.: P1437 

Svetlosak M.: P1202, P564 

Svirida O.N.: P613 

Swaans M.J.: P1180 

Swarup V.: P633 

Sweene C.A.: P1292 

Swissa M.: P234, P235 

Syeda F.: 83 

Szabados S.: P1209 

Szalay Z.: P529, P974 

Szenday I.: P515 

Szepesi J.: P39 

Szeplaki G.: 308, 449, 753, P1074, 

P1499, P222, P699 

Szilagyi J.: P1110, P1414 

Szilagyi S.Z.: 308, 449, 753, P699 

Szili-Torok T.: P1091, P1126, P1443, 

P1445, P222 

Szoelloesi G.A.: P543 

Szoke S.: P271 

Szucs G.: 449 

Szulik M.: P1055 

Szumowski L.: P560 

Szuts V.: 98 

Szwed H.: P231, P272 

Szydlo K.: P1109, P708 

Szymkiewicz S.: P1514 

Szymkiewicz S.J.: 903 

Szyszko A.: P1185, P657 

T 

Tabrizi F.: P936 

Tafur A.J.T.: P971 

235 

Tagliabue L.: P1399 

Tahin T.: 308, 753, P699 

Taieb J.: P1033, P1044 

Taillandier S.: P1369 

Takahashi T.: P1479 

Takamura M.: P1245, P634 

Takanari H.: P63, P65, P70 

Takatsu Y.: P554 

Takatsuki S.: P1139, P969, P984 

Takenaka K.: P1111 

Takeuchi T.: P1099 

Takii E.: P1122 

Talajic M.: P1215 

Talib A.: P1093, P1099, P1104 

Tamai N.: P1437 

Tamburino C.: P620, P621 

Tamisier R.: P1221 

Tammaro P.: P698 

Tamura M.: P975 

Tamura S.: P975 

Tamura U.: P984 

Tan H.H.: P1513 

Tan M.: P932 

Tan V.H.: P1248 

Tanabe Y.: 743, P1099 

Tanaka A.: P995 

Tanaka K.: P1229, P1237, P1434 

Tanaka N.: P1237, P1434 

Tang A.: 448 

Tani T.: P614 

Taniguchi H.: P1136, P649 

Taniguchi R.: P554 

Tanimoto K.: P1139, P969, P984 

Tanimoto Y.: P1139, P969 

Tanner F.C.: P513 

Tanno K.: P1282 

Tanos D.: P624 

Tao Q.: P546, P650, P651 

Tapanainen J.: P1005, P1162, P936 

Tarchalski J.: P1089, P1092 

Tarzimanova A.: P943 

Tasal A.: P1289 

Tatarskiy R.B.: P1276 

Tavano E.: P620, P621 

Tavares C.: P1268, P1519 

Tavernier R.: P1148, P1153, P1293 

Taylor R.: 488 

Taylor R.J.: P189 

Te Vootris R.: P54 

Tedrow U.B.: P1118 

Teixeira R.: P277, P278 

Teixeira R.A.: P1200, P1231 

Teixeira T.: P658 

INDEX

INDEX 


Tejima T.: 743 

Tekelioglu U.Y.: P1262 

Tekkesin I.: P238 

Temiz A.: P1539 

Tempio D.: P620, P621 

Temple I P.: 437 

Tercedor L.: P1182, P1186, P1288, 

P1548, P599, P655 

Tereshina O.: P635 

Terrier De La Chaise A.: P1201 

Tesi C.: P67 

Tesic M.: P1072 

Tessitore E.: 1320 

Thakur R.: P1131 

Thakur R.K.: 856, P1376, P185, P942 

Themistoclakis S.: 1316 

Theodorakis G.: P1415, P520 

Theuns D.: 899, P1126, P1443, P675 

Theuns D.A.: P591 

Theuns D.A.M.J.: P247, P678 

Thibault B.: 855, P1215 

Thijssen J.: 447, P1064, P668 

Thillaye-Du-Boullay N.: P1084 

Thomann S.: P1090, P622 

Thomas B.: P1407 

Thomson E.: P1067, P283 

Thudt K.: P1219 

Tidwell R.: P63 

Tieland R.: P65 

Tieland R.G.: P70, P74 

Tijssen J.G.P.: 1322 

Tilz R.: P1151, P1172, P526 

Tilz R.R.: 1323, 309, P215 

Timmermans W.: P959 

Timmers L.: P1293 

Tintera J.: P1411 

Tischer T.S.: P1230 

Toivonen L.: P1105 

Tolardo C.: P244 

Tolosana J.M.: 483, 489, 741, 785, 

P1036, P1058, P1195 

Tolosana J.T.: 799 

Tolosana Viu J.M.: P265, P270 

Toma M.: P554 

Toman O.: P1115, P1396, P1398 

Tomasi C.: P280, P580 

Tomasi L.: P592 

Tomaszewski A.: P1031, P1050, 

P1481, P579, P688 

Tomei R.: P592 

Tomita H.: P926 

Tondo C.: 1316, P1009, P1184, P1431, 

P204, P221, P549 

Tonet J.: P1267 

Toniolo M.: P1188, P1436 

Tonnis T.: P514 

Topal S.: P1041 

Topaz G.: P1211 

Topaz M.: P1211 

Toquero J.: P567 

Toquero Ramos J.: P1203, P187 

Tortajada G.: P655 

Toso E.: 1317 

Toth A.: P260 

Townend J.N.: P189 

Townsend P.A.: 95 

Toyoshima Y.: P1237, P1434 

Trafford A.W.: P53 

Trainini J.: P1063 

Tran N.: 1320 

Trapani G.: P1164, P1381 

Trapani M.: P253 

Treguer F.T.: P532 

Trentaz F.: P581 

Trevisi N.: 739, P1010, P225, P547 

Tribulova N.: 436 

Trigo C.: P677 

Trines S.A.: P211, P527 

Tritto M.: 1316, P1132, P1449 

Trivedi C.: P999 

Trivi M.: P196, P626 

Trucco M.E.: 489 

Trukshina M.: P1506, P588 

Trusz-Gluza M.: P1109, P708 

Tsakiridis K.: P1015, P944 

Tsaregorodtsev D.: P241 

Tschishow W.N.: 1358 

Tse H.F.: P1217 

Tsiachris D.: 739, P1010, P1020, 

P1047, P1081, P1222, P1265, P1382, 

P1461, P220, P577, P673, P674 

Tsuchiya T.: P536 

Tsuda E.: P1547 

Tsukada N.: P1427, P968 

Tsutsui H.: P667 

Tsutsumi T.: P1484 

Tuan H.T.M.: 329 

Tuccillo B.: P1489 

Tuinenburg A.E.: P1256 

Tulumen E.: P1532, P75 

Tuncer E.: P1297 

Tundo F.: P1009 

Tung S.: 493 

Tuohy S.: P248 

Turakhia M.: P687 

Turakhia M.P.: 451 

236 

Turco D.: P280 

Turfan M.: P1289 

Turgeman Y.: P264 

Turk U.O.: P1297 

Turkkan C.: P238 

Turner J.: P1373 

Tursunova F.: P1002, P1167, P1176, 

P1386 

Tutuianu C.: P1110, P1414 

Tzeis S.: P515 

U 

Uchida T.: P1484 

Uchiyama T.: P1136, P649 

Udre A.: P1108 

Ueberham L.: P535 

Uhm J.S.: P1400, P930, P967 

Uhm J.-S.: P1003 

Ui S.: P1479 

Ujeyl A.: P514 

Ukena C.: 757 

Umans V.A.: P591 

Umar F.: 488, P189 

Umezawa S.: P933 

Ungar A.: P531 

Unlu M.: P1041 

Upright J.: P1087 

Urban L.: P1202 

Urban V.: P1165, P1429, P989 

Urbanczyk D.: P1109, P708 

Urbanek B.: P1054, P1263 

Urbanek P.: P560 

Urbinati S.: P198 

Uribarri A.: P1088 

Uribe W.: P1117, P534 

Urlow M.A.: P1504 

Ushinohama H.: P77 

Usmani R.: 872 

Ustrell X.: P1077 

Uyan U.: P208 

Uysal A.: P1539 

V 

Vaananen H.: P1105 

Vaccari D.: 1359, P1515 

Vaccaro P.: P1076 

Vachulova A.: P1202, P564 

Vaczi K.: P40 

Vaglio A.: P1076 

Vaida P.: P1290 

Vaikhanskaya T.: P291 

Vakharia A.: 488 

Vaknin-Assa H.V.A.: P619

Valente B.: P1030 

Valenti R.: P1227, P253 

Valleggi A.: P1508 

Vallejos X.: P242 

Valles Gras E.: P1004, P233 

Valsecchi S.: P1062 

Van Beeumen K.: P1153 

Van Bergen En Henegouwen P.M.P.: P70 

Van Boven N.: P591 

Van Den Berg M.P.: 1322 

Van Den Bos E.J.: P990 

Van Den Branden F.: P1150, P538 

Van Der Geest R.J.: P546, P650, P651 

Van Der Heijden A.C.: P240, P516, 

P668 

Van Der Heyden M.: P63, P65 

Van Der Heyden M.A.G.: P70, P74 

Van Der Nagel R.: 800, P68, P76 

Van Der Palen J.: P1149 

Van Der Ploeg T.: P591 

Van Der Velde E.T.: 447, P1064 

Van Derh Heijden A.C.: 447, P1064 

Van Dessel P.F.: P1149 

Van Dessel P.F.H.M.: P1459 

Van Deursen C.J.M.: P1496 

Van Dijk V.F.: P542 

Van Doorn T.: P68 

Van Erven L.: 447, P1064, P240, 

P516, P668 

Van Gelder I.C.: 1322 

Van Heuverswyn F.: P1293 

Van Huls Van Taxis C.: P1195 

Van Huls Van Taxis C.F.B.: P546, 

P651 

Van Hunnik A.: P1066, P1496 

Van Langenhove G.: P1150 

Van Malderen S.: P1445 

Van Malderen S.C.H.: P1091 

Van Middendorp L.B.: P1066, P1496, 

P1528, P69 

Van Opstal J.: P565 

Van Opstal J.M.: P1149, P76 

Van Rees J.B.: 447, P1064 

Van Rennes B.: P565 

Van Rijen H.V.M.: P68 

Van Rossum A.C.: P1257, P1512, P672 

Van ‘T Sant J.: P267 

Van Veldhuisen D.J.: 1322 

Van Woerkens L.J.P.M.: P990 

Van Zaen J.: P1171 

Vandael E.: P1103 

Vandekerckhove Y.: P1148, P1153, 

P1293 


Vandekerkhove Y.: P1371 

Vandeneynde C.: P1204 

Vanderheyden M.: P959 

Vanerio G.: P1134, P960 

Varalda G.P.: P1549 

Varas G.: P1267 

Vardas P.: P1043 

Vardas P.E.: 490 

Vardas P.V.: 802, P569, P938, P958 

Varela G.: P1490 

Varela M.C.: P693 

Varga A.: P1272 

Varkevisser R.: P63, P65, P74 

Varma N.: P1205, P517 

Varro A.: P49, P52 

Vasankari T.: P961 

Vasconcelos M.: P1291 

Vasina L.: P1096 

Vasquez L.: P1076 

Vassanelli C.: P592 

Vassanelli F.: P262 

Vassilikos V.: P624 

Vassilikos V.P.: P1082 

Vatankulu M.A.: P1289 

Vecchiati A.: P513 

Vedrenne G.: P1061 

Vega M.: P558 

Vegh E.: P222 

Velasco Pucci J.O.A.O.P.: P1507 

Velasquez J.: P1117, P534 

Veltmann C.: P1532, P75 

Velu S.: P1087 

Vender S.: P1463 

Ventura M.: P278 

Verbal F.: P1063 

Vergara P.: 739, P1047, P1222, P225, 

P547, P630 

Vergaro G.: 1360 

Verkerk A.: P41 

Verlato R.: P1258 

Verma A.: P1476, P642 

Vernardos M.V.: P569, P938, P958 

Versteeg H.: P267 

Verstreken S.: P959 

Vesin J.M.: P1171, P1283, P979 

Vesin J.-M.: P1378, P73 

Vester E.G.: P1493 

Viani S.: 492, P1030, P261, P556 

Vicedomini G.: 486, P188 

Viczenczova C.: 436 

Vidal Amaral J.L.: P960 

Vidal B.: 312, P1141 

Vidal J.M.: P625 

237 

Vidal Perez R.: P625 

Videbaek R.: P247, P678 

Viecca M.: P1181, P1399 

Vieira C.: P639 

Viergever E.P.: P1226 

Vijgen J.: P1371 

Viles-Gonzalez J.: 1318, P1372, P648, 

P951 

Villacastin J.: P563 

Villani G.Q.: P1258, P195 

Villano A.: P697 

Villari B.: 1359 

Villuendas R.: P1471 

Vinereanu D.: P1034 

Vinet A.: P610, P704 

Vinolas P X.: P1206 

Vinolas Prat X.: P671 

Vinolas X.: P563, P567, P693 

Virag L.: P49, P52 

Virag N.: P1378, P73 

Virdee M.: P186 

Vischer A.: P991 

Viso A.: P1171, P1283 

Vitale R.: P188 

Vivada L.: P1370 

Vlami K.: P703 

Vlasseros I.: P1081, P1265 

Vloka M.: P1241, P274 

Vloumidi E.: 83 

Vock P.: P1219 

Voelker U.: P71 

Voigt N.: P42 

Volker R.: P1039 

Volkov D.Y.: P1220 

Volpicelli M.: P698 

Von Bardeleben S.: P1404 

Vos L.M.: P586 

Vos M.: P63, P65 

Vos M.A.: 800, P68, P70, P74, P76 

Voss W.: P1230 

Vouliotis A.: P1081, P1265, P1461, 

P674 

Vouliotis A.-I.: P1020 

Vourc’h P.: P1369 

Vrazic H.: P669 

Vyskubova E.: P689 

W 

W Isa W.Y.H.: P1133 

Wagner E.: 329 

Waintraub X.: P1469 

Walcher D.: P1027 

Walczak F.: P560 

INDEX

INDEX 


Walczak S.: P1420 

Walter M.W.: P632 

Walther T.: P529, P974 

Wan C.: 903, P1514 

Wang B.: P1105 

Wang L.: P1491 

Wang N.: 434 

Wang S.: P994 

Wang T.: P1451 

Wang W.Y.T.: P252 

Wang X.H.: P58, P948 

Wang X.-L.: 96 

Wang X.: P1128 

Wang Y.: P43 

Wang Y.T.: P1123 

Wanguemert F.: P604, P918 

Ward D.: P519 

Warnaars J.L.F.: P676 

Warrier N.: P1541 

Wasniewski M.: P1524 

Wassberg E.: P1135 

Watanabe H.: P1056, P691 

Watanabe I.: P1147, P1409, P1442, 

P544 

Watanabe M.: P667 

Watanabe N.: P1282 

Watanabe T.: P1056, P691 

Watson T.J.: P685 

Wauters K.: P1026 

Weber R.: 305, 306, P1397, P216, 

P218, P545, P643, P982 

Wei W.: P1444, P934 

Weiss A.: P1236 

Weiss J.P.: 784 

Weiss T.W.: P1039 

Wendig I.: P1230 

West T.: P531 

Westphal V.: 329 

Wettwer E.: P50 

Wey Moreira W.: P294 

Wheelan K.: 303 

Wi J.: P1003, P1400, P930, P967 

Wichterle D.: P1114, P1115, P1137, 

P1396, P1398, P1411, P1501, P1509, 

P217, P548, P712, P978 

Wickliffe A.: P1068, P1498, P595, 

P696 

Wielandts J.-Y.: P557, P647 

Wielusinski M.: P521 

Wierwille J.: P1189 

Wijchers S.: P1150 

Wijchers S.A.: P538 

Wijffels M.C.E.: P983 

Wijffels M.C.E.F.: P542 

Wijnmaalen A.P.: P1116, P1118 

Wilczek E.: P682 

Wilczek J.: P1253, P993 

Wilde A.A.M.: 899, P1459, P676 

Wilders R.: P44 

Wilinski J.: P589 

Willems R.: P1103, P296, P566 

Willems S.: P1194, P1448, P210, P530, 

P540 

Williams C.: P1407 

Williams R.: 855 

Willoughby S.R.: 754 

Wirth K.: 757, P72, P956 

Wissner E.: 1323, 309, P1151, P1172, 

P215, P523, P526 

Wittkampf F.H.: P1256 

Wnuk-Wojnar A.: P1127 

Wnuk-Wojnar A.M.: P525 

Wohlmuth P.: 1323, 309 

Wojakowski W.: P525 

Wojta J.: 1319, P1039 

Wold N.: P1036 

Wolk A.: 787 

Wolke C.: P71, P78 

Wollmann C.G.: P1219 

Wolpert C.: P1532 

Wolswinkel R.: P45 

Wong C.: P1402 

Wong K.: P1254, P1402, P539 

Wong T.: P1187, P205, P977 

Wong W.: P1023 

Woo W.S.I.: P615, P618 

Workman A.J.: P51 

Worley S.: P1063 

Worthley M.I.: 754 

Wozniak A.: P612, P705, P985 

Wozniak-Skowerska I.: P1127 

Wranicz J.K.: P1054, P1263 

Wright D.J.: P1210 

Wright D.J.: P511, P692 

Wright M.J.: 307, P1160, P1403, P214 

Wu H.P.: P1224 

Wu J.: P1373 

Wu L.: P1257, P1512, P672 

Wu S.L.: P1444 

Wu S.H.U.-L.I.: P659 

Wu S.L.: 435, P1455, P1513, P611, 

P934 

Wu W.Y.: P971 

Wu Y.: P931 

Wutzler A.W.: P1408 

Wykretowicz A.: P1089 

238 

Wysokinski W.: P971 

X 

Xhaet O.: P947 

Xiao J.: P1128 

Xie A.: P66 

Xu G.: P931 

Xue Y.M.: 435, P1455, P611, P659, 

P934, P1444 

y 

Yager-Yarom G.: P235 

Yagishita A.: P1152, P933 

Yahata M.: P1259 

Yakubbekov N.T.: P1517 

Yalin K.: P1284, P1458, P284 

Yamada A.: P1484 

Yamada O.: P1547 

Yamada T.: P1229, P617, P715 

Yamada Y.: 1324, P1441, P1492 

Yamagishi M.: P1245, P634 

Yamaguchi T.: P536 

Yamaguchi Y.: P1294, P232 

Yamamoto K.: P572 

Yamamoto M.Y.: P1144 

Yamanaka T.: 798 

Yamane T.: P949 

Yamasaki Y.: P1479 

Yamashita T.: P926 

Yamauchi Y.: P1152, P933 

Yamazaki M.: 798 

Yan P.: P67 

Yang P.: P1216, P273 

Yang Q.I.N.G.: P1007 

Yang W.: P194 

Yang W.S.: P58 

Yang Y.D.H.: P615, P618 

Yang Y.-Q.Y.S.: P632 

Yao L.: P64 

Yao N.: P1093, P1104 

Yashin S.: P1002, P1167, P1176, P1296, 

P1386 

Yasuda K.: P1547 

Yasuda S.: P1018, P1441 

Yasuhara Y.: P1479 

Yazaki S.: P1547 

Yazdani M.: P1277 

Yazici M.: P1262 

Yazici M.: P290 

Yee R.: P1476 

Yilmaz R.: P1458 

Ylitalo A.: P961, P992 

Yokoshiki H.: P667

Yoon N.S.: 900, P236 

Yoshida K.: P536 

Yoshida T.: P1437 

Yoshitani K.: P554 

Yotov Y.T.: P1391 

Young G.D.: 754 

Ypey D.L.: P46 

Yu C.-M.: 860 

Yu S.: P1128 

Yu Y.: P1059, P269 

Yuan L.E.I.: P55 

Yuan M.: P948 

Yuan R.: P931 

Yuan S.: P1491 

Yuksel S.: P1037 

Yulzari A.: P523 

Yuricheva Y.U.: P928 

Yuriev S.: P689 

Yusof Z.: P1133 

Z 

Zabek A.: P1225, P1475, P191, P192, 

P579 

Zabel M.: P184 

Zabunova M.: P1108 

Zagari D.: P1222 

Zagozdzon P.: P1546 

Zahn R.: 915, P1456, P249, P288 

Zahradnik I.: P61 

Zahradnikova A.: P61 

Zahradnikova A.: 472 

Zaidel E.: P1022 

Zajac D.: P231 

Zakke I.: P1108 

Zaltsberg S.: 859, P1426, P945 

Zaltsberg S.W.: P529, P974, P981 

Zamorano J.: P229, P656, P681, P695, 

P997 

Zanaboni P.: P1495 

Zanocco A.: P1070, P924 

Zanon F.: P1051 

Zanoni F.: P1068, P1498 

Zanotto G.: P1024, P1078, P1515 

Zaputovic L.: P921 

Zarabroski R.: P239 

Zarif H.: P288 

Zarqane N.: P1085 

Zarse M.: P1287, P1494, P254, P660 

Zarzoso V.: P1166 

Zavatta M.: P570 

Zeb M.: P680 

Zedlitz K.: P1407 

Zeka N.: P1098 


Zeljko H.M.: P1406 

Zellerhoff S.Z.: P1142 

Zeman M.: 436 

Zemgulis V.: P1135 

Zemtsovsky E.: P1096 

Zeppenfeld K.: P1116, P1118, P1193, 

P1195, P1453, P211, P527, P546, P600, 

P650, P651, P668 

Zerah T.: P1469 

Zerbo F.: P1070, P924 

Zeymer U.: 915, P288 

Zhan X.I.A.N.-Z.: P659 

Zhan X.Z.: P1444, P1455, P611, P934 

Zhang H.X.: P1224 

Zhang L.M.: P1060 

Zhang Q.H.: P1513 

Zhang Q.H.: 435, P1455 

Zhang S.: P1102 

Zhang Y.: P683 

Zhao Q.: P1128 

Zhekina N.V.: P243 

Zhelyakov E.: P1154 

Zhu T.G.: P1527 

Zhubrina E.S.: P613 

Ziacchi M.: P1208 

Ziayee F.: P1493 

Zidova K.: P1286 

Ziegler P.D.: 1357, P292, P607 

Zielonka J.: P521 

Zima E.: 449, P1074, P1499, P222, 

P699 

Zimmermann M.: P581 

Zingarini G.: 1359 

Zink M.Z.: P1480 

Zinzius P.Y.: P1012, P1301 

Zipoli A.: P1269 

Zivkovic M.: P571 

Zizek D.: P1101 

Zocalo Y.: P1490 

Zoga A.: 801 

Zoppo F.: P1070, P924 

Zoppo F.C.: P522 

Zorzi A.: P522 

Zou J.G.: P1224 

Zrenner B.: P669 

Zubarev E.: P1052, P588 

Zuba-Surma E.: P525 

Zucchelli G.: 492, P1030, P261, P556 

Zucchetti M.: P1009, P1431, P204, 

P221, P549 

Zuffada F.: P1264 

Zuo F.: P214 

Zupan I.: P1101 

239 

Zupan K.: P271 

Zweibel S.: 898 

INDEX

INDEX 

LIST oF InDUSTry PArTnerS 

The European Heart Rhythm Association wishes to express its sincere appreciation to all exhibitors, industry 

partners and sponsors mentioned below, who have contributed to the success of EHRA EUROPACE 2013 

in a variety of ways and initiatives. 

Abbott Vascular 

Access Point Technologies 

Arrhythmia Alliance 

Asia Pacific Heart Rhythm Society 

Bard Electrophysiology 

Bayer HealthCare 

Baylis Medical 

Biosense Webster 

BIOTRONIK 

Boehringer Ingelheim 

Boston Scientific 

Bristol-Myers Squibb/Pfizer 

Cardiac Rhythm News 

Cardiostim 2014 

Cardiotek 

Cook Medical 

CVRx 

Daiichi Sankyo Europe 

EBR Systems 

Endosense 

Ercules 

European Heart for Children 

Finapres Medical Systems 

GE Healthcare 

Hansen Medical 

240 

Heart Rhythm Society 

Heart Test Laboratories, Inc 

Impulse Dynamics Germany GmbH 

Imricor 

Japanese Heart Rhythm Society. 

Lemer Pax 

Medico Spa 

Medtronic 

Oxford University Press 

Philips Healthcare 

RESMED Europe 

SHANGHAI MICROPORT EP MEDTECH CO., LTD 

Siemens AG Healthcare Sector 

SOBRAC 

Sorin Group CRM 

Spectranetics 

St. Jude Medical 

Stereotaxis Inc 

Topera Medical 

TYRX Inc 

Venice Arrhytmia 

Wisepress Medical Bookshop 

Zoll CMS GmbH 

ZTS HAGMED

SAVE THE DATE! 

CARDIOSTIM 

EHRA EUROPACE 

World congress on cardiac electrophysiology 

June 18 -21 

Nice France 

Invasive & Non-Invasive Electrophysiology - Catheter Ablation - Pacing & Defi brillation - Heart 

Failure - Cardiac Imaging - Angiogenesis & Genetics - Emerging Cardiovascular Technologies 

Information: 

Dr Philippe Ritter • CARDIOSTIM 

E-mail: cardiostim@wanadoo.fr 

4 

www.cardiostim.com 

Created by Jacques Mugica 

Painting by Françoise Persillon

EHRA EUROPACE 2013 - European Society of Cardiology

Create successful ePaper yourself

Delete template?

Save as template?